AGE|AGE_SPECIFIC_CI_LOWER|AGE_SPECIFIC_CI_UPPER|AGE_SPECIFIC_RATE|COUNT|ICCC_GROUP|POPULATION|YEAR
1-4|190.8|205.0|197.8|2994|All ICCC Groups Combined|15136428|1999
1-4|75.0|84.0|79.4|1202|I Leukemias, myeloproliferative & myelodysplastic diseases|15136428|1999
1-4|62.6|70.9|66.7|1009|I(a) Lymphoid leukemias|15136428|1999
1-4|9.0|12.3|10.6|160|I(b) Acute myeloid leukemias|15136428|1999
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15136428|1999
1-4|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15136428|1999
1-4|1.1|2.5|1.7|26|I(e) Unspecified and other specified leukemias|15136428|1999
1-4|7.6|10.7|9.1|137|II Lymphomas and reticuloendothelial neoplasms|15136428|1999
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15136428|1999
1-4|3.8|6.1|4.9|74|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15136428|1999
1-4|1.1|2.4|1.7|25|II(c) Burkitt lymphoma|15136428|1999
1-4|0.8|2.0|1.3|20|II(d) Miscellaneous lymphoreticular neoplasms|15136428|1999
1-4|~|~|~|~|II(e) Unspecified lymphomas|15136428|1999
1-4|35.5|41.8|38.5|583|III CNS and misc intracranial and intraspinal neoplasms|15136428|1999
1-4|3.5|5.8|4.6|69|III(a) Ependymomas and choroid plexus tumor|15136428|1999
1-4|14.0|18.1|16.0|242|III(b) Astrocytomas|15136428|1999
1-4|8.6|11.9|10.2|154|III(c) Intracranial and intraspinal embryonal tumors|15136428|1999
1-4|5.1|7.7|6.3|95|III(d) Other gliomas|15136428|1999
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15136428|1999
1-4|0.7|1.9|1.2|18|III(f) Unspecified intracranial and intraspinal neoplasms|15136428|1999
1-4|19.6|24.4|21.9|331|IV Neuroblastoma and other peripheral nervous cell tumors|15136428|1999
1-4|19.6|24.4|21.9|331|IV(a) Neuroblastoma and ganglioneuroblastoma|15136428|1999
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15136428|1999
1-4|8.4|11.6|9.9|150|IX Soft tissue and other extraosseous sarcomas|15136428|1999
1-4|5.6|8.3|6.8|103|IX(a) Rhabdomyosarcomas|15136428|1999
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15136428|1999
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15136428|1999
1-4|1.3|2.8|1.9|29|IX(d) Other specified soft tissue sarcomas|15136428|1999
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15136428|1999
1-4|~|~|~|~|Not classified by ICCC|15136428|1999
1-4|7.5|10.6|9.0|136|V Retinoblastoma|15136428|1999
1-4|16.3|20.7|18.4|278|VI Renal tumors|15136428|1999
1-4|16.1|20.5|18.2|276|VI(a) Nephroblastoma and other nonepithelial renal tumors|15136428|1999
1-4|~|~|~|~|VI(b) Renal carcinomas|15136428|1999
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15136428|1999
1-4|3.3|5.4|4.2|64|VII Hepatic tumors|15136428|1999
1-4|3.0|5.0|3.9|59|VII(a) Hepatoblastoma|15136428|1999
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15136428|1999
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15136428|1999
1-4|1.0|2.3|1.5|23|VIII Malignant bone tumors|15136428|1999
1-4|~|~|~|~|VIII(a) Osteosarcomas|15136428|1999
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15136428|1999
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15136428|1999
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15136428|1999
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15136428|1999
1-4|2.7|4.7|3.6|54|X Germ cell, trophoblastic tumors & neoplasms of gonads|15136428|1999
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15136428|1999
1-4|1.0|2.4|1.6|24|X(b) Malignant extracranial & extragonadal germ cell tumors|15136428|1999
1-4|1.0|2.3|1.5|23|X(c) Malignant gonadal germ cell tumors|15136428|1999
1-4|~|~|~|~|X(d) Gonadal carcinomas|15136428|1999
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15136428|1999
1-4|0.7|1.9|1.2|18|XI Other malignant epithelial neoplasms and malignant melanomas|15136428|1999
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15136428|1999
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15136428|1999
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15136428|1999
1-4|~|~|~|~|XI(d) Malignant melanomas|15136428|1999
1-4|~|~|~|~|XI(e) Skin carcinomas|15136428|1999
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15136428|1999
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15136428|1999
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15136428|1999
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15136428|1999
10-14|119.5|129.3|124.4|2479|All ICCC Groups Combined|19935660|1999
10-14|26.2|30.9|28.5|568|I Leukemias, myeloproliferative & myelodysplastic diseases|19935660|1999
10-14|18.0|22.0|19.9|397|I(a) Lymphoid leukemias|19935660|1999
10-14|5.4|7.6|6.4|128|I(b) Acute myeloid leukemias|19935660|1999
10-14|0.5|1.4|0.9|18|I(c) Chronic myeloproliferative diseases|19935660|1999
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19935660|1999
10-14|0.7|1.7|1.2|23|I(e) Unspecified and other specified leukemias|19935660|1999
10-14|21.6|26.0|23.7|473|II Lymphomas and reticuloendothelial neoplasms|19935660|1999
10-14|10.1|13.2|11.6|231|II(a) Hodgkin lymphomas|19935660|1999
10-14|7.0|9.5|8.2|163|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19935660|1999
10-14|2.2|3.8|2.9|58|II(c) Burkitt lymphoma|19935660|1999
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19935660|1999
10-14|~|~|~|~|II(e) Unspecified lymphomas|19935660|1999
10-14|23.9|28.4|26.1|520|III CNS and misc intracranial and intraspinal neoplasms|19935660|1999
10-14|1.6|3.0|2.3|45|III(a) Ependymomas and choroid plexus tumor|19935660|1999
10-14|12.4|15.8|14.0|280|III(b) Astrocytomas|19935660|1999
10-14|4.6|6.8|5.6|112|III(c) Intracranial and intraspinal embryonal tumors|19935660|1999
10-14|2.6|4.3|3.4|68|III(d) Other gliomas|19935660|1999
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19935660|1999
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19935660|1999
10-14|0.7|1.7|1.2|23|IV Neuroblastoma and other peripheral nervous cell tumors|19935660|1999
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|19935660|1999
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19935660|1999
10-14|7.9|10.7|9.2|184|IX Soft tissue and other extraosseous sarcomas|19935660|1999
10-14|2.5|4.2|3.3|65|IX(a) Rhabdomyosarcomas|19935660|1999
10-14|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19935660|1999
10-14|~|~|~|~|IX(c) Kaposi sarcoma|19935660|1999
10-14|3.2|5.0|4.0|80|IX(d) Other specified soft tissue sarcomas|19935660|1999
10-14|0.8|1.8|1.2|24|IX(e) Unspecified soft tissue sarcomas|19935660|1999
10-14|~|~|~|~|Not classified by ICCC|19935660|1999
10-14|~|~|~|~|V Retinoblastoma|19935660|1999
10-14|0.8|1.8|1.2|24|VI Renal tumors|19935660|1999
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19935660|1999
10-14|~|~|~|~|VI(b) Renal carcinomas|19935660|1999
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|19935660|1999
10-14|~|~|~|~|VII Hepatic tumors|19935660|1999
10-14|~|~|~|~|VII(a) Hepatoblastoma|19935660|1999
10-14|~|~|~|~|VII(b) Hepatic carcinomas|19935660|1999
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19935660|1999
10-14|12.4|15.7|14.0|279|VIII Malignant bone tumors|19935660|1999
10-14|7.6|10.3|8.9|177|VIII(a) Osteosarcomas|19935660|1999
10-14|~|~|~|~|VIII(b) Chondrosarcomas|19935660|1999
10-14|3.5|5.3|4.3|86|VIII(c) Ewing tumor and related sarcomas of bone|19935660|1999
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|19935660|1999
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19935660|1999
10-14|5.6|7.9|6.7|133|X Germ cell, trophoblastic tumors & neoplasms of gonads|19935660|1999
10-14|1.8|3.2|2.5|49|X(a) Intracranial & intraspinal germ cell tumors|19935660|1999
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19935660|1999
10-14|2.5|4.2|3.3|65|X(c) Malignant gonadal germ cell tumors|19935660|1999
10-14|~|~|~|~|X(d) Gonadal carcinomas|19935660|1999
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19935660|1999
10-14|11.0|14.1|12.5|249|XI Other malignant epithelial neoplasms and malignant melanomas|19935660|1999
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|19935660|1999
10-14|3.0|4.7|3.8|75|XI(b) Thyroid carcinomas|19935660|1999
10-14|0.7|1.6|1.1|21|XI(c) Nasopharyngeal carcinomas|19935660|1999
10-14|2.9|4.7|3.7|74|XI(d) Malignant melanomas|19935660|1999
10-14|~|~|~|~|XI(e) Skin carcinomas|19935660|1999
10-14|2.6|4.3|3.4|68|XI(f) Other and unspecified carcinomas|19935660|1999
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|19935660|1999
10-14|~|~|~|~|XII(a) Other specified malignant tumors|19935660|1999
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|19935660|1999
15-19|190.7|203.1|196.8|3894|All ICCC Groups Combined|19785979|1999
15-19|24.4|29.0|26.6|526|I Leukemias, myeloproliferative & myelodysplastic diseases|19785979|1999
15-19|12.3|15.6|13.8|274|I(a) Lymphoid leukemias|19785979|1999
15-19|8.0|10.7|9.3|184|I(b) Acute myeloid leukemias|19785979|1999
15-19|1.6|3.0|2.2|44|I(c) Chronic myeloproliferative diseases|19785979|1999
15-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19785979|1999
15-19|0.7|1.7|1.2|23|I(e) Unspecified and other specified leukemias|19785979|1999
15-19|43.8|49.9|46.8|926|II Lymphomas and reticuloendothelial neoplasms|19785979|1999
15-19|28.4|33.4|30.8|610|II(a) Hodgkin lymphomas|19785979|1999
15-19|11.2|14.4|12.7|251|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19785979|1999
15-19|1.4|2.8|2.0|40|II(c) Burkitt lymphoma|19785979|1999
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19785979|1999
15-19|0.7|1.7|1.2|23|II(e) Unspecified lymphomas|19785979|1999
15-19|17.8|21.8|19.7|390|III CNS and misc intracranial and intraspinal neoplasms|19785979|1999
15-19|1.0|2.2|1.5|30|III(a) Ependymomas and choroid plexus tumor|19785979|1999
15-19|9.8|12.8|11.2|222|III(b) Astrocytomas|19785979|1999
15-19|2.3|3.8|3.0|59|III(c) Intracranial and intraspinal embryonal tumors|19785979|1999
15-19|2.4|4.1|3.2|63|III(d) Other gliomas|19785979|1999
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19785979|1999
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19785979|1999
15-19|0.7|1.7|1.1|22|IV Neuroblastoma and other peripheral nervous cell tumors|19785979|1999
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|19785979|1999
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19785979|1999
15-19|13.5|17.0|15.2|300|IX Soft tissue and other extraosseous sarcomas|19785979|1999
15-19|2.6|4.2|3.3|66|IX(a) Rhabdomyosarcomas|19785979|1999
15-19|1.1|2.3|1.7|33|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19785979|1999
15-19|~|~|~|~|IX(c) Kaposi sarcoma|19785979|1999
15-19|6.6|9.2|7.8|155|IX(d) Other specified soft tissue sarcomas|19785979|1999
15-19|1.6|3.0|2.2|44|IX(e) Unspecified soft tissue sarcomas|19785979|1999
15-19|~|~|~|~|Not classified by ICCC|19785979|1999
15-19|~|~|~|~|V Retinoblastoma|19785979|1999
15-19|0.9|2.0|1.4|27|VI Renal tumors|19785979|1999
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19785979|1999
15-19|0.5|1.4|0.9|17|VI(b) Renal carcinomas|19785979|1999
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|19785979|1999
15-19|1.1|2.3|1.6|32|VII Hepatic tumors|19785979|1999
15-19|~|~|~|~|VII(a) Hepatoblastoma|19785979|1999
15-19|1.0|2.2|1.5|30|VII(b) Hepatic carcinomas|19785979|1999
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19785979|1999
15-19|12.2|15.5|13.8|273|VIII Malignant bone tumors|19785979|1999
15-19|6.6|9.1|7.8|154|VIII(a) Osteosarcomas|19785979|1999
15-19|0.5|1.4|0.9|18|VIII(b) Chondrosarcomas|19785979|1999
15-19|3.0|4.8|3.8|76|VIII(c) Ewing tumor and related sarcomas of bone|19785979|1999
15-19|0.7|1.6|1.1|21|VIII(d) Other specified malignant bone tumors|19785979|1999
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19785979|1999
15-19|23.0|27.5|25.2|498|X Germ cell, trophoblastic tumors & neoplasms of gonads|19785979|1999
15-19|1.2|2.4|1.7|34|X(a) Intracranial & intraspinal germ cell tumors|19785979|1999
15-19|0.9|2.0|1.4|28|X(b) Malignant extracranial & extragonadal germ cell tumors|19785979|1999
15-19|18.1|22.1|20.1|397|X(c) Malignant gonadal germ cell tumors|19785979|1999
15-19|0.9|2.0|1.4|27|X(d) Gonadal carcinomas|19785979|1999
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19785979|1999
15-19|40.6|46.4|43.4|859|XI Other malignant epithelial neoplasms and malignant melanomas|19785979|1999
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|19785979|1999
15-19|15.9|19.7|17.7|351|XI(b) Thyroid carcinomas|19785979|1999
15-19|0.6|1.5|1.0|19|XI(c) Nasopharyngeal carcinomas|19785979|1999
15-19|12.0|15.3|13.5|268|XI(d) Malignant melanomas|19785979|1999
15-19|~|~|~|~|XI(e) Skin carcinomas|19785979|1999
15-19|9.4|12.3|10.8|213|XI(f) Other and unspecified carcinomas|19785979|1999
15-19|1.2|2.4|1.7|34|XII Other and unspecified malignant neoplasms|19785979|1999
15-19|~|~|~|~|XII(a) Other specified malignant tumors|19785979|1999
15-19|0.9|2.0|1.4|28|XII(b) Other unspecified malignant tumors|19785979|1999
5-9|105.6|114.8|110.2|2240|All ICCC Groups Combined|20334315|1999
5-9|33.4|38.7|36.0|732|I Leukemias, myeloproliferative & myelodysplastic diseases|20334315|1999
5-9|27.5|32.3|29.9|607|I(a) Lymphoid leukemias|20334315|1999
5-9|3.8|5.8|4.7|96|I(b) Acute myeloid leukemias|20334315|1999
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|20334315|1999
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20334315|1999
5-9|0.4|1.3|0.8|16|I(e) Unspecified and other specified leukemias|20334315|1999
5-9|11.6|14.9|13.2|268|II Lymphomas and reticuloendothelial neoplasms|20334315|1999
5-9|3.1|4.9|3.9|80|II(a) Hodgkin lymphomas|20334315|1999
5-9|4.4|6.4|5.3|108|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20334315|1999
5-9|2.5|4.1|3.2|65|II(c) Burkitt lymphoma|20334315|1999
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20334315|1999
5-9|~|~|~|~|II(e) Unspecified lymphomas|20334315|1999
5-9|30.1|35.1|32.6|662|III CNS and misc intracranial and intraspinal neoplasms|20334315|1999
5-9|1.7|3.0|2.3|46|III(a) Ependymomas and choroid plexus tumor|20334315|1999
5-9|12.7|16.1|14.3|291|III(b) Astrocytomas|20334315|1999
5-9|7.1|9.6|8.3|168|III(c) Intracranial and intraspinal embryonal tumors|20334315|1999
5-9|5.7|8.0|6.7|137|III(d) Other gliomas|20334315|1999
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20334315|1999
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20334315|1999
5-9|2.2|3.7|2.9|58|IV Neuroblastoma and other peripheral nervous cell tumors|20334315|1999
5-9|2.1|3.6|2.8|56|IV(a) Neuroblastoma and ganglioneuroblastoma|20334315|1999
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20334315|1999
5-9|7.1|9.6|8.3|168|IX Soft tissue and other extraosseous sarcomas|20334315|1999
5-9|3.8|5.7|4.7|95|IX(a) Rhabdomyosarcomas|20334315|1999
5-9|0.6|1.5|0.9|19|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20334315|1999
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20334315|1999
5-9|1.4|2.7|2.0|40|IX(d) Other specified soft tissue sarcomas|20334315|1999
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|20334315|1999
5-9|~|~|~|~|Not classified by ICCC|20334315|1999
5-9|~|~|~|~|V Retinoblastoma|20334315|1999
5-9|4.3|6.3|5.2|106|VI Renal tumors|20334315|1999
5-9|4.0|6.0|4.9|100|VI(a) Nephroblastoma and other nonepithelial renal tumors|20334315|1999
5-9|~|~|~|~|VI(b) Renal carcinomas|20334315|1999
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20334315|1999
5-9|~|~|~|~|VII Hepatic tumors|20334315|1999
5-9|~|~|~|~|VII(a) Hepatoblastoma|20334315|1999
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20334315|1999
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20334315|1999
5-9|4.7|6.8|5.7|116|VIII Malignant bone tumors|20334315|1999
5-9|2.4|4.0|3.1|64|VIII(a) Osteosarcomas|20334315|1999
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20334315|1999
5-9|1.4|2.6|1.9|39|VIII(c) Ewing tumor and related sarcomas of bone|20334315|1999
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20334315|1999
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20334315|1999
5-9|1.2|2.5|1.8|36|X Germ cell, trophoblastic tumors & neoplasms of gonads|20334315|1999
5-9|0.5|1.3|0.8|17|X(a) Intracranial & intraspinal germ cell tumors|20334315|1999
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20334315|1999
5-9|0.5|1.4|0.9|18|X(c) Malignant gonadal germ cell tumors|20334315|1999
5-9|~|~|~|~|X(d) Gonadal carcinomas|20334315|1999
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20334315|1999
5-9|2.4|4.0|3.1|64|XI Other malignant epithelial neoplasms and malignant melanomas|20334315|1999
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20334315|1999
5-9|1.1|2.2|1.6|32|XI(b) Thyroid carcinomas|20334315|1999
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20334315|1999
5-9|~|~|~|~|XI(d) Malignant melanomas|20334315|1999
5-9|~|~|~|~|XI(e) Skin carcinomas|20334315|1999
5-9|~|~|~|~|XI(f) Other and unspecified carcinomas|20334315|1999
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20334315|1999
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20334315|1999
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20334315|1999
<1|219.2|250.5|234.5|878|All ICCC Groups Combined|3744604|1999
<1|37.3|51.0|43.8|164|I Leukemias, myeloproliferative & myelodysplastic diseases|3744604|1999
<1|17.2|26.9|21.6|81|I(a) Lymphoid leukemias|3744604|1999
<1|11.8|20.0|15.5|58|I(b) Acute myeloid leukemias|3744604|1999
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3744604|1999
<1|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3744604|1999
<1|2.6|7.3|4.5|17|I(e) Unspecified and other specified leukemias|3744604|1999
<1|5.4|11.4|8.0|30|II Lymphomas and reticuloendothelial neoplasms|3744604|1999
<1|~|~|~|~|II(a) Hodgkin lymphomas|3744604|1999
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3744604|1999
<1|~|~|~|~|II(c) Burkitt lymphoma|3744604|1999
<1|3.1|7.9|5.1|19|II(d) Miscellaneous lymphoreticular neoplasms|3744604|1999
<1|~|~|~|~|II(e) Unspecified lymphomas|3744604|1999
<1|25.8|37.4|31.2|117|III CNS and misc intracranial and intraspinal neoplasms|3744604|1999
<1|2.6|7.3|4.5|17|III(a) Ependymomas and choroid plexus tumor|3744604|1999
<1|9.2|16.7|12.6|47|III(b) Astrocytomas|3744604|1999
<1|5.4|11.4|8.0|30|III(c) Intracranial and intraspinal embryonal tumors|3744604|1999
<1|~|~|~|~|III(d) Other gliomas|3744604|1999
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3744604|1999
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3744604|1999
<1|50.0|65.6|57.4|215|IV Neuroblastoma and other peripheral nervous cell tumors|3744604|1999
<1|50.0|65.6|57.4|215|IV(a) Neuroblastoma and ganglioneuroblastoma|3744604|1999
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3744604|1999
<1|11.5|19.7|15.2|57|IX Soft tissue and other extraosseous sarcomas|3744604|1999
<1|5.0|10.8|7.5|28|IX(a) Rhabdomyosarcomas|3744604|1999
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3744604|1999
<1|~|~|~|~|IX(c) Kaposi sarcoma|3744604|1999
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3744604|1999
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3744604|1999
<1|~|~|~|~|Not classified by ICCC|3744604|1999
<1|22.0|32.8|27.0|101|V Retinoblastoma|3744604|1999
<1|13.6|22.4|17.6|66|VI Renal tumors|3744604|1999
<1|12.2|20.6|16.0|60|VI(a) Nephroblastoma and other nonepithelial renal tumors|3744604|1999
<1|~|~|~|~|VI(b) Renal carcinomas|3744604|1999
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3744604|1999
<1|6.3|12.7|9.1|34|VII Hepatic tumors|3744604|1999
<1|6.3|12.7|9.1|34|VII(a) Hepatoblastoma|3744604|1999
<1|~|~|~|~|VII(b) Hepatic carcinomas|3744604|1999
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3744604|1999
<1|~|~|~|~|VIII Malignant bone tumors|3744604|1999
<1|~|~|~|~|VIII(a) Osteosarcomas|3744604|1999
<1|~|~|~|~|VIII(b) Chondrosarcomas|3744604|1999
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3744604|1999
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3744604|1999
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3744604|1999
<1|14.3|23.3|18.4|69|X Germ cell, trophoblastic tumors & neoplasms of gonads|3744604|1999
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3744604|1999
<1|8.5|15.8|11.8|44|X(b) Malignant extracranial & extragonadal germ cell tumors|3744604|1999
<1|3.1|7.9|5.1|19|X(c) Malignant gonadal germ cell tumors|3744604|1999
<1|~|~|~|~|X(d) Gonadal carcinomas|3744604|1999
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3744604|1999
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3744604|1999
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3744604|1999
<1|~|~|~|~|XI(b) Thyroid carcinomas|3744604|1999
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3744604|1999
<1|~|~|~|~|XI(d) Malignant melanomas|3744604|1999
<1|~|~|~|~|XI(e) Skin carcinomas|3744604|1999
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3744604|1999
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3744604|1999
<1|~|~|~|~|XII(a) Other specified malignant tumors|3744604|1999
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3744604|1999
1-4|199.0|213.6|206.2|3118|All ICCC Groups Combined|15119430|2000
1-4|79.7|89.0|84.3|1274|I Leukemias, myeloproliferative & myelodysplastic diseases|15119430|2000
1-4|68.5|77.2|72.8|1100|I(a) Lymphoid leukemias|15119430|2000
1-4|7.5|10.6|8.9|135|I(b) Acute myeloid leukemias|15119430|2000
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15119430|2000
1-4|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15119430|2000
1-4|1.3|2.8|1.9|29|I(e) Unspecified and other specified leukemias|15119430|2000
1-4|8.0|11.2|9.5|144|II Lymphomas and reticuloendothelial neoplasms|15119430|2000
1-4|0.6|1.7|1.1|16|II(a) Hodgkin lymphomas|15119430|2000
1-4|2.9|5.0|3.8|58|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15119430|2000
1-4|1.3|2.8|2.0|30|II(c) Burkitt lymphoma|15119430|2000
1-4|1.5|3.1|2.2|33|II(d) Miscellaneous lymphoreticular neoplasms|15119430|2000
1-4|~|~|~|~|II(e) Unspecified lymphomas|15119430|2000
1-4|36.8|43.3|39.9|604|III CNS and misc intracranial and intraspinal neoplasms|15119430|2000
1-4|3.8|6.1|4.9|74|III(a) Ependymomas and choroid plexus tumor|15119430|2000
1-4|17.2|21.7|19.3|292|III(b) Astrocytomas|15119430|2000
1-4|7.9|11.1|9.4|142|III(c) Intracranial and intraspinal embryonal tumors|15119430|2000
1-4|3.8|6.1|4.8|73|III(d) Other gliomas|15119430|2000
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15119430|2000
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15119430|2000
1-4|17.3|21.9|19.5|295|IV Neuroblastoma and other peripheral nervous cell tumors|15119430|2000
1-4|17.3|21.9|19.5|295|IV(a) Neuroblastoma and ganglioneuroblastoma|15119430|2000
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15119430|2000
1-4|9.4|12.8|11.0|166|IX Soft tissue and other extraosseous sarcomas|15119430|2000
1-4|7.1|10.1|8.5|128|IX(a) Rhabdomyosarcomas|15119430|2000
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15119430|2000
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15119430|2000
1-4|1.0|2.3|1.5|23|IX(d) Other specified soft tissue sarcomas|15119430|2000
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15119430|2000
1-4|~|~|~|~|Not classified by ICCC|15119430|2000
1-4|7.9|11.1|9.4|142|V Retinoblastoma|15119430|2000
1-4|19.0|23.7|21.2|321|VI Renal tumors|15119430|2000
1-4|18.8|23.5|21.0|318|VI(a) Nephroblastoma and other nonepithelial renal tumors|15119430|2000
1-4|~|~|~|~|VI(b) Renal carcinomas|15119430|2000
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15119430|2000
1-4|3.4|5.6|4.4|67|VII Hepatic tumors|15119430|2000
1-4|3.4|5.6|4.4|67|VII(a) Hepatoblastoma|15119430|2000
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15119430|2000
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15119430|2000
1-4|0.7|1.9|1.2|18|VIII Malignant bone tumors|15119430|2000
1-4|~|~|~|~|VIII(a) Osteosarcomas|15119430|2000
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15119430|2000
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15119430|2000
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15119430|2000
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15119430|2000
1-4|1.9|3.6|2.6|40|X Germ cell, trophoblastic tumors & neoplasms of gonads|15119430|2000
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15119430|2000
1-4|0.7|1.8|1.1|17|X(b) Malignant extracranial & extragonadal germ cell tumors|15119430|2000
1-4|0.7|1.8|1.1|17|X(c) Malignant gonadal germ cell tumors|15119430|2000
1-4|~|~|~|~|X(d) Gonadal carcinomas|15119430|2000
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15119430|2000
1-4|1.2|2.7|1.9|28|XI Other malignant epithelial neoplasms and malignant melanomas|15119430|2000
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15119430|2000
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15119430|2000
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15119430|2000
1-4|~|~|~|~|XI(d) Malignant melanomas|15119430|2000
1-4|~|~|~|~|XI(e) Skin carcinomas|15119430|2000
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15119430|2000
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15119430|2000
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15119430|2000
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15119430|2000
10-14|120.1|129.8|124.9|2542|All ICCC Groups Combined|20358437|2000
10-14|22.9|27.3|25.1|510|I Leukemias, myeloproliferative & myelodysplastic diseases|20358437|2000
10-14|16.1|19.8|17.9|364|I(a) Lymphoid leukemias|20358437|2000
10-14|4.3|6.4|5.3|107|I(b) Acute myeloid leukemias|20358437|2000
10-14|0.7|1.6|1.1|22|I(c) Chronic myeloproliferative diseases|20358437|2000
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20358437|2000
10-14|0.4|1.3|0.8|16|I(e) Unspecified and other specified leukemias|20358437|2000
10-14|22.7|27.1|24.8|505|II Lymphomas and reticuloendothelial neoplasms|20358437|2000
10-14|11.3|14.4|12.8|260|II(a) Hodgkin lymphomas|20358437|2000
10-14|7.0|9.5|8.2|167|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20358437|2000
10-14|2.2|3.7|2.8|58|II(c) Burkitt lymphoma|20358437|2000
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20358437|2000
10-14|~|~|~|~|II(e) Unspecified lymphomas|20358437|2000
10-14|25.4|30.0|27.7|563|III CNS and misc intracranial and intraspinal neoplasms|20358437|2000
10-14|1.0|2.0|1.4|29|III(a) Ependymomas and choroid plexus tumor|20358437|2000
10-14|14.8|18.4|16.6|337|III(b) Astrocytomas|20358437|2000
10-14|3.9|5.9|4.8|98|III(c) Intracranial and intraspinal embryonal tumors|20358437|2000
10-14|3.1|4.8|3.9|79|III(d) Other gliomas|20358437|2000
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20358437|2000
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20358437|2000
10-14|0.8|1.9|1.3|26|IV Neuroblastoma and other peripheral nervous cell tumors|20358437|2000
10-14|0.6|1.6|1.0|21|IV(a) Neuroblastoma and ganglioneuroblastoma|20358437|2000
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20358437|2000
10-14|9.9|12.9|11.3|231|IX Soft tissue and other extraosseous sarcomas|20358437|2000
10-14|3.0|4.7|3.8|77|IX(a) Rhabdomyosarcomas|20358437|2000
10-14|0.6|1.6|1.0|21|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20358437|2000
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20358437|2000
10-14|4.0|5.9|4.9|99|IX(d) Other specified soft tissue sarcomas|20358437|2000
10-14|1.2|2.3|1.7|34|IX(e) Unspecified soft tissue sarcomas|20358437|2000
10-14|~|~|~|~|Not classified by ICCC|20358437|2000
10-14|~|~|~|~|V Retinoblastoma|20358437|2000
10-14|0.7|1.6|1.1|22|VI Renal tumors|20358437|2000
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20358437|2000
10-14|~|~|~|~|VI(b) Renal carcinomas|20358437|2000
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20358437|2000
10-14|0.5|1.3|0.8|17|VII Hepatic tumors|20358437|2000
10-14|~|~|~|~|VII(a) Hepatoblastoma|20358437|2000
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20358437|2000
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20358437|2000
10-14|11.6|14.8|13.1|267|VIII Malignant bone tumors|20358437|2000
10-14|6.4|8.8|7.5|153|VIII(a) Osteosarcomas|20358437|2000
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20358437|2000
10-14|3.8|5.8|4.7|96|VIII(c) Ewing tumor and related sarcomas of bone|20358437|2000
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20358437|2000
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20358437|2000
10-14|5.6|7.9|6.7|136|X Germ cell, trophoblastic tumors & neoplasms of gonads|20358437|2000
10-14|1.7|3.0|2.3|46|X(a) Intracranial & intraspinal germ cell tumors|20358437|2000
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20358437|2000
10-14|3.0|4.8|3.8|78|X(c) Malignant gonadal germ cell tumors|20358437|2000
10-14|~|~|~|~|X(d) Gonadal carcinomas|20358437|2000
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20358437|2000
10-14|10.6|13.7|12.1|246|XI Other malignant epithelial neoplasms and malignant melanomas|20358437|2000
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20358437|2000
10-14|3.6|5.4|4.4|90|XI(b) Thyroid carcinomas|20358437|2000
10-14|0.5|1.3|0.8|17|XI(c) Nasopharyngeal carcinomas|20358437|2000
10-14|2.7|4.3|3.4|70|XI(d) Malignant melanomas|20358437|2000
10-14|~|~|~|~|XI(e) Skin carcinomas|20358437|2000
10-14|2.4|4.0|3.1|64|XI(f) Other and unspecified carcinomas|20358437|2000
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20358437|2000
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20358437|2000
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20358437|2000
15-19|199.1|211.7|205.3|4106|All ICCC Groups Combined|19998739|2000
15-19|25.2|29.8|27.5|549|I Leukemias, myeloproliferative & myelodysplastic diseases|19998739|2000
15-19|14.3|17.9|16.1|321|I(a) Lymphoid leukemias|19998739|2000
15-19|7.5|10.1|8.8|175|I(b) Acute myeloid leukemias|19998739|2000
15-19|0.9|2.0|1.4|27|I(c) Chronic myeloproliferative diseases|19998739|2000
15-19|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19998739|2000
15-19|0.8|1.8|1.3|25|I(e) Unspecified and other specified leukemias|19998739|2000
15-19|46.5|52.7|49.6|991|II Lymphomas and reticuloendothelial neoplasms|19998739|2000
15-19|29.2|34.2|31.6|632|II(a) Hodgkin lymphomas|19998739|2000
15-19|13.1|16.5|14.8|295|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19998739|2000
15-19|1.6|3.0|2.3|45|II(c) Burkitt lymphoma|19998739|2000
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19998739|2000
15-19|0.5|1.3|0.8|16|II(e) Unspecified lymphomas|19998739|2000
15-19|19.4|23.5|21.4|428|III CNS and misc intracranial and intraspinal neoplasms|19998739|2000
15-19|0.9|2.0|1.4|27|III(a) Ependymomas and choroid plexus tumor|19998739|2000
15-19|10.2|13.3|11.7|234|III(b) Astrocytomas|19998739|2000
15-19|2.4|4.0|3.2|63|III(c) Intracranial and intraspinal embryonal tumors|19998739|2000
15-19|3.4|5.3|4.3|85|III(d) Other gliomas|19998739|2000
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19998739|2000
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19998739|2000
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|19998739|2000
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|19998739|2000
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19998739|2000
15-19|14.8|18.4|16.5|330|IX Soft tissue and other extraosseous sarcomas|19998739|2000
15-19|2.9|4.7|3.8|75|IX(a) Rhabdomyosarcomas|19998739|2000
15-19|1.3|2.6|1.9|38|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19998739|2000
15-19|~|~|~|~|IX(c) Kaposi sarcoma|19998739|2000
15-19|7.3|9.9|8.5|170|IX(d) Other specified soft tissue sarcomas|19998739|2000
15-19|1.6|3.0|2.2|44|IX(e) Unspecified soft tissue sarcomas|19998739|2000
15-19|~|~|~|~|Not classified by ICCC|19998739|2000
15-19|~|~|~|~|V Retinoblastoma|19998739|2000
15-19|0.8|1.8|1.2|24|VI Renal tumors|19998739|2000
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|19998739|2000
15-19|0.5|1.3|0.8|16|VI(b) Renal carcinomas|19998739|2000
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|19998739|2000
15-19|0.5|1.3|0.8|16|VII Hepatic tumors|19998739|2000
15-19|~|~|~|~|VII(a) Hepatoblastoma|19998739|2000
15-19|~|~|~|~|VII(b) Hepatic carcinomas|19998739|2000
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19998739|2000
15-19|12.2|15.5|13.8|275|VIII Malignant bone tumors|19998739|2000
15-19|6.9|9.4|8.1|161|VIII(a) Osteosarcomas|19998739|2000
15-19|~|~|~|~|VIII(b) Chondrosarcomas|19998739|2000
15-19|3.4|5.3|4.3|85|VIII(c) Ewing tumor and related sarcomas of bone|19998739|2000
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|19998739|2000
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19998739|2000
15-19|25.8|30.5|28.1|562|X Germ cell, trophoblastic tumors & neoplasms of gonads|19998739|2000
15-19|1.7|3.1|2.3|46|X(a) Intracranial & intraspinal germ cell tumors|19998739|2000
15-19|1.6|2.9|2.2|43|X(b) Malignant extracranial & extragonadal germ cell tumors|19998739|2000
15-19|19.4|23.5|21.4|428|X(c) Malignant gonadal germ cell tumors|19998739|2000
15-19|1.1|2.3|1.6|32|X(d) Gonadal carcinomas|19998739|2000
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19998739|2000
15-19|41.9|47.8|44.8|895|XI Other malignant epithelial neoplasms and malignant melanomas|19998739|2000
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|19998739|2000
15-19|15.1|18.7|16.8|336|XI(b) Thyroid carcinomas|19998739|2000
15-19|0.7|1.6|1.1|21|XI(c) Nasopharyngeal carcinomas|19998739|2000
15-19|13.6|17.1|15.3|306|XI(d) Malignant melanomas|19998739|2000
15-19|~|~|~|~|XI(e) Skin carcinomas|19998739|2000
15-19|9.7|12.7|11.1|222|XI(f) Other and unspecified carcinomas|19998739|2000
15-19|0.6|1.5|1.0|20|XII Other and unspecified malignant neoplasms|19998739|2000
15-19|~|~|~|~|XII(a) Other specified malignant tumors|19998739|2000
15-19|0.5|1.4|0.9|18|XII(b) Other unspecified malignant tumors|19998739|2000
5-9|110.3|119.7|114.9|2320|All ICCC Groups Combined|20194272|2000
5-9|34.9|40.3|37.5|758|I Leukemias, myeloproliferative & myelodysplastic diseases|20194272|2000
5-9|29.2|34.1|31.6|638|I(a) Lymphoid leukemias|20194272|2000
5-9|3.5|5.4|4.4|88|I(b) Acute myeloid leukemias|20194272|2000
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|20194272|2000
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20194272|2000
5-9|0.6|1.6|1.0|21|I(e) Unspecified and other specified leukemias|20194272|2000
5-9|13.5|17.0|15.2|307|II Lymphomas and reticuloendothelial neoplasms|20194272|2000
5-9|2.8|4.5|3.6|72|II(a) Hodgkin lymphomas|20194272|2000
5-9|5.2|7.4|6.2|125|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20194272|2000
5-9|3.1|4.9|4.0|80|II(c) Burkitt lymphoma|20194272|2000
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20194272|2000
5-9|0.5|1.4|0.9|18|II(e) Unspecified lymphomas|20194272|2000
5-9|30.5|35.6|33.0|666|III CNS and misc intracranial and intraspinal neoplasms|20194272|2000
5-9|1.6|3.0|2.2|45|III(a) Ependymomas and choroid plexus tumor|20194272|2000
5-9|14.7|18.3|16.4|331|III(b) Astrocytomas|20194272|2000
5-9|7.1|9.6|8.3|167|III(c) Intracranial and intraspinal embryonal tumors|20194272|2000
5-9|4.5|6.6|5.4|110|III(d) Other gliomas|20194272|2000
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20194272|2000
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20194272|2000
5-9|2.4|4.0|3.2|64|IV Neuroblastoma and other peripheral nervous cell tumors|20194272|2000
5-9|2.3|3.9|3.0|61|IV(a) Neuroblastoma and ganglioneuroblastoma|20194272|2000
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20194272|2000
5-9|6.8|9.3|8.0|161|IX Soft tissue and other extraosseous sarcomas|20194272|2000
5-9|3.1|4.8|3.9|78|IX(a) Rhabdomyosarcomas|20194272|2000
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20194272|2000
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20194272|2000
5-9|2.0|3.5|2.7|54|IX(d) Other specified soft tissue sarcomas|20194272|2000
5-9|0.6|1.5|0.9|19|IX(e) Unspecified soft tissue sarcomas|20194272|2000
5-9|~|~|~|~|Not classified by ICCC|20194272|2000
5-9|~|~|~|~|V Retinoblastoma|20194272|2000
5-9|5.2|7.4|6.2|126|VI Renal tumors|20194272|2000
5-9|4.8|7.0|5.8|118|VI(a) Nephroblastoma and other nonepithelial renal tumors|20194272|2000
5-9|~|~|~|~|VI(b) Renal carcinomas|20194272|2000
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20194272|2000
5-9|~|~|~|~|VII Hepatic tumors|20194272|2000
5-9|~|~|~|~|VII(a) Hepatoblastoma|20194272|2000
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20194272|2000
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20194272|2000
5-9|4.1|6.1|5.0|101|VIII Malignant bone tumors|20194272|2000
5-9|2.0|3.5|2.7|54|VIII(a) Osteosarcomas|20194272|2000
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20194272|2000
5-9|1.7|3.0|2.3|46|VIII(c) Ewing tumor and related sarcomas of bone|20194272|2000
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20194272|2000
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20194272|2000
5-9|2.1|3.6|2.8|56|X Germ cell, trophoblastic tumors & neoplasms of gonads|20194272|2000
5-9|0.9|2.0|1.4|28|X(a) Intracranial & intraspinal germ cell tumors|20194272|2000
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20194272|2000
5-9|0.8|1.8|1.2|25|X(c) Malignant gonadal germ cell tumors|20194272|2000
5-9|~|~|~|~|X(d) Gonadal carcinomas|20194272|2000
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20194272|2000
5-9|2.3|3.8|3.0|60|XI Other malignant epithelial neoplasms and malignant melanomas|20194272|2000
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20194272|2000
5-9|0.6|1.5|1.0|20|XI(b) Thyroid carcinomas|20194272|2000
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20194272|2000
5-9|0.5|1.3|0.8|17|XI(d) Malignant melanomas|20194272|2000
5-9|~|~|~|~|XI(e) Skin carcinomas|20194272|2000
5-9|~|~|~|~|XI(f) Other and unspecified carcinomas|20194272|2000
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20194272|2000
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20194272|2000
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20194272|2000
<1|221.6|252.8|236.9|901|All ICCC Groups Combined|3804065|2000
<1|40.4|54.5|47.1|179|I Leukemias, myeloproliferative & myelodysplastic diseases|3804065|2000
<1|19.5|29.7|24.2|92|I(a) Lymphoid leukemias|3804065|2000
<1|12.7|21.2|16.6|63|I(b) Acute myeloid leukemias|3804065|2000
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3804065|2000
<1|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3804065|2000
<1|2.4|6.8|4.2|16|I(e) Unspecified and other specified leukemias|3804065|2000
<1|6.2|12.5|8.9|34|II Lymphomas and reticuloendothelial neoplasms|3804065|2000
<1|~|~|~|~|II(a) Hodgkin lymphomas|3804065|2000
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3804065|2000
<1|~|~|~|~|II(c) Burkitt lymphoma|3804065|2000
<1|3.8|9.1|6.0|23|II(d) Miscellaneous lymphoreticular neoplasms|3804065|2000
<1|~|~|~|~|II(e) Unspecified lymphomas|3804065|2000
<1|29.0|41.1|34.7|132|III CNS and misc intracranial and intraspinal neoplasms|3804065|2000
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3804065|2000
<1|11.6|19.7|15.2|58|III(b) Astrocytomas|3804065|2000
<1|6.4|12.8|9.2|35|III(c) Intracranial and intraspinal embryonal tumors|3804065|2000
<1|~|~|~|~|III(d) Other gliomas|3804065|2000
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3804065|2000
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3804065|2000
<1|47.5|62.6|54.7|208|IV Neuroblastoma and other peripheral nervous cell tumors|3804065|2000
<1|47.5|62.6|54.7|208|IV(a) Neuroblastoma and ganglioneuroblastoma|3804065|2000
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3804065|2000
<1|12.0|20.3|15.8|60|IX Soft tissue and other extraosseous sarcomas|3804065|2000
<1|4.7|10.3|7.1|27|IX(a) Rhabdomyosarcomas|3804065|2000
<1|2.4|6.8|4.2|16|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3804065|2000
<1|~|~|~|~|IX(c) Kaposi sarcoma|3804065|2000
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3804065|2000
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3804065|2000
<1|~|~|~|~|Not classified by ICCC|3804065|2000
<1|22.1|32.8|27.1|103|V Retinoblastoma|3804065|2000
<1|10.2|17.9|13.7|52|VI Renal tumors|3804065|2000
<1|10.2|17.9|13.7|52|VI(a) Nephroblastoma and other nonepithelial renal tumors|3804065|2000
<1|~|~|~|~|VI(b) Renal carcinomas|3804065|2000
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3804065|2000
<1|7.7|14.6|10.8|41|VII Hepatic tumors|3804065|2000
<1|7.1|13.7|10.0|38|VII(a) Hepatoblastoma|3804065|2000
<1|~|~|~|~|VII(b) Hepatic carcinomas|3804065|2000
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3804065|2000
<1|~|~|~|~|VIII Malignant bone tumors|3804065|2000
<1|~|~|~|~|VIII(a) Osteosarcomas|3804065|2000
<1|~|~|~|~|VIII(b) Chondrosarcomas|3804065|2000
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3804065|2000
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3804065|2000
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3804065|2000
<1|13.0|21.5|16.8|64|X Germ cell, trophoblastic tumors & neoplasms of gonads|3804065|2000
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3804065|2000
<1|8.0|14.9|11.0|42|X(b) Malignant extracranial & extragonadal germ cell tumors|3804065|2000
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3804065|2000
<1|~|~|~|~|X(d) Gonadal carcinomas|3804065|2000
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3804065|2000
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3804065|2000
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3804065|2000
<1|~|~|~|~|XI(b) Thyroid carcinomas|3804065|2000
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3804065|2000
<1|~|~|~|~|XI(d) Malignant melanomas|3804065|2000
<1|~|~|~|~|XI(e) Skin carcinomas|3804065|2000
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3804065|2000
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3804065|2000
<1|~|~|~|~|XII(a) Other specified malignant tumors|3804065|2000
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3804065|2000
1-4|209.9|224.8|217.3|3286|All ICCC Groups Combined|15123657|2001
1-4|86.8|96.5|91.6|1385|I Leukemias, myeloproliferative & myelodysplastic diseases|15123657|2001
1-4|72.4|81.3|76.8|1161|I(a) Lymphoid leukemias|15123657|2001
1-4|7.6|10.7|9.1|137|I(b) Acute myeloid leukemias|15123657|2001
1-4|0.9|2.2|1.5|22|I(c) Chronic myeloproliferative diseases|15123657|2001
1-4|1.6|3.2|2.3|35|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15123657|2001
1-4|1.3|2.8|2.0|30|I(e) Unspecified and other specified leukemias|15123657|2001
1-4|7.7|10.8|9.1|138|II Lymphomas and reticuloendothelial neoplasms|15123657|2001
1-4|0.8|2.0|1.3|20|II(a) Hodgkin lymphomas|15123657|2001
1-4|2.6|4.5|3.4|52|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15123657|2001
1-4|1.6|3.1|2.2|34|II(c) Burkitt lymphoma|15123657|2001
1-4|1.2|2.7|1.9|28|II(d) Miscellaneous lymphoreticular neoplasms|15123657|2001
1-4|~|~|~|~|II(e) Unspecified lymphomas|15123657|2001
1-4|37.1|43.5|40.2|608|III CNS and misc intracranial and intraspinal neoplasms|15123657|2001
1-4|3.2|5.3|4.2|63|III(a) Ependymomas and choroid plexus tumor|15123657|2001
1-4|17.7|22.2|19.8|300|III(b) Astrocytomas|15123657|2001
1-4|8.7|12.0|10.2|155|III(c) Intracranial and intraspinal embryonal tumors|15123657|2001
1-4|3.6|5.8|4.6|70|III(d) Other gliomas|15123657|2001
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15123657|2001
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15123657|2001
1-4|21.2|26.1|23.5|356|IV Neuroblastoma and other peripheral nervous cell tumors|15123657|2001
1-4|21.0|26.0|23.4|354|IV(a) Neuroblastoma and ganglioneuroblastoma|15123657|2001
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15123657|2001
1-4|10.1|13.6|11.8|178|IX Soft tissue and other extraosseous sarcomas|15123657|2001
1-4|7.6|10.7|9.1|137|IX(a) Rhabdomyosarcomas|15123657|2001
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15123657|2001
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15123657|2001
1-4|1.1|2.5|1.7|26|IX(d) Other specified soft tissue sarcomas|15123657|2001
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15123657|2001
1-4|~|~|~|~|Not classified by ICCC|15123657|2001
1-4|8.0|11.1|9.5|143|V Retinoblastoma|15123657|2001
1-4|18.2|22.8|20.4|308|VI Renal tumors|15123657|2001
1-4|17.9|22.5|20.1|304|VI(a) Nephroblastoma and other nonepithelial renal tumors|15123657|2001
1-4|~|~|~|~|VI(b) Renal carcinomas|15123657|2001
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15123657|2001
1-4|2.9|5.0|3.8|58|VII Hepatic tumors|15123657|2001
1-4|2.7|4.7|3.6|54|VII(a) Hepatoblastoma|15123657|2001
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15123657|2001
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15123657|2001
1-4|0.9|2.2|1.5|22|VIII Malignant bone tumors|15123657|2001
1-4|~|~|~|~|VIII(a) Osteosarcomas|15123657|2001
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15123657|2001
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15123657|2001
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15123657|2001
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15123657|2001
1-4|2.5|4.4|3.4|51|X Germ cell, trophoblastic tumors & neoplasms of gonads|15123657|2001
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15123657|2001
1-4|1.1|2.5|1.7|26|X(b) Malignant extracranial & extragonadal germ cell tumors|15123657|2001
1-4|1.0|2.3|1.5|23|X(c) Malignant gonadal germ cell tumors|15123657|2001
1-4|~|~|~|~|X(d) Gonadal carcinomas|15123657|2001
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15123657|2001
1-4|0.9|2.2|1.5|22|XI Other malignant epithelial neoplasms and malignant melanomas|15123657|2001
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15123657|2001
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15123657|2001
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15123657|2001
1-4|~|~|~|~|XI(d) Malignant melanomas|15123657|2001
1-4|~|~|~|~|XI(e) Skin carcinomas|15123657|2001
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15123657|2001
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15123657|2001
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15123657|2001
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15123657|2001
10-14|127.7|137.7|132.6|2753|All ICCC Groups Combined|20758808|2001
10-14|28.7|33.6|31.1|645|I Leukemias, myeloproliferative & myelodysplastic diseases|20758808|2001
10-14|18.6|22.6|20.5|426|I(a) Lymphoid leukemias|20758808|2001
10-14|5.9|8.2|6.9|144|I(b) Acute myeloid leukemias|20758808|2001
10-14|1.4|2.7|2.0|41|I(c) Chronic myeloproliferative diseases|20758808|2001
10-14|0.4|1.3|0.8|16|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20758808|2001
10-14|0.5|1.4|0.9|18|I(e) Unspecified and other specified leukemias|20758808|2001
10-14|22.9|27.2|25.0|519|II Lymphomas and reticuloendothelial neoplasms|20758808|2001
10-14|10.7|13.7|12.1|252|II(a) Hodgkin lymphomas|20758808|2001
10-14|8.6|11.3|9.9|205|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20758808|2001
10-14|1.7|3.1|2.3|48|II(c) Burkitt lymphoma|20758808|2001
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20758808|2001
10-14|~|~|~|~|II(e) Unspecified lymphomas|20758808|2001
10-14|24.1|28.6|26.3|546|III CNS and misc intracranial and intraspinal neoplasms|20758808|2001
10-14|1.3|2.5|1.8|37|III(a) Ependymomas and choroid plexus tumor|20758808|2001
10-14|12.3|15.5|13.8|287|III(b) Astrocytomas|20758808|2001
10-14|3.3|5.1|4.1|85|III(c) Intracranial and intraspinal embryonal tumors|20758808|2001
10-14|4.5|6.6|5.5|114|III(d) Other gliomas|20758808|2001
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20758808|2001
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20758808|2001
10-14|0.9|2.0|1.4|29|IV Neuroblastoma and other peripheral nervous cell tumors|20758808|2001
10-14|0.8|1.8|1.2|25|IV(a) Neuroblastoma and ganglioneuroblastoma|20758808|2001
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20758808|2001
10-14|9.9|12.8|11.3|234|IX Soft tissue and other extraosseous sarcomas|20758808|2001
10-14|2.7|4.3|3.4|71|IX(a) Rhabdomyosarcomas|20758808|2001
10-14|0.7|1.7|1.2|24|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20758808|2001
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20758808|2001
10-14|4.0|6.0|4.9|102|IX(d) Other specified soft tissue sarcomas|20758808|2001
10-14|1.3|2.5|1.8|37|IX(e) Unspecified soft tissue sarcomas|20758808|2001
10-14|~|~|~|~|Not classified by ICCC|20758808|2001
10-14|~|~|~|~|V Retinoblastoma|20758808|2001
10-14|0.9|2.0|1.4|29|VI Renal tumors|20758808|2001
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20758808|2001
10-14|~|~|~|~|VI(b) Renal carcinomas|20758808|2001
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20758808|2001
10-14|~|~|~|~|VII Hepatic tumors|20758808|2001
10-14|~|~|~|~|VII(a) Hepatoblastoma|20758808|2001
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20758808|2001
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20758808|2001
10-14|12.4|15.6|13.9|289|VIII Malignant bone tumors|20758808|2001
10-14|6.8|9.3|7.9|165|VIII(a) Osteosarcomas|20758808|2001
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20758808|2001
10-14|4.1|6.1|5.1|105|VIII(c) Ewing tumor and related sarcomas of bone|20758808|2001
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20758808|2001
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20758808|2001
10-14|5.4|7.6|6.4|133|X Germ cell, trophoblastic tumors & neoplasms of gonads|20758808|2001
10-14|2.0|3.4|2.6|54|X(a) Intracranial & intraspinal germ cell tumors|20758808|2001
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20758808|2001
10-14|2.2|3.7|2.8|59|X(c) Malignant gonadal germ cell tumors|20758808|2001
10-14|~|~|~|~|X(d) Gonadal carcinomas|20758808|2001
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20758808|2001
10-14|12.5|15.8|14.1|293|XI Other malignant epithelial neoplasms and malignant melanomas|20758808|2001
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20758808|2001
10-14|4.7|6.8|5.6|117|XI(b) Thyroid carcinomas|20758808|2001
10-14|0.5|1.3|0.8|17|XI(c) Nasopharyngeal carcinomas|20758808|2001
10-14|3.1|4.9|4.0|82|XI(d) Malignant melanomas|20758808|2001
10-14|~|~|~|~|XI(e) Skin carcinomas|20758808|2001
10-14|2.6|4.3|3.4|70|XI(f) Other and unspecified carcinomas|20758808|2001
10-14|0.4|1.3|0.8|16|XII Other and unspecified malignant neoplasms|20758808|2001
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20758808|2001
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20758808|2001
15-19|206.6|219.4|212.9|4307|All ICCC Groups Combined|20227701|2001
15-19|28.9|33.8|31.3|633|I Leukemias, myeloproliferative & myelodysplastic diseases|20227701|2001
15-19|14.0|17.5|15.7|317|I(a) Lymphoid leukemias|20227701|2001
15-19|7.8|10.5|9.0|183|I(b) Acute myeloid leukemias|20227701|2001
15-19|3.2|5.0|4.1|82|I(c) Chronic myeloproliferative diseases|20227701|2001
15-19|0.7|1.6|1.1|22|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20227701|2001
15-19|1.0|2.1|1.4|29|I(e) Unspecified and other specified leukemias|20227701|2001
15-19|47.1|53.4|50.2|1015|II Lymphomas and reticuloendothelial neoplasms|20227701|2001
15-19|29.7|34.7|32.1|650|II(a) Hodgkin lymphomas|20227701|2001
15-19|13.5|17.0|15.2|307|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20227701|2001
15-19|1.4|2.6|1.9|39|II(c) Burkitt lymphoma|20227701|2001
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20227701|2001
15-19|~|~|~|~|II(e) Unspecified lymphomas|20227701|2001
15-19|19.8|23.9|21.8|440|III CNS and misc intracranial and intraspinal neoplasms|20227701|2001
15-19|1.0|2.1|1.5|30|III(a) Ependymomas and choroid plexus tumor|20227701|2001
15-19|9.8|12.8|11.2|227|III(b) Astrocytomas|20227701|2001
15-19|3.3|5.1|4.2|84|III(c) Intracranial and intraspinal embryonal tumors|20227701|2001
15-19|3.3|5.1|4.2|84|III(d) Other gliomas|20227701|2001
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20227701|2001
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20227701|2001
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|20227701|2001
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20227701|2001
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20227701|2001
15-19|14.5|18.0|16.2|327|IX Soft tissue and other extraosseous sarcomas|20227701|2001
15-19|3.7|5.6|4.6|93|IX(a) Rhabdomyosarcomas|20227701|2001
15-19|1.4|2.7|2.0|40|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20227701|2001
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20227701|2001
15-19|6.2|8.6|7.3|148|IX(d) Other specified soft tissue sarcomas|20227701|2001
15-19|1.5|2.9|2.1|43|IX(e) Unspecified soft tissue sarcomas|20227701|2001
15-19|~|~|~|~|Not classified by ICCC|20227701|2001
15-19|~|~|~|~|V Retinoblastoma|20227701|2001
15-19|1.0|2.1|1.4|29|VI Renal tumors|20227701|2001
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20227701|2001
15-19|0.7|1.7|1.1|23|VI(b) Renal carcinomas|20227701|2001
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20227701|2001
15-19|0.6|1.5|0.9|19|VII Hepatic tumors|20227701|2001
15-19|~|~|~|~|VII(a) Hepatoblastoma|20227701|2001
15-19|0.5|1.4|0.9|18|VII(b) Hepatic carcinomas|20227701|2001
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20227701|2001
15-19|15.3|18.9|17.0|344|VIII Malignant bone tumors|20227701|2001
15-19|7.9|10.6|9.2|186|VIII(a) Osteosarcomas|20227701|2001
15-19|0.6|1.5|0.9|19|VIII(b) Chondrosarcomas|20227701|2001
15-19|4.6|6.7|5.6|113|VIII(c) Ewing tumor and related sarcomas of bone|20227701|2001
15-19|0.6|1.6|1.0|21|VIII(d) Other specified malignant bone tumors|20227701|2001
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20227701|2001
15-19|24.0|28.5|26.2|530|X Germ cell, trophoblastic tumors & neoplasms of gonads|20227701|2001
15-19|1.8|3.2|2.4|49|X(a) Intracranial & intraspinal germ cell tumors|20227701|2001
15-19|1.6|2.9|2.2|44|X(b) Malignant extracranial & extragonadal germ cell tumors|20227701|2001
15-19|18.1|22.1|20.0|405|X(c) Malignant gonadal germ cell tumors|20227701|2001
15-19|0.6|1.5|1.0|20|X(d) Gonadal carcinomas|20227701|2001
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20227701|2001
15-19|42.5|48.5|45.4|919|XI Other malignant epithelial neoplasms and malignant melanomas|20227701|2001
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20227701|2001
15-19|14.4|18.0|16.1|326|XI(b) Thyroid carcinomas|20227701|2001
15-19|0.8|1.8|1.2|24|XI(c) Nasopharyngeal carcinomas|20227701|2001
15-19|15.2|18.8|16.9|342|XI(d) Malignant melanomas|20227701|2001
15-19|~|~|~|~|XI(e) Skin carcinomas|20227701|2001
15-19|9.7|12.6|11.1|224|XI(f) Other and unspecified carcinomas|20227701|2001
15-19|1.0|2.1|1.4|29|XII Other and unspecified malignant neoplasms|20227701|2001
15-19|~|~|~|~|XII(a) Other specified malignant tumors|20227701|2001
15-19|0.6|1.6|1.0|21|XII(b) Other unspecified malignant tumors|20227701|2001
5-9|110.7|120.2|115.4|2303|All ICCC Groups Combined|19962452|2001
5-9|36.2|41.8|38.9|777|I Leukemias, myeloproliferative & myelodysplastic diseases|19962452|2001
5-9|29.1|34.1|31.6|630|I(a) Lymphoid leukemias|19962452|2001
5-9|3.8|5.8|4.7|94|I(b) Acute myeloid leukemias|19962452|2001
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|19962452|2001
5-9|0.7|1.6|1.1|21|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19962452|2001
5-9|0.5|1.4|0.9|17|I(e) Unspecified and other specified leukemias|19962452|2001
5-9|12.2|15.6|13.8|276|II Lymphomas and reticuloendothelial neoplasms|19962452|2001
5-9|3.4|5.2|4.2|84|II(a) Hodgkin lymphomas|19962452|2001
5-9|5.3|7.6|6.4|128|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19962452|2001
5-9|2.0|3.5|2.7|53|II(c) Burkitt lymphoma|19962452|2001
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19962452|2001
5-9|~|~|~|~|II(e) Unspecified lymphomas|19962452|2001
5-9|31.4|36.5|33.9|676|III CNS and misc intracranial and intraspinal neoplasms|19962452|2001
5-9|1.6|2.9|2.2|43|III(a) Ependymomas and choroid plexus tumor|19962452|2001
5-9|15.3|18.9|17.0|340|III(b) Astrocytomas|19962452|2001
5-9|6.5|9.0|7.7|153|III(c) Intracranial and intraspinal embryonal tumors|19962452|2001
5-9|5.3|7.5|6.3|126|III(d) Other gliomas|19962452|2001
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19962452|2001
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19962452|2001
5-9|2.5|4.2|3.3|65|IV Neuroblastoma and other peripheral nervous cell tumors|19962452|2001
5-9|2.4|4.0|3.2|63|IV(a) Neuroblastoma and ganglioneuroblastoma|19962452|2001
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19962452|2001
5-9|6.4|8.8|7.5|150|IX Soft tissue and other extraosseous sarcomas|19962452|2001
5-9|3.4|5.3|4.3|86|IX(a) Rhabdomyosarcomas|19962452|2001
5-9|0.6|1.5|1.0|20|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19962452|2001
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19962452|2001
5-9|1.3|2.6|1.9|37|IX(d) Other specified soft tissue sarcomas|19962452|2001
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19962452|2001
5-9|~|~|~|~|Not classified by ICCC|19962452|2001
5-9|~|~|~|~|V Retinoblastoma|19962452|2001
5-9|4.1|6.1|5.0|100|VI Renal tumors|19962452|2001
5-9|3.9|5.9|4.9|97|VI(a) Nephroblastoma and other nonepithelial renal tumors|19962452|2001
5-9|~|~|~|~|VI(b) Renal carcinomas|19962452|2001
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19962452|2001
5-9|~|~|~|~|VII Hepatic tumors|19962452|2001
5-9|~|~|~|~|VII(a) Hepatoblastoma|19962452|2001
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19962452|2001
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19962452|2001
5-9|4.5|6.6|5.5|109|VIII Malignant bone tumors|19962452|2001
5-9|2.4|4.0|3.1|62|VIII(a) Osteosarcomas|19962452|2001
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19962452|2001
5-9|1.5|2.8|2.1|41|VIII(c) Ewing tumor and related sarcomas of bone|19962452|2001
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19962452|2001
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19962452|2001
5-9|1.4|2.7|2.0|39|X Germ cell, trophoblastic tumors & neoplasms of gonads|19962452|2001
5-9|0.5|1.4|0.9|17|X(a) Intracranial & intraspinal germ cell tumors|19962452|2001
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19962452|2001
5-9|0.6|1.5|1.0|19|X(c) Malignant gonadal germ cell tumors|19962452|2001
5-9|~|~|~|~|X(d) Gonadal carcinomas|19962452|2001
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19962452|2001
5-9|3.1|4.9|3.9|78|XI Other malignant epithelial neoplasms and malignant melanomas|19962452|2001
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19962452|2001
5-9|0.7|1.6|1.1|21|XI(b) Thyroid carcinomas|19962452|2001
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19962452|2001
5-9|0.9|1.9|1.3|26|XI(d) Malignant melanomas|19962452|2001
5-9|~|~|~|~|XI(e) Skin carcinomas|19962452|2001
5-9|0.8|1.8|1.2|24|XI(f) Other and unspecified carcinomas|19962452|2001
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19962452|2001
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19962452|2001
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19962452|2001
<1|231.1|262.3|246.3|978|All ICCC Groups Combined|3970113|2001
<1|41.8|55.7|48.4|192|I Leukemias, myeloproliferative & myelodysplastic diseases|3970113|2001
<1|15.1|24.0|19.1|76|I(a) Lymphoid leukemias|3970113|2001
<1|11.8|19.7|15.4|61|I(b) Acute myeloid leukemias|3970113|2001
<1|3.3|8.1|5.3|21|I(c) Chronic myeloproliferative diseases|3970113|2001
<1|3.9|9.0|6.0|24|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3970113|2001
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3970113|2001
<1|4.9|10.5|7.3|29|II Lymphomas and reticuloendothelial neoplasms|3970113|2001
<1|~|~|~|~|II(a) Hodgkin lymphomas|3970113|2001
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3970113|2001
<1|~|~|~|~|II(c) Burkitt lymphoma|3970113|2001
<1|4.3|9.6|6.5|26|II(d) Miscellaneous lymphoreticular neoplasms|3970113|2001
<1|~|~|~|~|II(e) Unspecified lymphomas|3970113|2001
<1|26.9|38.3|32.2|128|III CNS and misc intracranial and intraspinal neoplasms|3970113|2001
<1|3.3|8.1|5.3|21|III(a) Ependymomas and choroid plexus tumor|3970113|2001
<1|8.7|15.7|11.8|47|III(b) Astrocytomas|3970113|2001
<1|7.6|14.3|10.6|42|III(c) Intracranial and intraspinal embryonal tumors|3970113|2001
<1|~|~|~|~|III(d) Other gliomas|3970113|2001
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3970113|2001
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3970113|2001
<1|53.8|69.4|61.2|243|IV Neuroblastoma and other peripheral nervous cell tumors|3970113|2001
<1|53.5|69.1|61.0|242|IV(a) Neuroblastoma and ganglioneuroblastoma|3970113|2001
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3970113|2001
<1|12.9|21.2|16.6|66|IX Soft tissue and other extraosseous sarcomas|3970113|2001
<1|~|~|~|~|IX(a) Rhabdomyosarcomas|3970113|2001
<1|4.3|9.6|6.5|26|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3970113|2001
<1|~|~|~|~|IX(c) Kaposi sarcoma|3970113|2001
<1|3.1|7.8|5.0|20|IX(d) Other specified soft tissue sarcomas|3970113|2001
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3970113|2001
<1|~|~|~|~|Not classified by ICCC|3970113|2001
<1|22.8|33.4|27.7|110|V Retinoblastoma|3970113|2001
<1|14.4|23.1|18.4|73|VI Renal tumors|3970113|2001
<1|14.2|22.8|18.1|72|VI(a) Nephroblastoma and other nonepithelial renal tumors|3970113|2001
<1|~|~|~|~|VI(b) Renal carcinomas|3970113|2001
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3970113|2001
<1|7.4|14.0|10.3|41|VII Hepatic tumors|3970113|2001
<1|7.0|13.4|9.8|39|VII(a) Hepatoblastoma|3970113|2001
<1|~|~|~|~|VII(b) Hepatic carcinomas|3970113|2001
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3970113|2001
<1|~|~|~|~|VIII Malignant bone tumors|3970113|2001
<1|~|~|~|~|VIII(a) Osteosarcomas|3970113|2001
<1|~|~|~|~|VIII(b) Chondrosarcomas|3970113|2001
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3970113|2001
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3970113|2001
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3970113|2001
<1|16.0|25.1|20.2|80|X Germ cell, trophoblastic tumors & neoplasms of gonads|3970113|2001
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3970113|2001
<1|9.1|16.3|12.3|49|X(b) Malignant extracranial & extragonadal germ cell tumors|3970113|2001
<1|3.1|7.8|5.0|20|X(c) Malignant gonadal germ cell tumors|3970113|2001
<1|~|~|~|~|X(d) Gonadal carcinomas|3970113|2001
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3970113|2001
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3970113|2001
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3970113|2001
<1|~|~|~|~|XI(b) Thyroid carcinomas|3970113|2001
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3970113|2001
<1|~|~|~|~|XI(d) Malignant melanomas|3970113|2001
<1|~|~|~|~|XI(e) Skin carcinomas|3970113|2001
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3970113|2001
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3970113|2001
<1|~|~|~|~|XII(a) Other specified malignant tumors|3970113|2001
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3970113|2001
1-4|206.0|220.7|213.3|3266|All ICCC Groups Combined|15313864|2002
1-4|82.8|92.2|87.4|1339|I Leukemias, myeloproliferative & myelodysplastic diseases|15313864|2002
1-4|68.4|77.0|72.6|1112|I(a) Lymphoid leukemias|15313864|2002
1-4|9.0|12.3|10.6|162|I(b) Acute myeloid leukemias|15313864|2002
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15313864|2002
1-4|1.3|2.8|2.0|30|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15313864|2002
1-4|1.0|2.3|1.6|24|I(e) Unspecified and other specified leukemias|15313864|2002
1-4|7.9|11.0|9.3|143|II Lymphomas and reticuloendothelial neoplasms|15313864|2002
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15313864|2002
1-4|3.9|6.2|5.0|76|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15313864|2002
1-4|1.4|2.9|2.0|31|II(c) Burkitt lymphoma|15313864|2002
1-4|1.1|2.5|1.7|26|II(d) Miscellaneous lymphoreticular neoplasms|15313864|2002
1-4|~|~|~|~|II(e) Unspecified lymphomas|15313864|2002
1-4|41.3|48.0|44.5|682|III CNS and misc intracranial and intraspinal neoplasms|15313864|2002
1-4|5.0|7.5|6.1|94|III(a) Ependymomas and choroid plexus tumor|15313864|2002
1-4|17.8|22.4|20.0|306|III(b) Astrocytomas|15313864|2002
1-4|9.2|12.5|10.8|165|III(c) Intracranial and intraspinal embryonal tumors|15313864|2002
1-4|5.0|7.6|6.2|95|III(d) Other gliomas|15313864|2002
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15313864|2002
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15313864|2002
1-4|18.2|22.8|20.4|312|IV Neuroblastoma and other peripheral nervous cell tumors|15313864|2002
1-4|18.1|22.6|20.2|310|IV(a) Neuroblastoma and ganglioneuroblastoma|15313864|2002
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15313864|2002
1-4|9.4|12.8|11.0|169|IX Soft tissue and other extraosseous sarcomas|15313864|2002
1-4|6.9|9.8|8.2|126|IX(a) Rhabdomyosarcomas|15313864|2002
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15313864|2002
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15313864|2002
1-4|1.2|2.6|1.8|27|IX(d) Other specified soft tissue sarcomas|15313864|2002
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15313864|2002
1-4|~|~|~|~|Not classified by ICCC|15313864|2002
1-4|7.1|10.1|8.5|130|V Retinoblastoma|15313864|2002
1-4|17.8|22.4|20.0|306|VI Renal tumors|15313864|2002
1-4|17.6|22.1|19.8|303|VI(a) Nephroblastoma and other nonepithelial renal tumors|15313864|2002
1-4|~|~|~|~|VI(b) Renal carcinomas|15313864|2002
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15313864|2002
1-4|3.1|5.2|4.0|62|VII Hepatic tumors|15313864|2002
1-4|2.9|5.0|3.9|59|VII(a) Hepatoblastoma|15313864|2002
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15313864|2002
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15313864|2002
1-4|1.1|2.4|1.6|25|VIII Malignant bone tumors|15313864|2002
1-4|~|~|~|~|VIII(a) Osteosarcomas|15313864|2002
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15313864|2002
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15313864|2002
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15313864|2002
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15313864|2002
1-4|2.3|4.2|3.1|48|X Germ cell, trophoblastic tumors & neoplasms of gonads|15313864|2002
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15313864|2002
1-4|0.7|1.9|1.2|19|X(b) Malignant extracranial & extragonadal germ cell tumors|15313864|2002
1-4|1.0|2.3|1.6|24|X(c) Malignant gonadal germ cell tumors|15313864|2002
1-4|~|~|~|~|X(d) Gonadal carcinomas|15313864|2002
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15313864|2002
1-4|1.4|2.9|2.1|32|XI Other malignant epithelial neoplasms and malignant melanomas|15313864|2002
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15313864|2002
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15313864|2002
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15313864|2002
1-4|0.6|1.8|1.1|17|XI(d) Malignant melanomas|15313864|2002
1-4|~|~|~|~|XI(e) Skin carcinomas|15313864|2002
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15313864|2002
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15313864|2002
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15313864|2002
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15313864|2002
10-14|122.2|131.9|126.9|2671|All ICCC Groups Combined|21040663|2002
10-14|27.1|31.7|29.3|617|I Leukemias, myeloproliferative & myelodysplastic diseases|21040663|2002
10-14|16.7|20.4|18.4|388|I(a) Lymphoid leukemias|21040663|2002
10-14|6.1|8.5|7.2|152|I(b) Acute myeloid leukemias|21040663|2002
10-14|1.4|2.6|1.9|40|I(c) Chronic myeloproliferative diseases|21040663|2002
10-14|0.6|1.5|1.0|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21040663|2002
10-14|0.5|1.3|0.8|17|I(e) Unspecified and other specified leukemias|21040663|2002
10-14|22.0|26.2|24.0|506|II Lymphomas and reticuloendothelial neoplasms|21040663|2002
10-14|10.9|13.9|12.3|259|II(a) Hodgkin lymphomas|21040663|2002
10-14|6.9|9.3|8.0|169|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21040663|2002
10-14|2.3|3.8|3.0|63|II(c) Burkitt lymphoma|21040663|2002
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21040663|2002
10-14|~|~|~|~|II(e) Unspecified lymphomas|21040663|2002
10-14|23.8|28.2|25.9|546|III CNS and misc intracranial and intraspinal neoplasms|21040663|2002
10-14|1.6|3.0|2.2|47|III(a) Ependymomas and choroid plexus tumor|21040663|2002
10-14|12.4|15.6|13.9|293|III(b) Astrocytomas|21040663|2002
10-14|3.4|5.3|4.3|90|III(c) Intracranial and intraspinal embryonal tumors|21040663|2002
10-14|3.7|5.6|4.6|96|III(d) Other gliomas|21040663|2002
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21040663|2002
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21040663|2002
10-14|0.9|2.0|1.4|29|IV Neuroblastoma and other peripheral nervous cell tumors|21040663|2002
10-14|0.8|1.8|1.2|26|IV(a) Neuroblastoma and ganglioneuroblastoma|21040663|2002
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21040663|2002
10-14|9.7|12.6|11.1|233|IX Soft tissue and other extraosseous sarcomas|21040663|2002
10-14|2.4|4.0|3.1|66|IX(a) Rhabdomyosarcomas|21040663|2002
10-14|0.8|1.9|1.3|27|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21040663|2002
10-14|~|~|~|~|IX(c) Kaposi sarcoma|21040663|2002
10-14|4.4|6.5|5.4|113|IX(d) Other specified soft tissue sarcomas|21040663|2002
10-14|0.8|1.9|1.3|27|IX(e) Unspecified soft tissue sarcomas|21040663|2002
10-14|~|~|~|~|Not classified by ICCC|21040663|2002
10-14|~|~|~|~|V Retinoblastoma|21040663|2002
10-14|0.7|1.6|1.1|23|VI Renal tumors|21040663|2002
10-14|0.4|1.2|0.8|16|VI(a) Nephroblastoma and other nonepithelial renal tumors|21040663|2002
10-14|~|~|~|~|VI(b) Renal carcinomas|21040663|2002
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|21040663|2002
10-14|~|~|~|~|VII Hepatic tumors|21040663|2002
10-14|~|~|~|~|VII(a) Hepatoblastoma|21040663|2002
10-14|~|~|~|~|VII(b) Hepatic carcinomas|21040663|2002
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21040663|2002
10-14|11.3|14.5|12.8|270|VIII Malignant bone tumors|21040663|2002
10-14|6.5|8.9|7.6|160|VIII(a) Osteosarcomas|21040663|2002
10-14|~|~|~|~|VIII(b) Chondrosarcomas|21040663|2002
10-14|3.2|5.0|4.0|85|VIII(c) Ewing tumor and related sarcomas of bone|21040663|2002
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|21040663|2002
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21040663|2002
10-14|5.2|7.4|6.3|132|X Germ cell, trophoblastic tumors & neoplasms of gonads|21040663|2002
10-14|1.9|3.3|2.5|53|X(a) Intracranial & intraspinal germ cell tumors|21040663|2002
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|21040663|2002
10-14|2.4|3.9|3.1|65|X(c) Malignant gonadal germ cell tumors|21040663|2002
10-14|~|~|~|~|X(d) Gonadal carcinomas|21040663|2002
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21040663|2002
10-14|11.8|15.0|13.4|281|XI Other malignant epithelial neoplasms and malignant melanomas|21040663|2002
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|21040663|2002
10-14|3.7|5.6|4.6|96|XI(b) Thyroid carcinomas|21040663|2002
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|21040663|2002
10-14|3.1|4.8|3.9|82|XI(d) Malignant melanomas|21040663|2002
10-14|~|~|~|~|XI(e) Skin carcinomas|21040663|2002
10-14|3.1|4.9|3.9|83|XI(f) Other and unspecified carcinomas|21040663|2002
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|21040663|2002
10-14|~|~|~|~|XII(a) Other specified malignant tumors|21040663|2002
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|21040663|2002
15-19|210.9|223.7|217.2|4428|All ICCC Groups Combined|20386049|2002
15-19|28.6|33.5|31.0|631|I Leukemias, myeloproliferative & myelodysplastic diseases|20386049|2002
15-19|14.7|18.3|16.4|335|I(a) Lymphoid leukemias|20386049|2002
15-19|7.5|10.2|8.8|179|I(b) Acute myeloid leukemias|20386049|2002
15-19|2.9|4.6|3.6|74|I(c) Chronic myeloproliferative diseases|20386049|2002
15-19|0.8|1.8|1.2|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20386049|2002
15-19|0.5|1.4|0.9|18|I(e) Unspecified and other specified leukemias|20386049|2002
15-19|48.2|54.4|51.2|1044|II Lymphomas and reticuloendothelial neoplasms|20386049|2002
15-19|30.4|35.4|32.8|669|II(a) Hodgkin lymphomas|20386049|2002
15-19|13.1|16.4|14.7|299|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20386049|2002
15-19|2.1|3.6|2.8|57|II(c) Burkitt lymphoma|20386049|2002
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20386049|2002
15-19|0.4|1.3|0.8|16|II(e) Unspecified lymphomas|20386049|2002
15-19|20.1|24.3|22.1|451|III CNS and misc intracranial and intraspinal neoplasms|20386049|2002
15-19|0.6|1.6|1.0|21|III(a) Ependymomas and choroid plexus tumor|20386049|2002
15-19|10.9|14.0|12.4|252|III(b) Astrocytomas|20386049|2002
15-19|2.5|4.1|3.2|65|III(c) Intracranial and intraspinal embryonal tumors|20386049|2002
15-19|3.5|5.4|4.4|89|III(d) Other gliomas|20386049|2002
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20386049|2002
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20386049|2002
15-19|0.4|1.3|0.8|16|IV Neuroblastoma and other peripheral nervous cell tumors|20386049|2002
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20386049|2002
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20386049|2002
15-19|12.9|16.3|14.5|296|IX Soft tissue and other extraosseous sarcomas|20386049|2002
15-19|2.7|4.3|3.4|70|IX(a) Rhabdomyosarcomas|20386049|2002
15-19|0.8|1.8|1.2|25|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20386049|2002
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20386049|2002
15-19|7.5|10.1|8.7|177|IX(d) Other specified soft tissue sarcomas|20386049|2002
15-19|0.8|1.8|1.2|24|IX(e) Unspecified soft tissue sarcomas|20386049|2002
15-19|~|~|~|~|Not classified by ICCC|20386049|2002
15-19|~|~|~|~|V Retinoblastoma|20386049|2002
15-19|0.9|1.9|1.3|27|VI Renal tumors|20386049|2002
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20386049|2002
15-19|0.8|1.8|1.2|24|VI(b) Renal carcinomas|20386049|2002
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20386049|2002
15-19|0.7|1.6|1.1|22|VII Hepatic tumors|20386049|2002
15-19|~|~|~|~|VII(a) Hepatoblastoma|20386049|2002
15-19|0.6|1.6|1.0|21|VII(b) Hepatic carcinomas|20386049|2002
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20386049|2002
15-19|14.2|17.7|15.9|324|VIII Malignant bone tumors|20386049|2002
15-19|7.4|10.0|8.6|176|VIII(a) Osteosarcomas|20386049|2002
15-19|1.0|2.2|1.5|31|VIII(b) Chondrosarcomas|20386049|2002
15-19|3.7|5.6|4.6|93|VIII(c) Ewing tumor and related sarcomas of bone|20386049|2002
15-19|0.6|1.6|1.0|21|VIII(d) Other specified malignant bone tumors|20386049|2002
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20386049|2002
15-19|25.8|30.5|28.1|572|X Germ cell, trophoblastic tumors & neoplasms of gonads|20386049|2002
15-19|1.7|3.1|2.3|47|X(a) Intracranial & intraspinal germ cell tumors|20386049|2002
15-19|1.3|2.5|1.8|37|X(b) Malignant extracranial & extragonadal germ cell tumors|20386049|2002
15-19|19.9|24.1|21.9|447|X(c) Malignant gonadal germ cell tumors|20386049|2002
15-19|0.8|1.8|1.2|24|X(d) Gonadal carcinomas|20386049|2002
15-19|0.5|1.3|0.8|17|X(e) Other and unspecified malignant gonadal tumors|20386049|2002
15-19|46.2|52.3|49.2|1003|XI Other malignant epithelial neoplasms and malignant melanomas|20386049|2002
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20386049|2002
15-19|15.5|19.1|17.2|351|XI(b) Thyroid carcinomas|20386049|2002
15-19|1.2|2.4|1.8|36|XI(c) Nasopharyngeal carcinomas|20386049|2002
15-19|17.0|20.9|18.9|385|XI(d) Malignant melanomas|20386049|2002
15-19|~|~|~|~|XI(e) Skin carcinomas|20386049|2002
15-19|9.6|12.6|11.0|225|XI(f) Other and unspecified carcinomas|20386049|2002
15-19|1.3|2.5|1.8|37|XII Other and unspecified malignant neoplasms|20386049|2002
15-19|0.4|1.3|0.8|16|XII(a) Other specified malignant tumors|20386049|2002
15-19|0.6|1.6|1.0|21|XII(b) Other unspecified malignant tumors|20386049|2002
5-9|116.4|126.1|121.2|2383|All ICCC Groups Combined|19665950|2002
5-9|37.3|43.0|40.1|788|I Leukemias, myeloproliferative & myelodysplastic diseases|19665950|2002
5-9|29.4|34.5|31.9|627|I(a) Lymphoid leukemias|19665950|2002
5-9|3.8|5.7|4.7|92|I(b) Acute myeloid leukemias|19665950|2002
5-9|0.8|1.8|1.2|24|I(c) Chronic myeloproliferative diseases|19665950|2002
5-9|0.5|1.4|0.9|18|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19665950|2002
5-9|0.9|2.0|1.4|27|I(e) Unspecified and other specified leukemias|19665950|2002
5-9|11.7|14.9|13.2|260|II Lymphomas and reticuloendothelial neoplasms|19665950|2002
5-9|2.7|4.4|3.5|69|II(a) Hodgkin lymphomas|19665950|2002
5-9|4.6|6.7|5.6|110|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19665950|2002
5-9|2.7|4.4|3.5|69|II(c) Burkitt lymphoma|19665950|2002
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19665950|2002
5-9|~|~|~|~|II(e) Unspecified lymphomas|19665950|2002
5-9|33.1|38.4|35.6|701|III CNS and misc intracranial and intraspinal neoplasms|19665950|2002
5-9|1.7|3.1|2.3|46|III(a) Ependymomas and choroid plexus tumor|19665950|2002
5-9|15.5|19.2|17.2|339|III(b) Astrocytomas|19665950|2002
5-9|6.4|8.8|7.5|148|III(c) Intracranial and intraspinal embryonal tumors|19665950|2002
5-9|6.5|9.0|7.6|150|III(d) Other gliomas|19665950|2002
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19665950|2002
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19665950|2002
5-9|3.4|5.3|4.3|84|IV Neuroblastoma and other peripheral nervous cell tumors|19665950|2002
5-9|3.3|5.1|4.1|81|IV(a) Neuroblastoma and ganglioneuroblastoma|19665950|2002
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19665950|2002
5-9|8.1|10.8|9.4|184|IX Soft tissue and other extraosseous sarcomas|19665950|2002
5-9|4.1|6.2|5.1|100|IX(a) Rhabdomyosarcomas|19665950|2002
5-9|0.5|1.3|0.8|16|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19665950|2002
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19665950|2002
5-9|2.1|3.6|2.8|55|IX(d) Other specified soft tissue sarcomas|19665950|2002
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19665950|2002
5-9|~|~|~|~|Not classified by ICCC|19665950|2002
5-9|~|~|~|~|V Retinoblastoma|19665950|2002
5-9|3.8|5.8|4.7|93|VI Renal tumors|19665950|2002
5-9|3.6|5.6|4.5|89|VI(a) Nephroblastoma and other nonepithelial renal tumors|19665950|2002
5-9|~|~|~|~|VI(b) Renal carcinomas|19665950|2002
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19665950|2002
5-9|~|~|~|~|VII Hepatic tumors|19665950|2002
5-9|~|~|~|~|VII(a) Hepatoblastoma|19665950|2002
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19665950|2002
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19665950|2002
5-9|5.0|7.2|6.1|119|VIII Malignant bone tumors|19665950|2002
5-9|2.1|3.6|2.8|55|VIII(a) Osteosarcomas|19665950|2002
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19665950|2002
5-9|2.2|3.8|2.9|57|VIII(c) Ewing tumor and related sarcomas of bone|19665950|2002
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19665950|2002
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19665950|2002
5-9|1.9|3.4|2.5|50|X Germ cell, trophoblastic tumors & neoplasms of gonads|19665950|2002
5-9|0.7|1.6|1.1|21|X(a) Intracranial & intraspinal germ cell tumors|19665950|2002
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19665950|2002
5-9|0.8|1.9|1.3|25|X(c) Malignant gonadal germ cell tumors|19665950|2002
5-9|~|~|~|~|X(d) Gonadal carcinomas|19665950|2002
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19665950|2002
5-9|3.1|5.0|4.0|78|XI Other malignant epithelial neoplasms and malignant melanomas|19665950|2002
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19665950|2002
5-9|0.7|1.6|1.1|21|XI(b) Thyroid carcinomas|19665950|2002
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19665950|2002
5-9|1.2|2.4|1.7|33|XI(d) Malignant melanomas|19665950|2002
5-9|~|~|~|~|XI(e) Skin carcinomas|19665950|2002
5-9|0.5|1.4|0.9|17|XI(f) Other and unspecified carcinomas|19665950|2002
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19665950|2002
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19665950|2002
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19665950|2002
<1|231.2|262.6|246.5|964|All ICCC Groups Combined|3910837|2002
<1|45.2|59.8|52.2|204|I Leukemias, myeloproliferative & myelodysplastic diseases|3910837|2002
<1|15.1|24.0|19.2|75|I(a) Lymphoid leukemias|3910837|2002
<1|13.7|22.3|17.6|69|I(b) Acute myeloid leukemias|3910837|2002
<1|3.3|8.2|5.4|21|I(c) Chronic myeloproliferative diseases|3910837|2002
<1|4.5|10.0|6.9|27|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3910837|2002
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3910837|2002
<1|6.7|13.0|9.5|37|II Lymphomas and reticuloendothelial neoplasms|3910837|2002
<1|~|~|~|~|II(a) Hodgkin lymphomas|3910837|2002
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3910837|2002
<1|~|~|~|~|II(c) Burkitt lymphoma|3910837|2002
<1|4.3|9.7|6.6|26|II(d) Miscellaneous lymphoreticular neoplasms|3910837|2002
<1|~|~|~|~|II(e) Unspecified lymphomas|3910837|2002
<1|28.2|40.0|33.8|132|III CNS and misc intracranial and intraspinal neoplasms|3910837|2002
<1|4.8|10.3|7.2|28|III(a) Ependymomas and choroid plexus tumor|3910837|2002
<1|8.8|16.0|12.0|47|III(b) Astrocytomas|3910837|2002
<1|6.9|13.3|9.7|38|III(c) Intracranial and intraspinal embryonal tumors|3910837|2002
<1|~|~|~|~|III(d) Other gliomas|3910837|2002
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3910837|2002
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3910837|2002
<1|53.1|68.8|60.6|237|IV Neuroblastoma and other peripheral nervous cell tumors|3910837|2002
<1|53.1|68.8|60.6|237|IV(a) Neuroblastoma and ganglioneuroblastoma|3910837|2002
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3910837|2002
<1|12.4|20.6|16.1|63|IX Soft tissue and other extraosseous sarcomas|3910837|2002
<1|4.5|10.0|6.9|27|IX(a) Rhabdomyosarcomas|3910837|2002
<1|3.1|7.9|5.1|20|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3910837|2002
<1|~|~|~|~|IX(c) Kaposi sarcoma|3910837|2002
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3910837|2002
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3910837|2002
<1|~|~|~|~|Not classified by ICCC|3910837|2002
<1|18.7|28.6|23.3|91|V Retinoblastoma|3910837|2002
<1|14.2|22.9|18.2|71|VI Renal tumors|3910837|2002
<1|14.2|22.9|18.2|71|VI(a) Nephroblastoma and other nonepithelial renal tumors|3910837|2002
<1|~|~|~|~|VI(b) Renal carcinomas|3910837|2002
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3910837|2002
<1|4.8|10.3|7.2|28|VII Hepatic tumors|3910837|2002
<1|4.5|10.0|6.9|27|VII(a) Hepatoblastoma|3910837|2002
<1|~|~|~|~|VII(b) Hepatic carcinomas|3910837|2002
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3910837|2002
<1|~|~|~|~|VIII Malignant bone tumors|3910837|2002
<1|~|~|~|~|VIII(a) Osteosarcomas|3910837|2002
<1|~|~|~|~|VIII(b) Chondrosarcomas|3910837|2002
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3910837|2002
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3910837|2002
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3910837|2002
<1|18.0|27.7|22.5|88|X Germ cell, trophoblastic tumors & neoplasms of gonads|3910837|2002
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3910837|2002
<1|11.9|20.0|15.6|61|X(b) Malignant extracranial & extragonadal germ cell tumors|3910837|2002
<1|3.1|7.9|5.1|20|X(c) Malignant gonadal germ cell tumors|3910837|2002
<1|~|~|~|~|X(d) Gonadal carcinomas|3910837|2002
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3910837|2002
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3910837|2002
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3910837|2002
<1|~|~|~|~|XI(b) Thyroid carcinomas|3910837|2002
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3910837|2002
<1|~|~|~|~|XI(d) Malignant melanomas|3910837|2002
<1|~|~|~|~|XI(e) Skin carcinomas|3910837|2002
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3910837|2002
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3910837|2002
<1|~|~|~|~|XII(a) Other specified malignant tumors|3910837|2002
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3910837|2002
1-4|200.9|215.3|208.0|3248|All ICCC Groups Combined|15616575|2003
1-4|78.6|87.7|83.1|1297|I Leukemias, myeloproliferative & myelodysplastic diseases|15616575|2003
1-4|64.4|72.7|68.5|1069|I(a) Lymphoid leukemias|15616575|2003
1-4|8.3|11.5|9.8|153|I(b) Acute myeloid leukemias|15616575|2003
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15616575|2003
1-4|2.0|3.7|2.8|43|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15616575|2003
1-4|0.7|1.8|1.2|18|I(e) Unspecified and other specified leukemias|15616575|2003
1-4|9.3|12.6|10.8|169|II Lymphomas and reticuloendothelial neoplasms|15616575|2003
1-4|0.7|1.8|1.2|18|II(a) Hodgkin lymphomas|15616575|2003
1-4|3.9|6.2|4.9|77|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15616575|2003
1-4|1.7|3.3|2.4|37|II(c) Burkitt lymphoma|15616575|2003
1-4|1.6|3.1|2.2|35|II(d) Miscellaneous lymphoreticular neoplasms|15616575|2003
1-4|~|~|~|~|II(e) Unspecified lymphomas|15616575|2003
1-4|37.9|44.3|41.0|640|III CNS and misc intracranial and intraspinal neoplasms|15616575|2003
1-4|3.7|5.9|4.7|73|III(a) Ependymomas and choroid plexus tumor|15616575|2003
1-4|18.5|23.1|20.7|324|III(b) Astrocytomas|15616575|2003
1-4|8.0|11.1|9.4|147|III(c) Intracranial and intraspinal embryonal tumors|15616575|2003
1-4|4.1|6.4|5.1|80|III(d) Other gliomas|15616575|2003
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15616575|2003
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15616575|2003
1-4|18.5|23.1|20.7|323|IV Neuroblastoma and other peripheral nervous cell tumors|15616575|2003
1-4|18.4|23.0|20.6|322|IV(a) Neuroblastoma and ganglioneuroblastoma|15616575|2003
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15616575|2003
1-4|9.6|13.0|11.2|175|IX Soft tissue and other extraosseous sarcomas|15616575|2003
1-4|6.3|9.1|7.6|119|IX(a) Rhabdomyosarcomas|15616575|2003
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15616575|2003
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15616575|2003
1-4|1.7|3.3|2.4|38|IX(d) Other specified soft tissue sarcomas|15616575|2003
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15616575|2003
1-4|~|~|~|~|Not classified by ICCC|15616575|2003
1-4|6.4|9.3|7.7|121|V Retinoblastoma|15616575|2003
1-4|17.6|22.1|19.8|309|VI Renal tumors|15616575|2003
1-4|17.3|21.8|19.5|304|VI(a) Nephroblastoma and other nonepithelial renal tumors|15616575|2003
1-4|~|~|~|~|VI(b) Renal carcinomas|15616575|2003
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15616575|2003
1-4|3.3|5.4|4.3|67|VII Hepatic tumors|15616575|2003
1-4|3.2|5.2|4.1|64|VII(a) Hepatoblastoma|15616575|2003
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15616575|2003
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15616575|2003
1-4|1.2|2.6|1.8|28|VIII Malignant bone tumors|15616575|2003
1-4|~|~|~|~|VIII(a) Osteosarcomas|15616575|2003
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15616575|2003
1-4|0.7|1.8|1.2|18|VIII(c) Ewing tumor and related sarcomas of bone|15616575|2003
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15616575|2003
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15616575|2003
1-4|3.0|5.1|4.0|62|X Germ cell, trophoblastic tumors & neoplasms of gonads|15616575|2003
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15616575|2003
1-4|1.2|2.7|1.9|29|X(b) Malignant extracranial & extragonadal germ cell tumors|15616575|2003
1-4|1.2|2.7|1.9|29|X(c) Malignant gonadal germ cell tumors|15616575|2003
1-4|~|~|~|~|X(d) Gonadal carcinomas|15616575|2003
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15616575|2003
1-4|1.2|2.6|1.8|28|XI Other malignant epithelial neoplasms and malignant melanomas|15616575|2003
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15616575|2003
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15616575|2003
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15616575|2003
1-4|~|~|~|~|XI(d) Malignant melanomas|15616575|2003
1-4|~|~|~|~|XI(e) Skin carcinomas|15616575|2003
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15616575|2003
1-4|1.0|2.3|1.5|24|XII Other and unspecified malignant neoplasms|15616575|2003
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15616575|2003
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15616575|2003
10-14|123.0|132.6|127.8|2736|All ICCC Groups Combined|21415353|2003
10-14|25.6|30.1|27.8|595|I Leukemias, myeloproliferative & myelodysplastic diseases|21415353|2003
10-14|15.7|19.3|17.5|374|I(a) Lymphoid leukemias|21415353|2003
10-14|5.7|7.9|6.7|144|I(b) Acute myeloid leukemias|21415353|2003
10-14|1.0|2.1|1.4|31|I(c) Chronic myeloproliferative diseases|21415353|2003
10-14|1.1|2.2|1.5|33|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21415353|2003
10-14|~|~|~|~|I(e) Unspecified and other specified leukemias|21415353|2003
10-14|20.5|24.6|22.5|482|II Lymphomas and reticuloendothelial neoplasms|21415353|2003
10-14|10.4|13.4|11.9|254|II(a) Hodgkin lymphomas|21415353|2003
10-14|6.8|9.3|8.0|171|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21415353|2003
10-14|1.8|3.1|2.4|51|II(c) Burkitt lymphoma|21415353|2003
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21415353|2003
10-14|~|~|~|~|II(e) Unspecified lymphomas|21415353|2003
10-14|24.3|28.7|26.4|566|III CNS and misc intracranial and intraspinal neoplasms|21415353|2003
10-14|0.9|1.9|1.4|29|III(a) Ependymomas and choroid plexus tumor|21415353|2003
10-14|12.7|15.9|14.2|305|III(b) Astrocytomas|21415353|2003
10-14|3.1|4.9|3.9|84|III(c) Intracranial and intraspinal embryonal tumors|21415353|2003
10-14|4.8|6.9|5.7|123|III(d) Other gliomas|21415353|2003
10-14|0.4|1.2|0.7|16|III(e) Other specified intracranial & intraspinal neoplasms|21415353|2003
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21415353|2003
10-14|1.4|2.6|1.9|41|IV Neuroblastoma and other peripheral nervous cell tumors|21415353|2003
10-14|1.1|2.3|1.6|35|IV(a) Neuroblastoma and ganglioneuroblastoma|21415353|2003
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21415353|2003
10-14|10.4|13.4|11.9|254|IX Soft tissue and other extraosseous sarcomas|21415353|2003
10-14|3.0|4.7|3.8|81|IX(a) Rhabdomyosarcomas|21415353|2003
10-14|0.6|1.6|1.0|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21415353|2003
10-14|~|~|~|~|IX(c) Kaposi sarcoma|21415353|2003
10-14|4.6|6.6|5.5|118|IX(d) Other specified soft tissue sarcomas|21415353|2003
10-14|1.1|2.2|1.5|33|IX(e) Unspecified soft tissue sarcomas|21415353|2003
10-14|~|~|~|~|Not classified by ICCC|21415353|2003
10-14|~|~|~|~|V Retinoblastoma|21415353|2003
10-14|1.1|2.2|1.5|33|VI Renal tumors|21415353|2003
10-14|0.6|1.5|1.0|21|VI(a) Nephroblastoma and other nonepithelial renal tumors|21415353|2003
10-14|~|~|~|~|VI(b) Renal carcinomas|21415353|2003
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|21415353|2003
10-14|0.6|1.5|1.0|21|VII Hepatic tumors|21415353|2003
10-14|~|~|~|~|VII(a) Hepatoblastoma|21415353|2003
10-14|0.4|1.2|0.7|16|VII(b) Hepatic carcinomas|21415353|2003
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21415353|2003
10-14|11.9|15.0|13.4|286|VIII Malignant bone tumors|21415353|2003
10-14|6.9|9.4|8.1|173|VIII(a) Osteosarcomas|21415353|2003
10-14|~|~|~|~|VIII(b) Chondrosarcomas|21415353|2003
10-14|3.1|4.8|3.9|83|VIII(c) Ewing tumor and related sarcomas of bone|21415353|2003
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|21415353|2003
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21415353|2003
10-14|5.9|8.2|7.0|149|X Germ cell, trophoblastic tumors & neoplasms of gonads|21415353|2003
10-14|1.7|3.1|2.3|50|X(a) Intracranial & intraspinal germ cell tumors|21415353|2003
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|21415353|2003
10-14|2.8|4.5|3.6|77|X(c) Malignant gonadal germ cell tumors|21415353|2003
10-14|~|~|~|~|X(d) Gonadal carcinomas|21415353|2003
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21415353|2003
10-14|11.9|15.1|13.4|288|XI Other malignant epithelial neoplasms and malignant melanomas|21415353|2003
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|21415353|2003
10-14|4.3|6.2|5.2|111|XI(b) Thyroid carcinomas|21415353|2003
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|21415353|2003
10-14|3.0|4.6|3.7|80|XI(d) Malignant melanomas|21415353|2003
10-14|~|~|~|~|XI(e) Skin carcinomas|21415353|2003
10-14|3.1|4.8|3.9|83|XI(f) Other and unspecified carcinomas|21415353|2003
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|21415353|2003
10-14|~|~|~|~|XII(a) Other specified malignant tumors|21415353|2003
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|21415353|2003
15-19|207.6|220.3|213.9|4448|All ICCC Groups Combined|20797166|2003
15-19|28.6|33.4|30.9|643|I Leukemias, myeloproliferative & myelodysplastic diseases|20797166|2003
15-19|13.3|16.7|14.9|310|I(a) Lymphoid leukemias|20797166|2003
15-19|7.5|10.1|8.7|181|I(b) Acute myeloid leukemias|20797166|2003
15-19|4.0|5.9|4.9|101|I(c) Chronic myeloproliferative diseases|20797166|2003
15-19|0.8|1.8|1.3|26|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20797166|2003
15-19|0.8|1.8|1.2|25|I(e) Unspecified and other specified leukemias|20797166|2003
15-19|45.2|51.3|48.2|1002|II Lymphomas and reticuloendothelial neoplasms|20797166|2003
15-19|29.5|34.5|31.9|664|II(a) Hodgkin lymphomas|20797166|2003
15-19|11.8|14.9|13.3|276|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20797166|2003
15-19|1.7|3.1|2.4|49|II(c) Burkitt lymphoma|20797166|2003
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20797166|2003
15-19|~|~|~|~|II(e) Unspecified lymphomas|20797166|2003
15-19|20.0|24.1|22.0|457|III CNS and misc intracranial and intraspinal neoplasms|20797166|2003
15-19|1.3|2.5|1.8|37|III(a) Ependymomas and choroid plexus tumor|20797166|2003
15-19|10.7|13.7|12.1|252|III(b) Astrocytomas|20797166|2003
15-19|2.2|3.7|2.8|59|III(c) Intracranial and intraspinal embryonal tumors|20797166|2003
15-19|3.2|5.0|4.0|84|III(d) Other gliomas|20797166|2003
15-19|0.4|1.2|0.8|16|III(e) Other specified intracranial & intraspinal neoplasms|20797166|2003
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20797166|2003
15-19|0.4|1.2|0.8|16|IV Neuroblastoma and other peripheral nervous cell tumors|20797166|2003
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20797166|2003
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20797166|2003
15-19|15.1|18.6|16.8|349|IX Soft tissue and other extraosseous sarcomas|20797166|2003
15-19|3.2|4.9|4.0|83|IX(a) Rhabdomyosarcomas|20797166|2003
15-19|2.0|3.4|2.6|55|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20797166|2003
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20797166|2003
15-19|6.8|9.3|8.0|166|IX(d) Other specified soft tissue sarcomas|20797166|2003
15-19|1.5|2.8|2.1|44|IX(e) Unspecified soft tissue sarcomas|20797166|2003
15-19|~|~|~|~|Not classified by ICCC|20797166|2003
15-19|~|~|~|~|V Retinoblastoma|20797166|2003
15-19|0.9|1.9|1.3|27|VI Renal tumors|20797166|2003
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20797166|2003
15-19|0.7|1.7|1.2|24|VI(b) Renal carcinomas|20797166|2003
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20797166|2003
15-19|0.7|1.6|1.1|22|VII Hepatic tumors|20797166|2003
15-19|~|~|~|~|VII(a) Hepatoblastoma|20797166|2003
15-19|0.7|1.6|1.1|22|VII(b) Hepatic carcinomas|20797166|2003
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20797166|2003
15-19|13.1|16.5|14.7|306|VIII Malignant bone tumors|20797166|2003
15-19|8.7|11.5|10.0|209|VIII(a) Osteosarcomas|20797166|2003
15-19|~|~|~|~|VIII(b) Chondrosarcomas|20797166|2003
15-19|2.8|4.5|3.6|75|VIII(c) Ewing tumor and related sarcomas of bone|20797166|2003
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|20797166|2003
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20797166|2003
15-19|23.7|28.2|25.9|538|X Germ cell, trophoblastic tumors & neoplasms of gonads|20797166|2003
15-19|1.3|2.6|1.9|39|X(a) Intracranial & intraspinal germ cell tumors|20797166|2003
15-19|1.1|2.2|1.6|33|X(b) Malignant extracranial & extragonadal germ cell tumors|20797166|2003
15-19|18.3|22.2|20.1|419|X(c) Malignant gonadal germ cell tumors|20797166|2003
15-19|0.8|1.8|1.2|25|X(d) Gonadal carcinomas|20797166|2003
15-19|0.7|1.6|1.1|22|X(e) Other and unspecified malignant gonadal tumors|20797166|2003
15-19|47.1|53.2|50.1|1041|XI Other malignant epithelial neoplasms and malignant melanomas|20797166|2003
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20797166|2003
15-19|16.4|20.1|18.2|378|XI(b) Thyroid carcinomas|20797166|2003
15-19|1.4|2.7|2.0|41|XI(c) Nasopharyngeal carcinomas|20797166|2003
15-19|16.0|19.7|17.8|370|XI(d) Malignant melanomas|20797166|2003
15-19|~|~|~|~|XI(e) Skin carcinomas|20797166|2003
15-19|10.0|12.9|11.4|237|XI(f) Other and unspecified carcinomas|20797166|2003
15-19|1.4|2.6|1.9|40|XII Other and unspecified malignant neoplasms|20797166|2003
15-19|0.6|1.4|0.9|19|XII(a) Other specified malignant tumors|20797166|2003
15-19|0.6|1.5|1.0|21|XII(b) Other unspecified malignant tumors|20797166|2003
5-9|110.0|119.5|114.7|2250|All ICCC Groups Combined|19620851|2003
5-9|37.1|42.7|39.9|782|I Leukemias, myeloproliferative & myelodysplastic diseases|19620851|2003
5-9|30.4|35.5|32.9|645|I(a) Lymphoid leukemias|19620851|2003
5-9|3.6|5.6|4.5|89|I(b) Acute myeloid leukemias|19620851|2003
5-9|0.7|1.7|1.1|22|I(c) Chronic myeloproliferative diseases|19620851|2003
5-9|0.5|1.3|0.8|16|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19620851|2003
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|19620851|2003
5-9|13.6|17.1|15.2|299|II Lymphomas and reticuloendothelial neoplasms|19620851|2003
5-9|3.6|5.5|4.4|87|II(a) Hodgkin lymphomas|19620851|2003
5-9|5.3|7.6|6.4|126|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19620851|2003
5-9|3.0|4.7|3.8|74|II(c) Burkitt lymphoma|19620851|2003
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19620851|2003
5-9|~|~|~|~|II(e) Unspecified lymphomas|19620851|2003
5-9|30.2|35.3|32.7|641|III CNS and misc intracranial and intraspinal neoplasms|19620851|2003
5-9|1.2|2.4|1.7|34|III(a) Ependymomas and choroid plexus tumor|19620851|2003
5-9|13.9|17.5|15.6|307|III(b) Astrocytomas|19620851|2003
5-9|6.5|9.0|7.7|151|III(c) Intracranial and intraspinal embryonal tumors|19620851|2003
5-9|5.2|7.4|6.2|122|III(d) Other gliomas|19620851|2003
5-9|0.7|1.8|1.2|23|III(e) Other specified intracranial & intraspinal neoplasms|19620851|2003
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19620851|2003
5-9|2.2|3.8|3.0|58|IV Neuroblastoma and other peripheral nervous cell tumors|19620851|2003
5-9|2.2|3.7|2.9|56|IV(a) Neuroblastoma and ganglioneuroblastoma|19620851|2003
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19620851|2003
5-9|6.8|9.3|8.0|156|IX Soft tissue and other extraosseous sarcomas|19620851|2003
5-9|3.6|5.5|4.4|87|IX(a) Rhabdomyosarcomas|19620851|2003
5-9|0.6|1.5|1.0|19|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19620851|2003
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19620851|2003
5-9|1.6|3.0|2.2|43|IX(d) Other specified soft tissue sarcomas|19620851|2003
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19620851|2003
5-9|~|~|~|~|Not classified by ICCC|19620851|2003
5-9|~|~|~|~|V Retinoblastoma|19620851|2003
5-9|4.3|6.4|5.2|103|VI Renal tumors|19620851|2003
5-9|3.9|5.9|4.8|95|VI(a) Nephroblastoma and other nonepithelial renal tumors|19620851|2003
5-9|~|~|~|~|VI(b) Renal carcinomas|19620851|2003
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19620851|2003
5-9|~|~|~|~|VII Hepatic tumors|19620851|2003
5-9|~|~|~|~|VII(a) Hepatoblastoma|19620851|2003
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19620851|2003
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19620851|2003
5-9|3.6|5.5|4.5|88|VIII Malignant bone tumors|19620851|2003
5-9|1.7|3.1|2.3|46|VIII(a) Osteosarcomas|19620851|2003
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19620851|2003
5-9|1.1|2.3|1.6|32|VIII(c) Ewing tumor and related sarcomas of bone|19620851|2003
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19620851|2003
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19620851|2003
5-9|1.2|2.5|1.8|35|X Germ cell, trophoblastic tumors & neoplasms of gonads|19620851|2003
5-9|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|19620851|2003
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19620851|2003
5-9|0.5|1.3|0.8|16|X(c) Malignant gonadal germ cell tumors|19620851|2003
5-9|~|~|~|~|X(d) Gonadal carcinomas|19620851|2003
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19620851|2003
5-9|2.2|3.7|2.9|56|XI Other malignant epithelial neoplasms and malignant melanomas|19620851|2003
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19620851|2003
5-9|~|~|~|~|XI(b) Thyroid carcinomas|19620851|2003
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19620851|2003
5-9|~|~|~|~|XI(d) Malignant melanomas|19620851|2003
5-9|~|~|~|~|XI(e) Skin carcinomas|19620851|2003
5-9|0.7|1.7|1.1|22|XI(f) Other and unspecified carcinomas|19620851|2003
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19620851|2003
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19620851|2003
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19620851|2003
<1|235.9|267.3|251.3|999|All ICCC Groups Combined|3975871|2003
<1|44.7|59.1|51.6|205|I Leukemias, myeloproliferative & myelodysplastic diseases|3975871|2003
<1|15.3|24.2|19.4|77|I(a) Lymphoid leukemias|3975871|2003
<1|13.9|22.5|17.9|71|I(b) Acute myeloid leukemias|3975871|2003
<1|3.7|8.7|5.8|23|I(c) Chronic myeloproliferative diseases|3975871|2003
<1|2.9|7.5|4.8|19|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3975871|2003
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3975871|2003
<1|5.5|11.4|8.0|32|II Lymphomas and reticuloendothelial neoplasms|3975871|2003
<1|~|~|~|~|II(a) Hodgkin lymphomas|3975871|2003
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3975871|2003
<1|~|~|~|~|II(c) Burkitt lymphoma|3975871|2003
<1|3.7|8.7|5.8|23|II(d) Miscellaneous lymphoreticular neoplasms|3975871|2003
<1|~|~|~|~|II(e) Unspecified lymphomas|3975871|2003
<1|29.4|41.3|35.0|139|III CNS and misc intracranial and intraspinal neoplasms|3975871|2003
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3975871|2003
<1|11.3|19.1|14.8|59|III(b) Astrocytomas|3975871|2003
<1|9.6|16.9|12.8|51|III(c) Intracranial and intraspinal embryonal tumors|3975871|2003
<1|~|~|~|~|III(d) Other gliomas|3975871|2003
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3975871|2003
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3975871|2003
<1|50.4|65.6|57.6|229|IV Neuroblastoma and other peripheral nervous cell tumors|3975871|2003
<1|50.1|65.3|57.3|228|IV(a) Neuroblastoma and ganglioneuroblastoma|3975871|2003
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3975871|2003
<1|12.6|20.8|16.3|65|IX Soft tissue and other extraosseous sarcomas|3975871|2003
<1|2.9|7.5|4.8|19|IX(a) Rhabdomyosarcomas|3975871|2003
<1|2.3|6.5|4.0|16|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3975871|2003
<1|~|~|~|~|IX(c) Kaposi sarcoma|3975871|2003
<1|3.3|8.1|5.3|21|IX(d) Other specified soft tissue sarcomas|3975871|2003
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3975871|2003
<1|~|~|~|~|Not classified by ICCC|3975871|2003
<1|23.0|33.6|27.9|111|V Retinoblastoma|3975871|2003
<1|14.2|22.8|18.1|72|VI Renal tumors|3975871|2003
<1|14.2|22.8|18.1|72|VI(a) Nephroblastoma and other nonepithelial renal tumors|3975871|2003
<1|~|~|~|~|VI(b) Renal carcinomas|3975871|2003
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3975871|2003
<1|9.3|16.6|12.6|50|VII Hepatic tumors|3975871|2003
<1|9.1|16.3|12.3|49|VII(a) Hepatoblastoma|3975871|2003
<1|~|~|~|~|VII(b) Hepatic carcinomas|3975871|2003
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3975871|2003
<1|~|~|~|~|VIII Malignant bone tumors|3975871|2003
<1|~|~|~|~|VIII(a) Osteosarcomas|3975871|2003
<1|~|~|~|~|VIII(b) Chondrosarcomas|3975871|2003
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3975871|2003
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3975871|2003
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3975871|2003
<1|12.8|21.1|16.6|66|X Germ cell, trophoblastic tumors & neoplasms of gonads|3975871|2003
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3975871|2003
<1|8.7|15.7|11.8|47|X(b) Malignant extracranial & extragonadal germ cell tumors|3975871|2003
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3975871|2003
<1|~|~|~|~|X(d) Gonadal carcinomas|3975871|2003
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3975871|2003
<1|2.5|6.8|4.3|17|XI Other malignant epithelial neoplasms and malignant melanomas|3975871|2003
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3975871|2003
<1|~|~|~|~|XI(b) Thyroid carcinomas|3975871|2003
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3975871|2003
<1|~|~|~|~|XI(d) Malignant melanomas|3975871|2003
<1|~|~|~|~|XI(e) Skin carcinomas|3975871|2003
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3975871|2003
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3975871|2003
<1|~|~|~|~|XII(a) Other specified malignant tumors|3975871|2003
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3975871|2003
1-4|216.1|230.9|223.4|3524|All ICCC Groups Combined|15771627|2004
1-4|88.9|98.5|93.6|1476|I Leukemias, myeloproliferative & myelodysplastic diseases|15771627|2004
1-4|73.2|82.0|77.5|1222|I(a) Lymphoid leukemias|15771627|2004
1-4|9.0|12.3|10.6|167|I(b) Acute myeloid leukemias|15771627|2004
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15771627|2004
1-4|1.8|3.4|2.5|39|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15771627|2004
1-4|1.5|3.0|2.2|34|I(e) Unspecified and other specified leukemias|15771627|2004
1-4|8.9|12.1|10.4|164|II Lymphomas and reticuloendothelial neoplasms|15771627|2004
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15771627|2004
1-4|3.5|5.7|4.5|71|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15771627|2004
1-4|1.6|3.2|2.3|36|II(c) Burkitt lymphoma|15771627|2004
1-4|1.8|3.5|2.5|40|II(d) Miscellaneous lymphoreticular neoplasms|15771627|2004
1-4|~|~|~|~|II(e) Unspecified lymphomas|15771627|2004
1-4|42.6|49.3|45.8|723|III CNS and misc intracranial and intraspinal neoplasms|15771627|2004
1-4|3.9|6.1|4.9|77|III(a) Ependymomas and choroid plexus tumor|15771627|2004
1-4|20.0|24.8|22.3|352|III(b) Astrocytomas|15771627|2004
1-4|10.0|13.4|11.6|183|III(c) Intracranial and intraspinal embryonal tumors|15771627|2004
1-4|4.2|6.6|5.3|84|III(d) Other gliomas|15771627|2004
1-4|0.6|1.6|1.0|16|III(e) Other specified intracranial & intraspinal neoplasms|15771627|2004
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15771627|2004
1-4|19.7|24.4|21.9|346|IV Neuroblastoma and other peripheral nervous cell tumors|15771627|2004
1-4|19.6|24.2|21.8|344|IV(a) Neuroblastoma and ganglioneuroblastoma|15771627|2004
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15771627|2004
1-4|8.0|11.1|9.4|149|IX Soft tissue and other extraosseous sarcomas|15771627|2004
1-4|5.7|8.4|7.0|110|IX(a) Rhabdomyosarcomas|15771627|2004
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15771627|2004
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15771627|2004
1-4|1.2|2.6|1.8|28|IX(d) Other specified soft tissue sarcomas|15771627|2004
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15771627|2004
1-4|~|~|~|~|Not classified by ICCC|15771627|2004
1-4|7.9|11.0|9.3|147|V Retinoblastoma|15771627|2004
1-4|17.7|22.2|19.8|313|VI Renal tumors|15771627|2004
1-4|17.6|22.0|19.7|311|VI(a) Nephroblastoma and other nonepithelial renal tumors|15771627|2004
1-4|~|~|~|~|VI(b) Renal carcinomas|15771627|2004
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15771627|2004
1-4|4.4|6.7|5.5|86|VII Hepatic tumors|15771627|2004
1-4|4.2|6.5|5.3|83|VII(a) Hepatoblastoma|15771627|2004
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15771627|2004
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15771627|2004
1-4|0.9|2.2|1.5|23|VIII Malignant bone tumors|15771627|2004
1-4|~|~|~|~|VIII(a) Osteosarcomas|15771627|2004
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15771627|2004
1-4|0.6|1.6|1.0|16|VIII(c) Ewing tumor and related sarcomas of bone|15771627|2004
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15771627|2004
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15771627|2004
1-4|2.3|4.1|3.1|49|X Germ cell, trophoblastic tumors & neoplasms of gonads|15771627|2004
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15771627|2004
1-4|1.1|2.4|1.6|26|X(b) Malignant extracranial & extragonadal germ cell tumors|15771627|2004
1-4|0.7|1.8|1.1|18|X(c) Malignant gonadal germ cell tumors|15771627|2004
1-4|~|~|~|~|X(d) Gonadal carcinomas|15771627|2004
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15771627|2004
1-4|1.5|3.1|2.2|35|XI Other malignant epithelial neoplasms and malignant melanomas|15771627|2004
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15771627|2004
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15771627|2004
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15771627|2004
1-4|0.8|2.0|1.3|20|XI(d) Malignant melanomas|15771627|2004
1-4|~|~|~|~|XI(e) Skin carcinomas|15771627|2004
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15771627|2004
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15771627|2004
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15771627|2004
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15771627|2004
10-14|129.0|138.8|133.8|2865|All ICCC Groups Combined|21411680|2004
10-14|27.3|31.9|29.5|632|I Leukemias, myeloproliferative & myelodysplastic diseases|21411680|2004
10-14|17.0|20.7|18.8|402|I(a) Lymphoid leukemias|21411680|2004
10-14|5.8|8.0|6.8|146|I(b) Acute myeloid leukemias|21411680|2004
10-14|1.6|2.9|2.1|46|I(c) Chronic myeloproliferative diseases|21411680|2004
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21411680|2004
10-14|0.7|1.6|1.1|23|I(e) Unspecified and other specified leukemias|21411680|2004
10-14|22.5|26.7|24.5|525|II Lymphomas and reticuloendothelial neoplasms|21411680|2004
10-14|9.9|12.8|11.3|242|II(a) Hodgkin lymphomas|21411680|2004
10-14|9.1|11.9|10.5|224|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21411680|2004
10-14|1.8|3.2|2.4|52|II(c) Burkitt lymphoma|21411680|2004
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21411680|2004
10-14|~|~|~|~|II(e) Unspecified lymphomas|21411680|2004
10-14|24.0|28.4|26.1|559|III CNS and misc intracranial and intraspinal neoplasms|21411680|2004
10-14|1.1|2.2|1.5|33|III(a) Ependymomas and choroid plexus tumor|21411680|2004
10-14|12.8|16.0|14.3|307|III(b) Astrocytomas|21411680|2004
10-14|3.8|5.6|4.6|99|III(c) Intracranial and intraspinal embryonal tumors|21411680|2004
10-14|3.6|5.4|4.4|95|III(d) Other gliomas|21411680|2004
10-14|0.4|1.2|0.7|16|III(e) Other specified intracranial & intraspinal neoplasms|21411680|2004
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21411680|2004
10-14|0.7|1.7|1.1|24|IV Neuroblastoma and other peripheral nervous cell tumors|21411680|2004
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21411680|2004
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21411680|2004
10-14|11.4|14.5|12.9|276|IX Soft tissue and other extraosseous sarcomas|21411680|2004
10-14|2.8|4.5|3.6|77|IX(a) Rhabdomyosarcomas|21411680|2004
10-14|1.2|2.4|1.7|37|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21411680|2004
10-14|~|~|~|~|IX(c) Kaposi sarcoma|21411680|2004
10-14|4.9|7.0|5.9|126|IX(d) Other specified soft tissue sarcomas|21411680|2004
10-14|1.1|2.3|1.6|35|IX(e) Unspecified soft tissue sarcomas|21411680|2004
10-14|~|~|~|~|Not classified by ICCC|21411680|2004
10-14|~|~|~|~|V Retinoblastoma|21411680|2004
10-14|1.1|2.3|1.6|35|VI Renal tumors|21411680|2004
10-14|0.5|1.3|0.8|18|VI(a) Nephroblastoma and other nonepithelial renal tumors|21411680|2004
10-14|0.5|1.3|0.8|17|VI(b) Renal carcinomas|21411680|2004
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|21411680|2004
10-14|~|~|~|~|VII Hepatic tumors|21411680|2004
10-14|~|~|~|~|VII(a) Hepatoblastoma|21411680|2004
10-14|~|~|~|~|VII(b) Hepatic carcinomas|21411680|2004
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21411680|2004
10-14|12.6|15.8|14.2|303|VIII Malignant bone tumors|21411680|2004
10-14|7.4|9.9|8.5|183|VIII(a) Osteosarcomas|21411680|2004
10-14|~|~|~|~|VIII(b) Chondrosarcomas|21411680|2004
10-14|3.5|5.3|4.3|92|VIII(c) Ewing tumor and related sarcomas of bone|21411680|2004
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|21411680|2004
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21411680|2004
10-14|7.3|9.8|8.5|181|X Germ cell, trophoblastic tumors & neoplasms of gonads|21411680|2004
10-14|2.1|3.6|2.8|60|X(a) Intracranial & intraspinal germ cell tumors|21411680|2004
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|21411680|2004
10-14|3.7|5.6|4.6|98|X(c) Malignant gonadal germ cell tumors|21411680|2004
10-14|~|~|~|~|X(d) Gonadal carcinomas|21411680|2004
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21411680|2004
10-14|12.3|15.4|13.8|295|XI Other malignant epithelial neoplasms and malignant melanomas|21411680|2004
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|21411680|2004
10-14|4.5|6.5|5.4|116|XI(b) Thyroid carcinomas|21411680|2004
10-14|0.7|1.6|1.1|23|XI(c) Nasopharyngeal carcinomas|21411680|2004
10-14|3.4|5.2|4.2|90|XI(d) Malignant melanomas|21411680|2004
10-14|~|~|~|~|XI(e) Skin carcinomas|21411680|2004
10-14|2.1|3.6|2.8|60|XI(f) Other and unspecified carcinomas|21411680|2004
10-14|0.5|1.4|0.9|19|XII Other and unspecified malignant neoplasms|21411680|2004
10-14|~|~|~|~|XII(a) Other specified malignant tumors|21411680|2004
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|21411680|2004
15-19|211.2|223.8|217.5|4589|All ICCC Groups Combined|21102552|2004
15-19|29.3|34.1|31.7|668|I Leukemias, myeloproliferative & myelodysplastic diseases|21102552|2004
15-19|15.1|18.6|16.8|354|I(a) Lymphoid leukemias|21102552|2004
15-19|7.8|10.4|9.1|191|I(b) Acute myeloid leukemias|21102552|2004
15-19|3.3|5.0|4.1|86|I(c) Chronic myeloproliferative diseases|21102552|2004
15-19|0.6|1.5|0.9|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21102552|2004
15-19|0.5|1.3|0.8|17|I(e) Unspecified and other specified leukemias|21102552|2004
15-19|45.4|51.3|48.3|1019|II Lymphomas and reticuloendothelial neoplasms|21102552|2004
15-19|29.3|34.1|31.6|667|II(a) Hodgkin lymphomas|21102552|2004
15-19|12.0|15.2|13.6|286|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21102552|2004
15-19|1.5|2.8|2.1|44|II(c) Burkitt lymphoma|21102552|2004
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21102552|2004
15-19|~|~|~|~|II(e) Unspecified lymphomas|21102552|2004
15-19|21.3|25.5|23.4|493|III CNS and misc intracranial and intraspinal neoplasms|21102552|2004
15-19|1.5|2.7|2.0|43|III(a) Ependymomas and choroid plexus tumor|21102552|2004
15-19|11.8|15.0|13.4|282|III(b) Astrocytomas|21102552|2004
15-19|2.3|3.8|2.9|62|III(c) Intracranial and intraspinal embryonal tumors|21102552|2004
15-19|3.3|5.1|4.2|88|III(d) Other gliomas|21102552|2004
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21102552|2004
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21102552|2004
15-19|0.5|1.3|0.8|17|IV Neuroblastoma and other peripheral nervous cell tumors|21102552|2004
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21102552|2004
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21102552|2004
15-19|14.7|18.2|16.3|345|IX Soft tissue and other extraosseous sarcomas|21102552|2004
15-19|2.5|4.1|3.3|69|IX(a) Rhabdomyosarcomas|21102552|2004
15-19|1.2|2.4|1.8|37|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21102552|2004
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21102552|2004
15-19|8.2|10.8|9.4|199|IX(d) Other specified soft tissue sarcomas|21102552|2004
15-19|1.3|2.5|1.8|38|IX(e) Unspecified soft tissue sarcomas|21102552|2004
15-19|~|~|~|~|Not classified by ICCC|21102552|2004
15-19|~|~|~|~|V Retinoblastoma|21102552|2004
15-19|1.2|2.3|1.7|35|VI Renal tumors|21102552|2004
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21102552|2004
15-19|0.7|1.7|1.1|24|VI(b) Renal carcinomas|21102552|2004
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21102552|2004
15-19|1.1|2.2|1.6|33|VII Hepatic tumors|21102552|2004
15-19|~|~|~|~|VII(a) Hepatoblastoma|21102552|2004
15-19|1.1|2.2|1.6|33|VII(b) Hepatic carcinomas|21102552|2004
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21102552|2004
15-19|13.2|16.5|14.8|312|VIII Malignant bone tumors|21102552|2004
15-19|6.9|9.4|8.1|171|VIII(a) Osteosarcomas|21102552|2004
15-19|0.8|1.7|1.2|25|VIII(b) Chondrosarcomas|21102552|2004
15-19|3.2|4.9|4.0|84|VIII(c) Ewing tumor and related sarcomas of bone|21102552|2004
15-19|0.7|1.7|1.1|24|VIII(d) Other specified malignant bone tumors|21102552|2004
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21102552|2004
15-19|25.3|29.9|27.5|581|X Germ cell, trophoblastic tumors & neoplasms of gonads|21102552|2004
15-19|1.8|3.2|2.5|52|X(a) Intracranial & intraspinal germ cell tumors|21102552|2004
15-19|0.9|1.9|1.3|28|X(b) Malignant extracranial & extragonadal germ cell tumors|21102552|2004
15-19|19.9|23.9|21.8|461|X(c) Malignant gonadal germ cell tumors|21102552|2004
15-19|0.7|1.6|1.1|23|X(d) Gonadal carcinomas|21102552|2004
15-19|0.5|1.3|0.8|17|X(e) Other and unspecified malignant gonadal tumors|21102552|2004
15-19|46.6|52.7|49.6|1046|XI Other malignant epithelial neoplasms and malignant melanomas|21102552|2004
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21102552|2004
15-19|17.5|21.3|19.3|407|XI(b) Thyroid carcinomas|21102552|2004
15-19|0.7|1.6|1.0|22|XI(c) Nasopharyngeal carcinomas|21102552|2004
15-19|16.6|20.3|18.4|388|XI(d) Malignant melanomas|21102552|2004
15-19|~|~|~|~|XI(e) Skin carcinomas|21102552|2004
15-19|9.3|12.1|10.6|224|XI(f) Other and unspecified carcinomas|21102552|2004
15-19|0.9|2.0|1.4|29|XII Other and unspecified malignant neoplasms|21102552|2004
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21102552|2004
15-19|0.5|1.4|0.9|19|XII(b) Other unspecified malignant tumors|21102552|2004
5-9|114.8|124.6|119.6|2327|All ICCC Groups Combined|19454237|2004
5-9|38.2|43.9|41.0|797|I Leukemias, myeloproliferative & myelodysplastic diseases|19454237|2004
5-9|30.5|35.7|33.0|642|I(a) Lymphoid leukemias|19454237|2004
5-9|4.1|6.2|5.1|99|I(b) Acute myeloid leukemias|19454237|2004
5-9|0.7|1.8|1.2|23|I(c) Chronic myeloproliferative diseases|19454237|2004
5-9|0.5|1.5|0.9|18|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19454237|2004
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|19454237|2004
5-9|11.8|15.1|13.4|261|II Lymphomas and reticuloendothelial neoplasms|19454237|2004
5-9|2.7|4.4|3.5|68|II(a) Hodgkin lymphomas|19454237|2004
5-9|5.0|7.3|6.1|118|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19454237|2004
5-9|2.3|3.9|3.0|58|II(c) Burkitt lymphoma|19454237|2004
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19454237|2004
5-9|~|~|~|~|II(e) Unspecified lymphomas|19454237|2004
5-9|32.9|38.3|35.5|691|III CNS and misc intracranial and intraspinal neoplasms|19454237|2004
5-9|1.7|3.1|2.3|45|III(a) Ependymomas and choroid plexus tumor|19454237|2004
5-9|15.8|19.6|17.6|343|III(b) Astrocytomas|19454237|2004
5-9|6.4|8.9|7.6|147|III(c) Intracranial and intraspinal embryonal tumors|19454237|2004
5-9|5.9|8.3|7.0|137|III(d) Other gliomas|19454237|2004
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19454237|2004
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19454237|2004
5-9|2.6|4.3|3.3|65|IV Neuroblastoma and other peripheral nervous cell tumors|19454237|2004
5-9|2.5|4.2|3.3|64|IV(a) Neuroblastoma and ganglioneuroblastoma|19454237|2004
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19454237|2004
5-9|6.4|8.9|7.6|148|IX Soft tissue and other extraosseous sarcomas|19454237|2004
5-9|3.1|4.9|3.9|76|IX(a) Rhabdomyosarcomas|19454237|2004
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19454237|2004
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19454237|2004
5-9|1.9|3.3|2.5|49|IX(d) Other specified soft tissue sarcomas|19454237|2004
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19454237|2004
5-9|~|~|~|~|Not classified by ICCC|19454237|2004
5-9|~|~|~|~|V Retinoblastoma|19454237|2004
5-9|3.8|5.7|4.7|91|VI Renal tumors|19454237|2004
5-9|3.6|5.5|4.5|87|VI(a) Nephroblastoma and other nonepithelial renal tumors|19454237|2004
5-9|~|~|~|~|VI(b) Renal carcinomas|19454237|2004
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19454237|2004
5-9|~|~|~|~|VII Hepatic tumors|19454237|2004
5-9|~|~|~|~|VII(a) Hepatoblastoma|19454237|2004
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19454237|2004
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19454237|2004
5-9|4.5|6.6|5.4|106|VIII Malignant bone tumors|19454237|2004
5-9|2.5|4.2|3.3|64|VIII(a) Osteosarcomas|19454237|2004
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19454237|2004
5-9|1.2|2.4|1.7|33|VIII(c) Ewing tumor and related sarcomas of bone|19454237|2004
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19454237|2004
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19454237|2004
5-9|1.6|3.0|2.2|43|X Germ cell, trophoblastic tumors & neoplasms of gonads|19454237|2004
5-9|0.6|1.5|1.0|19|X(a) Intracranial & intraspinal germ cell tumors|19454237|2004
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19454237|2004
5-9|0.6|1.6|1.0|20|X(c) Malignant gonadal germ cell tumors|19454237|2004
5-9|~|~|~|~|X(d) Gonadal carcinomas|19454237|2004
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19454237|2004
5-9|4.0|6.1|5.0|97|XI Other malignant epithelial neoplasms and malignant melanomas|19454237|2004
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19454237|2004
5-9|1.5|2.8|2.1|40|XI(b) Thyroid carcinomas|19454237|2004
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19454237|2004
5-9|1.1|2.3|1.6|32|XI(d) Malignant melanomas|19454237|2004
5-9|~|~|~|~|XI(e) Skin carcinomas|19454237|2004
5-9|0.7|1.7|1.1|21|XI(f) Other and unspecified carcinomas|19454237|2004
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19454237|2004
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19454237|2004
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19454237|2004
<1|238.0|269.4|253.3|1017|All ICCC Groups Combined|4014258|2004
<1|43.2|57.2|49.8|200|I Leukemias, myeloproliferative & myelodysplastic diseases|4014258|2004
<1|16.0|25.1|20.2|81|I(a) Lymphoid leukemias|4014258|2004
<1|14.5|23.1|18.4|74|I(b) Acute myeloid leukemias|4014258|2004
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|4014258|2004
<1|3.0|7.7|5.0|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4014258|2004
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|4014258|2004
<1|5.2|11.0|7.7|31|II Lymphomas and reticuloendothelial neoplasms|4014258|2004
<1|~|~|~|~|II(a) Hodgkin lymphomas|4014258|2004
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4014258|2004
<1|~|~|~|~|II(c) Burkitt lymphoma|4014258|2004
<1|4.0|9.2|6.2|25|II(d) Miscellaneous lymphoreticular neoplasms|4014258|2004
<1|~|~|~|~|II(e) Unspecified lymphomas|4014258|2004
<1|31.4|43.6|37.1|149|III CNS and misc intracranial and intraspinal neoplasms|4014258|2004
<1|4.2|9.5|6.5|26|III(a) Ependymomas and choroid plexus tumor|4014258|2004
<1|11.4|19.2|14.9|60|III(b) Astrocytomas|4014258|2004
<1|7.3|13.9|10.2|41|III(c) Intracranial and intraspinal embryonal tumors|4014258|2004
<1|~|~|~|~|III(d) Other gliomas|4014258|2004
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4014258|2004
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4014258|2004
<1|53.2|68.6|60.5|243|IV Neuroblastoma and other peripheral nervous cell tumors|4014258|2004
<1|52.5|67.8|59.8|240|IV(a) Neuroblastoma and ganglioneuroblastoma|4014258|2004
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4014258|2004
<1|14.3|22.9|18.2|73|IX Soft tissue and other extraosseous sarcomas|4014258|2004
<1|2.8|7.4|4.7|19|IX(a) Rhabdomyosarcomas|4014258|2004
<1|4.2|9.5|6.5|26|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4014258|2004
<1|~|~|~|~|IX(c) Kaposi sarcoma|4014258|2004
<1|3.2|8.0|5.2|21|IX(d) Other specified soft tissue sarcomas|4014258|2004
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4014258|2004
<1|~|~|~|~|Not classified by ICCC|4014258|2004
<1|22.7|33.3|27.7|111|V Retinoblastoma|4014258|2004
<1|10.1|17.6|13.5|54|VI Renal tumors|4014258|2004
<1|10.1|17.6|13.5|54|VI(a) Nephroblastoma and other nonepithelial renal tumors|4014258|2004
<1|~|~|~|~|VI(b) Renal carcinomas|4014258|2004
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4014258|2004
<1|10.5|18.1|14.0|56|VII Hepatic tumors|4014258|2004
<1|9.7|17.0|13.0|52|VII(a) Hepatoblastoma|4014258|2004
<1|~|~|~|~|VII(b) Hepatic carcinomas|4014258|2004
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4014258|2004
<1|~|~|~|~|VIII Malignant bone tumors|4014258|2004
<1|~|~|~|~|VIII(a) Osteosarcomas|4014258|2004
<1|~|~|~|~|VIII(b) Chondrosarcomas|4014258|2004
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4014258|2004
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4014258|2004
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4014258|2004
<1|14.3|22.9|18.2|73|X Germ cell, trophoblastic tumors & neoplasms of gonads|4014258|2004
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4014258|2004
<1|8.8|15.9|12.0|48|X(b) Malignant extracranial & extragonadal germ cell tumors|4014258|2004
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|4014258|2004
<1|~|~|~|~|X(d) Gonadal carcinomas|4014258|2004
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4014258|2004
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|4014258|2004
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4014258|2004
<1|~|~|~|~|XI(b) Thyroid carcinomas|4014258|2004
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4014258|2004
<1|~|~|~|~|XI(d) Malignant melanomas|4014258|2004
<1|~|~|~|~|XI(e) Skin carcinomas|4014258|2004
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4014258|2004
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4014258|2004
<1|~|~|~|~|XII(a) Other specified malignant tumors|4014258|2004
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4014258|2004
1-4|207.9|222.4|215.0|3422|All ICCC Groups Combined|15913007|2005
1-4|83.9|93.2|88.4|1407|I Leukemias, myeloproliferative & myelodysplastic diseases|15913007|2005
1-4|69.6|78.1|73.8|1174|I(a) Lymphoid leukemias|15913007|2005
1-4|8.3|11.5|9.8|156|I(b) Acute myeloid leukemias|15913007|2005
1-4|0.6|1.7|1.1|17|I(c) Chronic myeloproliferative diseases|15913007|2005
1-4|1.5|3.0|2.1|34|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15913007|2005
1-4|1.1|2.4|1.6|26|I(e) Unspecified and other specified leukemias|15913007|2005
1-4|8.6|11.7|10.1|160|II Lymphomas and reticuloendothelial neoplasms|15913007|2005
1-4|0.6|1.6|1.0|16|II(a) Hodgkin lymphomas|15913007|2005
1-4|3.5|5.6|4.5|71|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15913007|2005
1-4|1.4|2.9|2.1|33|II(c) Burkitt lymphoma|15913007|2005
1-4|1.7|3.3|2.4|38|II(d) Miscellaneous lymphoreticular neoplasms|15913007|2005
1-4|~|~|~|~|II(e) Unspecified lymphomas|15913007|2005
1-4|39.0|45.5|42.2|671|III CNS and misc intracranial and intraspinal neoplasms|15913007|2005
1-4|4.0|6.3|5.1|81|III(a) Ependymomas and choroid plexus tumor|15913007|2005
1-4|18.7|23.3|20.9|333|III(b) Astrocytomas|15913007|2005
1-4|8.7|11.9|10.2|163|III(c) Intracranial and intraspinal embryonal tumors|15913007|2005
1-4|4.0|6.3|5.1|81|III(d) Other gliomas|15913007|2005
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15913007|2005
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15913007|2005
1-4|21.5|26.3|23.8|379|IV Neuroblastoma and other peripheral nervous cell tumors|15913007|2005
1-4|21.4|26.2|23.7|377|IV(a) Neuroblastoma and ganglioneuroblastoma|15913007|2005
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15913007|2005
1-4|8.6|11.8|10.1|161|IX Soft tissue and other extraosseous sarcomas|15913007|2005
1-4|6.4|9.2|7.7|122|IX(a) Rhabdomyosarcomas|15913007|2005
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15913007|2005
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15913007|2005
1-4|0.8|2.0|1.3|21|IX(d) Other specified soft tissue sarcomas|15913007|2005
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15913007|2005
1-4|~|~|~|~|Not classified by ICCC|15913007|2005
1-4|6.7|9.6|8.0|128|V Retinoblastoma|15913007|2005
1-4|17.7|22.2|19.9|316|VI Renal tumors|15913007|2005
1-4|17.7|22.1|19.8|315|VI(a) Nephroblastoma and other nonepithelial renal tumors|15913007|2005
1-4|~|~|~|~|VI(b) Renal carcinomas|15913007|2005
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15913007|2005
1-4|3.7|5.8|4.7|74|VII Hepatic tumors|15913007|2005
1-4|3.4|5.6|4.4|70|VII(a) Hepatoblastoma|15913007|2005
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15913007|2005
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15913007|2005
1-4|1.1|2.5|1.7|27|VIII Malignant bone tumors|15913007|2005
1-4|~|~|~|~|VIII(a) Osteosarcomas|15913007|2005
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15913007|2005
1-4|0.6|1.7|1.1|17|VIII(c) Ewing tumor and related sarcomas of bone|15913007|2005
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15913007|2005
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15913007|2005
1-4|2.5|4.4|3.4|54|X Germ cell, trophoblastic tumors & neoplasms of gonads|15913007|2005
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15913007|2005
1-4|1.1|2.4|1.6|26|X(b) Malignant extracranial & extragonadal germ cell tumors|15913007|2005
1-4|0.9|2.2|1.4|23|X(c) Malignant gonadal germ cell tumors|15913007|2005
1-4|~|~|~|~|X(d) Gonadal carcinomas|15913007|2005
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15913007|2005
1-4|1.2|2.6|1.8|29|XI Other malignant epithelial neoplasms and malignant melanomas|15913007|2005
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15913007|2005
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15913007|2005
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15913007|2005
1-4|0.7|1.8|1.1|18|XI(d) Malignant melanomas|15913007|2005
1-4|~|~|~|~|XI(e) Skin carcinomas|15913007|2005
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15913007|2005
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15913007|2005
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15913007|2005
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15913007|2005
10-14|125.6|135.3|130.4|2766|All ICCC Groups Combined|21212579|2005
10-14|27.6|32.3|29.8|633|I Leukemias, myeloproliferative & myelodysplastic diseases|21212579|2005
10-14|17.1|20.9|19.0|402|I(a) Lymphoid leukemias|21212579|2005
10-14|5.6|7.9|6.7|142|I(b) Acute myeloid leukemias|21212579|2005
10-14|1.5|2.8|2.1|45|I(c) Chronic myeloproliferative diseases|21212579|2005
10-14|0.6|1.5|0.9|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21212579|2005
10-14|0.7|1.7|1.1|24|I(e) Unspecified and other specified leukemias|21212579|2005
10-14|23.4|27.8|25.6|542|II Lymphomas and reticuloendothelial neoplasms|21212579|2005
10-14|11.1|14.2|12.6|267|II(a) Hodgkin lymphomas|21212579|2005
10-14|7.6|10.2|8.9|188|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21212579|2005
10-14|2.4|3.9|3.1|65|II(c) Burkitt lymphoma|21212579|2005
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21212579|2005
10-14|~|~|~|~|II(e) Unspecified lymphomas|21212579|2005
10-14|24.1|28.5|26.2|556|III CNS and misc intracranial and intraspinal neoplasms|21212579|2005
10-14|1.3|2.5|1.8|39|III(a) Ependymomas and choroid plexus tumor|21212579|2005
10-14|13.9|17.3|15.6|330|III(b) Astrocytomas|21212579|2005
10-14|2.8|4.5|3.6|76|III(c) Intracranial and intraspinal embryonal tumors|21212579|2005
10-14|3.6|5.4|4.4|94|III(d) Other gliomas|21212579|2005
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21212579|2005
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21212579|2005
10-14|1.0|2.0|1.4|30|IV Neuroblastoma and other peripheral nervous cell tumors|21212579|2005
10-14|0.8|1.8|1.2|26|IV(a) Neuroblastoma and ganglioneuroblastoma|21212579|2005
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21212579|2005
10-14|10.2|13.2|11.6|247|IX Soft tissue and other extraosseous sarcomas|21212579|2005
10-14|2.9|4.5|3.6|77|IX(a) Rhabdomyosarcomas|21212579|2005
10-14|1.0|2.0|1.4|30|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21212579|2005
10-14|~|~|~|~|IX(c) Kaposi sarcoma|21212579|2005
10-14|4.6|6.6|5.5|117|IX(d) Other specified soft tissue sarcomas|21212579|2005
10-14|0.6|1.6|1.0|22|IX(e) Unspecified soft tissue sarcomas|21212579|2005
10-14|~|~|~|~|Not classified by ICCC|21212579|2005
10-14|~|~|~|~|V Retinoblastoma|21212579|2005
10-14|0.7|1.7|1.1|24|VI Renal tumors|21212579|2005
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21212579|2005
10-14|~|~|~|~|VI(b) Renal carcinomas|21212579|2005
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|21212579|2005
10-14|0.6|1.5|0.9|20|VII Hepatic tumors|21212579|2005
10-14|~|~|~|~|VII(a) Hepatoblastoma|21212579|2005
10-14|0.5|1.3|0.8|17|VII(b) Hepatic carcinomas|21212579|2005
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21212579|2005
10-14|11.2|14.3|12.7|269|VIII Malignant bone tumors|21212579|2005
10-14|6.5|8.9|7.6|162|VIII(a) Osteosarcomas|21212579|2005
10-14|~|~|~|~|VIII(b) Chondrosarcomas|21212579|2005
10-14|3.2|4.9|4.0|84|VIII(c) Ewing tumor and related sarcomas of bone|21212579|2005
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|21212579|2005
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21212579|2005
10-14|5.6|7.8|6.6|140|X Germ cell, trophoblastic tumors & neoplasms of gonads|21212579|2005
10-14|1.4|2.7|2.0|42|X(a) Intracranial & intraspinal germ cell tumors|21212579|2005
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|21212579|2005
10-14|2.9|4.6|3.7|78|X(c) Malignant gonadal germ cell tumors|21212579|2005
10-14|~|~|~|~|X(d) Gonadal carcinomas|21212579|2005
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21212579|2005
10-14|12.1|15.3|13.6|289|XI Other malignant epithelial neoplasms and malignant melanomas|21212579|2005
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|21212579|2005
10-14|4.5|6.5|5.4|115|XI(b) Thyroid carcinomas|21212579|2005
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|21212579|2005
10-14|2.8|4.5|3.6|76|XI(d) Malignant melanomas|21212579|2005
10-14|~|~|~|~|XI(e) Skin carcinomas|21212579|2005
10-14|3.1|4.8|3.9|82|XI(f) Other and unspecified carcinomas|21212579|2005
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|21212579|2005
10-14|~|~|~|~|XII(a) Other specified malignant tumors|21212579|2005
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|21212579|2005
15-19|215.8|228.4|222.0|4771|All ICCC Groups Combined|21486214|2005
15-19|28.2|33.0|30.5|656|I Leukemias, myeloproliferative & myelodysplastic diseases|21486214|2005
15-19|14.3|17.7|15.9|342|I(a) Lymphoid leukemias|21486214|2005
15-19|7.1|9.6|8.3|178|I(b) Acute myeloid leukemias|21486214|2005
15-19|3.1|4.8|3.9|84|I(c) Chronic myeloproliferative diseases|21486214|2005
15-19|1.0|2.0|1.4|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21486214|2005
15-19|0.6|1.5|1.0|21|I(e) Unspecified and other specified leukemias|21486214|2005
15-19|50.1|56.3|53.2|1142|II Lymphomas and reticuloendothelial neoplasms|21486214|2005
15-19|30.7|35.6|33.0|710|II(a) Hodgkin lymphomas|21486214|2005
15-19|14.9|18.4|16.6|357|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21486214|2005
15-19|1.7|3.1|2.3|50|II(c) Burkitt lymphoma|21486214|2005
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21486214|2005
15-19|~|~|~|~|II(e) Unspecified lymphomas|21486214|2005
15-19|19.8|23.8|21.7|467|III CNS and misc intracranial and intraspinal neoplasms|21486214|2005
15-19|1.4|2.6|1.9|41|III(a) Ependymomas and choroid plexus tumor|21486214|2005
15-19|10.4|13.4|11.8|254|III(b) Astrocytomas|21486214|2005
15-19|2.0|3.4|2.7|57|III(c) Intracranial and intraspinal embryonal tumors|21486214|2005
15-19|3.3|5.1|4.1|89|III(d) Other gliomas|21486214|2005
15-19|0.5|1.3|0.8|17|III(e) Other specified intracranial & intraspinal neoplasms|21486214|2005
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21486214|2005
15-19|0.5|1.4|0.9|19|IV Neuroblastoma and other peripheral nervous cell tumors|21486214|2005
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21486214|2005
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21486214|2005
15-19|15.7|19.3|17.4|374|IX Soft tissue and other extraosseous sarcomas|21486214|2005
15-19|2.9|4.5|3.6|78|IX(a) Rhabdomyosarcomas|21486214|2005
15-19|1.6|3.0|2.2|48|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21486214|2005
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21486214|2005
15-19|8.3|10.9|9.5|205|IX(d) Other specified soft tissue sarcomas|21486214|2005
15-19|1.4|2.6|1.9|41|IX(e) Unspecified soft tissue sarcomas|21486214|2005
15-19|~|~|~|~|Not classified by ICCC|21486214|2005
15-19|~|~|~|~|V Retinoblastoma|21486214|2005
15-19|1.6|2.9|2.2|47|VI Renal tumors|21486214|2005
15-19|0.4|1.2|0.7|16|VI(a) Nephroblastoma and other nonepithelial renal tumors|21486214|2005
15-19|1.0|2.0|1.4|31|VI(b) Renal carcinomas|21486214|2005
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21486214|2005
15-19|0.6|1.5|1.0|21|VII Hepatic tumors|21486214|2005
15-19|~|~|~|~|VII(a) Hepatoblastoma|21486214|2005
15-19|0.6|1.4|0.9|20|VII(b) Hepatic carcinomas|21486214|2005
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21486214|2005
15-19|13.3|16.7|14.9|321|VIII Malignant bone tumors|21486214|2005
15-19|7.7|10.2|8.9|191|VIII(a) Osteosarcomas|21486214|2005
15-19|~|~|~|~|VIII(b) Chondrosarcomas|21486214|2005
15-19|3.6|5.4|4.4|95|VIII(c) Ewing tumor and related sarcomas of bone|21486214|2005
15-19|0.4|1.2|0.7|16|VIII(d) Other specified malignant bone tumors|21486214|2005
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21486214|2005
15-19|26.8|31.4|29.0|624|X Germ cell, trophoblastic tumors & neoplasms of gonads|21486214|2005
15-19|1.7|3.1|2.3|50|X(a) Intracranial & intraspinal germ cell tumors|21486214|2005
15-19|1.1|2.2|1.6|34|X(b) Malignant extracranial & extragonadal germ cell tumors|21486214|2005
15-19|21.1|25.3|23.1|497|X(c) Malignant gonadal germ cell tumors|21486214|2005
15-19|0.8|1.8|1.3|27|X(d) Gonadal carcinomas|21486214|2005
15-19|0.4|1.2|0.7|16|X(e) Other and unspecified malignant gonadal tumors|21486214|2005
15-19|46.2|52.2|49.1|1055|XI Other malignant epithelial neoplasms and malignant melanomas|21486214|2005
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21486214|2005
15-19|16.1|19.7|17.8|383|XI(b) Thyroid carcinomas|21486214|2005
15-19|0.6|1.4|0.9|20|XI(c) Nasopharyngeal carcinomas|21486214|2005
15-19|17.0|20.7|18.8|403|XI(d) Malignant melanomas|21486214|2005
15-19|~|~|~|~|XI(e) Skin carcinomas|21486214|2005
15-19|9.8|12.7|11.2|240|XI(f) Other and unspecified carcinomas|21486214|2005
15-19|1.3|2.4|1.8|38|XII Other and unspecified malignant neoplasms|21486214|2005
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21486214|2005
15-19|0.8|1.7|1.2|25|XII(b) Other unspecified malignant tumors|21486214|2005
5-9|114.1|123.8|118.9|2305|All ICCC Groups Combined|19389067|2005
5-9|36.3|41.9|39.0|756|I Leukemias, myeloproliferative & myelodysplastic diseases|19389067|2005
5-9|29.1|34.2|31.6|612|I(a) Lymphoid leukemias|19389067|2005
5-9|3.4|5.2|4.2|82|I(b) Acute myeloid leukemias|19389067|2005
5-9|0.6|1.5|1.0|19|I(c) Chronic myeloproliferative diseases|19389067|2005
5-9|0.8|1.8|1.2|24|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19389067|2005
5-9|0.6|1.5|1.0|19|I(e) Unspecified and other specified leukemias|19389067|2005
5-9|12.3|15.6|13.9|269|II Lymphomas and reticuloendothelial neoplasms|19389067|2005
5-9|3.1|5.0|4.0|77|II(a) Hodgkin lymphomas|19389067|2005
5-9|5.1|7.3|6.1|119|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19389067|2005
5-9|2.2|3.8|2.9|57|II(c) Burkitt lymphoma|19389067|2005
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19389067|2005
5-9|~|~|~|~|II(e) Unspecified lymphomas|19389067|2005
5-9|31.8|37.1|34.4|667|III CNS and misc intracranial and intraspinal neoplasms|19389067|2005
5-9|2.2|3.8|2.9|56|III(a) Ependymomas and choroid plexus tumor|19389067|2005
5-9|14.5|18.1|16.2|315|III(b) Astrocytomas|19389067|2005
5-9|6.4|8.9|7.5|146|III(c) Intracranial and intraspinal embryonal tumors|19389067|2005
5-9|5.3|7.6|6.3|123|III(d) Other gliomas|19389067|2005
5-9|0.5|1.3|0.8|16|III(e) Other specified intracranial & intraspinal neoplasms|19389067|2005
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19389067|2005
5-9|2.6|4.3|3.4|65|IV Neuroblastoma and other peripheral nervous cell tumors|19389067|2005
5-9|2.5|4.2|3.2|63|IV(a) Neuroblastoma and ganglioneuroblastoma|19389067|2005
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19389067|2005
5-9|8.0|10.7|9.3|180|IX Soft tissue and other extraosseous sarcomas|19389067|2005
5-9|4.4|6.5|5.4|104|IX(a) Rhabdomyosarcomas|19389067|2005
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19389067|2005
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19389067|2005
5-9|1.5|2.8|2.1|40|IX(d) Other specified soft tissue sarcomas|19389067|2005
5-9|0.7|1.7|1.1|21|IX(e) Unspecified soft tissue sarcomas|19389067|2005
5-9|~|~|~|~|Not classified by ICCC|19389067|2005
5-9|~|~|~|~|V Retinoblastoma|19389067|2005
5-9|4.1|6.1|5.0|97|VI Renal tumors|19389067|2005
5-9|3.6|5.6|4.5|88|VI(a) Nephroblastoma and other nonepithelial renal tumors|19389067|2005
5-9|~|~|~|~|VI(b) Renal carcinomas|19389067|2005
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19389067|2005
5-9|~|~|~|~|VII Hepatic tumors|19389067|2005
5-9|~|~|~|~|VII(a) Hepatoblastoma|19389067|2005
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19389067|2005
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19389067|2005
5-9|4.8|7.0|5.8|113|VIII Malignant bone tumors|19389067|2005
5-9|2.3|3.9|3.0|59|VIII(a) Osteosarcomas|19389067|2005
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19389067|2005
5-9|1.7|3.1|2.3|45|VIII(c) Ewing tumor and related sarcomas of bone|19389067|2005
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19389067|2005
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19389067|2005
5-9|1.6|3.0|2.2|43|X Germ cell, trophoblastic tumors & neoplasms of gonads|19389067|2005
5-9|0.8|1.8|1.2|23|X(a) Intracranial & intraspinal germ cell tumors|19389067|2005
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19389067|2005
5-9|0.5|1.4|0.9|17|X(c) Malignant gonadal germ cell tumors|19389067|2005
5-9|~|~|~|~|X(d) Gonadal carcinomas|19389067|2005
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19389067|2005
5-9|3.4|5.3|4.3|83|XI Other malignant epithelial neoplasms and malignant melanomas|19389067|2005
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19389067|2005
5-9|0.6|1.5|0.9|18|XI(b) Thyroid carcinomas|19389067|2005
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19389067|2005
5-9|1.4|2.7|2.0|38|XI(d) Malignant melanomas|19389067|2005
5-9|~|~|~|~|XI(e) Skin carcinomas|19389067|2005
5-9|0.8|1.9|1.3|25|XI(f) Other and unspecified carcinomas|19389067|2005
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19389067|2005
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19389067|2005
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19389067|2005
<1|232.1|263.1|247.2|990|All ICCC Groups Combined|4004393|2005
<1|40.9|54.7|47.4|190|I Leukemias, myeloproliferative & myelodysplastic diseases|4004393|2005
<1|15.4|24.3|19.5|78|I(a) Lymphoid leukemias|4004393|2005
<1|12.3|20.4|16.0|64|I(b) Acute myeloid leukemias|4004393|2005
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|4004393|2005
<1|3.8|8.9|6.0|24|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4004393|2005
<1|2.5|6.8|4.2|17|I(e) Unspecified and other specified leukemias|4004393|2005
<1|7.6|14.2|10.5|42|II Lymphomas and reticuloendothelial neoplasms|4004393|2005
<1|~|~|~|~|II(a) Hodgkin lymphomas|4004393|2005
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4004393|2005
<1|~|~|~|~|II(c) Burkitt lymphoma|4004393|2005
<1|4.9|10.4|7.2|29|II(d) Miscellaneous lymphoreticular neoplasms|4004393|2005
<1|~|~|~|~|II(e) Unspecified lymphomas|4004393|2005
<1|23.0|33.7|28.0|112|III CNS and misc intracranial and intraspinal neoplasms|4004393|2005
<1|3.8|8.9|6.0|24|III(a) Ependymomas and choroid plexus tumor|4004393|2005
<1|6.7|13.0|9.5|38|III(b) Astrocytomas|4004393|2005
<1|6.1|12.2|8.7|35|III(c) Intracranial and intraspinal embryonal tumors|4004393|2005
<1|~|~|~|~|III(d) Other gliomas|4004393|2005
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4004393|2005
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4004393|2005
<1|55.6|71.5|63.2|253|IV Neuroblastoma and other peripheral nervous cell tumors|4004393|2005
<1|55.4|71.2|62.9|252|IV(a) Neuroblastoma and ganglioneuroblastoma|4004393|2005
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4004393|2005
<1|10.6|18.2|14.0|56|IX Soft tissue and other extraosseous sarcomas|4004393|2005
<1|2.5|6.8|4.2|17|IX(a) Rhabdomyosarcomas|4004393|2005
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4004393|2005
<1|~|~|~|~|IX(c) Kaposi sarcoma|4004393|2005
<1|4.0|9.2|6.2|25|IX(d) Other specified soft tissue sarcomas|4004393|2005
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4004393|2005
<1|~|~|~|~|Not classified by ICCC|4004393|2005
<1|21.2|31.5|26.0|104|V Retinoblastoma|4004393|2005
<1|12.3|20.4|16.0|64|VI Renal tumors|4004393|2005
<1|12.3|20.4|16.0|64|VI(a) Nephroblastoma and other nonepithelial renal tumors|4004393|2005
<1|~|~|~|~|VI(b) Renal carcinomas|4004393|2005
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4004393|2005
<1|6.9|13.3|9.7|39|VII Hepatic tumors|4004393|2005
<1|6.7|13.0|9.5|38|VII(a) Hepatoblastoma|4004393|2005
<1|~|~|~|~|VII(b) Hepatic carcinomas|4004393|2005
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4004393|2005
<1|~|~|~|~|VIII Malignant bone tumors|4004393|2005
<1|~|~|~|~|VIII(a) Osteosarcomas|4004393|2005
<1|~|~|~|~|VIII(b) Chondrosarcomas|4004393|2005
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4004393|2005
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4004393|2005
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4004393|2005
<1|20.5|30.6|25.2|101|X Germ cell, trophoblastic tumors & neoplasms of gonads|4004393|2005
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4004393|2005
<1|12.7|21.0|16.5|66|X(b) Malignant extracranial & extragonadal germ cell tumors|4004393|2005
<1|3.1|7.7|5.0|20|X(c) Malignant gonadal germ cell tumors|4004393|2005
<1|~|~|~|~|X(d) Gonadal carcinomas|4004393|2005
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4004393|2005
<1|2.3|6.5|4.0|16|XI Other malignant epithelial neoplasms and malignant melanomas|4004393|2005
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4004393|2005
<1|~|~|~|~|XI(b) Thyroid carcinomas|4004393|2005
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4004393|2005
<1|~|~|~|~|XI(d) Malignant melanomas|4004393|2005
<1|~|~|~|~|XI(e) Skin carcinomas|4004393|2005
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4004393|2005
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4004393|2005
<1|~|~|~|~|XII(a) Other specified malignant tumors|4004393|2005
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4004393|2005
1-4|206.7|221.2|213.9|3400|All ICCC Groups Combined|15897145|2006
1-4|84.3|93.6|88.9|1413|I Leukemias, myeloproliferative & myelodysplastic diseases|15897145|2006
1-4|69.5|78.0|73.7|1171|I(a) Lymphoid leukemias|15897145|2006
1-4|9.0|12.2|10.5|167|I(b) Acute myeloid leukemias|15897145|2006
1-4|0.8|1.9|1.3|20|I(c) Chronic myeloproliferative diseases|15897145|2006
1-4|1.5|3.1|2.2|35|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15897145|2006
1-4|0.8|1.9|1.3|20|I(e) Unspecified and other specified leukemias|15897145|2006
1-4|8.3|11.5|9.8|156|II Lymphomas and reticuloendothelial neoplasms|15897145|2006
1-4|0.6|1.7|1.1|17|II(a) Hodgkin lymphomas|15897145|2006
1-4|3.0|5.0|3.9|62|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15897145|2006
1-4|1.3|2.8|2.0|31|II(c) Burkitt lymphoma|15897145|2006
1-4|1.9|3.5|2.6|41|II(d) Miscellaneous lymphoreticular neoplasms|15897145|2006
1-4|~|~|~|~|II(e) Unspecified lymphomas|15897145|2006
1-4|42.2|48.9|45.5|723|III CNS and misc intracranial and intraspinal neoplasms|15897145|2006
1-4|3.7|5.8|4.7|74|III(a) Ependymomas and choroid plexus tumor|15897145|2006
1-4|18.7|23.3|20.9|332|III(b) Astrocytomas|15897145|2006
1-4|10.8|14.3|12.5|198|III(c) Intracranial and intraspinal embryonal tumors|15897145|2006
1-4|4.8|7.3|6.0|95|III(d) Other gliomas|15897145|2006
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15897145|2006
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15897145|2006
1-4|18.1|22.6|20.3|322|IV Neuroblastoma and other peripheral nervous cell tumors|15897145|2006
1-4|18.1|22.6|20.3|322|IV(a) Neuroblastoma and ganglioneuroblastoma|15897145|2006
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15897145|2006
1-4|9.1|12.4|10.7|170|IX Soft tissue and other extraosseous sarcomas|15897145|2006
1-4|5.8|8.5|7.0|112|IX(a) Rhabdomyosarcomas|15897145|2006
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15897145|2006
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15897145|2006
1-4|1.2|2.6|1.8|29|IX(d) Other specified soft tissue sarcomas|15897145|2006
1-4|0.7|1.9|1.2|19|IX(e) Unspecified soft tissue sarcomas|15897145|2006
1-4|~|~|~|~|Not classified by ICCC|15897145|2006
1-4|5.6|8.3|6.9|109|V Retinoblastoma|15897145|2006
1-4|17.5|21.9|19.6|312|VI Renal tumors|15897145|2006
1-4|17.4|21.8|19.5|310|VI(a) Nephroblastoma and other nonepithelial renal tumors|15897145|2006
1-4|~|~|~|~|VI(b) Renal carcinomas|15897145|2006
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15897145|2006
1-4|3.7|5.8|4.7|74|VII Hepatic tumors|15897145|2006
1-4|3.5|5.7|4.5|72|VII(a) Hepatoblastoma|15897145|2006
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15897145|2006
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15897145|2006
1-4|1.0|2.2|1.5|24|VIII Malignant bone tumors|15897145|2006
1-4|~|~|~|~|VIII(a) Osteosarcomas|15897145|2006
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15897145|2006
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15897145|2006
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15897145|2006
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15897145|2006
1-4|2.3|4.1|3.1|50|X Germ cell, trophoblastic tumors & neoplasms of gonads|15897145|2006
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15897145|2006
1-4|1.3|2.8|2.0|31|X(b) Malignant extracranial & extragonadal germ cell tumors|15897145|2006
1-4|0.6|1.7|1.1|17|X(c) Malignant gonadal germ cell tumors|15897145|2006
1-4|~|~|~|~|X(d) Gonadal carcinomas|15897145|2006
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15897145|2006
1-4|1.3|2.7|1.9|30|XI Other malignant epithelial neoplasms and malignant melanomas|15897145|2006
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15897145|2006
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15897145|2006
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15897145|2006
1-4|~|~|~|~|XI(d) Malignant melanomas|15897145|2006
1-4|~|~|~|~|XI(e) Skin carcinomas|15897145|2006
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15897145|2006
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15897145|2006
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15897145|2006
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15897145|2006
10-14|130.3|140.3|135.3|2845|All ICCC Groups Combined|21033138|2006
10-14|31.2|36.2|33.6|707|I Leukemias, myeloproliferative & myelodysplastic diseases|21033138|2006
10-14|20.1|24.2|22.1|465|I(a) Lymphoid leukemias|21033138|2006
10-14|6.5|8.9|7.6|160|I(b) Acute myeloid leukemias|21033138|2006
10-14|1.3|2.5|1.9|39|I(c) Chronic myeloproliferative diseases|21033138|2006
10-14|0.7|1.6|1.0|22|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21033138|2006
10-14|0.6|1.5|1.0|21|I(e) Unspecified and other specified leukemias|21033138|2006
10-14|23.3|27.6|25.4|534|II Lymphomas and reticuloendothelial neoplasms|21033138|2006
10-14|11.1|14.2|12.6|265|II(a) Hodgkin lymphomas|21033138|2006
10-14|8.0|10.6|9.2|194|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21033138|2006
10-14|2.3|3.8|2.9|62|II(c) Burkitt lymphoma|21033138|2006
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21033138|2006
10-14|~|~|~|~|II(e) Unspecified lymphomas|21033138|2006
10-14|23.7|28.1|25.8|543|III CNS and misc intracranial and intraspinal neoplasms|21033138|2006
10-14|1.3|2.5|1.9|39|III(a) Ependymomas and choroid plexus tumor|21033138|2006
10-14|13.4|16.7|15.0|315|III(b) Astrocytomas|21033138|2006
10-14|2.8|4.4|3.5|74|III(c) Intracranial and intraspinal embryonal tumors|21033138|2006
10-14|3.8|5.7|4.7|98|III(d) Other gliomas|21033138|2006
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21033138|2006
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21033138|2006
10-14|0.7|1.7|1.1|24|IV Neuroblastoma and other peripheral nervous cell tumors|21033138|2006
10-14|0.5|1.4|0.9|19|IV(a) Neuroblastoma and ganglioneuroblastoma|21033138|2006
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21033138|2006
10-14|10.1|13.1|11.6|243|IX Soft tissue and other extraosseous sarcomas|21033138|2006
10-14|2.8|4.4|3.5|74|IX(a) Rhabdomyosarcomas|21033138|2006
10-14|1.0|2.1|1.5|32|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21033138|2006
10-14|~|~|~|~|IX(c) Kaposi sarcoma|21033138|2006
10-14|4.3|6.3|5.2|110|IX(d) Other specified soft tissue sarcomas|21033138|2006
10-14|0.8|1.8|1.2|26|IX(e) Unspecified soft tissue sarcomas|21033138|2006
10-14|~|~|~|~|Not classified by ICCC|21033138|2006
10-14|~|~|~|~|V Retinoblastoma|21033138|2006
10-14|0.8|1.8|1.2|25|VI Renal tumors|21033138|2006
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21033138|2006
10-14|0.4|1.2|0.8|16|VI(b) Renal carcinomas|21033138|2006
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|21033138|2006
10-14|0.5|1.4|0.9|18|VII Hepatic tumors|21033138|2006
10-14|~|~|~|~|VII(a) Hepatoblastoma|21033138|2006
10-14|0.4|1.2|0.8|16|VII(b) Hepatic carcinomas|21033138|2006
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21033138|2006
10-14|11.1|14.2|12.6|265|VIII Malignant bone tumors|21033138|2006
10-14|6.8|9.2|7.9|167|VIII(a) Osteosarcomas|21033138|2006
10-14|~|~|~|~|VIII(b) Chondrosarcomas|21033138|2006
10-14|2.8|4.5|3.6|76|VIII(c) Ewing tumor and related sarcomas of bone|21033138|2006
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|21033138|2006
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21033138|2006
10-14|5.9|8.2|6.9|146|X Germ cell, trophoblastic tumors & neoplasms of gonads|21033138|2006
10-14|2.1|3.5|2.7|57|X(a) Intracranial & intraspinal germ cell tumors|21033138|2006
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|21033138|2006
10-14|2.7|4.4|3.5|73|X(c) Malignant gonadal germ cell tumors|21033138|2006
10-14|~|~|~|~|X(d) Gonadal carcinomas|21033138|2006
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21033138|2006
10-14|13.9|17.3|15.5|327|XI Other malignant epithelial neoplasms and malignant melanomas|21033138|2006
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|21033138|2006
10-14|5.1|7.2|6.1|128|XI(b) Thyroid carcinomas|21033138|2006
10-14|0.4|1.2|0.8|16|XI(c) Nasopharyngeal carcinomas|21033138|2006
10-14|3.7|5.6|4.6|97|XI(d) Malignant melanomas|21033138|2006
10-14|~|~|~|~|XI(e) Skin carcinomas|21033138|2006
10-14|3.1|4.8|3.9|81|XI(f) Other and unspecified carcinomas|21033138|2006
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|21033138|2006
10-14|~|~|~|~|XII(a) Other specified malignant tumors|21033138|2006
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|21033138|2006
15-19|209.7|222.1|215.8|4707|All ICCC Groups Combined|21807709|2006
15-19|30.9|35.8|33.2|725|I Leukemias, myeloproliferative & myelodysplastic diseases|21807709|2006
15-19|15.1|18.5|16.7|365|I(a) Lymphoid leukemias|21807709|2006
15-19|7.9|10.5|9.2|200|I(b) Acute myeloid leukemias|21807709|2006
15-19|3.6|5.5|4.5|98|I(c) Chronic myeloproliferative diseases|21807709|2006
15-19|0.9|1.9|1.3|29|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21807709|2006
15-19|1.0|2.1|1.5|33|I(e) Unspecified and other specified leukemias|21807709|2006
15-19|47.1|53.0|50.0|1090|II Lymphomas and reticuloendothelial neoplasms|21807709|2006
15-19|29.0|33.8|31.3|683|II(a) Hodgkin lymphomas|21807709|2006
15-19|13.9|17.3|15.5|339|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21807709|2006
15-19|1.7|3.0|2.2|49|II(c) Burkitt lymphoma|21807709|2006
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|21807709|2006
15-19|~|~|~|~|II(e) Unspecified lymphomas|21807709|2006
15-19|21.1|25.2|23.1|504|III CNS and misc intracranial and intraspinal neoplasms|21807709|2006
15-19|1.6|2.9|2.2|47|III(a) Ependymomas and choroid plexus tumor|21807709|2006
15-19|11.3|14.3|12.7|277|III(b) Astrocytomas|21807709|2006
15-19|1.7|3.1|2.3|51|III(c) Intracranial and intraspinal embryonal tumors|21807709|2006
15-19|3.9|5.7|4.7|103|III(d) Other gliomas|21807709|2006
15-19|0.5|1.2|0.8|17|III(e) Other specified intracranial & intraspinal neoplasms|21807709|2006
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21807709|2006
15-19|0.5|1.2|0.8|17|IV Neuroblastoma and other peripheral nervous cell tumors|21807709|2006
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21807709|2006
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21807709|2006
15-19|13.4|16.7|15.0|327|IX Soft tissue and other extraosseous sarcomas|21807709|2006
15-19|2.9|4.5|3.6|79|IX(a) Rhabdomyosarcomas|21807709|2006
15-19|1.4|2.6|1.9|42|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21807709|2006
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21807709|2006
15-19|6.5|8.9|7.6|166|IX(d) Other specified soft tissue sarcomas|21807709|2006
15-19|1.2|2.3|1.7|37|IX(e) Unspecified soft tissue sarcomas|21807709|2006
15-19|~|~|~|~|Not classified by ICCC|21807709|2006
15-19|~|~|~|~|V Retinoblastoma|21807709|2006
15-19|1.5|2.8|2.1|46|VI Renal tumors|21807709|2006
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21807709|2006
15-19|1.2|2.4|1.7|38|VI(b) Renal carcinomas|21807709|2006
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21807709|2006
15-19|1.0|2.1|1.5|32|VII Hepatic tumors|21807709|2006
15-19|~|~|~|~|VII(a) Hepatoblastoma|21807709|2006
15-19|0.9|2.0|1.4|30|VII(b) Hepatic carcinomas|21807709|2006
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21807709|2006
15-19|14.4|17.8|16.0|350|VIII Malignant bone tumors|21807709|2006
15-19|8.2|10.8|9.4|206|VIII(a) Osteosarcomas|21807709|2006
15-19|~|~|~|~|VIII(b) Chondrosarcomas|21807709|2006
15-19|3.9|5.8|4.8|105|VIII(c) Ewing tumor and related sarcomas of bone|21807709|2006
15-19|0.8|1.7|1.2|26|VIII(d) Other specified malignant bone tumors|21807709|2006
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21807709|2006
15-19|23.5|27.8|25.6|558|X Germ cell, trophoblastic tumors & neoplasms of gonads|21807709|2006
15-19|1.7|3.0|2.2|49|X(a) Intracranial & intraspinal germ cell tumors|21807709|2006
15-19|1.1|2.2|1.6|34|X(b) Malignant extracranial & extragonadal germ cell tumors|21807709|2006
15-19|17.5|21.2|19.3|420|X(c) Malignant gonadal germ cell tumors|21807709|2006
15-19|1.1|2.2|1.6|34|X(d) Gonadal carcinomas|21807709|2006
15-19|0.6|1.5|1.0|21|X(e) Other and unspecified malignant gonadal tumors|21807709|2006
15-19|43.8|49.5|46.6|1016|XI Other malignant epithelial neoplasms and malignant melanomas|21807709|2006
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21807709|2006
15-19|17.2|20.9|18.9|413|XI(b) Thyroid carcinomas|21807709|2006
15-19|1.2|2.3|1.7|36|XI(c) Nasopharyngeal carcinomas|21807709|2006
15-19|12.8|16.1|14.4|314|XI(d) Malignant melanomas|21807709|2006
15-19|~|~|~|~|XI(e) Skin carcinomas|21807709|2006
15-19|10.0|12.9|11.4|249|XI(f) Other and unspecified carcinomas|21807709|2006
15-19|0.9|1.9|1.3|28|XII Other and unspecified malignant neoplasms|21807709|2006
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21807709|2006
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21807709|2006
5-9|116.6|126.5|121.5|2374|All ICCC Groups Combined|19544688|2006
5-9|37.5|43.1|40.2|786|I Leukemias, myeloproliferative & myelodysplastic diseases|19544688|2006
5-9|29.7|34.8|32.2|629|I(a) Lymphoid leukemias|19544688|2006
5-9|3.5|5.4|4.4|86|I(b) Acute myeloid leukemias|19544688|2006
5-9|0.8|1.8|1.2|24|I(c) Chronic myeloproliferative diseases|19544688|2006
5-9|0.8|1.9|1.3|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19544688|2006
5-9|0.7|1.7|1.1|22|I(e) Unspecified and other specified leukemias|19544688|2006
5-9|13.0|16.4|14.6|286|II Lymphomas and reticuloendothelial neoplasms|19544688|2006
5-9|3.8|5.8|4.7|92|II(a) Hodgkin lymphomas|19544688|2006
5-9|5.1|7.3|6.1|120|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19544688|2006
5-9|2.2|3.8|2.9|57|II(c) Burkitt lymphoma|19544688|2006
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19544688|2006
5-9|~|~|~|~|II(e) Unspecified lymphomas|19544688|2006
5-9|31.1|36.3|33.6|657|III CNS and misc intracranial and intraspinal neoplasms|19544688|2006
5-9|1.9|3.3|2.5|49|III(a) Ependymomas and choroid plexus tumor|19544688|2006
5-9|13.5|17.0|15.1|296|III(b) Astrocytomas|19544688|2006
5-9|6.1|8.6|7.3|142|III(c) Intracranial and intraspinal embryonal tumors|19544688|2006
5-9|6.4|8.9|7.6|148|III(d) Other gliomas|19544688|2006
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19544688|2006
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19544688|2006
5-9|2.9|4.7|3.7|73|IV Neuroblastoma and other peripheral nervous cell tumors|19544688|2006
5-9|2.8|4.6|3.6|71|IV(a) Neuroblastoma and ganglioneuroblastoma|19544688|2006
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19544688|2006
5-9|7.2|9.8|8.4|165|IX Soft tissue and other extraosseous sarcomas|19544688|2006
5-9|3.7|5.7|4.6|90|IX(a) Rhabdomyosarcomas|19544688|2006
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19544688|2006
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19544688|2006
5-9|1.9|3.4|2.6|51|IX(d) Other specified soft tissue sarcomas|19544688|2006
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|19544688|2006
5-9|~|~|~|~|Not classified by ICCC|19544688|2006
5-9|~|~|~|~|V Retinoblastoma|19544688|2006
5-9|4.4|6.5|5.4|105|VI Renal tumors|19544688|2006
5-9|4.1|6.2|5.1|99|VI(a) Nephroblastoma and other nonepithelial renal tumors|19544688|2006
5-9|~|~|~|~|VI(b) Renal carcinomas|19544688|2006
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19544688|2006
5-9|~|~|~|~|VII Hepatic tumors|19544688|2006
5-9|~|~|~|~|VII(a) Hepatoblastoma|19544688|2006
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19544688|2006
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19544688|2006
5-9|5.7|8.1|6.8|133|VIII Malignant bone tumors|19544688|2006
5-9|2.7|4.4|3.5|68|VIII(a) Osteosarcomas|19544688|2006
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19544688|2006
5-9|2.2|3.7|2.9|56|VIII(c) Ewing tumor and related sarcomas of bone|19544688|2006
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19544688|2006
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19544688|2006
5-9|1.6|3.0|2.3|44|X Germ cell, trophoblastic tumors & neoplasms of gonads|19544688|2006
5-9|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|19544688|2006
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19544688|2006
5-9|0.7|1.7|1.1|22|X(c) Malignant gonadal germ cell tumors|19544688|2006
5-9|~|~|~|~|X(d) Gonadal carcinomas|19544688|2006
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19544688|2006
5-9|3.7|5.7|4.7|91|XI Other malignant epithelial neoplasms and malignant melanomas|19544688|2006
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19544688|2006
5-9|1.0|2.2|1.5|30|XI(b) Thyroid carcinomas|19544688|2006
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19544688|2006
5-9|1.1|2.3|1.6|31|XI(d) Malignant melanomas|19544688|2006
5-9|~|~|~|~|XI(e) Skin carcinomas|19544688|2006
5-9|0.8|1.9|1.3|25|XI(f) Other and unspecified carcinomas|19544688|2006
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19544688|2006
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19544688|2006
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19544688|2006
<1|246.7|278.5|262.3|1060|All ICCC Groups Combined|4041738|2006
<1|50.5|65.5|57.6|233|I Leukemias, myeloproliferative & myelodysplastic diseases|4041738|2006
<1|18.8|28.5|23.3|94|I(a) Lymphoid leukemias|4041738|2006
<1|13.1|21.3|16.8|68|I(b) Acute myeloid leukemias|4041738|2006
<1|3.8|8.8|5.9|24|I(c) Chronic myeloproliferative diseases|4041738|2006
<1|4.8|10.3|7.2|29|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4041738|2006
<1|2.6|7.0|4.5|18|I(e) Unspecified and other specified leukemias|4041738|2006
<1|7.1|13.5|9.9|40|II Lymphomas and reticuloendothelial neoplasms|4041738|2006
<1|~|~|~|~|II(a) Hodgkin lymphomas|4041738|2006
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4041738|2006
<1|~|~|~|~|II(c) Burkitt lymphoma|4041738|2006
<1|4.2|9.4|6.4|26|II(d) Miscellaneous lymphoreticular neoplasms|4041738|2006
<1|~|~|~|~|II(e) Unspecified lymphomas|4041738|2006
<1|30.3|42.2|35.9|145|III CNS and misc intracranial and intraspinal neoplasms|4041738|2006
<1|3.8|8.8|5.9|24|III(a) Ependymomas and choroid plexus tumor|4041738|2006
<1|9.2|16.3|12.4|50|III(b) Astrocytomas|4041738|2006
<1|10.0|17.4|13.4|54|III(c) Intracranial and intraspinal embryonal tumors|4041738|2006
<1|~|~|~|~|III(d) Other gliomas|4041738|2006
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4041738|2006
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4041738|2006
<1|46.6|61.1|53.4|216|IV Neuroblastoma and other peripheral nervous cell tumors|4041738|2006
<1|46.6|61.1|53.4|216|IV(a) Neuroblastoma and ganglioneuroblastoma|4041738|2006
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4041738|2006
<1|13.7|22.2|17.6|71|IX Soft tissue and other extraosseous sarcomas|4041738|2006
<1|3.4|8.2|5.4|22|IX(a) Rhabdomyosarcomas|4041738|2006
<1|2.8|7.3|4.7|19|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4041738|2006
<1|~|~|~|~|IX(c) Kaposi sarcoma|4041738|2006
<1|4.0|9.1|6.2|25|IX(d) Other specified soft tissue sarcomas|4041738|2006
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4041738|2006
<1|~|~|~|~|Not classified by ICCC|4041738|2006
<1|27.8|39.3|33.2|134|V Retinoblastoma|4041738|2006
<1|12.0|19.9|15.6|63|VI Renal tumors|4041738|2006
<1|12.0|19.9|15.6|63|VI(a) Nephroblastoma and other nonepithelial renal tumors|4041738|2006
<1|~|~|~|~|VI(b) Renal carcinomas|4041738|2006
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4041738|2006
<1|10.5|18.0|13.9|56|VII Hepatic tumors|4041738|2006
<1|9.8|17.2|13.1|53|VII(a) Hepatoblastoma|4041738|2006
<1|~|~|~|~|VII(b) Hepatic carcinomas|4041738|2006
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4041738|2006
<1|~|~|~|~|VIII Malignant bone tumors|4041738|2006
<1|~|~|~|~|VIII(a) Osteosarcomas|4041738|2006
<1|~|~|~|~|VIII(b) Chondrosarcomas|4041738|2006
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4041738|2006
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4041738|2006
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4041738|2006
<1|14.4|23.0|18.3|74|X Germ cell, trophoblastic tumors & neoplasms of gonads|4041738|2006
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4041738|2006
<1|10.3|17.7|13.6|55|X(b) Malignant extracranial & extragonadal germ cell tumors|4041738|2006
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|4041738|2006
<1|~|~|~|~|X(d) Gonadal carcinomas|4041738|2006
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4041738|2006
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|4041738|2006
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4041738|2006
<1|~|~|~|~|XI(b) Thyroid carcinomas|4041738|2006
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4041738|2006
<1|~|~|~|~|XI(d) Malignant melanomas|4041738|2006
<1|~|~|~|~|XI(e) Skin carcinomas|4041738|2006
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4041738|2006
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4041738|2006
<1|~|~|~|~|XII(a) Other specified malignant tumors|4041738|2006
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4041738|2006
1-4|218.9|233.7|226.2|3614|All ICCC Groups Combined|15977965|2007
1-4|90.6|100.2|95.3|1523|I Leukemias, myeloproliferative & myelodysplastic diseases|15977965|2007
1-4|76.5|85.3|80.8|1291|I(a) Lymphoid leukemias|15977965|2007
1-4|7.9|10.9|9.3|149|I(b) Acute myeloid leukemias|15977965|2007
1-4|0.7|1.9|1.2|19|I(c) Chronic myeloproliferative diseases|15977965|2007
1-4|1.8|3.4|2.5|40|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15977965|2007
1-4|1.0|2.2|1.5|24|I(e) Unspecified and other specified leukemias|15977965|2007
1-4|7.3|10.3|8.7|139|II Lymphomas and reticuloendothelial neoplasms|15977965|2007
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15977965|2007
1-4|3.1|5.2|4.1|65|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15977965|2007
1-4|1.2|2.6|1.8|29|II(c) Burkitt lymphoma|15977965|2007
1-4|1.3|2.8|1.9|31|II(d) Miscellaneous lymphoreticular neoplasms|15977965|2007
1-4|~|~|~|~|II(e) Unspecified lymphomas|15977965|2007
1-4|42.6|49.3|45.9|733|III CNS and misc intracranial and intraspinal neoplasms|15977965|2007
1-4|4.2|6.5|5.3|84|III(a) Ependymomas and choroid plexus tumor|15977965|2007
1-4|18.0|22.4|20.1|321|III(b) Astrocytomas|15977965|2007
1-4|10.1|13.5|11.7|187|III(c) Intracranial and intraspinal embryonal tumors|15977965|2007
1-4|6.1|8.8|7.4|118|III(d) Other gliomas|15977965|2007
1-4|0.6|1.6|1.0|16|III(e) Other specified intracranial & intraspinal neoplasms|15977965|2007
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15977965|2007
1-4|20.6|25.4|22.9|366|IV Neuroblastoma and other peripheral nervous cell tumors|15977965|2007
1-4|20.5|25.2|22.8|364|IV(a) Neuroblastoma and ganglioneuroblastoma|15977965|2007
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15977965|2007
1-4|9.7|13.0|11.3|180|IX Soft tissue and other extraosseous sarcomas|15977965|2007
1-4|7.4|10.3|8.8|140|IX(a) Rhabdomyosarcomas|15977965|2007
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15977965|2007
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15977965|2007
1-4|1.1|2.5|1.7|27|IX(d) Other specified soft tissue sarcomas|15977965|2007
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15977965|2007
1-4|~|~|~|~|Not classified by ICCC|15977965|2007
1-4|7.9|11.0|9.4|150|V Retinoblastoma|15977965|2007
1-4|17.2|21.6|19.3|309|VI Renal tumors|15977965|2007
1-4|17.2|21.6|19.3|308|VI(a) Nephroblastoma and other nonepithelial renal tumors|15977965|2007
1-4|~|~|~|~|VI(b) Renal carcinomas|15977965|2007
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15977965|2007
1-4|4.2|6.6|5.3|85|VII Hepatic tumors|15977965|2007
1-4|4.0|6.3|5.1|81|VII(a) Hepatoblastoma|15977965|2007
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15977965|2007
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15977965|2007
1-4|1.2|2.6|1.8|29|VIII Malignant bone tumors|15977965|2007
1-4|~|~|~|~|VIII(a) Osteosarcomas|15977965|2007
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15977965|2007
1-4|0.6|1.7|1.1|17|VIII(c) Ewing tumor and related sarcomas of bone|15977965|2007
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15977965|2007
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15977965|2007
1-4|2.4|4.3|3.3|52|X Germ cell, trophoblastic tumors & neoplasms of gonads|15977965|2007
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15977965|2007
1-4|0.9|2.1|1.4|22|X(b) Malignant extracranial & extragonadal germ cell tumors|15977965|2007
1-4|1.1|2.4|1.6|26|X(c) Malignant gonadal germ cell tumors|15977965|2007
1-4|~|~|~|~|X(d) Gonadal carcinomas|15977965|2007
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15977965|2007
1-4|1.2|2.5|1.8|28|XI Other malignant epithelial neoplasms and malignant melanomas|15977965|2007
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15977965|2007
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15977965|2007
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15977965|2007
1-4|0.6|1.6|1.0|16|XI(d) Malignant melanomas|15977965|2007
1-4|~|~|~|~|XI(e) Skin carcinomas|15977965|2007
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15977965|2007
1-4|0.7|1.9|1.2|19|XII Other and unspecified malignant neoplasms|15977965|2007
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15977965|2007
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15977965|2007
10-14|128.4|138.3|133.3|2778|All ICCC Groups Combined|20841042|2007
10-14|27.6|32.4|29.9|624|I Leukemias, myeloproliferative & myelodysplastic diseases|20841042|2007
10-14|17.3|21.1|19.1|398|I(a) Lymphoid leukemias|20841042|2007
10-14|6.3|8.7|7.4|154|I(b) Acute myeloid leukemias|20841042|2007
10-14|1.4|2.6|1.9|40|I(c) Chronic myeloproliferative diseases|20841042|2007
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20841042|2007
10-14|0.5|1.4|0.9|18|I(e) Unspecified and other specified leukemias|20841042|2007
10-14|23.6|28.0|25.7|536|II Lymphomas and reticuloendothelial neoplasms|20841042|2007
10-14|10.5|13.5|11.9|249|II(a) Hodgkin lymphomas|20841042|2007
10-14|8.7|11.4|10.0|208|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20841042|2007
10-14|2.4|4.0|3.2|66|II(c) Burkitt lymphoma|20841042|2007
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20841042|2007
10-14|~|~|~|~|II(e) Unspecified lymphomas|20841042|2007
10-14|25.9|30.5|28.2|587|III CNS and misc intracranial and intraspinal neoplasms|20841042|2007
10-14|1.2|2.4|1.7|36|III(a) Ependymomas and choroid plexus tumor|20841042|2007
10-14|14.1|17.5|15.7|328|III(b) Astrocytomas|20841042|2007
10-14|3.6|5.4|4.4|92|III(c) Intracranial and intraspinal embryonal tumors|20841042|2007
10-14|4.2|6.2|5.1|107|III(d) Other gliomas|20841042|2007
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20841042|2007
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20841042|2007
10-14|1.1|2.2|1.5|32|IV Neuroblastoma and other peripheral nervous cell tumors|20841042|2007
10-14|0.8|1.8|1.2|25|IV(a) Neuroblastoma and ganglioneuroblastoma|20841042|2007
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20841042|2007
10-14|10.1|13.0|11.5|239|IX Soft tissue and other extraosseous sarcomas|20841042|2007
10-14|2.7|4.4|3.5|72|IX(a) Rhabdomyosarcomas|20841042|2007
10-14|1.1|2.2|1.5|32|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20841042|2007
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20841042|2007
10-14|4.5|6.6|5.5|114|IX(d) Other specified soft tissue sarcomas|20841042|2007
10-14|0.6|1.5|1.0|21|IX(e) Unspecified soft tissue sarcomas|20841042|2007
10-14|~|~|~|~|Not classified by ICCC|20841042|2007
10-14|~|~|~|~|V Retinoblastoma|20841042|2007
10-14|0.9|2.0|1.4|29|VI Renal tumors|20841042|2007
10-14|0.4|1.2|0.8|16|VI(a) Nephroblastoma and other nonepithelial renal tumors|20841042|2007
10-14|~|~|~|~|VI(b) Renal carcinomas|20841042|2007
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20841042|2007
10-14|~|~|~|~|VII Hepatic tumors|20841042|2007
10-14|~|~|~|~|VII(a) Hepatoblastoma|20841042|2007
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20841042|2007
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20841042|2007
10-14|11.5|14.6|13.0|271|VIII Malignant bone tumors|20841042|2007
10-14|6.3|8.7|7.4|155|VIII(a) Osteosarcomas|20841042|2007
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20841042|2007
10-14|3.5|5.3|4.3|90|VIII(c) Ewing tumor and related sarcomas of bone|20841042|2007
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20841042|2007
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20841042|2007
10-14|6.3|8.7|7.4|155|X Germ cell, trophoblastic tumors & neoplasms of gonads|20841042|2007
10-14|2.0|3.4|2.6|55|X(a) Intracranial & intraspinal germ cell tumors|20841042|2007
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20841042|2007
10-14|3.2|4.9|4.0|83|X(c) Malignant gonadal germ cell tumors|20841042|2007
10-14|~|~|~|~|X(d) Gonadal carcinomas|20841042|2007
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20841042|2007
10-14|12.2|15.5|13.8|287|XI Other malignant epithelial neoplasms and malignant melanomas|20841042|2007
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20841042|2007
10-14|4.8|6.9|5.8|120|XI(b) Thyroid carcinomas|20841042|2007
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20841042|2007
10-14|2.8|4.5|3.6|74|XI(d) Malignant melanomas|20841042|2007
10-14|~|~|~|~|XI(e) Skin carcinomas|20841042|2007
10-14|2.9|4.6|3.7|77|XI(f) Other and unspecified carcinomas|20841042|2007
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20841042|2007
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20841042|2007
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20841042|2007
15-19|215.7|228.2|221.9|4896|All ICCC Groups Combined|22067816|2007
15-19|31.0|35.9|33.4|736|I Leukemias, myeloproliferative & myelodysplastic diseases|22067816|2007
15-19|15.5|19.0|17.2|379|I(a) Lymphoid leukemias|22067816|2007
15-19|7.6|10.1|8.8|194|I(b) Acute myeloid leukemias|22067816|2007
15-19|4.3|6.3|5.2|115|I(c) Chronic myeloproliferative diseases|22067816|2007
15-19|0.8|1.7|1.2|26|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|22067816|2007
15-19|0.6|1.5|1.0|22|I(e) Unspecified and other specified leukemias|22067816|2007
15-19|47.0|52.9|49.9|1101|II Lymphomas and reticuloendothelial neoplasms|22067816|2007
15-19|29.7|34.4|32.0|706|II(a) Hodgkin lymphomas|22067816|2007
15-19|12.5|15.7|14.0|309|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|22067816|2007
15-19|1.8|3.2|2.4|54|II(c) Burkitt lymphoma|22067816|2007
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|22067816|2007
15-19|0.6|1.5|1.0|22|II(e) Unspecified lymphomas|22067816|2007
15-19|20.1|24.0|22.0|485|III CNS and misc intracranial and intraspinal neoplasms|22067816|2007
15-19|1.0|2.0|1.4|31|III(a) Ependymomas and choroid plexus tumor|22067816|2007
15-19|12.1|15.2|13.5|299|III(b) Astrocytomas|22067816|2007
15-19|2.1|3.6|2.8|61|III(c) Intracranial and intraspinal embryonal tumors|22067816|2007
15-19|2.7|4.3|3.4|76|III(d) Other gliomas|22067816|2007
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|22067816|2007
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|22067816|2007
15-19|0.5|1.3|0.8|18|IV Neuroblastoma and other peripheral nervous cell tumors|22067816|2007
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|22067816|2007
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|22067816|2007
15-19|15.5|19.0|17.2|379|IX Soft tissue and other extraosseous sarcomas|22067816|2007
15-19|3.0|4.6|3.7|82|IX(a) Rhabdomyosarcomas|22067816|2007
15-19|1.4|2.7|2.0|44|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|22067816|2007
15-19|~|~|~|~|IX(c) Kaposi sarcoma|22067816|2007
15-19|7.9|10.5|9.1|201|IX(d) Other specified soft tissue sarcomas|22067816|2007
15-19|1.6|2.9|2.2|49|IX(e) Unspecified soft tissue sarcomas|22067816|2007
15-19|~|~|~|~|Not classified by ICCC|22067816|2007
15-19|~|~|~|~|V Retinoblastoma|22067816|2007
15-19|1.3|2.5|1.8|40|VI Renal tumors|22067816|2007
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|22067816|2007
15-19|0.8|1.8|1.3|28|VI(b) Renal carcinomas|22067816|2007
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|22067816|2007
15-19|1.1|2.2|1.5|34|VII Hepatic tumors|22067816|2007
15-19|~|~|~|~|VII(a) Hepatoblastoma|22067816|2007
15-19|1.0|2.1|1.5|33|VII(b) Hepatic carcinomas|22067816|2007
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|22067816|2007
15-19|13.0|16.2|14.5|320|VIII Malignant bone tumors|22067816|2007
15-19|6.6|9.0|7.7|171|VIII(a) Osteosarcomas|22067816|2007
15-19|0.6|1.5|1.0|22|VIII(b) Chondrosarcomas|22067816|2007
15-19|3.9|5.8|4.8|105|VIII(c) Ewing tumor and related sarcomas of bone|22067816|2007
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|22067816|2007
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|22067816|2007
15-19|26.0|30.4|28.1|621|X Germ cell, trophoblastic tumors & neoplasms of gonads|22067816|2007
15-19|1.6|2.9|2.2|49|X(a) Intracranial & intraspinal germ cell tumors|22067816|2007
15-19|1.1|2.3|1.6|36|X(b) Malignant extracranial & extragonadal germ cell tumors|22067816|2007
15-19|20.3|24.3|22.2|491|X(c) Malignant gonadal germ cell tumors|22067816|2007
15-19|0.8|1.7|1.2|26|X(d) Gonadal carcinomas|22067816|2007
15-19|0.5|1.3|0.9|19|X(e) Other and unspecified malignant gonadal tumors|22067816|2007
15-19|48.1|54.1|51.1|1127|XI Other malignant epithelial neoplasms and malignant melanomas|22067816|2007
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|22067816|2007
15-19|20.7|24.7|22.6|499|XI(b) Thyroid carcinomas|22067816|2007
15-19|1.1|2.2|1.6|35|XI(c) Nasopharyngeal carcinomas|22067816|2007
15-19|13.5|16.8|15.1|333|XI(d) Malignant melanomas|22067816|2007
15-19|~|~|~|~|XI(e) Skin carcinomas|22067816|2007
15-19|10.1|13.0|11.5|253|XI(f) Other and unspecified carcinomas|22067816|2007
15-19|0.8|1.8|1.2|27|XII Other and unspecified malignant neoplasms|22067816|2007
15-19|~|~|~|~|XII(a) Other specified malignant tumors|22067816|2007
15-19|0.6|1.5|1.0|21|XII(b) Other unspecified malignant tumors|22067816|2007
5-9|119.1|128.9|123.9|2443|All ICCC Groups Combined|19714611|2007
5-9|38.9|44.7|41.7|823|I Leukemias, myeloproliferative & myelodysplastic diseases|19714611|2007
5-9|31.5|36.7|34.0|670|I(a) Lymphoid leukemias|19714611|2007
5-9|4.1|6.2|5.1|100|I(b) Acute myeloid leukemias|19714611|2007
5-9|0.7|1.6|1.1|21|I(c) Chronic myeloproliferative diseases|19714611|2007
5-9|0.5|1.3|0.8|16|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19714611|2007
5-9|0.5|1.3|0.8|16|I(e) Unspecified and other specified leukemias|19714611|2007
5-9|13.2|16.6|14.8|292|II Lymphomas and reticuloendothelial neoplasms|19714611|2007
5-9|2.7|4.4|3.5|69|II(a) Hodgkin lymphomas|19714611|2007
5-9|5.9|8.3|7.0|138|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19714611|2007
5-9|2.5|4.2|3.3|65|II(c) Burkitt lymphoma|19714611|2007
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19714611|2007
5-9|~|~|~|~|II(e) Unspecified lymphomas|19714611|2007
5-9|31.9|37.2|34.5|680|III CNS and misc intracranial and intraspinal neoplasms|19714611|2007
5-9|1.4|2.8|2.0|40|III(a) Ependymomas and choroid plexus tumor|19714611|2007
5-9|14.7|18.3|16.4|324|III(b) Astrocytomas|19714611|2007
5-9|6.3|8.8|7.5|148|III(c) Intracranial and intraspinal embryonal tumors|19714611|2007
5-9|6.4|8.9|7.6|150|III(d) Other gliomas|19714611|2007
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19714611|2007
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19714611|2007
5-9|2.9|4.7|3.8|74|IV Neuroblastoma and other peripheral nervous cell tumors|19714611|2007
5-9|2.9|4.6|3.7|72|IV(a) Neuroblastoma and ganglioneuroblastoma|19714611|2007
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19714611|2007
5-9|7.6|10.2|8.8|174|IX Soft tissue and other extraosseous sarcomas|19714611|2007
5-9|4.1|6.1|5.0|99|IX(a) Rhabdomyosarcomas|19714611|2007
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19714611|2007
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19714611|2007
5-9|1.6|3.0|2.2|44|IX(d) Other specified soft tissue sarcomas|19714611|2007
5-9|0.5|1.4|0.9|18|IX(e) Unspecified soft tissue sarcomas|19714611|2007
5-9|~|~|~|~|Not classified by ICCC|19714611|2007
5-9|~|~|~|~|V Retinoblastoma|19714611|2007
5-9|5.1|7.4|6.2|122|VI Renal tumors|19714611|2007
5-9|4.6|6.7|5.6|110|VI(a) Nephroblastoma and other nonepithelial renal tumors|19714611|2007
5-9|~|~|~|~|VI(b) Renal carcinomas|19714611|2007
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19714611|2007
5-9|0.5|1.4|0.9|17|VII Hepatic tumors|19714611|2007
5-9|~|~|~|~|VII(a) Hepatoblastoma|19714611|2007
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19714611|2007
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19714611|2007
5-9|4.7|6.9|5.7|113|VIII Malignant bone tumors|19714611|2007
5-9|2.4|4.0|3.1|61|VIII(a) Osteosarcomas|19714611|2007
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19714611|2007
5-9|1.5|2.8|2.1|41|VIII(c) Ewing tumor and related sarcomas of bone|19714611|2007
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19714611|2007
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19714611|2007
5-9|2.0|3.5|2.7|53|X Germ cell, trophoblastic tumors & neoplasms of gonads|19714611|2007
5-9|0.6|1.5|1.0|19|X(a) Intracranial & intraspinal germ cell tumors|19714611|2007
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19714611|2007
5-9|0.9|2.0|1.4|27|X(c) Malignant gonadal germ cell tumors|19714611|2007
5-9|~|~|~|~|X(d) Gonadal carcinomas|19714611|2007
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19714611|2007
5-9|3.0|4.8|3.8|75|XI Other malignant epithelial neoplasms and malignant melanomas|19714611|2007
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19714611|2007
5-9|0.5|1.4|0.9|18|XI(b) Thyroid carcinomas|19714611|2007
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19714611|2007
5-9|1.1|2.2|1.6|31|XI(d) Malignant melanomas|19714611|2007
5-9|~|~|~|~|XI(e) Skin carcinomas|19714611|2007
5-9|0.6|1.6|1.0|20|XI(f) Other and unspecified carcinomas|19714611|2007
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19714611|2007
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19714611|2007
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19714611|2007
<1|247.6|279.1|263.0|1091|All ICCC Groups Combined|4147997|2007
<1|43.8|57.7|50.4|209|I Leukemias, myeloproliferative & myelodysplastic diseases|4147997|2007
<1|14.6|23.2|18.6|77|I(a) Lymphoid leukemias|4147997|2007
<1|12.5|20.5|16.2|67|I(b) Acute myeloid leukemias|4147997|2007
<1|3.5|8.3|5.5|23|I(c) Chronic myeloproliferative diseases|4147997|2007
<1|4.3|9.5|6.5|27|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4147997|2007
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|4147997|2007
<1|7.7|14.2|10.6|44|II Lymphomas and reticuloendothelial neoplasms|4147997|2007
<1|~|~|~|~|II(a) Hodgkin lymphomas|4147997|2007
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4147997|2007
<1|~|~|~|~|II(c) Burkitt lymphoma|4147997|2007
<1|4.7|10.0|7.0|29|II(d) Miscellaneous lymphoreticular neoplasms|4147997|2007
<1|~|~|~|~|II(e) Unspecified lymphomas|4147997|2007
<1|31.7|43.7|37.4|155|III CNS and misc intracranial and intraspinal neoplasms|4147997|2007
<1|2.6|6.9|4.3|18|III(a) Ependymomas and choroid plexus tumor|4147997|2007
<1|12.1|20.0|15.7|65|III(b) Astrocytomas|4147997|2007
<1|6.9|13.1|9.6|40|III(c) Intracranial and intraspinal embryonal tumors|4147997|2007
<1|2.9|7.4|4.8|20|III(d) Other gliomas|4147997|2007
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4147997|2007
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4147997|2007
<1|56.2|71.8|63.6|264|IV Neuroblastoma and other peripheral nervous cell tumors|4147997|2007
<1|56.0|71.5|63.4|263|IV(a) Neuroblastoma and ganglioneuroblastoma|4147997|2007
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4147997|2007
<1|14.9|23.5|18.8|78|IX Soft tissue and other extraosseous sarcomas|4147997|2007
<1|5.5|11.2|8.0|33|IX(a) Rhabdomyosarcomas|4147997|2007
<1|3.7|8.6|5.8|24|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4147997|2007
<1|~|~|~|~|IX(c) Kaposi sarcoma|4147997|2007
<1|2.4|6.6|4.1|17|IX(d) Other specified soft tissue sarcomas|4147997|2007
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4147997|2007
<1|~|~|~|~|Not classified by ICCC|4147997|2007
<1|23.8|34.3|28.7|119|V Retinoblastoma|4147997|2007
<1|13.2|21.3|16.9|70|VI Renal tumors|4147997|2007
<1|12.9|21.1|16.6|69|VI(a) Nephroblastoma and other nonepithelial renal tumors|4147997|2007
<1|~|~|~|~|VI(b) Renal carcinomas|4147997|2007
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4147997|2007
<1|8.1|14.8|11.1|46|VII Hepatic tumors|4147997|2007
<1|7.9|14.5|10.8|45|VII(a) Hepatoblastoma|4147997|2007
<1|~|~|~|~|VII(b) Hepatic carcinomas|4147997|2007
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4147997|2007
<1|~|~|~|~|VIII Malignant bone tumors|4147997|2007
<1|~|~|~|~|VIII(a) Osteosarcomas|4147997|2007
<1|~|~|~|~|VIII(b) Chondrosarcomas|4147997|2007
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4147997|2007
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4147997|2007
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4147997|2007
<1|14.6|23.2|18.6|77|X Germ cell, trophoblastic tumors & neoplasms of gonads|4147997|2007
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4147997|2007
<1|8.5|15.3|11.6|48|X(b) Malignant extracranial & extragonadal germ cell tumors|4147997|2007
<1|3.1|7.7|5.1|21|X(c) Malignant gonadal germ cell tumors|4147997|2007
<1|~|~|~|~|X(d) Gonadal carcinomas|4147997|2007
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4147997|2007
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|4147997|2007
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4147997|2007
<1|~|~|~|~|XI(b) Thyroid carcinomas|4147997|2007
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4147997|2007
<1|~|~|~|~|XI(d) Malignant melanomas|4147997|2007
<1|~|~|~|~|XI(e) Skin carcinomas|4147997|2007
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4147997|2007
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4147997|2007
<1|~|~|~|~|XII(a) Other specified malignant tumors|4147997|2007
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4147997|2007
1-4|220.0|234.8|227.3|3668|All ICCC Groups Combined|16138392|2008
1-4|90.2|99.7|94.9|1531|I Leukemias, myeloproliferative & myelodysplastic diseases|16138392|2008
1-4|74.4|83.1|78.7|1270|I(a) Lymphoid leukemias|16138392|2008
1-4|9.5|12.8|11.0|178|I(b) Acute myeloid leukemias|16138392|2008
1-4|1.2|2.6|1.8|29|I(c) Chronic myeloproliferative diseases|16138392|2008
1-4|1.4|2.8|2.0|32|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|16138392|2008
1-4|0.9|2.1|1.4|22|I(e) Unspecified and other specified leukemias|16138392|2008
1-4|8.3|11.4|9.7|157|II Lymphomas and reticuloendothelial neoplasms|16138392|2008
1-4|0.6|1.6|1.0|16|II(a) Hodgkin lymphomas|16138392|2008
1-4|3.5|5.7|4.5|73|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|16138392|2008
1-4|1.7|3.2|2.4|38|II(c) Burkitt lymphoma|16138392|2008
1-4|1.1|2.4|1.7|27|II(d) Miscellaneous lymphoreticular neoplasms|16138392|2008
1-4|~|~|~|~|II(e) Unspecified lymphomas|16138392|2008
1-4|43.5|50.2|46.8|755|III CNS and misc intracranial and intraspinal neoplasms|16138392|2008
1-4|3.5|5.6|4.5|72|III(a) Ependymomas and choroid plexus tumor|16138392|2008
1-4|20.4|25.1|22.6|365|III(b) Astrocytomas|16138392|2008
1-4|9.9|13.3|11.5|186|III(c) Intracranial and intraspinal embryonal tumors|16138392|2008
1-4|5.8|8.4|7.0|113|III(d) Other gliomas|16138392|2008
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|16138392|2008
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|16138392|2008
1-4|18.5|23.0|20.6|333|IV Neuroblastoma and other peripheral nervous cell tumors|16138392|2008
1-4|18.1|22.6|20.3|327|IV(a) Neuroblastoma and ganglioneuroblastoma|16138392|2008
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|16138392|2008
1-4|10.5|14.0|12.1|196|IX Soft tissue and other extraosseous sarcomas|16138392|2008
1-4|6.7|9.6|8.1|130|IX(a) Rhabdomyosarcomas|16138392|2008
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|16138392|2008
1-4|~|~|~|~|IX(c) Kaposi sarcoma|16138392|2008
1-4|1.8|3.4|2.5|40|IX(d) Other specified soft tissue sarcomas|16138392|2008
1-4|0.6|1.6|1.0|16|IX(e) Unspecified soft tissue sarcomas|16138392|2008
1-4|~|~|~|~|Not classified by ICCC|16138392|2008
1-4|7.1|10.0|8.5|137|V Retinoblastoma|16138392|2008
1-4|19.2|23.8|21.4|346|VI Renal tumors|16138392|2008
1-4|18.9|23.4|21.1|340|VI(a) Nephroblastoma and other nonepithelial renal tumors|16138392|2008
1-4|~|~|~|~|VI(b) Renal carcinomas|16138392|2008
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|16138392|2008
1-4|4.3|6.6|5.4|87|VII Hepatic tumors|16138392|2008
1-4|4.2|6.4|5.2|84|VII(a) Hepatoblastoma|16138392|2008
1-4|~|~|~|~|VII(b) Hepatic carcinomas|16138392|2008
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|16138392|2008
1-4|0.9|2.1|1.4|23|VIII Malignant bone tumors|16138392|2008
1-4|~|~|~|~|VIII(a) Osteosarcomas|16138392|2008
1-4|~|~|~|~|VIII(b) Chondrosarcomas|16138392|2008
1-4|0.6|1.6|1.0|16|VIII(c) Ewing tumor and related sarcomas of bone|16138392|2008
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|16138392|2008
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|16138392|2008
1-4|2.3|4.1|3.1|50|X Germ cell, trophoblastic tumors & neoplasms of gonads|16138392|2008
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|16138392|2008
1-4|0.8|2.0|1.3|21|X(b) Malignant extracranial & extragonadal germ cell tumors|16138392|2008
1-4|1.1|2.4|1.6|26|X(c) Malignant gonadal germ cell tumors|16138392|2008
1-4|~|~|~|~|X(d) Gonadal carcinomas|16138392|2008
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|16138392|2008
1-4|1.5|2.9|2.1|34|XI Other malignant epithelial neoplasms and malignant melanomas|16138392|2008
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|16138392|2008
1-4|~|~|~|~|XI(b) Thyroid carcinomas|16138392|2008
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|16138392|2008
1-4|~|~|~|~|XI(d) Malignant melanomas|16138392|2008
1-4|~|~|~|~|XI(e) Skin carcinomas|16138392|2008
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|16138392|2008
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|16138392|2008
1-4|~|~|~|~|XII(a) Other specified malignant tumors|16138392|2008
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|16138392|2008
10-14|129.1|139.1|134.0|2775|All ICCC Groups Combined|20706655|2008
10-14|31.1|36.2|33.6|695|I Leukemias, myeloproliferative & myelodysplastic diseases|20706655|2008
10-14|20.0|24.1|22.0|455|I(a) Lymphoid leukemias|20706655|2008
10-14|5.7|8.0|6.8|140|I(b) Acute myeloid leukemias|20706655|2008
10-14|1.8|3.2|2.4|50|I(c) Chronic myeloproliferative diseases|20706655|2008
10-14|0.9|2.0|1.4|28|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20706655|2008
10-14|0.7|1.6|1.1|22|I(e) Unspecified and other specified leukemias|20706655|2008
10-14|23.6|28.0|25.7|532|II Lymphomas and reticuloendothelial neoplasms|20706655|2008
10-14|11.8|15.0|13.3|276|II(a) Hodgkin lymphomas|20706655|2008
10-14|7.5|10.1|8.7|181|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20706655|2008
10-14|2.2|3.7|2.9|60|II(c) Burkitt lymphoma|20706655|2008
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20706655|2008
10-14|~|~|~|~|II(e) Unspecified lymphomas|20706655|2008
10-14|24.2|28.7|26.4|547|III CNS and misc intracranial and intraspinal neoplasms|20706655|2008
10-14|1.1|2.2|1.5|32|III(a) Ependymomas and choroid plexus tumor|20706655|2008
10-14|12.8|16.2|14.4|299|III(b) Astrocytomas|20706655|2008
10-14|3.9|5.8|4.8|99|III(c) Intracranial and intraspinal embryonal tumors|20706655|2008
10-14|3.9|5.9|4.8|100|III(d) Other gliomas|20706655|2008
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20706655|2008
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20706655|2008
10-14|0.7|1.7|1.1|23|IV Neuroblastoma and other peripheral nervous cell tumors|20706655|2008
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20706655|2008
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20706655|2008
10-14|9.4|12.2|10.7|222|IX Soft tissue and other extraosseous sarcomas|20706655|2008
10-14|3.0|4.8|3.8|79|IX(a) Rhabdomyosarcomas|20706655|2008
10-14|0.6|1.6|1.0|21|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20706655|2008
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20706655|2008
10-14|3.6|5.4|4.4|92|IX(d) Other specified soft tissue sarcomas|20706655|2008
10-14|1.0|2.1|1.4|30|IX(e) Unspecified soft tissue sarcomas|20706655|2008
10-14|~|~|~|~|Not classified by ICCC|20706655|2008
10-14|~|~|~|~|V Retinoblastoma|20706655|2008
10-14|0.7|1.7|1.1|23|VI Renal tumors|20706655|2008
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20706655|2008
10-14|~|~|~|~|VI(b) Renal carcinomas|20706655|2008
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20706655|2008
10-14|~|~|~|~|VII Hepatic tumors|20706655|2008
10-14|~|~|~|~|VII(a) Hepatoblastoma|20706655|2008
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20706655|2008
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20706655|2008
10-14|11.3|14.5|12.8|266|VIII Malignant bone tumors|20706655|2008
10-14|6.4|8.8|7.5|156|VIII(a) Osteosarcomas|20706655|2008
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20706655|2008
10-14|3.3|5.1|4.2|86|VIII(c) Ewing tumor and related sarcomas of bone|20706655|2008
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20706655|2008
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20706655|2008
10-14|5.5|7.7|6.5|135|X Germ cell, trophoblastic tumors & neoplasms of gonads|20706655|2008
10-14|1.7|3.0|2.3|47|X(a) Intracranial & intraspinal germ cell tumors|20706655|2008
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20706655|2008
10-14|2.6|4.3|3.4|70|X(c) Malignant gonadal germ cell tumors|20706655|2008
10-14|~|~|~|~|X(d) Gonadal carcinomas|20706655|2008
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20706655|2008
10-14|13.1|16.4|14.7|304|XI Other malignant epithelial neoplasms and malignant melanomas|20706655|2008
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20706655|2008
10-14|5.1|7.2|6.1|126|XI(b) Thyroid carcinomas|20706655|2008
10-14|0.5|1.3|0.8|17|XI(c) Nasopharyngeal carcinomas|20706655|2008
10-14|3.0|4.7|3.8|78|XI(d) Malignant melanomas|20706655|2008
10-14|~|~|~|~|XI(e) Skin carcinomas|20706655|2008
10-14|3.0|4.8|3.8|79|XI(f) Other and unspecified carcinomas|20706655|2008
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20706655|2008
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20706655|2008
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20706655|2008
15-19|216.0|228.4|222.1|4934|All ICCC Groups Combined|22210880|2008
15-19|31.7|36.6|34.1|758|I Leukemias, myeloproliferative & myelodysplastic diseases|22210880|2008
15-19|15.8|19.3|17.5|389|I(a) Lymphoid leukemias|22210880|2008
15-19|8.2|10.8|9.4|209|I(b) Acute myeloid leukemias|22210880|2008
15-19|3.9|5.8|4.8|106|I(c) Chronic myeloproliferative diseases|22210880|2008
15-19|0.8|1.8|1.3|28|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|22210880|2008
15-19|0.8|1.7|1.2|26|I(e) Unspecified and other specified leukemias|22210880|2008
15-19|47.3|53.2|50.2|1114|II Lymphomas and reticuloendothelial neoplasms|22210880|2008
15-19|30.2|35.0|32.5|722|II(a) Hodgkin lymphomas|22210880|2008
15-19|13.2|16.4|14.7|327|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|22210880|2008
15-19|1.6|2.9|2.2|49|II(c) Burkitt lymphoma|22210880|2008
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|22210880|2008
15-19|~|~|~|~|II(e) Unspecified lymphomas|22210880|2008
15-19|21.2|25.2|23.1|514|III CNS and misc intracranial and intraspinal neoplasms|22210880|2008
15-19|1.0|2.1|1.5|33|III(a) Ependymomas and choroid plexus tumor|22210880|2008
15-19|11.3|14.4|12.8|284|III(b) Astrocytomas|22210880|2008
15-19|1.9|3.3|2.5|56|III(c) Intracranial and intraspinal embryonal tumors|22210880|2008
15-19|4.2|6.1|5.1|113|III(d) Other gliomas|22210880|2008
15-19|0.4|1.2|0.8|17|III(e) Other specified intracranial & intraspinal neoplasms|22210880|2008
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|22210880|2008
15-19|0.5|1.3|0.9|19|IV Neuroblastoma and other peripheral nervous cell tumors|22210880|2008
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|22210880|2008
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|22210880|2008
15-19|14.4|17.8|16.0|356|IX Soft tissue and other extraosseous sarcomas|22210880|2008
15-19|3.7|5.5|4.5|100|IX(a) Rhabdomyosarcomas|22210880|2008
15-19|1.0|2.1|1.5|33|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|22210880|2008
15-19|~|~|~|~|IX(c) Kaposi sarcoma|22210880|2008
15-19|6.7|9.1|7.8|174|IX(d) Other specified soft tissue sarcomas|22210880|2008
15-19|1.6|2.9|2.2|48|IX(e) Unspecified soft tissue sarcomas|22210880|2008
15-19|~|~|~|~|Not classified by ICCC|22210880|2008
15-19|~|~|~|~|V Retinoblastoma|22210880|2008
15-19|1.4|2.7|2.0|44|VI Renal tumors|22210880|2008
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|22210880|2008
15-19|1.2|2.3|1.7|38|VI(b) Renal carcinomas|22210880|2008
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|22210880|2008
15-19|0.7|1.6|1.1|24|VII Hepatic tumors|22210880|2008
15-19|~|~|~|~|VII(a) Hepatoblastoma|22210880|2008
15-19|0.6|1.4|0.9|21|VII(b) Hepatic carcinomas|22210880|2008
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|22210880|2008
15-19|13.0|16.3|14.6|324|VIII Malignant bone tumors|22210880|2008
15-19|7.0|9.5|8.2|182|VIII(a) Osteosarcomas|22210880|2008
15-19|0.7|1.7|1.1|25|VIII(b) Chondrosarcomas|22210880|2008
15-19|3.0|4.7|3.8|84|VIII(c) Ewing tumor and related sarcomas of bone|22210880|2008
15-19|0.6|1.5|1.0|22|VIII(d) Other specified malignant bone tumors|22210880|2008
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|22210880|2008
15-19|25.7|30.1|27.8|618|X Germ cell, trophoblastic tumors & neoplasms of gonads|22210880|2008
15-19|2.2|3.7|2.9|64|X(a) Intracranial & intraspinal germ cell tumors|22210880|2008
15-19|1.1|2.1|1.5|34|X(b) Malignant extracranial & extragonadal germ cell tumors|22210880|2008
15-19|20.1|24.0|22.0|488|X(c) Malignant gonadal germ cell tumors|22210880|2008
15-19|0.6|1.5|1.0|22|X(d) Gonadal carcinomas|22210880|2008
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|22210880|2008
15-19|48.0|54.0|50.9|1131|XI Other malignant epithelial neoplasms and malignant melanomas|22210880|2008
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|22210880|2008
15-19|22.6|26.8|24.7|548|XI(b) Thyroid carcinomas|22210880|2008
15-19|0.9|1.9|1.3|29|XI(c) Nasopharyngeal carcinomas|22210880|2008
15-19|11.2|14.2|12.7|281|XI(d) Malignant melanomas|22210880|2008
15-19|~|~|~|~|XI(e) Skin carcinomas|22210880|2008
15-19|10.6|13.6|12.0|267|XI(f) Other and unspecified carcinomas|22210880|2008
15-19|0.8|1.7|1.2|26|XII Other and unspecified malignant neoplasms|22210880|2008
15-19|~|~|~|~|XII(a) Other specified malignant tumors|22210880|2008
15-19|0.5|1.3|0.8|18|XII(b) Other unspecified malignant tumors|22210880|2008
5-9|124.1|134.1|129.0|2571|All ICCC Groups Combined|19929602|2008
5-9|40.5|46.3|43.3|863|I Leukemias, myeloproliferative & myelodysplastic diseases|19929602|2008
5-9|33.1|38.4|35.7|711|I(a) Lymphoid leukemias|19929602|2008
5-9|3.9|5.8|4.8|95|I(b) Acute myeloid leukemias|19929602|2008
5-9|0.7|1.6|1.1|21|I(c) Chronic myeloproliferative diseases|19929602|2008
5-9|0.7|1.7|1.1|22|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19929602|2008
5-9|~|~|~|~|I(e) Unspecified and other specified leukemias|19929602|2008
5-9|14.0|17.5|15.7|312|II Lymphomas and reticuloendothelial neoplasms|19929602|2008
5-9|3.6|5.5|4.5|89|II(a) Hodgkin lymphomas|19929602|2008
5-9|6.0|8.4|7.1|142|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19929602|2008
5-9|2.5|4.2|3.3|65|II(c) Burkitt lymphoma|19929602|2008
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|19929602|2008
5-9|~|~|~|~|II(e) Unspecified lymphomas|19929602|2008
5-9|33.3|38.6|35.9|715|III CNS and misc intracranial and intraspinal neoplasms|19929602|2008
5-9|1.5|2.8|2.1|42|III(a) Ependymomas and choroid plexus tumor|19929602|2008
5-9|16.3|20.1|18.1|361|III(b) Astrocytomas|19929602|2008
5-9|6.2|8.7|7.4|147|III(c) Intracranial and intraspinal embryonal tumors|19929602|2008
5-9|6.1|8.5|7.2|144|III(d) Other gliomas|19929602|2008
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19929602|2008
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19929602|2008
5-9|3.5|5.4|4.4|87|IV Neuroblastoma and other peripheral nervous cell tumors|19929602|2008
5-9|3.4|5.2|4.2|84|IV(a) Neuroblastoma and ganglioneuroblastoma|19929602|2008
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19929602|2008
5-9|7.9|10.6|9.2|183|IX Soft tissue and other extraosseous sarcomas|19929602|2008
5-9|3.7|5.7|4.6|92|IX(a) Rhabdomyosarcomas|19929602|2008
5-9|0.5|1.3|0.8|16|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19929602|2008
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19929602|2008
5-9|2.2|3.7|2.9|57|IX(d) Other specified soft tissue sarcomas|19929602|2008
5-9|0.5|1.4|0.9|17|IX(e) Unspecified soft tissue sarcomas|19929602|2008
5-9|~|~|~|~|Not classified by ICCC|19929602|2008
5-9|~|~|~|~|V Retinoblastoma|19929602|2008
5-9|4.8|7.0|5.8|116|VI Renal tumors|19929602|2008
5-9|4.3|6.4|5.3|105|VI(a) Nephroblastoma and other nonepithelial renal tumors|19929602|2008
5-9|~|~|~|~|VI(b) Renal carcinomas|19929602|2008
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19929602|2008
5-9|0.5|1.3|0.8|16|VII Hepatic tumors|19929602|2008
5-9|~|~|~|~|VII(a) Hepatoblastoma|19929602|2008
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19929602|2008
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19929602|2008
5-9|5.1|7.4|6.2|123|VIII Malignant bone tumors|19929602|2008
5-9|2.7|4.4|3.5|70|VIII(a) Osteosarcomas|19929602|2008
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19929602|2008
5-9|1.6|3.0|2.3|45|VIII(c) Ewing tumor and related sarcomas of bone|19929602|2008
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19929602|2008
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19929602|2008
5-9|2.1|3.6|2.8|55|X Germ cell, trophoblastic tumors & neoplasms of gonads|19929602|2008
5-9|0.9|1.9|1.3|26|X(a) Intracranial & intraspinal germ cell tumors|19929602|2008
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19929602|2008
5-9|0.8|1.8|1.2|24|X(c) Malignant gonadal germ cell tumors|19929602|2008
5-9|~|~|~|~|X(d) Gonadal carcinomas|19929602|2008
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19929602|2008
5-9|3.1|4.9|3.9|78|XI Other malignant epithelial neoplasms and malignant melanomas|19929602|2008
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19929602|2008
5-9|0.8|1.9|1.3|25|XI(b) Thyroid carcinomas|19929602|2008
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19929602|2008
5-9|1.0|2.1|1.5|29|XI(d) Malignant melanomas|19929602|2008
5-9|~|~|~|~|XI(e) Skin carcinomas|19929602|2008
5-9|0.6|1.5|1.0|20|XI(f) Other and unspecified carcinomas|19929602|2008
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19929602|2008
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19929602|2008
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19929602|2008
<1|252.3|284.1|267.9|1107|All ICCC Groups Combined|4132735|2008
<1|48.7|63.3|55.7|230|I Leukemias, myeloproliferative & myelodysplastic diseases|4132735|2008
<1|16.0|24.9|20.1|83|I(a) Lymphoid leukemias|4132735|2008
<1|15.1|23.8|19.1|79|I(b) Acute myeloid leukemias|4132735|2008
<1|5.7|11.5|8.2|34|I(c) Chronic myeloproliferative diseases|4132735|2008
<1|3.7|8.6|5.8|24|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4132735|2008
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|4132735|2008
<1|7.5|14.0|10.4|43|II Lymphomas and reticuloendothelial neoplasms|4132735|2008
<1|~|~|~|~|II(a) Hodgkin lymphomas|4132735|2008
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4132735|2008
<1|~|~|~|~|II(c) Burkitt lymphoma|4132735|2008
<1|4.3|9.5|6.5|27|II(d) Miscellaneous lymphoreticular neoplasms|4132735|2008
<1|~|~|~|~|II(e) Unspecified lymphomas|4132735|2008
<1|32.1|44.2|37.7|156|III CNS and misc intracranial and intraspinal neoplasms|4132735|2008
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|4132735|2008
<1|10.0|17.3|13.3|55|III(b) Astrocytomas|4132735|2008
<1|13.0|21.1|16.7|69|III(c) Intracranial and intraspinal embryonal tumors|4132735|2008
<1|~|~|~|~|III(d) Other gliomas|4132735|2008
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4132735|2008
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4132735|2008
<1|51.6|66.7|58.8|243|IV Neuroblastoma and other peripheral nervous cell tumors|4132735|2008
<1|51.4|66.4|58.6|242|IV(a) Neuroblastoma and ganglioneuroblastoma|4132735|2008
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4132735|2008
<1|14.1|22.5|17.9|74|IX Soft tissue and other extraosseous sarcomas|4132735|2008
<1|3.5|8.4|5.6|23|IX(a) Rhabdomyosarcomas|4132735|2008
<1|2.2|6.3|3.9|16|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4132735|2008
<1|~|~|~|~|IX(c) Kaposi sarcoma|4132735|2008
<1|3.1|7.8|5.1|21|IX(d) Other specified soft tissue sarcomas|4132735|2008
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4132735|2008
<1|~|~|~|~|Not classified by ICCC|4132735|2008
<1|24.1|34.7|29.0|120|V Retinoblastoma|4132735|2008
<1|13.2|21.4|16.9|70|VI Renal tumors|4132735|2008
<1|13.2|21.4|16.9|70|VI(a) Nephroblastoma and other nonepithelial renal tumors|4132735|2008
<1|~|~|~|~|VI(b) Renal carcinomas|4132735|2008
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4132735|2008
<1|8.4|15.1|11.4|47|VII Hepatic tumors|4132735|2008
<1|8.1|14.8|11.1|46|VII(a) Hepatoblastoma|4132735|2008
<1|~|~|~|~|VII(b) Hepatic carcinomas|4132735|2008
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4132735|2008
<1|~|~|~|~|VIII Malignant bone tumors|4132735|2008
<1|~|~|~|~|VIII(a) Osteosarcomas|4132735|2008
<1|~|~|~|~|VIII(b) Chondrosarcomas|4132735|2008
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4132735|2008
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4132735|2008
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4132735|2008
<1|16.9|26.0|21.1|87|X Germ cell, trophoblastic tumors & neoplasms of gonads|4132735|2008
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4132735|2008
<1|10.9|18.4|14.3|59|X(b) Malignant extracranial & extragonadal germ cell tumors|4132735|2008
<1|3.1|7.8|5.1|21|X(c) Malignant gonadal germ cell tumors|4132735|2008
<1|~|~|~|~|X(d) Gonadal carcinomas|4132735|2008
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4132735|2008
<1|3.5|8.4|5.6|23|XI Other malignant epithelial neoplasms and malignant melanomas|4132735|2008
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4132735|2008
<1|~|~|~|~|XI(b) Thyroid carcinomas|4132735|2008
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4132735|2008
<1|2.2|6.3|3.9|16|XI(d) Malignant melanomas|4132735|2008
<1|~|~|~|~|XI(e) Skin carcinomas|4132735|2008
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4132735|2008
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4132735|2008
<1|~|~|~|~|XII(a) Other specified malignant tumors|4132735|2008
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4132735|2008
1-4|216.2|230.8|223.4|3628|All ICCC Groups Combined|16240931|2009
1-4|89.8|99.4|94.5|1535|I Leukemias, myeloproliferative & myelodysplastic diseases|16240931|2009
1-4|74.4|83.1|78.7|1278|I(a) Lymphoid leukemias|16240931|2009
1-4|9.1|12.4|10.7|173|I(b) Acute myeloid leukemias|16240931|2009
1-4|0.7|1.8|1.1|18|I(c) Chronic myeloproliferative diseases|16240931|2009
1-4|1.7|3.3|2.4|39|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|16240931|2009
1-4|1.1|2.4|1.7|27|I(e) Unspecified and other specified leukemias|16240931|2009
1-4|9.4|12.7|11.0|178|II Lymphomas and reticuloendothelial neoplasms|16240931|2009
1-4|0.8|2.1|1.4|22|II(a) Hodgkin lymphomas|16240931|2009
1-4|3.6|5.8|4.6|75|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|16240931|2009
1-4|1.3|2.8|2.0|32|II(c) Burkitt lymphoma|16240931|2009
1-4|2.2|4.0|3.0|49|II(d) Miscellaneous lymphoreticular neoplasms|16240931|2009
1-4|~|~|~|~|II(e) Unspecified lymphomas|16240931|2009
1-4|41.6|48.1|44.8|727|III CNS and misc intracranial and intraspinal neoplasms|16240931|2009
1-4|4.2|6.5|5.2|85|III(a) Ependymomas and choroid plexus tumor|16240931|2009
1-4|19.7|24.3|21.9|356|III(b) Astrocytomas|16240931|2009
1-4|8.4|11.5|9.9|160|III(c) Intracranial and intraspinal embryonal tumors|16240931|2009
1-4|5.5|8.1|6.7|109|III(d) Other gliomas|16240931|2009
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|16240931|2009
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|16240931|2009
1-4|18.8|23.3|20.9|340|IV Neuroblastoma and other peripheral nervous cell tumors|16240931|2009
1-4|18.6|23.1|20.8|337|IV(a) Neuroblastoma and ganglioneuroblastoma|16240931|2009
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|16240931|2009
1-4|8.6|11.7|10.0|163|IX Soft tissue and other extraosseous sarcomas|16240931|2009
1-4|5.3|7.9|6.5|106|IX(a) Rhabdomyosarcomas|16240931|2009
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|16240931|2009
1-4|~|~|~|~|IX(c) Kaposi sarcoma|16240931|2009
1-4|1.4|2.9|2.1|34|IX(d) Other specified soft tissue sarcomas|16240931|2009
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|16240931|2009
1-4|~|~|~|~|Not classified by ICCC|16240931|2009
1-4|7.3|10.2|8.7|141|V Retinoblastoma|16240931|2009
1-4|19.1|23.6|21.2|345|VI Renal tumors|16240931|2009
1-4|18.9|23.5|21.1|343|VI(a) Nephroblastoma and other nonepithelial renal tumors|16240931|2009
1-4|~|~|~|~|VI(b) Renal carcinomas|16240931|2009
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|16240931|2009
1-4|3.8|6.0|4.8|78|VII Hepatic tumors|16240931|2009
1-4|3.6|5.7|4.6|74|VII(a) Hepatoblastoma|16240931|2009
1-4|~|~|~|~|VII(b) Hepatic carcinomas|16240931|2009
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|16240931|2009
1-4|0.8|2.0|1.3|21|VIII Malignant bone tumors|16240931|2009
1-4|~|~|~|~|VIII(a) Osteosarcomas|16240931|2009
1-4|~|~|~|~|VIII(b) Chondrosarcomas|16240931|2009
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|16240931|2009
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|16240931|2009
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|16240931|2009
1-4|2.4|4.2|3.2|52|X Germ cell, trophoblastic tumors & neoplasms of gonads|16240931|2009
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|16240931|2009
1-4|0.8|2.1|1.4|22|X(b) Malignant extracranial & extragonadal germ cell tumors|16240931|2009
1-4|1.1|2.5|1.7|28|X(c) Malignant gonadal germ cell tumors|16240931|2009
1-4|~|~|~|~|X(d) Gonadal carcinomas|16240931|2009
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|16240931|2009
1-4|0.9|2.1|1.4|23|XI Other malignant epithelial neoplasms and malignant melanomas|16240931|2009
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|16240931|2009
1-4|~|~|~|~|XI(b) Thyroid carcinomas|16240931|2009
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|16240931|2009
1-4|~|~|~|~|XI(d) Malignant melanomas|16240931|2009
1-4|~|~|~|~|XI(e) Skin carcinomas|16240931|2009
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|16240931|2009
1-4|0.6|1.7|1.0|17|XII Other and unspecified malignant neoplasms|16240931|2009
1-4|~|~|~|~|XII(a) Other specified malignant tumors|16240931|2009
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|16240931|2009
10-14|131.9|142.0|136.9|2828|All ICCC Groups Combined|20660564|2009
10-14|29.6|34.5|31.9|660|I Leukemias, myeloproliferative & myelodysplastic diseases|20660564|2009
10-14|20.1|24.2|22.1|456|I(a) Lymphoid leukemias|20660564|2009
10-14|5.4|7.6|6.4|133|I(b) Acute myeloid leukemias|20660564|2009
10-14|1.5|2.8|2.1|43|I(c) Chronic myeloproliferative diseases|20660564|2009
10-14|0.6|1.5|1.0|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20660564|2009
10-14|~|~|~|~|I(e) Unspecified and other specified leukemias|20660564|2009
10-14|22.7|27.0|24.8|512|II Lymphomas and reticuloendothelial neoplasms|20660564|2009
10-14|10.2|13.2|11.6|240|II(a) Hodgkin lymphomas|20660564|2009
10-14|8.3|11.1|9.6|199|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20660564|2009
10-14|2.1|3.6|2.8|57|II(c) Burkitt lymphoma|20660564|2009
10-14|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20660564|2009
10-14|~|~|~|~|II(e) Unspecified lymphomas|20660564|2009
10-14|25.7|30.3|27.9|577|III CNS and misc intracranial and intraspinal neoplasms|20660564|2009
10-14|0.7|1.6|1.1|22|III(a) Ependymomas and choroid plexus tumor|20660564|2009
10-14|14.3|17.8|16.0|331|III(b) Astrocytomas|20660564|2009
10-14|3.2|5.0|4.0|83|III(c) Intracranial and intraspinal embryonal tumors|20660564|2009
10-14|4.7|6.8|5.7|118|III(d) Other gliomas|20660564|2009
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20660564|2009
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20660564|2009
10-14|0.5|1.3|0.8|17|IV Neuroblastoma and other peripheral nervous cell tumors|20660564|2009
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20660564|2009
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20660564|2009
10-14|10.0|13.0|11.4|236|IX Soft tissue and other extraosseous sarcomas|20660564|2009
10-14|2.3|3.9|3.0|63|IX(a) Rhabdomyosarcomas|20660564|2009
10-14|0.7|1.7|1.1|23|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20660564|2009
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20660564|2009
10-14|4.5|6.6|5.5|113|IX(d) Other specified soft tissue sarcomas|20660564|2009
10-14|1.3|2.5|1.8|37|IX(e) Unspecified soft tissue sarcomas|20660564|2009
10-14|~|~|~|~|Not classified by ICCC|20660564|2009
10-14|~|~|~|~|V Retinoblastoma|20660564|2009
10-14|0.9|2.0|1.4|29|VI Renal tumors|20660564|2009
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20660564|2009
10-14|0.5|1.3|0.8|17|VI(b) Renal carcinomas|20660564|2009
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20660564|2009
10-14|0.6|1.5|1.0|20|VII Hepatic tumors|20660564|2009
10-14|~|~|~|~|VII(a) Hepatoblastoma|20660564|2009
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20660564|2009
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20660564|2009
10-14|12.5|15.8|14.1|291|VIII Malignant bone tumors|20660564|2009
10-14|7.1|9.6|8.3|171|VIII(a) Osteosarcomas|20660564|2009
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20660564|2009
10-14|3.5|5.4|4.4|91|VIII(c) Ewing tumor and related sarcomas of bone|20660564|2009
10-14|0.4|1.3|0.8|16|VIII(d) Other specified malignant bone tumors|20660564|2009
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20660564|2009
10-14|6.0|8.4|7.1|147|X Germ cell, trophoblastic tumors & neoplasms of gonads|20660564|2009
10-14|1.7|3.0|2.3|47|X(a) Intracranial & intraspinal germ cell tumors|20660564|2009
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20660564|2009
10-14|3.2|5.0|4.0|83|X(c) Malignant gonadal germ cell tumors|20660564|2009
10-14|~|~|~|~|X(d) Gonadal carcinomas|20660564|2009
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20660564|2009
10-14|13.7|17.2|15.4|318|XI Other malignant epithelial neoplasms and malignant melanomas|20660564|2009
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20660564|2009
10-14|6.0|8.3|7.1|146|XI(b) Thyroid carcinomas|20660564|2009
10-14|0.7|1.6|1.1|22|XI(c) Nasopharyngeal carcinomas|20660564|2009
10-14|1.8|3.1|2.4|49|XI(d) Malignant melanomas|20660564|2009
10-14|~|~|~|~|XI(e) Skin carcinomas|20660564|2009
10-14|3.5|5.3|4.3|89|XI(f) Other and unspecified carcinomas|20660564|2009
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20660564|2009
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20660564|2009
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20660564|2009
15-19|216.2|228.7|222.4|4935|All ICCC Groups Combined|22192810|2009
15-19|29.7|34.5|32.0|711|I Leukemias, myeloproliferative & myelodysplastic diseases|22192810|2009
15-19|14.2|17.6|15.9|352|I(a) Lymphoid leukemias|22192810|2009
15-19|7.5|10.0|8.7|193|I(b) Acute myeloid leukemias|22192810|2009
15-19|3.8|5.7|4.7|104|I(c) Chronic myeloproliferative diseases|22192810|2009
15-19|1.1|2.2|1.6|35|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|22192810|2009
15-19|0.8|1.8|1.2|27|I(e) Unspecified and other specified leukemias|22192810|2009
15-19|47.4|53.4|50.3|1117|II Lymphomas and reticuloendothelial neoplasms|22192810|2009
15-19|30.6|35.5|33.0|732|II(a) Hodgkin lymphomas|22192810|2009
15-19|12.9|16.1|14.5|321|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|22192810|2009
15-19|1.3|2.5|1.8|41|II(c) Burkitt lymphoma|22192810|2009
15-19|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|22192810|2009
15-19|~|~|~|~|II(e) Unspecified lymphomas|22192810|2009
15-19|19.9|23.8|21.8|484|III CNS and misc intracranial and intraspinal neoplasms|22192810|2009
15-19|1.6|2.9|2.2|48|III(a) Ependymomas and choroid plexus tumor|22192810|2009
15-19|10.6|13.6|12.0|267|III(b) Astrocytomas|22192810|2009
15-19|1.9|3.3|2.6|57|III(c) Intracranial and intraspinal embryonal tumors|22192810|2009
15-19|3.3|5.1|4.1|92|III(d) Other gliomas|22192810|2009
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|22192810|2009
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|22192810|2009
15-19|0.5|1.3|0.9|19|IV Neuroblastoma and other peripheral nervous cell tumors|22192810|2009
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|22192810|2009
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|22192810|2009
15-19|14.8|18.2|16.4|365|IX Soft tissue and other extraosseous sarcomas|22192810|2009
15-19|2.8|4.4|3.5|78|IX(a) Rhabdomyosarcomas|22192810|2009
15-19|1.8|3.1|2.4|53|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|22192810|2009
15-19|~|~|~|~|IX(c) Kaposi sarcoma|22192810|2009
15-19|7.2|9.6|8.3|185|IX(d) Other specified soft tissue sarcomas|22192810|2009
15-19|1.4|2.6|1.9|42|IX(e) Unspecified soft tissue sarcomas|22192810|2009
15-19|~|~|~|~|Not classified by ICCC|22192810|2009
15-19|~|~|~|~|V Retinoblastoma|22192810|2009
15-19|1.4|2.6|1.9|42|VI Renal tumors|22192810|2009
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|22192810|2009
15-19|1.0|2.0|1.4|32|VI(b) Renal carcinomas|22192810|2009
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|22192810|2009
15-19|0.9|1.9|1.4|30|VII Hepatic tumors|22192810|2009
15-19|~|~|~|~|VII(a) Hepatoblastoma|22192810|2009
15-19|0.9|1.9|1.4|30|VII(b) Hepatic carcinomas|22192810|2009
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|22192810|2009
15-19|13.2|16.5|14.8|328|VIII Malignant bone tumors|22192810|2009
15-19|7.1|9.5|8.2|182|VIII(a) Osteosarcomas|22192810|2009
15-19|0.7|1.6|1.0|23|VIII(b) Chondrosarcomas|22192810|2009
15-19|3.7|5.6|4.6|102|VIII(c) Ewing tumor and related sarcomas of bone|22192810|2009
15-19|0.5|1.3|0.8|18|VIII(d) Other specified malignant bone tumors|22192810|2009
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|22192810|2009
15-19|27.6|32.1|29.8|661|X Germ cell, trophoblastic tumors & neoplasms of gonads|22192810|2009
15-19|1.9|3.3|2.6|57|X(a) Intracranial & intraspinal germ cell tumors|22192810|2009
15-19|1.4|2.6|1.9|42|X(b) Malignant extracranial & extragonadal germ cell tumors|22192810|2009
15-19|20.4|24.4|22.3|496|X(c) Malignant gonadal germ cell tumors|22192810|2009
15-19|1.5|2.7|2.0|45|X(d) Gonadal carcinomas|22192810|2009
15-19|0.6|1.4|0.9|21|X(e) Other and unspecified malignant gonadal tumors|22192810|2009
15-19|48.5|54.5|51.5|1142|XI Other malignant epithelial neoplasms and malignant melanomas|22192810|2009
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|22192810|2009
15-19|22.5|26.7|24.5|544|XI(b) Thyroid carcinomas|22192810|2009
15-19|1.1|2.1|1.5|34|XI(c) Nasopharyngeal carcinomas|22192810|2009
15-19|11.3|14.3|12.7|282|XI(d) Malignant melanomas|22192810|2009
15-19|~|~|~|~|XI(e) Skin carcinomas|22192810|2009
15-19|10.8|13.8|12.3|272|XI(f) Other and unspecified carcinomas|22192810|2009
15-19|0.8|1.8|1.2|27|XII Other and unspecified malignant neoplasms|22192810|2009
15-19|~|~|~|~|XII(a) Other specified malignant tumors|22192810|2009
15-19|0.4|1.2|0.8|17|XII(b) Other unspecified malignant tumors|22192810|2009
5-9|120.8|130.6|125.7|2536|All ICCC Groups Combined|20182499|2009
5-9|39.9|45.6|42.7|861|I Leukemias, myeloproliferative & myelodysplastic diseases|20182499|2009
5-9|33.3|38.5|35.8|723|I(a) Lymphoid leukemias|20182499|2009
5-9|3.2|5.0|4.0|81|I(b) Acute myeloid leukemias|20182499|2009
5-9|0.6|1.5|1.0|20|I(c) Chronic myeloproliferative diseases|20182499|2009
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20182499|2009
5-9|0.8|1.8|1.2|24|I(e) Unspecified and other specified leukemias|20182499|2009
5-9|13.1|16.5|14.8|298|II Lymphomas and reticuloendothelial neoplasms|20182499|2009
5-9|3.4|5.3|4.3|86|II(a) Hodgkin lymphomas|20182499|2009
5-9|5.6|7.9|6.7|135|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20182499|2009
5-9|2.0|3.5|2.7|54|II(c) Burkitt lymphoma|20182499|2009
5-9|~|~|~|~|II(d) Miscellaneous lymphoreticular neoplasms|20182499|2009
5-9|~|~|~|~|II(e) Unspecified lymphomas|20182499|2009
5-9|33.2|38.5|35.8|722|III CNS and misc intracranial and intraspinal neoplasms|20182499|2009
5-9|1.2|2.4|1.7|35|III(a) Ependymomas and choroid plexus tumor|20182499|2009
5-9|15.1|18.7|16.8|339|III(b) Astrocytomas|20182499|2009
5-9|7.0|9.6|8.2|166|III(c) Intracranial and intraspinal embryonal tumors|20182499|2009
5-9|7.2|9.7|8.4|169|III(d) Other gliomas|20182499|2009
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20182499|2009
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20182499|2009
5-9|3.3|5.2|4.2|84|IV Neuroblastoma and other peripheral nervous cell tumors|20182499|2009
5-9|3.1|4.9|4.0|80|IV(a) Neuroblastoma and ganglioneuroblastoma|20182499|2009
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20182499|2009
5-9|7.6|10.2|8.8|178|IX Soft tissue and other extraosseous sarcomas|20182499|2009
5-9|3.4|5.3|4.3|86|IX(a) Rhabdomyosarcomas|20182499|2009
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20182499|2009
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20182499|2009
5-9|2.3|3.9|3.0|61|IX(d) Other specified soft tissue sarcomas|20182499|2009
5-9|0.5|1.4|0.9|18|IX(e) Unspecified soft tissue sarcomas|20182499|2009
5-9|~|~|~|~|Not classified by ICCC|20182499|2009
5-9|~|~|~|~|V Retinoblastoma|20182499|2009
5-9|5.0|7.2|6.0|122|VI Renal tumors|20182499|2009
5-9|4.3|6.4|5.3|107|VI(a) Nephroblastoma and other nonepithelial renal tumors|20182499|2009
5-9|~|~|~|~|VI(b) Renal carcinomas|20182499|2009
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20182499|2009
5-9|~|~|~|~|VII Hepatic tumors|20182499|2009
5-9|~|~|~|~|VII(a) Hepatoblastoma|20182499|2009
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20182499|2009
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20182499|2009
5-9|4.5|6.6|5.5|110|VIII Malignant bone tumors|20182499|2009
5-9|2.4|4.0|3.2|64|VIII(a) Osteosarcomas|20182499|2009
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20182499|2009
5-9|1.3|2.6|1.9|38|VIII(c) Ewing tumor and related sarcomas of bone|20182499|2009
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20182499|2009
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20182499|2009
5-9|2.0|3.5|2.7|54|X Germ cell, trophoblastic tumors & neoplasms of gonads|20182499|2009
5-9|0.9|1.9|1.3|27|X(a) Intracranial & intraspinal germ cell tumors|20182499|2009
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20182499|2009
5-9|0.7|1.7|1.1|22|X(c) Malignant gonadal germ cell tumors|20182499|2009
5-9|~|~|~|~|X(d) Gonadal carcinomas|20182499|2009
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20182499|2009
5-9|3.0|4.8|3.8|77|XI Other malignant epithelial neoplasms and malignant melanomas|20182499|2009
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20182499|2009
5-9|0.9|2.0|1.4|28|XI(b) Thyroid carcinomas|20182499|2009
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20182499|2009
5-9|0.8|1.9|1.3|26|XI(d) Malignant melanomas|20182499|2009
5-9|~|~|~|~|XI(e) Skin carcinomas|20182499|2009
5-9|0.6|1.5|1.0|20|XI(f) Other and unspecified carcinomas|20182499|2009
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20182499|2009
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20182499|2009
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20182499|2009
<1|249.1|281.2|264.8|1060|All ICCC Groups Combined|4003587|2009
<1|40.9|54.7|47.5|190|I Leukemias, myeloproliferative & myelodysplastic diseases|4003587|2009
<1|15.4|24.3|19.5|78|I(a) Lymphoid leukemias|4003587|2009
<1|11.4|19.3|15.0|60|I(b) Acute myeloid leukemias|4003587|2009
<1|2.7|7.1|4.5|18|I(c) Chronic myeloproliferative diseases|4003587|2009
<1|3.6|8.6|5.7|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|4003587|2009
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|4003587|2009
<1|7.3|13.9|10.2|41|II Lymphomas and reticuloendothelial neoplasms|4003587|2009
<1|~|~|~|~|II(a) Hodgkin lymphomas|4003587|2009
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|4003587|2009
<1|~|~|~|~|II(c) Burkitt lymphoma|4003587|2009
<1|4.4|9.8|6.7|27|II(d) Miscellaneous lymphoreticular neoplasms|4003587|2009
<1|~|~|~|~|II(e) Unspecified lymphomas|4003587|2009
<1|34.7|47.5|40.7|163|III CNS and misc intracranial and intraspinal neoplasms|4003587|2009
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|4003587|2009
<1|13.4|21.8|17.2|69|III(b) Astrocytomas|4003587|2009
<1|11.0|18.7|14.5|58|III(c) Intracranial and intraspinal embryonal tumors|4003587|2009
<1|~|~|~|~|III(d) Other gliomas|4003587|2009
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|4003587|2009
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|4003587|2009
<1|50.7|65.9|57.9|232|IV Neuroblastoma and other peripheral nervous cell tumors|4003587|2009
<1|50.5|65.6|57.7|231|IV(a) Neuroblastoma and ganglioneuroblastoma|4003587|2009
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|4003587|2009
<1|16.7|26.0|21.0|84|IX Soft tissue and other extraosseous sarcomas|4003587|2009
<1|3.8|8.9|6.0|24|IX(a) Rhabdomyosarcomas|4003587|2009
<1|5.1|10.7|7.5|30|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|4003587|2009
<1|~|~|~|~|IX(c) Kaposi sarcoma|4003587|2009
<1|3.4|8.3|5.5|22|IX(d) Other specified soft tissue sarcomas|4003587|2009
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|4003587|2009
<1|~|~|~|~|Not classified by ICCC|4003587|2009
<1|26.7|38.0|32.0|128|V Retinoblastoma|4003587|2009
<1|15.0|23.8|19.0|76|VI Renal tumors|4003587|2009
<1|14.3|22.9|18.2|73|VI(a) Nephroblastoma and other nonepithelial renal tumors|4003587|2009
<1|~|~|~|~|VI(b) Renal carcinomas|4003587|2009
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|4003587|2009
<1|5.3|11.0|7.7|31|VII Hepatic tumors|4003587|2009
<1|4.9|10.4|7.2|29|VII(a) Hepatoblastoma|4003587|2009
<1|~|~|~|~|VII(b) Hepatic carcinomas|4003587|2009
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|4003587|2009
<1|~|~|~|~|VIII Malignant bone tumors|4003587|2009
<1|~|~|~|~|VIII(a) Osteosarcomas|4003587|2009
<1|~|~|~|~|VIII(b) Chondrosarcomas|4003587|2009
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|4003587|2009
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|4003587|2009
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|4003587|2009
<1|15.8|24.9|20.0|80|X Germ cell, trophoblastic tumors & neoplasms of gonads|4003587|2009
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|4003587|2009
<1|7.6|14.2|10.5|42|X(b) Malignant extracranial & extragonadal germ cell tumors|4003587|2009
<1|4.6|10.1|7.0|28|X(c) Malignant gonadal germ cell tumors|4003587|2009
<1|~|~|~|~|X(d) Gonadal carcinomas|4003587|2009
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|4003587|2009
<1|2.3|6.5|4.0|16|XI Other malignant epithelial neoplasms and malignant melanomas|4003587|2009
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|4003587|2009
<1|~|~|~|~|XI(b) Thyroid carcinomas|4003587|2009
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|4003587|2009
<1|~|~|~|~|XI(d) Malignant melanomas|4003587|2009
<1|~|~|~|~|XI(e) Skin carcinomas|4003587|2009
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|4003587|2009
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|4003587|2009
<1|~|~|~|~|XII(a) Other specified malignant tumors|4003587|2009
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|4003587|2009
1-4|227.4|242.3|234.8|3812|All ICCC Groups Combined|16238083|2010
1-4|89.0|98.5|93.7|1521|I Leukemias, myeloproliferative & myelodysplastic diseases|16238083|2010
1-4|72.7|81.2|76.9|1248|I(a) Lymphoid leukemias|16238083|2010
1-4|8.7|11.8|10.2|165|I(b) Acute myeloid leukemias|16238083|2010
1-4|1.1|2.4|1.7|27|I(c) Chronic myeloproliferative diseases|16238083|2010
1-4|1.6|3.1|2.3|37|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|16238083|2010
1-4|2.0|3.6|2.7|44|I(e) Unspecified and other specified leukemias|16238083|2010
1-4|13.8|17.7|15.6|254|II Lymphomas and reticuloendothelial neoplasms|16238083|2010
1-4|~|~|~|~|II(a) Hodgkin lymphomas|16238083|2010
1-4|3.9|6.1|4.9|79|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|16238083|2010
1-4|1.5|2.9|2.1|34|II(c) Burkitt lymphoma|16238083|2010
1-4|6.5|9.2|7.8|126|II(d) Miscellaneous lymphoreticular neoplasms|16238083|2010
1-4|~|~|~|~|II(e) Unspecified lymphomas|16238083|2010
1-4|45.0|51.8|48.3|785|III CNS and misc intracranial and intraspinal neoplasms|16238083|2010
1-4|6.0|8.7|7.3|118|III(a) Ependymomas and choroid plexus tumor|16238083|2010
1-4|21.6|26.5|24.0|389|III(b) Astrocytomas|16238083|2010
1-4|9.4|12.7|11.0|178|III(c) Intracranial and intraspinal embryonal tumors|16238083|2010
1-4|4.3|6.7|5.4|88|III(d) Other gliomas|16238083|2010
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|16238083|2010
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|16238083|2010
1-4|19.9|24.6|22.2|360|IV Neuroblastoma and other peripheral nervous cell tumors|16238083|2010
1-4|19.8|24.4|22.0|357|IV(a) Neuroblastoma and ganglioneuroblastoma|16238083|2010
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|16238083|2010
1-4|10.0|13.4|11.6|189|IX Soft tissue and other extraosseous sarcomas|16238083|2010
1-4|6.3|9.0|7.6|123|IX(a) Rhabdomyosarcomas|16238083|2010
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|16238083|2010
1-4|~|~|~|~|IX(c) Kaposi sarcoma|16238083|2010
1-4|2.1|3.8|2.9|47|IX(d) Other specified soft tissue sarcomas|16238083|2010
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|16238083|2010
1-4|~|~|~|~|Not classified by ICCC|16238083|2010
1-4|7.9|10.9|9.3|151|V Retinoblastoma|16238083|2010
1-4|18.2|22.7|20.4|331|VI Renal tumors|16238083|2010
1-4|18.2|22.6|20.3|330|VI(a) Nephroblastoma and other nonepithelial renal tumors|16238083|2010
1-4|~|~|~|~|VI(b) Renal carcinomas|16238083|2010
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|16238083|2010
1-4|4.8|7.3|6.0|97|VII Hepatic tumors|16238083|2010
1-4|4.5|6.9|5.6|91|VII(a) Hepatoblastoma|16238083|2010
1-4|~|~|~|~|VII(b) Hepatic carcinomas|16238083|2010
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|16238083|2010
1-4|0.8|2.1|1.4|22|VIII Malignant bone tumors|16238083|2010
1-4|~|~|~|~|VIII(a) Osteosarcomas|16238083|2010
1-4|~|~|~|~|VIII(b) Chondrosarcomas|16238083|2010
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|16238083|2010
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|16238083|2010
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|16238083|2010
1-4|2.7|4.6|3.6|58|X Germ cell, trophoblastic tumors & neoplasms of gonads|16238083|2010
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|16238083|2010
1-4|0.9|2.1|1.4|23|X(b) Malignant extracranial & extragonadal germ cell tumors|16238083|2010
1-4|1.2|2.6|1.8|29|X(c) Malignant gonadal germ cell tumors|16238083|2010
1-4|~|~|~|~|X(d) Gonadal carcinomas|16238083|2010
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|16238083|2010
1-4|0.8|1.9|1.2|20|XI Other malignant epithelial neoplasms and malignant melanomas|16238083|2010
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|16238083|2010
1-4|~|~|~|~|XI(b) Thyroid carcinomas|16238083|2010
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|16238083|2010
1-4|~|~|~|~|XI(d) Malignant melanomas|16238083|2010
1-4|~|~|~|~|XI(e) Skin carcinomas|16238083|2010
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|16238083|2010
1-4|0.7|1.8|1.2|19|XII Other and unspecified malignant neoplasms|16238083|2010
1-4|~|~|~|~|XII(a) Other specified malignant tumors|16238083|2010
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|16238083|2010
10-14|137.0|147.3|142.1|2939|All ICCC Groups Combined|20681024|2010
10-14|32.3|37.5|34.8|720|I Leukemias, myeloproliferative & myelodysplastic diseases|20681024|2010
10-14|20.3|24.5|22.3|462|I(a) Lymphoid leukemias|20681024|2010
10-14|6.2|8.6|7.3|152|I(b) Acute myeloid leukemias|20681024|2010
10-14|2.0|3.4|2.6|54|I(c) Chronic myeloproliferative diseases|20681024|2010
10-14|0.8|1.8|1.2|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20681024|2010
10-14|0.9|1.9|1.3|27|I(e) Unspecified and other specified leukemias|20681024|2010
10-14|23.0|27.4|25.1|520|II Lymphomas and reticuloendothelial neoplasms|20681024|2010
10-14|9.8|12.8|11.2|232|II(a) Hodgkin lymphomas|20681024|2010
10-14|7.7|10.3|8.9|185|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20681024|2010
10-14|1.8|3.2|2.4|50|II(c) Burkitt lymphoma|20681024|2010
10-14|1.7|3.0|2.3|47|II(d) Miscellaneous lymphoreticular neoplasms|20681024|2010
10-14|~|~|~|~|II(e) Unspecified lymphomas|20681024|2010
10-14|26.1|30.8|28.4|587|III CNS and misc intracranial and intraspinal neoplasms|20681024|2010
10-14|0.9|1.9|1.3|27|III(a) Ependymomas and choroid plexus tumor|20681024|2010
10-14|14.1|17.5|15.7|325|III(b) Astrocytomas|20681024|2010
10-14|3.8|5.7|4.6|96|III(c) Intracranial and intraspinal embryonal tumors|20681024|2010
10-14|4.6|6.7|5.6|115|III(d) Other gliomas|20681024|2010
10-14|0.4|1.3|0.8|16|III(e) Other specified intracranial & intraspinal neoplasms|20681024|2010
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20681024|2010
10-14|1.0|2.1|1.5|31|IV Neuroblastoma and other peripheral nervous cell tumors|20681024|2010
10-14|0.8|1.8|1.2|25|IV(a) Neuroblastoma and ganglioneuroblastoma|20681024|2010
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20681024|2010
10-14|11.6|14.8|13.1|271|IX Soft tissue and other extraosseous sarcomas|20681024|2010
10-14|3.7|5.6|4.5|94|IX(a) Rhabdomyosarcomas|20681024|2010
10-14|0.7|1.6|1.1|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20681024|2010
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20681024|2010
10-14|4.9|7.1|5.9|123|IX(d) Other specified soft tissue sarcomas|20681024|2010
10-14|1.1|2.2|1.5|32|IX(e) Unspecified soft tissue sarcomas|20681024|2010
10-14|~|~|~|~|Not classified by ICCC|20681024|2010
10-14|~|~|~|~|V Retinoblastoma|20681024|2010
10-14|0.7|1.7|1.2|24|VI Renal tumors|20681024|2010
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20681024|2010
10-14|~|~|~|~|VI(b) Renal carcinomas|20681024|2010
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20681024|2010
10-14|0.6|1.4|0.9|19|VII Hepatic tumors|20681024|2010
10-14|~|~|~|~|VII(a) Hepatoblastoma|20681024|2010
10-14|0.5|1.3|0.8|17|VII(b) Hepatic carcinomas|20681024|2010
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20681024|2010
10-14|11.8|15.0|13.3|276|VIII Malignant bone tumors|20681024|2010
10-14|6.8|9.3|8.0|165|VIII(a) Osteosarcomas|20681024|2010
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20681024|2010
10-14|3.2|4.9|4.0|82|VIII(c) Ewing tumor and related sarcomas of bone|20681024|2010
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20681024|2010
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20681024|2010
10-14|6.9|9.3|8.0|166|X Germ cell, trophoblastic tumors & neoplasms of gonads|20681024|2010
10-14|2.3|3.8|3.0|62|X(a) Intracranial & intraspinal germ cell tumors|20681024|2010
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20681024|2010
10-14|3.1|4.8|3.9|80|X(c) Malignant gonadal germ cell tumors|20681024|2010
10-14|~|~|~|~|X(d) Gonadal carcinomas|20681024|2010
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20681024|2010
10-14|13.3|16.7|14.9|309|XI Other malignant epithelial neoplasms and malignant melanomas|20681024|2010
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20681024|2010
10-14|6.1|8.5|7.2|149|XI(b) Thyroid carcinomas|20681024|2010
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20681024|2010
10-14|2.0|3.4|2.6|54|XI(d) Malignant melanomas|20681024|2010
10-14|~|~|~|~|XI(e) Skin carcinomas|20681024|2010
10-14|3.2|5.0|4.0|83|XI(f) Other and unspecified carcinomas|20681024|2010
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20681024|2010
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20681024|2010
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20681024|2010
15-19|211.6|224.0|217.8|4787|All ICCC Groups Combined|21981869|2010
15-19|31.5|36.4|33.9|745|I Leukemias, myeloproliferative & myelodysplastic diseases|21981869|2010
15-19|14.3|17.6|15.9|349|I(a) Lymphoid leukemias|21981869|2010
15-19|8.9|11.6|10.2|224|I(b) Acute myeloid leukemias|21981869|2010
15-19|4.1|6.0|5.0|109|I(c) Chronic myeloproliferative diseases|21981869|2010
15-19|1.0|2.1|1.5|33|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21981869|2010
15-19|0.9|1.9|1.4|30|I(e) Unspecified and other specified leukemias|21981869|2010
15-19|47.1|53.1|50.0|1100|II Lymphomas and reticuloendothelial neoplasms|21981869|2010
15-19|30.1|34.9|32.4|712|II(a) Hodgkin lymphomas|21981869|2010
15-19|11.7|14.8|13.2|290|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21981869|2010
15-19|1.7|3.0|2.3|50|II(c) Burkitt lymphoma|21981869|2010
15-19|0.8|1.8|1.3|28|II(d) Miscellaneous lymphoreticular neoplasms|21981869|2010
15-19|0.6|1.4|0.9|20|II(e) Unspecified lymphomas|21981869|2010
15-19|18.9|22.8|20.8|457|III CNS and misc intracranial and intraspinal neoplasms|21981869|2010
15-19|1.1|2.2|1.5|34|III(a) Ependymomas and choroid plexus tumor|21981869|2010
15-19|10.7|13.7|12.1|267|III(b) Astrocytomas|21981869|2010
15-19|1.6|2.9|2.2|48|III(c) Intracranial and intraspinal embryonal tumors|21981869|2010
15-19|3.4|5.1|4.2|92|III(d) Other gliomas|21981869|2010
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21981869|2010
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21981869|2010
15-19|0.5|1.2|0.8|17|IV Neuroblastoma and other peripheral nervous cell tumors|21981869|2010
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21981869|2010
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21981869|2010
15-19|14.8|18.3|16.5|362|IX Soft tissue and other extraosseous sarcomas|21981869|2010
15-19|3.5|5.3|4.3|95|IX(a) Rhabdomyosarcomas|21981869|2010
15-19|1.3|2.4|1.8|39|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21981869|2010
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21981869|2010
15-19|6.2|8.5|7.3|160|IX(d) Other specified soft tissue sarcomas|21981869|2010
15-19|2.2|3.7|2.9|64|IX(e) Unspecified soft tissue sarcomas|21981869|2010
15-19|~|~|~|~|Not classified by ICCC|21981869|2010
15-19|~|~|~|~|V Retinoblastoma|21981869|2010
15-19|0.9|1.9|1.4|30|VI Renal tumors|21981869|2010
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21981869|2010
15-19|0.7|1.6|1.0|23|VI(b) Renal carcinomas|21981869|2010
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21981869|2010
15-19|1.1|2.2|1.6|35|VII Hepatic tumors|21981869|2010
15-19|~|~|~|~|VII(a) Hepatoblastoma|21981869|2010
15-19|1.0|2.0|1.4|31|VII(b) Hepatic carcinomas|21981869|2010
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21981869|2010
15-19|11.7|14.8|13.2|290|VIII Malignant bone tumors|21981869|2010
15-19|6.7|9.1|7.8|172|VIII(a) Osteosarcomas|21981869|2010
15-19|0.6|1.5|1.0|22|VIII(b) Chondrosarcomas|21981869|2010
15-19|2.6|4.2|3.4|74|VIII(c) Ewing tumor and related sarcomas of bone|21981869|2010
15-19|0.4|1.2|0.7|16|VIII(d) Other specified malignant bone tumors|21981869|2010
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21981869|2010
15-19|25.5|29.9|27.7|608|X Germ cell, trophoblastic tumors & neoplasms of gonads|21981869|2010
15-19|1.9|3.3|2.5|56|X(a) Intracranial & intraspinal germ cell tumors|21981869|2010
15-19|0.8|1.8|1.3|28|X(b) Malignant extracranial & extragonadal germ cell tumors|21981869|2010
15-19|19.5|23.4|21.4|470|X(c) Malignant gonadal germ cell tumors|21981869|2010
15-19|1.1|2.2|1.6|35|X(d) Gonadal carcinomas|21981869|2010
15-19|0.5|1.3|0.9|19|X(e) Other and unspecified malignant gonadal tumors|21981869|2010
15-19|48.0|54.0|50.9|1119|XI Other malignant epithelial neoplasms and malignant melanomas|21981869|2010
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21981869|2010
15-19|23.8|28.1|25.8|568|XI(b) Thyroid carcinomas|21981869|2010
15-19|1.0|2.1|1.5|32|XI(c) Nasopharyngeal carcinomas|21981869|2010
15-19|9.3|12.1|10.6|234|XI(d) Malignant melanomas|21981869|2010
15-19|~|~|~|~|XI(e) Skin carcinomas|21981869|2010
15-19|11.0|14.0|12.5|274|XI(f) Other and unspecified carcinomas|21981869|2010
15-19|0.5|1.3|0.9|19|XII Other and unspecified malignant neoplasms|21981869|2010
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21981869|2010
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21981869|2010
5-9|128.1|138.2|133.0|2705|All ICCC Groups Combined|20331821|2010
5-9|41.7|47.5|44.5|905|I Leukemias, myeloproliferative & myelodysplastic diseases|20331821|2010
5-9|34.6|39.9|37.2|756|I(a) Lymphoid leukemias|20331821|2010
5-9|3.2|5.0|4.0|81|I(b) Acute myeloid leukemias|20331821|2010
5-9|0.8|1.9|1.3|26|I(c) Chronic myeloproliferative diseases|20331821|2010
5-9|0.7|1.7|1.1|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20331821|2010
5-9|0.6|1.5|0.9|19|I(e) Unspecified and other specified leukemias|20331821|2010
5-9|16.8|20.6|18.6|379|II Lymphomas and reticuloendothelial neoplasms|20331821|2010
5-9|3.0|4.7|3.8|77|II(a) Hodgkin lymphomas|20331821|2010
5-9|6.9|9.4|8.1|164|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20331821|2010
5-9|2.4|4.0|3.1|64|II(c) Burkitt lymphoma|20331821|2010
5-9|2.8|4.5|3.5|72|II(d) Miscellaneous lymphoreticular neoplasms|20331821|2010
5-9|~|~|~|~|II(e) Unspecified lymphomas|20331821|2010
5-9|34.5|39.9|37.1|755|III CNS and misc intracranial and intraspinal neoplasms|20331821|2010
5-9|1.5|2.8|2.1|43|III(a) Ependymomas and choroid plexus tumor|20331821|2010
5-9|17.4|21.3|19.3|392|III(b) Astrocytomas|20331821|2010
5-9|5.6|7.9|6.6|135|III(c) Intracranial and intraspinal embryonal tumors|20331821|2010
5-9|6.9|9.5|8.1|165|III(d) Other gliomas|20331821|2010
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20331821|2010
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20331821|2010
5-9|2.5|4.1|3.2|66|IV Neuroblastoma and other peripheral nervous cell tumors|20331821|2010
5-9|2.4|4.0|3.1|64|IV(a) Neuroblastoma and ganglioneuroblastoma|20331821|2010
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20331821|2010
5-9|8.2|10.9|9.4|192|IX Soft tissue and other extraosseous sarcomas|20331821|2010
5-9|4.4|6.5|5.4|110|IX(a) Rhabdomyosarcomas|20331821|2010
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20331821|2010
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20331821|2010
5-9|1.9|3.3|2.5|51|IX(d) Other specified soft tissue sarcomas|20331821|2010
5-9|0.6|1.6|1.0|21|IX(e) Unspecified soft tissue sarcomas|20331821|2010
5-9|~|~|~|~|Not classified by ICCC|20331821|2010
5-9|0.4|1.3|0.8|16|V Retinoblastoma|20331821|2010
5-9|4.6|6.7|5.6|113|VI Renal tumors|20331821|2010
5-9|4.3|6.4|5.3|107|VI(a) Nephroblastoma and other nonepithelial renal tumors|20331821|2010
5-9|~|~|~|~|VI(b) Renal carcinomas|20331821|2010
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20331821|2010
5-9|0.4|1.3|0.8|16|VII Hepatic tumors|20331821|2010
5-9|~|~|~|~|VII(a) Hepatoblastoma|20331821|2010
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20331821|2010
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20331821|2010
5-9|4.4|6.5|5.4|109|VIII Malignant bone tumors|20331821|2010
5-9|2.1|3.6|2.8|56|VIII(a) Osteosarcomas|20331821|2010
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20331821|2010
5-9|1.6|2.9|2.2|44|VIII(c) Ewing tumor and related sarcomas of bone|20331821|2010
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20331821|2010
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20331821|2010
5-9|2.6|4.3|3.4|69|X Germ cell, trophoblastic tumors & neoplasms of gonads|20331821|2010
5-9|1.4|2.7|2.0|41|X(a) Intracranial & intraspinal germ cell tumors|20331821|2010
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20331821|2010
5-9|0.6|1.5|1.0|20|X(c) Malignant gonadal germ cell tumors|20331821|2010
5-9|~|~|~|~|X(d) Gonadal carcinomas|20331821|2010
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20331821|2010
5-9|3.1|4.8|3.9|79|XI Other malignant epithelial neoplasms and malignant melanomas|20331821|2010
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20331821|2010
5-9|0.8|1.8|1.2|24|XI(b) Thyroid carcinomas|20331821|2010
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20331821|2010
5-9|1.0|2.1|1.5|30|XI(d) Malignant melanomas|20331821|2010
5-9|~|~|~|~|XI(e) Skin carcinomas|20331821|2010
5-9|0.6|1.5|0.9|19|XI(f) Other and unspecified carcinomas|20331821|2010
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20331821|2010
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20331821|2010
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20331821|2010
<1|247.7|279.9|263.4|1041|All ICCC Groups Combined|3951495|2010
<1|43.1|57.3|49.9|197|I Leukemias, myeloproliferative & myelodysplastic diseases|3951495|2010
<1|12.0|20.1|15.7|62|I(a) Lymphoid leukemias|3951495|2010
<1|15.8|24.9|20.0|79|I(b) Acute myeloid leukemias|3951495|2010
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3951495|2010
<1|5.3|11.1|7.8|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3951495|2010
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3951495|2010
<1|14.5|23.2|18.5|73|II Lymphomas and reticuloendothelial neoplasms|3951495|2010
<1|~|~|~|~|II(a) Hodgkin lymphomas|3951495|2010
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3951495|2010
<1|~|~|~|~|II(c) Burkitt lymphoma|3951495|2010
<1|12.3|20.4|15.9|63|II(d) Miscellaneous lymphoreticular neoplasms|3951495|2010
<1|~|~|~|~|II(e) Unspecified lymphomas|3951495|2010
<1|28.4|40.2|33.9|134|III CNS and misc intracranial and intraspinal neoplasms|3951495|2010
<1|2.5|6.9|4.3|17|III(a) Ependymomas and choroid plexus tumor|3951495|2010
<1|10.7|18.4|14.2|56|III(b) Astrocytomas|3951495|2010
<1|8.1|14.9|11.1|44|III(c) Intracranial and intraspinal embryonal tumors|3951495|2010
<1|~|~|~|~|III(d) Other gliomas|3951495|2010
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3951495|2010
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3951495|2010
<1|53.1|68.7|60.5|239|IV Neuroblastoma and other peripheral nervous cell tumors|3951495|2010
<1|52.8|68.4|60.2|238|IV(a) Neuroblastoma and ganglioneuroblastoma|3951495|2010
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3951495|2010
<1|11.8|19.8|15.4|61|IX Soft tissue and other extraosseous sarcomas|3951495|2010
<1|2.5|6.9|4.3|17|IX(a) Rhabdomyosarcomas|3951495|2010
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3951495|2010
<1|~|~|~|~|IX(c) Kaposi sarcoma|3951495|2010
<1|2.7|7.2|4.6|18|IX(d) Other specified soft tissue sarcomas|3951495|2010
<1|2.3|6.6|4.0|16|IX(e) Unspecified soft tissue sarcomas|3951495|2010
<1|~|~|~|~|Not classified by ICCC|3951495|2010
<1|23.6|34.4|28.6|113|V Retinoblastoma|3951495|2010
<1|10.9|18.7|14.4|57|VI Renal tumors|3951495|2010
<1|10.9|18.7|14.4|57|VI(a) Nephroblastoma and other nonepithelial renal tumors|3951495|2010
<1|~|~|~|~|VI(b) Renal carcinomas|3951495|2010
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3951495|2010
<1|10.3|17.8|13.7|54|VII Hepatic tumors|3951495|2010
<1|9.8|17.3|13.2|52|VII(a) Hepatoblastoma|3951495|2010
<1|~|~|~|~|VII(b) Hepatic carcinomas|3951495|2010
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3951495|2010
<1|~|~|~|~|VIII Malignant bone tumors|3951495|2010
<1|~|~|~|~|VIII(a) Osteosarcomas|3951495|2010
<1|~|~|~|~|VIII(b) Chondrosarcomas|3951495|2010
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3951495|2010
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3951495|2010
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3951495|2010
<1|17.0|26.3|21.3|84|X Germ cell, trophoblastic tumors & neoplasms of gonads|3951495|2010
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3951495|2010
<1|9.4|16.7|12.7|50|X(b) Malignant extracranial & extragonadal germ cell tumors|3951495|2010
<1|4.9|10.5|7.3|29|X(c) Malignant gonadal germ cell tumors|3951495|2010
<1|~|~|~|~|X(d) Gonadal carcinomas|3951495|2010
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3951495|2010
<1|2.5|6.9|4.3|17|XI Other malignant epithelial neoplasms and malignant melanomas|3951495|2010
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3951495|2010
<1|~|~|~|~|XI(b) Thyroid carcinomas|3951495|2010
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3951495|2010
<1|~|~|~|~|XI(d) Malignant melanomas|3951495|2010
<1|~|~|~|~|XI(e) Skin carcinomas|3951495|2010
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3951495|2010
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3951495|2010
<1|~|~|~|~|XII(a) Other specified malignant tumors|3951495|2010
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3951495|2010
1-4|227.5|242.5|234.9|3797|All ICCC Groups Combined|16162947|2011
1-4|89.7|99.2|94.4|1525|I Leukemias, myeloproliferative & myelodysplastic diseases|16162947|2011
1-4|74.9|83.7|79.2|1280|I(a) Lymphoid leukemias|16162947|2011
1-4|9.1|12.3|10.6|171|I(b) Acute myeloid leukemias|16162947|2011
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|16162947|2011
1-4|1.3|2.7|1.9|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|16162947|2011
1-4|1.2|2.5|1.7|28|I(e) Unspecified and other specified leukemias|16162947|2011
1-4|13.6|17.4|15.4|249|II Lymphomas and reticuloendothelial neoplasms|16162947|2011
1-4|~|~|~|~|II(a) Hodgkin lymphomas|16162947|2011
1-4|3.5|5.7|4.5|73|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|16162947|2011
1-4|1.2|2.6|1.8|29|II(c) Burkitt lymphoma|16162947|2011
1-4|6.6|9.4|7.9|128|II(d) Miscellaneous lymphoreticular neoplasms|16162947|2011
1-4|~|~|~|~|II(e) Unspecified lymphomas|16162947|2011
1-4|43.2|49.9|46.5|751|III CNS and misc intracranial and intraspinal neoplasms|16162947|2011
1-4|4.9|7.4|6.1|98|III(a) Ependymomas and choroid plexus tumor|16162947|2011
1-4|20.6|25.3|22.9|370|III(b) Astrocytomas|16162947|2011
1-4|9.3|12.6|10.9|176|III(c) Intracranial and intraspinal embryonal tumors|16162947|2011
1-4|4.6|7.0|5.8|93|III(d) Other gliomas|16162947|2011
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|16162947|2011
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|16162947|2011
1-4|20.0|24.6|22.2|359|IV Neuroblastoma and other peripheral nervous cell tumors|16162947|2011
1-4|19.8|24.4|22.0|356|IV(a) Neuroblastoma and ganglioneuroblastoma|16162947|2011
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|16162947|2011
1-4|9.9|13.3|11.5|186|IX Soft tissue and other extraosseous sarcomas|16162947|2011
1-4|7.0|9.9|8.4|135|IX(a) Rhabdomyosarcomas|16162947|2011
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|16162947|2011
1-4|~|~|~|~|IX(c) Kaposi sarcoma|16162947|2011
1-4|1.4|2.9|2.0|33|IX(d) Other specified soft tissue sarcomas|16162947|2011
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|16162947|2011
1-4|~|~|~|~|Not classified by ICCC|16162947|2011
1-4|7.2|10.1|8.5|138|V Retinoblastoma|16162947|2011
1-4|19.3|23.9|21.5|348|VI Renal tumors|16162947|2011
1-4|19.2|23.8|21.4|346|VI(a) Nephroblastoma and other nonepithelial renal tumors|16162947|2011
1-4|~|~|~|~|VI(b) Renal carcinomas|16162947|2011
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|16162947|2011
1-4|5.4|8.0|6.6|107|VII Hepatic tumors|16162947|2011
1-4|5.3|7.8|6.4|104|VII(a) Hepatoblastoma|16162947|2011
1-4|~|~|~|~|VII(b) Hepatic carcinomas|16162947|2011
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|16162947|2011
1-4|1.6|3.1|2.2|36|VIII Malignant bone tumors|16162947|2011
1-4|~|~|~|~|VIII(a) Osteosarcomas|16162947|2011
1-4|~|~|~|~|VIII(b) Chondrosarcomas|16162947|2011
1-4|0.9|2.1|1.4|22|VIII(c) Ewing tumor and related sarcomas of bone|16162947|2011
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|16162947|2011
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|16162947|2011
1-4|2.6|4.4|3.4|55|X Germ cell, trophoblastic tumors & neoplasms of gonads|16162947|2011
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|16162947|2011
1-4|1.1|2.4|1.7|27|X(b) Malignant extracranial & extragonadal germ cell tumors|16162947|2011
1-4|0.7|1.8|1.2|19|X(c) Malignant gonadal germ cell tumors|16162947|2011
1-4|~|~|~|~|X(d) Gonadal carcinomas|16162947|2011
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|16162947|2011
1-4|1.1|2.4|1.6|26|XI Other malignant epithelial neoplasms and malignant melanomas|16162947|2011
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|16162947|2011
1-4|~|~|~|~|XI(b) Thyroid carcinomas|16162947|2011
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|16162947|2011
1-4|~|~|~|~|XI(d) Malignant melanomas|16162947|2011
1-4|~|~|~|~|XI(e) Skin carcinomas|16162947|2011
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|16162947|2011
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|16162947|2011
1-4|~|~|~|~|XII(a) Other specified malignant tumors|16162947|2011
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|16162947|2011
10-14|136.6|146.9|141.6|2934|All ICCC Groups Combined|20715026|2011
10-14|30.8|35.8|33.3|689|I Leukemias, myeloproliferative & myelodysplastic diseases|20715026|2011
10-14|20.0|24.1|22.0|455|I(a) Lymphoid leukemias|20715026|2011
10-14|5.6|7.9|6.7|139|I(b) Acute myeloid leukemias|20715026|2011
10-14|2.0|3.5|2.7|56|I(c) Chronic myeloproliferative diseases|20715026|2011
10-14|0.6|1.4|0.9|19|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20715026|2011
10-14|0.6|1.5|1.0|20|I(e) Unspecified and other specified leukemias|20715026|2011
10-14|23.6|28.0|25.7|533|II Lymphomas and reticuloendothelial neoplasms|20715026|2011
10-14|9.6|12.5|11.0|228|II(a) Hodgkin lymphomas|20715026|2011
10-14|7.3|9.8|8.5|176|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20715026|2011
10-14|2.0|3.5|2.7|55|II(c) Burkitt lymphoma|20715026|2011
10-14|2.5|4.2|3.3|68|II(d) Miscellaneous lymphoreticular neoplasms|20715026|2011
10-14|~|~|~|~|II(e) Unspecified lymphomas|20715026|2011
10-14|26.5|31.2|28.8|596|III CNS and misc intracranial and intraspinal neoplasms|20715026|2011
10-14|1.4|2.6|1.9|40|III(a) Ependymomas and choroid plexus tumor|20715026|2011
10-14|14.5|18.1|16.2|336|III(b) Astrocytomas|20715026|2011
10-14|2.8|4.4|3.5|73|III(c) Intracranial and intraspinal embryonal tumors|20715026|2011
10-14|4.9|7.0|5.9|122|III(d) Other gliomas|20715026|2011
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20715026|2011
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20715026|2011
10-14|0.9|2.0|1.4|28|IV Neuroblastoma and other peripheral nervous cell tumors|20715026|2011
10-14|0.6|1.5|1.0|21|IV(a) Neuroblastoma and ganglioneuroblastoma|20715026|2011
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20715026|2011
10-14|10.4|13.5|11.9|246|IX Soft tissue and other extraosseous sarcomas|20715026|2011
10-14|2.8|4.5|3.6|74|IX(a) Rhabdomyosarcomas|20715026|2011
10-14|0.7|1.7|1.1|23|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20715026|2011
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20715026|2011
10-14|4.6|6.7|5.6|115|IX(d) Other specified soft tissue sarcomas|20715026|2011
10-14|1.1|2.3|1.6|34|IX(e) Unspecified soft tissue sarcomas|20715026|2011
10-14|~|~|~|~|Not classified by ICCC|20715026|2011
10-14|~|~|~|~|V Retinoblastoma|20715026|2011
10-14|1.1|2.2|1.5|32|VI Renal tumors|20715026|2011
10-14|0.6|1.4|0.9|19|VI(a) Nephroblastoma and other nonepithelial renal tumors|20715026|2011
10-14|~|~|~|~|VI(b) Renal carcinomas|20715026|2011
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20715026|2011
10-14|0.8|1.8|1.2|25|VII Hepatic tumors|20715026|2011
10-14|~|~|~|~|VII(a) Hepatoblastoma|20715026|2011
10-14|0.4|1.3|0.8|16|VII(b) Hepatic carcinomas|20715026|2011
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20715026|2011
10-14|12.3|15.6|13.9|288|VIII Malignant bone tumors|20715026|2011
10-14|7.2|9.7|8.4|173|VIII(a) Osteosarcomas|20715026|2011
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20715026|2011
10-14|3.8|5.7|4.7|97|VIII(c) Ewing tumor and related sarcomas of bone|20715026|2011
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20715026|2011
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20715026|2011
10-14|5.7|8.0|6.8|141|X Germ cell, trophoblastic tumors & neoplasms of gonads|20715026|2011
10-14|2.0|3.5|2.7|55|X(a) Intracranial & intraspinal germ cell tumors|20715026|2011
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20715026|2011
10-14|2.8|4.4|3.5|73|X(c) Malignant gonadal germ cell tumors|20715026|2011
10-14|~|~|~|~|X(d) Gonadal carcinomas|20715026|2011
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20715026|2011
10-14|14.7|18.3|16.4|340|XI Other malignant epithelial neoplasms and malignant melanomas|20715026|2011
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20715026|2011
10-14|7.1|9.6|8.3|171|XI(b) Thyroid carcinomas|20715026|2011
10-14|0.5|1.3|0.8|17|XI(c) Nasopharyngeal carcinomas|20715026|2011
10-14|2.5|4.1|3.2|66|XI(d) Malignant melanomas|20715026|2011
10-14|~|~|~|~|XI(e) Skin carcinomas|20715026|2011
10-14|3.1|4.9|4.0|82|XI(f) Other and unspecified carcinomas|20715026|2011
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20715026|2011
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20715026|2011
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20715026|2011
15-19|219.6|232.3|225.9|4894|All ICCC Groups Combined|21661743|2011
15-19|32.1|37.1|34.6|749|I Leukemias, myeloproliferative & myelodysplastic diseases|21661743|2011
15-19|15.9|19.4|17.6|381|I(a) Lymphoid leukemias|21661743|2011
15-19|8.9|11.7|10.2|222|I(b) Acute myeloid leukemias|21661743|2011
15-19|3.4|5.2|4.2|92|I(c) Chronic myeloproliferative diseases|21661743|2011
15-19|0.7|1.6|1.1|24|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21661743|2011
15-19|0.9|2.0|1.4|30|I(e) Unspecified and other specified leukemias|21661743|2011
15-19|48.0|54.0|50.9|1103|II Lymphomas and reticuloendothelial neoplasms|21661743|2011
15-19|29.4|34.2|31.8|688|II(a) Hodgkin lymphomas|21661743|2011
15-19|13.1|16.3|14.6|317|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21661743|2011
15-19|1.6|2.8|2.1|46|II(c) Burkitt lymphoma|21661743|2011
15-19|1.2|2.4|1.7|37|II(d) Miscellaneous lymphoreticular neoplasms|21661743|2011
15-19|~|~|~|~|II(e) Unspecified lymphomas|21661743|2011
15-19|23.5|27.8|25.6|554|III CNS and misc intracranial and intraspinal neoplasms|21661743|2011
15-19|0.8|1.8|1.2|27|III(a) Ependymomas and choroid plexus tumor|21661743|2011
15-19|13.3|16.6|14.9|322|III(b) Astrocytomas|21661743|2011
15-19|2.7|4.3|3.4|74|III(c) Intracranial and intraspinal embryonal tumors|21661743|2011
15-19|4.2|6.2|5.1|111|III(d) Other gliomas|21661743|2011
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21661743|2011
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21661743|2011
15-19|0.4|1.2|0.7|16|IV Neuroblastoma and other peripheral nervous cell tumors|21661743|2011
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21661743|2011
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21661743|2011
15-19|13.9|17.3|15.5|336|IX Soft tissue and other extraosseous sarcomas|21661743|2011
15-19|2.6|4.2|3.3|72|IX(a) Rhabdomyosarcomas|21661743|2011
15-19|1.5|2.8|2.1|45|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21661743|2011
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21661743|2011
15-19|6.9|9.3|8.0|174|IX(d) Other specified soft tissue sarcomas|21661743|2011
15-19|1.3|2.5|1.8|40|IX(e) Unspecified soft tissue sarcomas|21661743|2011
15-19|~|~|~|~|Not classified by ICCC|21661743|2011
15-19|~|~|~|~|V Retinoblastoma|21661743|2011
15-19|1.3|2.5|1.8|40|VI Renal tumors|21661743|2011
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21661743|2011
15-19|1.1|2.2|1.6|34|VI(b) Renal carcinomas|21661743|2011
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21661743|2011
15-19|0.6|1.4|0.9|20|VII Hepatic tumors|21661743|2011
15-19|~|~|~|~|VII(a) Hepatoblastoma|21661743|2011
15-19|0.5|1.4|0.9|19|VII(b) Hepatic carcinomas|21661743|2011
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21661743|2011
15-19|12.0|15.2|13.5|293|VIII Malignant bone tumors|21661743|2011
15-19|6.8|9.2|7.9|172|VIII(a) Osteosarcomas|21661743|2011
15-19|~|~|~|~|VIII(b) Chondrosarcomas|21661743|2011
15-19|3.3|5.1|4.2|90|VIII(c) Ewing tumor and related sarcomas of bone|21661743|2011
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|21661743|2011
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21661743|2011
15-19|25.6|30.1|27.7|601|X Germ cell, trophoblastic tumors & neoplasms of gonads|21661743|2011
15-19|1.5|2.8|2.1|45|X(a) Intracranial & intraspinal germ cell tumors|21661743|2011
15-19|1.4|2.6|1.9|42|X(b) Malignant extracranial & extragonadal germ cell tumors|21661743|2011
15-19|20.2|24.2|22.2|480|X(c) Malignant gonadal germ cell tumors|21661743|2011
15-19|0.5|1.4|0.9|19|X(d) Gonadal carcinomas|21661743|2011
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21661743|2011
15-19|50.2|56.3|53.2|1152|XI Other malignant epithelial neoplasms and malignant melanomas|21661743|2011
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21661743|2011
15-19|25.3|29.8|27.5|596|XI(b) Thyroid carcinomas|21661743|2011
15-19|1.0|2.1|1.5|33|XI(c) Nasopharyngeal carcinomas|21661743|2011
15-19|9.6|12.5|11.0|238|XI(d) Malignant melanomas|21661743|2011
15-19|~|~|~|~|XI(e) Skin carcinomas|21661743|2011
15-19|11.2|14.3|12.7|275|XI(f) Other and unspecified carcinomas|21661743|2011
15-19|0.5|1.4|0.9|19|XII Other and unspecified malignant neoplasms|21661743|2011
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21661743|2011
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21661743|2011
5-9|129.5|139.7|134.5|2736|All ICCC Groups Combined|20335489|2011
5-9|43.0|48.9|45.9|933|I Leukemias, myeloproliferative & myelodysplastic diseases|20335489|2011
5-9|35.2|40.6|37.9|770|I(a) Lymphoid leukemias|20335489|2011
5-9|3.8|5.8|4.7|96|I(b) Acute myeloid leukemias|20335489|2011
5-9|0.7|1.6|1.1|22|I(c) Chronic myeloproliferative diseases|20335489|2011
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20335489|2011
5-9|1.1|2.3|1.6|33|I(e) Unspecified and other specified leukemias|20335489|2011
5-9|17.5|21.4|19.4|394|II Lymphomas and reticuloendothelial neoplasms|20335489|2011
5-9|2.9|4.6|3.6|74|II(a) Hodgkin lymphomas|20335489|2011
5-9|5.5|7.8|6.6|134|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20335489|2011
5-9|3.0|4.7|3.8|77|II(c) Burkitt lymphoma|20335489|2011
5-9|4.3|6.3|5.2|106|II(d) Miscellaneous lymphoreticular neoplasms|20335489|2011
5-9|~|~|~|~|II(e) Unspecified lymphomas|20335489|2011
5-9|33.6|38.9|36.2|736|III CNS and misc intracranial and intraspinal neoplasms|20335489|2011
5-9|1.5|2.8|2.1|43|III(a) Ependymomas and choroid plexus tumor|20335489|2011
5-9|16.9|20.8|18.8|382|III(b) Astrocytomas|20335489|2011
5-9|5.7|8.1|6.8|139|III(c) Intracranial and intraspinal embryonal tumors|20335489|2011
5-9|6.5|8.9|7.6|155|III(d) Other gliomas|20335489|2011
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20335489|2011
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20335489|2011
5-9|3.7|5.7|4.6|94|IV Neuroblastoma and other peripheral nervous cell tumors|20335489|2011
5-9|3.6|5.5|4.5|91|IV(a) Neuroblastoma and ganglioneuroblastoma|20335489|2011
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20335489|2011
5-9|6.9|9.5|8.1|165|IX Soft tissue and other extraosseous sarcomas|20335489|2011
5-9|3.2|5.0|4.0|82|IX(a) Rhabdomyosarcomas|20335489|2011
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20335489|2011
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20335489|2011
5-9|2.1|3.6|2.8|56|IX(d) Other specified soft tissue sarcomas|20335489|2011
5-9|0.4|1.3|0.8|16|IX(e) Unspecified soft tissue sarcomas|20335489|2011
5-9|~|~|~|~|Not classified by ICCC|20335489|2011
5-9|~|~|~|~|V Retinoblastoma|20335489|2011
5-9|4.8|7.0|5.9|119|VI Renal tumors|20335489|2011
5-9|4.5|6.6|5.5|112|VI(a) Nephroblastoma and other nonepithelial renal tumors|20335489|2011
5-9|~|~|~|~|VI(b) Renal carcinomas|20335489|2011
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20335489|2011
5-9|~|~|~|~|VII Hepatic tumors|20335489|2011
5-9|~|~|~|~|VII(a) Hepatoblastoma|20335489|2011
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20335489|2011
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20335489|2011
5-9|5.0|7.2|6.0|122|VIII Malignant bone tumors|20335489|2011
5-9|2.5|4.1|3.2|66|VIII(a) Osteosarcomas|20335489|2011
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20335489|2011
5-9|1.8|3.2|2.4|49|VIII(c) Ewing tumor and related sarcomas of bone|20335489|2011
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20335489|2011
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20335489|2011
5-9|2.1|3.6|2.8|57|X Germ cell, trophoblastic tumors & neoplasms of gonads|20335489|2011
5-9|0.7|1.7|1.1|23|X(a) Intracranial & intraspinal germ cell tumors|20335489|2011
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20335489|2011
5-9|0.9|2.0|1.4|28|X(c) Malignant gonadal germ cell tumors|20335489|2011
5-9|~|~|~|~|X(d) Gonadal carcinomas|20335489|2011
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20335489|2011
5-9|3.4|5.3|4.3|87|XI Other malignant epithelial neoplasms and malignant melanomas|20335489|2011
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20335489|2011
5-9|0.9|2.0|1.4|28|XI(b) Thyroid carcinomas|20335489|2011
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20335489|2011
5-9|1.2|2.4|1.7|35|XI(d) Malignant melanomas|20335489|2011
5-9|~|~|~|~|XI(e) Skin carcinomas|20335489|2011
5-9|0.5|1.4|0.9|18|XI(f) Other and unspecified carcinomas|20335489|2011
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20335489|2011
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20335489|2011
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20335489|2011
<1|240.1|271.8|255.6|1013|All ICCC Groups Combined|3963264|2011
<1|42.1|56.1|48.7|193|I Leukemias, myeloproliferative & myelodysplastic diseases|3963264|2011
<1|15.6|24.6|19.7|78|I(a) Lymphoid leukemias|3963264|2011
<1|12.7|20.9|16.4|65|I(b) Acute myeloid leukemias|3963264|2011
<1|2.9|7.5|4.8|19|I(c) Chronic myeloproliferative diseases|3963264|2011
<1|3.3|8.1|5.3|21|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3963264|2011
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3963264|2011
<1|13.8|22.3|17.7|70|II Lymphomas and reticuloendothelial neoplasms|3963264|2011
<1|~|~|~|~|II(a) Hodgkin lymphomas|3963264|2011
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3963264|2011
<1|~|~|~|~|II(c) Burkitt lymphoma|3963264|2011
<1|11.8|19.8|15.4|61|II(d) Miscellaneous lymphoreticular neoplasms|3963264|2011
<1|~|~|~|~|II(e) Unspecified lymphomas|3963264|2011
<1|29.3|41.1|34.8|138|III CNS and misc intracranial and intraspinal neoplasms|3963264|2011
<1|4.7|10.2|7.1|28|III(a) Ependymomas and choroid plexus tumor|3963264|2011
<1|7.6|14.3|10.6|42|III(b) Astrocytomas|3963264|2011
<1|8.3|15.2|11.4|45|III(c) Intracranial and intraspinal embryonal tumors|3963264|2011
<1|2.3|6.6|4.0|16|III(d) Other gliomas|3963264|2011
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3963264|2011
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3963264|2011
<1|48.4|63.3|55.5|220|IV Neuroblastoma and other peripheral nervous cell tumors|3963264|2011
<1|48.4|63.3|55.5|220|IV(a) Neuroblastoma and ganglioneuroblastoma|3963264|2011
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3963264|2011
<1|16.5|25.7|20.7|82|IX Soft tissue and other extraosseous sarcomas|3963264|2011
<1|4.3|9.6|6.6|26|IX(a) Rhabdomyosarcomas|3963264|2011
<1|3.1|7.8|5.0|20|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3963264|2011
<1|~|~|~|~|IX(c) Kaposi sarcoma|3963264|2011
<1|4.3|9.6|6.6|26|IX(d) Other specified soft tissue sarcomas|3963264|2011
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3963264|2011
<1|~|~|~|~|Not classified by ICCC|3963264|2011
<1|24.2|35.1|29.3|116|V Retinoblastoma|3963264|2011
<1|10.9|18.6|14.4|57|VI Renal tumors|3963264|2011
<1|10.7|18.3|14.1|56|VI(a) Nephroblastoma and other nonepithelial renal tumors|3963264|2011
<1|~|~|~|~|VI(b) Renal carcinomas|3963264|2011
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3963264|2011
<1|9.4|16.6|12.6|50|VII Hepatic tumors|3963264|2011
<1|8.9|16.1|12.1|48|VII(a) Hepatoblastoma|3963264|2011
<1|~|~|~|~|VII(b) Hepatic carcinomas|3963264|2011
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3963264|2011
<1|~|~|~|~|VIII Malignant bone tumors|3963264|2011
<1|~|~|~|~|VIII(a) Osteosarcomas|3963264|2011
<1|~|~|~|~|VIII(b) Chondrosarcomas|3963264|2011
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3963264|2011
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3963264|2011
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3963264|2011
<1|11.3|19.2|14.9|59|X Germ cell, trophoblastic tumors & neoplasms of gonads|3963264|2011
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3963264|2011
<1|7.2|13.7|10.1|40|X(b) Malignant extracranial & extragonadal germ cell tumors|3963264|2011
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3963264|2011
<1|~|~|~|~|X(d) Gonadal carcinomas|3963264|2011
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3963264|2011
<1|2.7|7.2|4.5|18|XI Other malignant epithelial neoplasms and malignant melanomas|3963264|2011
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3963264|2011
<1|~|~|~|~|XI(b) Thyroid carcinomas|3963264|2011
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3963264|2011
<1|~|~|~|~|XI(d) Malignant melanomas|3963264|2011
<1|~|~|~|~|XI(e) Skin carcinomas|3963264|2011
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3963264|2011
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3963264|2011
<1|~|~|~|~|XII(a) Other specified malignant tumors|3963264|2011
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3963264|2011
1-4|228.8|243.9|236.3|3793|All ICCC Groups Combined|16054205|2012
1-4|88.5|98.0|93.2|1496|I Leukemias, myeloproliferative & myelodysplastic diseases|16054205|2012
1-4|73.4|82.1|77.7|1247|I(a) Lymphoid leukemias|16054205|2012
1-4|8.8|12.0|10.3|166|I(b) Acute myeloid leukemias|16054205|2012
1-4|0.7|1.8|1.2|19|I(c) Chronic myeloproliferative diseases|16054205|2012
1-4|1.0|2.3|1.6|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|16054205|2012
1-4|1.7|3.3|2.4|39|I(e) Unspecified and other specified leukemias|16054205|2012
1-4|14.3|18.4|16.3|261|II Lymphomas and reticuloendothelial neoplasms|16054205|2012
1-4|0.8|2.0|1.3|21|II(a) Hodgkin lymphomas|16054205|2012
1-4|3.5|5.6|4.4|71|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|16054205|2012
1-4|1.2|2.6|1.8|29|II(c) Burkitt lymphoma|16054205|2012
1-4|7.1|10.0|8.5|136|II(d) Miscellaneous lymphoreticular neoplasms|16054205|2012
1-4|~|~|~|~|II(e) Unspecified lymphomas|16054205|2012
1-4|44.7|51.5|48.0|771|III CNS and misc intracranial and intraspinal neoplasms|16054205|2012
1-4|3.7|5.9|4.7|76|III(a) Ependymomas and choroid plexus tumor|16054205|2012
1-4|21.4|26.2|23.7|381|III(b) Astrocytomas|16054205|2012
1-4|10.1|13.5|11.7|188|III(c) Intracranial and intraspinal embryonal tumors|16054205|2012
1-4|4.9|7.4|6.0|97|III(d) Other gliomas|16054205|2012
1-4|0.6|1.7|1.1|17|III(e) Other specified intracranial & intraspinal neoplasms|16054205|2012
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|16054205|2012
1-4|21.1|25.8|23.4|375|IV Neuroblastoma and other peripheral nervous cell tumors|16054205|2012
1-4|20.9|25.7|23.2|372|IV(a) Neuroblastoma and ganglioneuroblastoma|16054205|2012
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|16054205|2012
1-4|10.2|13.6|11.8|189|IX Soft tissue and other extraosseous sarcomas|16054205|2012
1-4|6.6|9.4|7.9|127|IX(a) Rhabdomyosarcomas|16054205|2012
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|16054205|2012
1-4|~|~|~|~|IX(c) Kaposi sarcoma|16054205|2012
1-4|1.5|3.0|2.1|34|IX(d) Other specified soft tissue sarcomas|16054205|2012
1-4|0.6|1.7|1.1|17|IX(e) Unspecified soft tissue sarcomas|16054205|2012
1-4|~|~|~|~|Not classified by ICCC|16054205|2012
1-4|6.9|9.8|8.3|133|V Retinoblastoma|16054205|2012
1-4|17.9|22.3|20.0|321|VI Renal tumors|16054205|2012
1-4|17.6|22.0|19.7|317|VI(a) Nephroblastoma and other nonepithelial renal tumors|16054205|2012
1-4|~|~|~|~|VI(b) Renal carcinomas|16054205|2012
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|16054205|2012
1-4|5.9|8.5|7.1|114|VII Hepatic tumors|16054205|2012
1-4|5.5|8.1|6.7|108|VII(a) Hepatoblastoma|16054205|2012
1-4|~|~|~|~|VII(b) Hepatic carcinomas|16054205|2012
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|16054205|2012
1-4|1.1|2.4|1.7|27|VIII Malignant bone tumors|16054205|2012
1-4|~|~|~|~|VIII(a) Osteosarcomas|16054205|2012
1-4|~|~|~|~|VIII(b) Chondrosarcomas|16054205|2012
1-4|0.6|1.7|1.1|17|VIII(c) Ewing tumor and related sarcomas of bone|16054205|2012
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|16054205|2012
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|16054205|2012
1-4|2.2|4.0|3.0|48|X Germ cell, trophoblastic tumors & neoplasms of gonads|16054205|2012
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|16054205|2012
1-4|1.0|2.2|1.5|24|X(b) Malignant extracranial & extragonadal germ cell tumors|16054205|2012
1-4|0.7|1.8|1.1|18|X(c) Malignant gonadal germ cell tumors|16054205|2012
1-4|~|~|~|~|X(d) Gonadal carcinomas|16054205|2012
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|16054205|2012
1-4|1.4|2.9|2.1|33|XI Other malignant epithelial neoplasms and malignant melanomas|16054205|2012
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|16054205|2012
1-4|~|~|~|~|XI(b) Thyroid carcinomas|16054205|2012
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|16054205|2012
1-4|0.8|1.9|1.2|20|XI(d) Malignant melanomas|16054205|2012
1-4|~|~|~|~|XI(e) Skin carcinomas|16054205|2012
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|16054205|2012
1-4|0.9|2.1|1.4|22|XII Other and unspecified malignant neoplasms|16054205|2012
1-4|~|~|~|~|XII(a) Other specified malignant tumors|16054205|2012
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|16054205|2012
10-14|139.1|149.5|144.2|2982|All ICCC Groups Combined|20673843|2012
10-14|29.8|34.8|32.2|666|I Leukemias, myeloproliferative & myelodysplastic diseases|20673843|2012
10-14|19.6|23.6|21.5|445|I(a) Lymphoid leukemias|20673843|2012
10-14|4.9|7.0|5.9|122|I(b) Acute myeloid leukemias|20673843|2012
10-14|1.7|3.1|2.3|48|I(c) Chronic myeloproliferative diseases|20673843|2012
10-14|0.8|1.8|1.2|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20673843|2012
10-14|0.8|1.8|1.3|26|I(e) Unspecified and other specified leukemias|20673843|2012
10-14|27.4|32.2|29.7|615|II Lymphomas and reticuloendothelial neoplasms|20673843|2012
10-14|11.2|14.3|12.7|262|II(a) Hodgkin lymphomas|20673843|2012
10-14|9.5|12.4|10.8|224|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20673843|2012
10-14|1.9|3.4|2.6|53|II(c) Burkitt lymphoma|20673843|2012
10-14|2.5|4.1|3.2|66|II(d) Miscellaneous lymphoreticular neoplasms|20673843|2012
10-14|~|~|~|~|II(e) Unspecified lymphomas|20673843|2012
10-14|25.8|30.4|28.0|579|III CNS and misc intracranial and intraspinal neoplasms|20673843|2012
10-14|1.3|2.6|1.9|39|III(a) Ependymomas and choroid plexus tumor|20673843|2012
10-14|14.6|18.1|16.3|336|III(b) Astrocytomas|20673843|2012
10-14|2.9|4.6|3.7|76|III(c) Intracranial and intraspinal embryonal tumors|20673843|2012
10-14|4.2|6.1|5.1|105|III(d) Other gliomas|20673843|2012
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20673843|2012
10-14|0.5|1.3|0.8|17|III(f) Unspecified intracranial and intraspinal neoplasms|20673843|2012
10-14|1.1|2.2|1.5|32|IV Neuroblastoma and other peripheral nervous cell tumors|20673843|2012
10-14|0.8|1.8|1.3|26|IV(a) Neuroblastoma and ganglioneuroblastoma|20673843|2012
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20673843|2012
10-14|10.5|13.5|11.9|247|IX Soft tissue and other extraosseous sarcomas|20673843|2012
10-14|2.7|4.4|3.5|72|IX(a) Rhabdomyosarcomas|20673843|2012
10-14|0.8|1.8|1.2|25|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20673843|2012
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20673843|2012
10-14|4.5|6.6|5.5|114|IX(d) Other specified soft tissue sarcomas|20673843|2012
10-14|1.2|2.4|1.7|35|IX(e) Unspecified soft tissue sarcomas|20673843|2012
10-14|~|~|~|~|Not classified by ICCC|20673843|2012
10-14|~|~|~|~|V Retinoblastoma|20673843|2012
10-14|1.1|2.2|1.5|32|VI Renal tumors|20673843|2012
10-14|0.6|1.6|1.0|21|VI(a) Nephroblastoma and other nonepithelial renal tumors|20673843|2012
10-14|~|~|~|~|VI(b) Renal carcinomas|20673843|2012
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20673843|2012
10-14|0.7|1.7|1.1|23|VII Hepatic tumors|20673843|2012
10-14|~|~|~|~|VII(a) Hepatoblastoma|20673843|2012
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20673843|2012
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20673843|2012
10-14|13.1|16.4|14.7|303|VIII Malignant bone tumors|20673843|2012
10-14|8.6|11.3|9.9|204|VIII(a) Osteosarcomas|20673843|2012
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20673843|2012
10-14|3.1|4.8|3.9|80|VIII(c) Ewing tumor and related sarcomas of bone|20673843|2012
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20673843|2012
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20673843|2012
10-14|6.1|8.5|7.2|149|X Germ cell, trophoblastic tumors & neoplasms of gonads|20673843|2012
10-14|1.9|3.3|2.5|52|X(a) Intracranial & intraspinal germ cell tumors|20673843|2012
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20673843|2012
10-14|2.8|4.5|3.6|74|X(c) Malignant gonadal germ cell tumors|20673843|2012
10-14|~|~|~|~|X(d) Gonadal carcinomas|20673843|2012
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20673843|2012
10-14|13.8|17.2|15.4|319|XI Other malignant epithelial neoplasms and malignant melanomas|20673843|2012
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20673843|2012
10-14|6.8|9.2|7.9|164|XI(b) Thyroid carcinomas|20673843|2012
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20673843|2012
10-14|1.8|3.1|2.4|49|XI(d) Malignant melanomas|20673843|2012
10-14|~|~|~|~|XI(e) Skin carcinomas|20673843|2012
10-14|3.4|5.2|4.2|87|XI(f) Other and unspecified carcinomas|20673843|2012
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20673843|2012
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20673843|2012
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20673843|2012
15-19|226.9|239.9|233.3|4987|All ICCC Groups Combined|21374020|2012
15-19|31.5|36.4|33.9|724|I Leukemias, myeloproliferative & myelodysplastic diseases|21374020|2012
15-19|14.3|17.7|16.0|341|I(a) Lymphoid leukemias|21374020|2012
15-19|8.6|11.3|9.9|211|I(b) Acute myeloid leukemias|21374020|2012
15-19|4.2|6.2|5.1|109|I(c) Chronic myeloproliferative diseases|21374020|2012
15-19|0.7|1.6|1.1|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21374020|2012
15-19|1.3|2.5|1.9|40|I(e) Unspecified and other specified leukemias|21374020|2012
15-19|51.6|57.9|54.7|1169|II Lymphomas and reticuloendothelial neoplasms|21374020|2012
15-19|30.4|35.3|32.8|700|II(a) Hodgkin lymphomas|21374020|2012
15-19|15.3|18.8|17.0|363|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21374020|2012
15-19|1.7|3.0|2.2|48|II(c) Burkitt lymphoma|21374020|2012
15-19|1.5|2.7|2.0|43|II(d) Miscellaneous lymphoreticular neoplasms|21374020|2012
15-19|~|~|~|~|II(e) Unspecified lymphomas|21374020|2012
15-19|21.3|25.4|23.3|498|III CNS and misc intracranial and intraspinal neoplasms|21374020|2012
15-19|1.3|2.5|1.9|40|III(a) Ependymomas and choroid plexus tumor|21374020|2012
15-19|11.9|15.0|13.4|286|III(b) Astrocytomas|21374020|2012
15-19|1.4|2.7|2.0|42|III(c) Intracranial and intraspinal embryonal tumors|21374020|2012
15-19|4.3|6.3|5.2|111|III(d) Other gliomas|21374020|2012
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21374020|2012
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21374020|2012
15-19|0.5|1.4|0.9|19|IV Neuroblastoma and other peripheral nervous cell tumors|21374020|2012
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21374020|2012
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21374020|2012
15-19|12.4|15.6|13.9|298|IX Soft tissue and other extraosseous sarcomas|21374020|2012
15-19|2.4|3.9|3.1|66|IX(a) Rhabdomyosarcomas|21374020|2012
15-19|1.0|2.1|1.5|31|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21374020|2012
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21374020|2012
15-19|6.2|8.5|7.3|156|IX(d) Other specified soft tissue sarcomas|21374020|2012
15-19|1.4|2.7|2.0|42|IX(e) Unspecified soft tissue sarcomas|21374020|2012
15-19|~|~|~|~|Not classified by ICCC|21374020|2012
15-19|~|~|~|~|V Retinoblastoma|21374020|2012
15-19|1.8|3.1|2.4|51|VI Renal tumors|21374020|2012
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21374020|2012
15-19|1.4|2.6|1.9|41|VI(b) Renal carcinomas|21374020|2012
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21374020|2012
15-19|0.8|1.7|1.2|25|VII Hepatic tumors|21374020|2012
15-19|~|~|~|~|VII(a) Hepatoblastoma|21374020|2012
15-19|0.7|1.7|1.1|24|VII(b) Hepatic carcinomas|21374020|2012
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21374020|2012
15-19|12.8|16.0|14.3|306|VIII Malignant bone tumors|21374020|2012
15-19|6.5|8.9|7.7|164|VIII(a) Osteosarcomas|21374020|2012
15-19|0.4|1.2|0.7|16|VIII(b) Chondrosarcomas|21374020|2012
15-19|3.8|5.6|4.6|99|VIII(c) Ewing tumor and related sarcomas of bone|21374020|2012
15-19|0.4|1.2|0.7|16|VIII(d) Other specified malignant bone tumors|21374020|2012
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21374020|2012
15-19|28.7|33.5|31.1|664|X Germ cell, trophoblastic tumors & neoplasms of gonads|21374020|2012
15-19|1.7|3.0|2.2|48|X(a) Intracranial & intraspinal germ cell tumors|21374020|2012
15-19|1.7|3.0|2.2|48|X(b) Malignant extracranial & extragonadal germ cell tumors|21374020|2012
15-19|22.3|26.5|24.3|520|X(c) Malignant gonadal germ cell tumors|21374020|2012
15-19|1.0|2.1|1.5|31|X(d) Gonadal carcinomas|21374020|2012
15-19|0.5|1.3|0.8|17|X(e) Other and unspecified malignant gonadal tumors|21374020|2012
15-19|52.7|59.1|55.9|1194|XI Other malignant epithelial neoplasms and malignant melanomas|21374020|2012
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21374020|2012
15-19|26.8|31.4|29.0|620|XI(b) Thyroid carcinomas|21374020|2012
15-19|0.7|1.7|1.1|24|XI(c) Nasopharyngeal carcinomas|21374020|2012
15-19|9.9|12.7|11.2|240|XI(d) Malignant melanomas|21374020|2012
15-19|~|~|~|~|XI(e) Skin carcinomas|21374020|2012
15-19|12.3|15.5|13.8|296|XI(f) Other and unspecified carcinomas|21374020|2012
15-19|0.9|2.0|1.4|30|XII Other and unspecified malignant neoplasms|21374020|2012
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21374020|2012
15-19|0.5|1.4|0.9|19|XII(b) Other unspecified malignant tumors|21374020|2012
5-9|121.5|131.3|126.3|2586|All ICCC Groups Combined|20472679|2012
5-9|39.3|45.0|42.1|862|I Leukemias, myeloproliferative & myelodysplastic diseases|20472679|2012
5-9|32.0|37.1|34.5|706|I(a) Lymphoid leukemias|20472679|2012
5-9|3.5|5.4|4.4|90|I(b) Acute myeloid leukemias|20472679|2012
5-9|0.5|1.4|0.9|18|I(c) Chronic myeloproliferative diseases|20472679|2012
5-9|0.6|1.5|1.0|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20472679|2012
5-9|0.9|2.0|1.4|28|I(e) Unspecified and other specified leukemias|20472679|2012
5-9|16.2|20.0|18.0|369|II Lymphomas and reticuloendothelial neoplasms|20472679|2012
5-9|2.5|4.1|3.2|66|II(a) Hodgkin lymphomas|20472679|2012
5-9|6.0|8.4|7.1|146|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20472679|2012
5-9|2.3|3.8|3.0|61|II(c) Burkitt lymphoma|20472679|2012
5-9|3.4|5.2|4.2|87|II(d) Miscellaneous lymphoreticular neoplasms|20472679|2012
5-9|~|~|~|~|II(e) Unspecified lymphomas|20472679|2012
5-9|31.6|36.7|34.1|698|III CNS and misc intracranial and intraspinal neoplasms|20472679|2012
5-9|1.5|2.8|2.1|42|III(a) Ependymomas and choroid plexus tumor|20472679|2012
5-9|17.2|21.0|19.0|389|III(b) Astrocytomas|20472679|2012
5-9|5.3|7.5|6.3|129|III(c) Intracranial and intraspinal embryonal tumors|20472679|2012
5-9|4.7|6.8|5.7|117|III(d) Other gliomas|20472679|2012
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20472679|2012
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20472679|2012
5-9|3.0|4.7|3.8|77|IV Neuroblastoma and other peripheral nervous cell tumors|20472679|2012
5-9|2.8|4.4|3.5|72|IV(a) Neuroblastoma and ganglioneuroblastoma|20472679|2012
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20472679|2012
5-9|7.4|10.0|8.6|177|IX Soft tissue and other extraosseous sarcomas|20472679|2012
5-9|3.5|5.3|4.3|89|IX(a) Rhabdomyosarcomas|20472679|2012
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20472679|2012
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20472679|2012
5-9|1.9|3.4|2.6|53|IX(d) Other specified soft tissue sarcomas|20472679|2012
5-9|0.6|1.5|1.0|20|IX(e) Unspecified soft tissue sarcomas|20472679|2012
5-9|~|~|~|~|Not classified by ICCC|20472679|2012
5-9|~|~|~|~|V Retinoblastoma|20472679|2012
5-9|4.5|6.6|5.5|113|VI Renal tumors|20472679|2012
5-9|4.2|6.3|5.2|106|VI(a) Nephroblastoma and other nonepithelial renal tumors|20472679|2012
5-9|~|~|~|~|VI(b) Renal carcinomas|20472679|2012
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20472679|2012
5-9|0.4|1.3|0.8|16|VII Hepatic tumors|20472679|2012
5-9|~|~|~|~|VII(a) Hepatoblastoma|20472679|2012
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20472679|2012
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20472679|2012
5-9|4.5|6.6|5.5|112|VIII Malignant bone tumors|20472679|2012
5-9|2.3|3.8|3.0|61|VIII(a) Osteosarcomas|20472679|2012
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20472679|2012
5-9|1.3|2.5|1.8|37|VIII(c) Ewing tumor and related sarcomas of bone|20472679|2012
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20472679|2012
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20472679|2012
5-9|1.6|3.0|2.2|46|X Germ cell, trophoblastic tumors & neoplasms of gonads|20472679|2012
5-9|0.6|1.6|1.0|21|X(a) Intracranial & intraspinal germ cell tumors|20472679|2012
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20472679|2012
5-9|0.6|1.6|1.0|21|X(c) Malignant gonadal germ cell tumors|20472679|2012
5-9|~|~|~|~|X(d) Gonadal carcinomas|20472679|2012
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20472679|2012
5-9|3.9|5.8|4.8|98|XI Other malignant epithelial neoplasms and malignant melanomas|20472679|2012
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20472679|2012
5-9|0.9|1.9|1.3|27|XI(b) Thyroid carcinomas|20472679|2012
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20472679|2012
5-9|1.4|2.6|1.9|39|XI(d) Malignant melanomas|20472679|2012
5-9|~|~|~|~|XI(e) Skin carcinomas|20472679|2012
5-9|0.8|1.8|1.2|25|XI(f) Other and unspecified carcinomas|20472679|2012
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20472679|2012
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20472679|2012
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20472679|2012
<1|253.4|286.2|269.4|1058|All ICCC Groups Combined|3926731|2012
<1|45.1|59.6|52.0|204|I Leukemias, myeloproliferative & myelodysplastic diseases|3926731|2012
<1|16.2|25.4|20.4|80|I(a) Lymphoid leukemias|3926731|2012
<1|11.4|19.4|15.0|59|I(b) Acute myeloid leukemias|3926731|2012
<1|3.3|8.2|5.3|21|I(c) Chronic myeloproliferative diseases|3926731|2012
<1|5.6|11.5|8.1|32|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3926731|2012
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3926731|2012
<1|15.9|25.1|20.1|79|II Lymphomas and reticuloendothelial neoplasms|3926731|2012
<1|~|~|~|~|II(a) Hodgkin lymphomas|3926731|2012
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3926731|2012
<1|~|~|~|~|II(c) Burkitt lymphoma|3926731|2012
<1|12.6|20.8|16.3|64|II(d) Miscellaneous lymphoreticular neoplasms|3926731|2012
<1|~|~|~|~|II(e) Unspecified lymphomas|3926731|2012
<1|29.3|41.2|34.9|137|III CNS and misc intracranial and intraspinal neoplasms|3926731|2012
<1|3.9|9.1|6.1|24|III(a) Ependymomas and choroid plexus tumor|3926731|2012
<1|11.0|18.8|14.5|57|III(b) Astrocytomas|3926731|2012
<1|8.1|15.0|11.2|44|III(c) Intracranial and intraspinal embryonal tumors|3926731|2012
<1|~|~|~|~|III(d) Other gliomas|3926731|2012
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3926731|2012
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3926731|2012
<1|48.6|63.7|55.8|219|IV Neuroblastoma and other peripheral nervous cell tumors|3926731|2012
<1|48.6|63.7|55.8|219|IV(a) Neuroblastoma and ganglioneuroblastoma|3926731|2012
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3926731|2012
<1|13.7|22.2|17.6|69|IX Soft tissue and other extraosseous sarcomas|3926731|2012
<1|3.3|8.2|5.3|21|IX(a) Rhabdomyosarcomas|3926731|2012
<1|3.5|8.5|5.6|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3926731|2012
<1|~|~|~|~|IX(c) Kaposi sarcoma|3926731|2012
<1|3.7|8.8|5.9|23|IX(d) Other specified soft tissue sarcomas|3926731|2012
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3926731|2012
<1|~|~|~|~|Not classified by ICCC|3926731|2012
<1|27.9|39.6|33.4|131|V Retinoblastoma|3926731|2012
<1|12.8|21.1|16.6|65|VI Renal tumors|3926731|2012
<1|12.3|20.5|16.0|63|VI(a) Nephroblastoma and other nonepithelial renal tumors|3926731|2012
<1|~|~|~|~|VI(b) Renal carcinomas|3926731|2012
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3926731|2012
<1|9.9|17.4|13.2|52|VII Hepatic tumors|3926731|2012
<1|9.5|16.8|12.7|50|VII(a) Hepatoblastoma|3926731|2012
<1|~|~|~|~|VII(b) Hepatic carcinomas|3926731|2012
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3926731|2012
<1|~|~|~|~|VIII Malignant bone tumors|3926731|2012
<1|~|~|~|~|VIII(a) Osteosarcomas|3926731|2012
<1|~|~|~|~|VIII(b) Chondrosarcomas|3926731|2012
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3926731|2012
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3926731|2012
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3926731|2012
<1|14.8|23.7|18.8|74|X Germ cell, trophoblastic tumors & neoplasms of gonads|3926731|2012
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3926731|2012
<1|10.6|18.2|14.0|55|X(b) Malignant extracranial & extragonadal germ cell tumors|3926731|2012
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3926731|2012
<1|~|~|~|~|X(d) Gonadal carcinomas|3926731|2012
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3926731|2012
<1|2.3|6.6|4.1|16|XI Other malignant epithelial neoplasms and malignant melanomas|3926731|2012
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3926731|2012
<1|~|~|~|~|XI(b) Thyroid carcinomas|3926731|2012
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3926731|2012
<1|~|~|~|~|XI(d) Malignant melanomas|3926731|2012
<1|~|~|~|~|XI(e) Skin carcinomas|3926731|2012
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3926731|2012
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3926731|2012
<1|~|~|~|~|XII(a) Other specified malignant tumors|3926731|2012
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3926731|2012
1-4|222.6|237.5|230.0|3662|All ICCC Groups Combined|15923773|2013
1-4|81.8|91.0|86.3|1374|I Leukemias, myeloproliferative & myelodysplastic diseases|15923773|2013
1-4|67.7|76.1|71.8|1144|I(a) Lymphoid leukemias|15923773|2013
1-4|8.4|11.5|9.9|157|I(b) Acute myeloid leukemias|15923773|2013
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15923773|2013
1-4|0.9|2.2|1.4|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15923773|2013
1-4|1.6|3.2|2.3|37|I(e) Unspecified and other specified leukemias|15923773|2013
1-4|15.5|19.6|17.5|278|II Lymphomas and reticuloendothelial neoplasms|15923773|2013
1-4|0.6|1.6|1.0|16|II(a) Hodgkin lymphomas|15923773|2013
1-4|4.7|7.2|5.8|93|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15923773|2013
1-4|1.7|3.3|2.4|39|II(c) Burkitt lymphoma|15923773|2013
1-4|6.8|9.7|8.2|130|II(d) Miscellaneous lymphoreticular neoplasms|15923773|2013
1-4|~|~|~|~|II(e) Unspecified lymphomas|15923773|2013
1-4|43.1|49.9|46.4|739|III CNS and misc intracranial and intraspinal neoplasms|15923773|2013
1-4|4.1|6.4|5.1|82|III(a) Ependymomas and choroid plexus tumor|15923773|2013
1-4|21.4|26.3|23.7|378|III(b) Astrocytomas|15923773|2013
1-4|8.6|11.7|10.0|160|III(c) Intracranial and intraspinal embryonal tumors|15923773|2013
1-4|5.1|7.6|6.3|100|III(d) Other gliomas|15923773|2013
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15923773|2013
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15923773|2013
1-4|21.8|26.7|24.1|384|IV Neuroblastoma and other peripheral nervous cell tumors|15923773|2013
1-4|21.5|26.4|23.9|380|IV(a) Neuroblastoma and ganglioneuroblastoma|15923773|2013
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15923773|2013
1-4|10.4|13.8|12.0|191|IX Soft tissue and other extraosseous sarcomas|15923773|2013
1-4|7.0|9.9|8.4|133|IX(a) Rhabdomyosarcomas|15923773|2013
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15923773|2013
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15923773|2013
1-4|1.6|3.2|2.3|37|IX(d) Other specified soft tissue sarcomas|15923773|2013
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15923773|2013
1-4|~|~|~|~|Not classified by ICCC|15923773|2013
1-4|7.0|9.9|8.4|133|V Retinoblastoma|15923773|2013
1-4|18.6|23.2|20.8|331|VI Renal tumors|15923773|2013
1-4|18.5|23.1|20.7|330|VI(a) Nephroblastoma and other nonepithelial renal tumors|15923773|2013
1-4|~|~|~|~|VI(b) Renal carcinomas|15923773|2013
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15923773|2013
1-4|4.7|7.1|5.8|92|VII Hepatic tumors|15923773|2013
1-4|4.4|6.7|5.5|87|VII(a) Hepatoblastoma|15923773|2013
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15923773|2013
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15923773|2013
1-4|2.1|3.8|2.8|45|VIII Malignant bone tumors|15923773|2013
1-4|~|~|~|~|VIII(a) Osteosarcomas|15923773|2013
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15923773|2013
1-4|1.4|2.8|2.0|32|VIII(c) Ewing tumor and related sarcomas of bone|15923773|2013
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15923773|2013
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15923773|2013
1-4|2.1|3.8|2.8|45|X Germ cell, trophoblastic tumors & neoplasms of gonads|15923773|2013
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15923773|2013
1-4|0.7|1.9|1.2|19|X(b) Malignant extracranial & extragonadal germ cell tumors|15923773|2013
1-4|0.9|2.1|1.4|22|X(c) Malignant gonadal germ cell tumors|15923773|2013
1-4|~|~|~|~|X(d) Gonadal carcinomas|15923773|2013
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15923773|2013
1-4|1.2|2.6|1.8|29|XI Other malignant epithelial neoplasms and malignant melanomas|15923773|2013
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15923773|2013
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15923773|2013
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15923773|2013
1-4|0.6|1.7|1.1|17|XI(d) Malignant melanomas|15923773|2013
1-4|~|~|~|~|XI(e) Skin carcinomas|15923773|2013
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15923773|2013
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15923773|2013
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15923773|2013
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15923773|2013
10-14|142.5|153.0|147.7|3051|All ICCC Groups Combined|20656987|2013
10-14|29.9|34.9|32.3|668|I Leukemias, myeloproliferative & myelodysplastic diseases|20656987|2013
10-14|18.5|22.5|20.4|422|I(a) Lymphoid leukemias|20656987|2013
10-14|6.2|8.6|7.4|152|I(b) Acute myeloid leukemias|20656987|2013
10-14|1.4|2.6|1.9|40|I(c) Chronic myeloproliferative diseases|20656987|2013
10-14|0.7|1.6|1.1|22|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20656987|2013
10-14|1.1|2.2|1.5|32|I(e) Unspecified and other specified leukemias|20656987|2013
10-14|24.8|29.3|27.0|558|II Lymphomas and reticuloendothelial neoplasms|20656987|2013
10-14|9.4|12.3|10.8|223|II(a) Hodgkin lymphomas|20656987|2013
10-14|9.3|12.2|10.7|221|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20656987|2013
10-14|1.5|2.7|2.0|42|II(c) Burkitt lymphoma|20656987|2013
10-14|2.5|4.1|3.2|66|II(d) Miscellaneous lymphoreticular neoplasms|20656987|2013
10-14|~|~|~|~|II(e) Unspecified lymphomas|20656987|2013
10-14|29.1|34.0|31.5|651|III CNS and misc intracranial and intraspinal neoplasms|20656987|2013
10-14|1.4|2.7|2.0|41|III(a) Ependymomas and choroid plexus tumor|20656987|2013
10-14|15.9|19.5|17.6|364|III(b) Astrocytomas|20656987|2013
10-14|3.6|5.5|4.5|93|III(c) Intracranial and intraspinal embryonal tumors|20656987|2013
10-14|5.2|7.4|6.2|128|III(d) Other gliomas|20656987|2013
10-14|0.5|1.3|0.8|17|III(e) Other specified intracranial & intraspinal neoplasms|20656987|2013
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20656987|2013
10-14|1.1|2.3|1.6|34|IV Neuroblastoma and other peripheral nervous cell tumors|20656987|2013
10-14|0.6|1.6|1.0|21|IV(a) Neuroblastoma and ganglioneuroblastoma|20656987|2013
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20656987|2013
10-14|10.6|13.6|12.1|249|IX Soft tissue and other extraosseous sarcomas|20656987|2013
10-14|3.1|4.9|3.9|81|IX(a) Rhabdomyosarcomas|20656987|2013
10-14|0.9|2.0|1.4|29|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20656987|2013
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20656987|2013
10-14|4.5|6.6|5.5|113|IX(d) Other specified soft tissue sarcomas|20656987|2013
10-14|0.8|1.8|1.3|26|IX(e) Unspecified soft tissue sarcomas|20656987|2013
10-14|~|~|~|~|Not classified by ICCC|20656987|2013
10-14|~|~|~|~|V Retinoblastoma|20656987|2013
10-14|1.0|2.1|1.5|31|VI Renal tumors|20656987|2013
10-14|0.4|1.3|0.8|16|VI(a) Nephroblastoma and other nonepithelial renal tumors|20656987|2013
10-14|~|~|~|~|VI(b) Renal carcinomas|20656987|2013
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20656987|2013
10-14|0.5|1.3|0.8|17|VII Hepatic tumors|20656987|2013
10-14|~|~|~|~|VII(a) Hepatoblastoma|20656987|2013
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20656987|2013
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20656987|2013
10-14|12.0|15.2|13.5|279|VIII Malignant bone tumors|20656987|2013
10-14|6.6|9.1|7.8|161|VIII(a) Osteosarcomas|20656987|2013
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20656987|2013
10-14|3.6|5.5|4.5|92|VIII(c) Ewing tumor and related sarcomas of bone|20656987|2013
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20656987|2013
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20656987|2013
10-14|6.9|9.4|8.0|166|X Germ cell, trophoblastic tumors & neoplasms of gonads|20656987|2013
10-14|2.4|4.0|3.1|65|X(a) Intracranial & intraspinal germ cell tumors|20656987|2013
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20656987|2013
10-14|3.1|4.9|3.9|81|X(c) Malignant gonadal germ cell tumors|20656987|2013
10-14|~|~|~|~|X(d) Gonadal carcinomas|20656987|2013
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20656987|2013
10-14|16.6|20.3|18.4|380|XI Other malignant epithelial neoplasms and malignant melanomas|20656987|2013
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20656987|2013
10-14|7.5|10.1|8.7|180|XI(b) Thyroid carcinomas|20656987|2013
10-14|0.6|1.5|1.0|20|XI(c) Nasopharyngeal carcinomas|20656987|2013
10-14|2.3|3.8|3.0|62|XI(d) Malignant melanomas|20656987|2013
10-14|~|~|~|~|XI(e) Skin carcinomas|20656987|2013
10-14|4.4|6.5|5.4|111|XI(f) Other and unspecified carcinomas|20656987|2013
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20656987|2013
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20656987|2013
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20656987|2013
15-19|216.6|229.4|223.0|4723|All ICCC Groups Combined|21183476|2013
15-19|31.9|36.9|34.3|727|I Leukemias, myeloproliferative & myelodysplastic diseases|21183476|2013
15-19|14.8|18.3|16.5|349|I(a) Lymphoid leukemias|21183476|2013
15-19|8.3|10.9|9.5|202|I(b) Acute myeloid leukemias|21183476|2013
15-19|3.9|5.8|4.8|102|I(c) Chronic myeloproliferative diseases|21183476|2013
15-19|1.5|2.7|2.0|43|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21183476|2013
15-19|1.0|2.1|1.5|31|I(e) Unspecified and other specified leukemias|21183476|2013
15-19|45.2|51.2|48.2|1020|II Lymphomas and reticuloendothelial neoplasms|21183476|2013
15-19|27.3|32.0|29.6|626|II(a) Hodgkin lymphomas|21183476|2013
15-19|12.8|16.1|14.4|304|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21183476|2013
15-19|1.7|3.0|2.3|48|II(c) Burkitt lymphoma|21183476|2013
15-19|0.8|1.8|1.2|26|II(d) Miscellaneous lymphoreticular neoplasms|21183476|2013
15-19|0.4|1.2|0.8|16|II(e) Unspecified lymphomas|21183476|2013
15-19|21.2|25.3|23.2|491|III CNS and misc intracranial and intraspinal neoplasms|21183476|2013
15-19|0.9|2.0|1.4|29|III(a) Ependymomas and choroid plexus tumor|21183476|2013
15-19|12.3|15.5|13.8|293|III(b) Astrocytomas|21183476|2013
15-19|1.6|3.0|2.2|47|III(c) Intracranial and intraspinal embryonal tumors|21183476|2013
15-19|3.6|5.5|4.5|95|III(d) Other gliomas|21183476|2013
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21183476|2013
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21183476|2013
15-19|0.5|1.3|0.8|17|IV Neuroblastoma and other peripheral nervous cell tumors|21183476|2013
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21183476|2013
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21183476|2013
15-19|12.6|15.8|14.1|299|IX Soft tissue and other extraosseous sarcomas|21183476|2013
15-19|2.7|4.4|3.5|74|IX(a) Rhabdomyosarcomas|21183476|2013
15-19|1.0|2.1|1.5|31|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21183476|2013
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21183476|2013
15-19|6.1|8.4|7.2|152|IX(d) Other specified soft tissue sarcomas|21183476|2013
15-19|1.4|2.7|2.0|42|IX(e) Unspecified soft tissue sarcomas|21183476|2013
15-19|~|~|~|~|Not classified by ICCC|21183476|2013
15-19|~|~|~|~|V Retinoblastoma|21183476|2013
15-19|1.9|3.3|2.5|53|VI Renal tumors|21183476|2013
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21183476|2013
15-19|1.6|3.0|2.2|47|VI(b) Renal carcinomas|21183476|2013
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21183476|2013
15-19|0.8|1.9|1.3|27|VII Hepatic tumors|21183476|2013
15-19|~|~|~|~|VII(a) Hepatoblastoma|21183476|2013
15-19|0.8|1.9|1.3|27|VII(b) Hepatic carcinomas|21183476|2013
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21183476|2013
15-19|13.1|16.4|14.6|310|VIII Malignant bone tumors|21183476|2013
15-19|7.3|9.9|8.5|181|VIII(a) Osteosarcomas|21183476|2013
15-19|0.4|1.2|0.8|16|VIII(b) Chondrosarcomas|21183476|2013
15-19|3.2|5.0|4.1|86|VIII(c) Ewing tumor and related sarcomas of bone|21183476|2013
15-19|0.5|1.3|0.8|18|VIII(d) Other specified malignant bone tumors|21183476|2013
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21183476|2013
15-19|27.8|32.5|30.1|638|X Germ cell, trophoblastic tumors & neoplasms of gonads|21183476|2013
15-19|2.1|3.5|2.7|58|X(a) Intracranial & intraspinal germ cell tumors|21183476|2013
15-19|1.0|2.1|1.5|32|X(b) Malignant extracranial & extragonadal germ cell tumors|21183476|2013
15-19|21.0|25.1|23.0|487|X(c) Malignant gonadal germ cell tumors|21183476|2013
15-19|1.3|2.5|1.8|39|X(d) Gonadal carcinomas|21183476|2013
15-19|0.7|1.6|1.0|22|X(e) Other and unspecified malignant gonadal tumors|21183476|2013
15-19|49.0|55.2|52.1|1103|XI Other malignant epithelial neoplasms and malignant melanomas|21183476|2013
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21183476|2013
15-19|24.6|29.0|26.7|566|XI(b) Thyroid carcinomas|21183476|2013
15-19|1.0|2.0|1.4|30|XI(c) Nasopharyngeal carcinomas|21183476|2013
15-19|9.2|12.0|10.5|223|XI(d) Malignant melanomas|21183476|2013
15-19|~|~|~|~|XI(e) Skin carcinomas|21183476|2013
15-19|11.8|14.9|13.3|281|XI(f) Other and unspecified carcinomas|21183476|2013
15-19|1.0|2.1|1.5|31|XII Other and unspecified malignant neoplasms|21183476|2013
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21183476|2013
15-19|0.5|1.3|0.8|18|XII(b) Other unspecified malignant tumors|21183476|2013
5-9|127.3|137.3|132.2|2721|All ICCC Groups Combined|20575591|2013
5-9|40.1|45.8|42.9|883|I Leukemias, myeloproliferative & myelodysplastic diseases|20575591|2013
5-9|31.8|36.9|34.3|706|I(a) Lymphoid leukemias|20575591|2013
5-9|4.0|6.0|4.9|101|I(b) Acute myeloid leukemias|20575591|2013
5-9|0.7|1.7|1.1|23|I(c) Chronic myeloproliferative diseases|20575591|2013
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20575591|2013
5-9|1.5|2.8|2.1|43|I(e) Unspecified and other specified leukemias|20575591|2013
5-9|17.2|21.0|19.0|391|II Lymphomas and reticuloendothelial neoplasms|20575591|2013
5-9|3.8|5.8|4.7|97|II(a) Hodgkin lymphomas|20575591|2013
5-9|5.1|7.3|6.1|126|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20575591|2013
5-9|2.2|3.8|2.9|60|II(c) Burkitt lymphoma|20575591|2013
5-9|4.0|6.0|4.9|101|II(d) Miscellaneous lymphoreticular neoplasms|20575591|2013
5-9|~|~|~|~|II(e) Unspecified lymphomas|20575591|2013
5-9|33.5|38.8|36.1|742|III CNS and misc intracranial and intraspinal neoplasms|20575591|2013
5-9|2.1|3.5|2.7|56|III(a) Ependymomas and choroid plexus tumor|20575591|2013
5-9|17.2|21.0|19.1|392|III(b) Astrocytomas|20575591|2013
5-9|5.3|7.5|6.3|130|III(c) Intracranial and intraspinal embryonal tumors|20575591|2013
5-9|5.8|8.1|6.9|142|III(d) Other gliomas|20575591|2013
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20575591|2013
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20575591|2013
5-9|3.9|5.8|4.8|98|IV Neuroblastoma and other peripheral nervous cell tumors|20575591|2013
5-9|3.7|5.6|4.6|95|IV(a) Neuroblastoma and ganglioneuroblastoma|20575591|2013
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20575591|2013
5-9|6.7|9.1|7.8|161|IX Soft tissue and other extraosseous sarcomas|20575591|2013
5-9|3.3|5.1|4.1|84|IX(a) Rhabdomyosarcomas|20575591|2013
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20575591|2013
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20575591|2013
5-9|2.0|3.5|2.7|55|IX(d) Other specified soft tissue sarcomas|20575591|2013
5-9|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|20575591|2013
5-9|~|~|~|~|Not classified by ICCC|20575591|2013
5-9|~|~|~|~|V Retinoblastoma|20575591|2013
5-9|5.1|7.2|6.1|125|VI Renal tumors|20575591|2013
5-9|4.7|6.8|5.6|116|VI(a) Nephroblastoma and other nonepithelial renal tumors|20575591|2013
5-9|~|~|~|~|VI(b) Renal carcinomas|20575591|2013
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20575591|2013
5-9|0.6|1.5|1.0|20|VII Hepatic tumors|20575591|2013
5-9|~|~|~|~|VII(a) Hepatoblastoma|20575591|2013
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20575591|2013
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20575591|2013
5-9|5.0|7.1|6.0|123|VIII Malignant bone tumors|20575591|2013
5-9|2.2|3.8|2.9|60|VIII(a) Osteosarcomas|20575591|2013
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20575591|2013
5-9|1.7|3.1|2.3|48|VIII(c) Ewing tumor and related sarcomas of bone|20575591|2013
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20575591|2013
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20575591|2013
5-9|1.7|3.1|2.3|48|X Germ cell, trophoblastic tumors & neoplasms of gonads|20575591|2013
5-9|0.6|1.5|1.0|20|X(a) Intracranial & intraspinal germ cell tumors|20575591|2013
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20575591|2013
5-9|0.7|1.6|1.1|22|X(c) Malignant gonadal germ cell tumors|20575591|2013
5-9|~|~|~|~|X(d) Gonadal carcinomas|20575591|2013
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20575591|2013
5-9|4.5|6.6|5.5|113|XI Other malignant epithelial neoplasms and malignant melanomas|20575591|2013
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20575591|2013
5-9|1.1|2.3|1.7|34|XI(b) Thyroid carcinomas|20575591|2013
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20575591|2013
5-9|1.5|2.8|2.0|42|XI(d) Malignant melanomas|20575591|2013
5-9|~|~|~|~|XI(e) Skin carcinomas|20575591|2013
5-9|1.2|2.4|1.7|35|XI(f) Other and unspecified carcinomas|20575591|2013
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20575591|2013
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20575591|2013
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20575591|2013
<1|272.1|306.0|288.7|1135|All ICCC Groups Combined|3931411|2013
<1|48.6|63.6|55.7|219|I Leukemias, myeloproliferative & myelodysplastic diseases|3931411|2013
<1|13.4|21.9|17.3|68|I(a) Lymphoid leukemias|3931411|2013
<1|13.9|22.5|17.8|70|I(b) Acute myeloid leukemias|3931411|2013
<1|4.5|10.0|6.9|27|I(c) Chronic myeloproliferative diseases|3931411|2013
<1|6.8|13.3|9.7|38|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3931411|2013
<1|2.3|6.6|4.1|16|I(e) Unspecified and other specified leukemias|3931411|2013
<1|21.6|32.1|26.5|104|II Lymphomas and reticuloendothelial neoplasms|3931411|2013
<1|~|~|~|~|II(a) Hodgkin lymphomas|3931411|2013
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3931411|2013
<1|~|~|~|~|II(c) Burkitt lymphoma|3931411|2013
<1|18.9|28.7|23.4|92|II(d) Miscellaneous lymphoreticular neoplasms|3931411|2013
<1|~|~|~|~|II(e) Unspecified lymphomas|3931411|2013
<1|29.3|41.2|34.8|137|III CNS and misc intracranial and intraspinal neoplasms|3931411|2013
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3931411|2013
<1|12.5|20.8|16.3|64|III(b) Astrocytomas|3931411|2013
<1|7.3|13.9|10.2|40|III(c) Intracranial and intraspinal embryonal tumors|3931411|2013
<1|~|~|~|~|III(d) Other gliomas|3931411|2013
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3931411|2013
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3931411|2013
<1|52.9|68.5|60.3|237|IV Neuroblastoma and other peripheral nervous cell tumors|3931411|2013
<1|52.9|68.5|60.3|237|IV(a) Neuroblastoma and ganglioneuroblastoma|3931411|2013
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3931411|2013
<1|16.1|25.3|20.3|80|IX Soft tissue and other extraosseous sarcomas|3931411|2013
<1|3.7|8.8|5.9|23|IX(a) Rhabdomyosarcomas|3931411|2013
<1|4.5|10.0|6.9|27|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3931411|2013
<1|~|~|~|~|IX(c) Kaposi sarcoma|3931411|2013
<1|3.1|7.9|5.1|20|IX(d) Other specified soft tissue sarcomas|3931411|2013
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3931411|2013
<1|~|~|~|~|Not classified by ICCC|3931411|2013
<1|24.6|35.7|29.8|117|V Retinoblastoma|3931411|2013
<1|12.5|20.8|16.3|64|VI Renal tumors|3931411|2013
<1|12.1|20.2|15.8|62|VI(a) Nephroblastoma and other nonepithelial renal tumors|3931411|2013
<1|~|~|~|~|VI(b) Renal carcinomas|3931411|2013
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3931411|2013
<1|9.4|16.8|12.7|50|VII Hepatic tumors|3931411|2013
<1|9.2|16.5|12.5|49|VII(a) Hepatoblastoma|3931411|2013
<1|~|~|~|~|VII(b) Hepatic carcinomas|3931411|2013
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3931411|2013
<1|~|~|~|~|VIII Malignant bone tumors|3931411|2013
<1|~|~|~|~|VIII(a) Osteosarcomas|3931411|2013
<1|~|~|~|~|VIII(b) Chondrosarcomas|3931411|2013
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3931411|2013
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3931411|2013
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3931411|2013
<1|19.1|29.0|23.7|93|X Germ cell, trophoblastic tumors & neoplasms of gonads|3931411|2013
<1|2.3|6.6|4.1|16|X(a) Intracranial & intraspinal germ cell tumors|3931411|2013
<1|10.8|18.5|14.2|56|X(b) Malignant extracranial & extragonadal germ cell tumors|3931411|2013
<1|3.3|8.2|5.3|21|X(c) Malignant gonadal germ cell tumors|3931411|2013
<1|~|~|~|~|X(d) Gonadal carcinomas|3931411|2013
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3931411|2013
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3931411|2013
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3931411|2013
<1|~|~|~|~|XI(b) Thyroid carcinomas|3931411|2013
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3931411|2013
<1|~|~|~|~|XI(d) Malignant melanomas|3931411|2013
<1|~|~|~|~|XI(e) Skin carcinomas|3931411|2013
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3931411|2013
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3931411|2013
<1|~|~|~|~|XII(a) Other specified malignant tumors|3931411|2013
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3931411|2013
1-4|221.7|236.6|229.0|3647|All ICCC Groups Combined|15923833|2014
1-4|85.3|94.7|89.9|1432|I Leukemias, myeloproliferative & myelodysplastic diseases|15923833|2014
1-4|69.8|78.3|73.9|1177|I(a) Lymphoid leukemias|15923833|2014
1-4|9.1|12.3|10.6|169|I(b) Acute myeloid leukemias|15923833|2014
1-4|0.6|1.7|1.1|17|I(c) Chronic myeloproliferative diseases|15923833|2014
1-4|1.1|2.4|1.6|26|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15923833|2014
1-4|2.0|3.6|2.7|43|I(e) Unspecified and other specified leukemias|15923833|2014
1-4|14.9|19.0|16.8|268|II Lymphomas and reticuloendothelial neoplasms|15923833|2014
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15923833|2014
1-4|4.6|7.0|5.7|91|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15923833|2014
1-4|1.6|3.2|2.3|37|II(c) Burkitt lymphoma|15923833|2014
1-4|7.1|10.0|8.4|134|II(d) Miscellaneous lymphoreticular neoplasms|15923833|2014
1-4|~|~|~|~|II(e) Unspecified lymphomas|15923833|2014
1-4|42.3|49.0|45.6|726|III CNS and misc intracranial and intraspinal neoplasms|15923833|2014
1-4|4.4|6.8|5.5|88|III(a) Ependymomas and choroid plexus tumor|15923833|2014
1-4|21.4|26.3|23.7|378|III(b) Astrocytomas|15923833|2014
1-4|7.7|10.7|9.1|145|III(c) Intracranial and intraspinal embryonal tumors|15923833|2014
1-4|4.5|6.9|5.6|89|III(d) Other gliomas|15923833|2014
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15923833|2014
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15923833|2014
1-4|18.7|23.3|20.9|333|IV Neuroblastoma and other peripheral nervous cell tumors|15923833|2014
1-4|18.7|23.2|20.8|332|IV(a) Neuroblastoma and ganglioneuroblastoma|15923833|2014
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15923833|2014
1-4|10.1|13.5|11.7|186|IX Soft tissue and other extraosseous sarcomas|15923833|2014
1-4|6.7|9.6|8.0|128|IX(a) Rhabdomyosarcomas|15923833|2014
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15923833|2014
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15923833|2014
1-4|1.6|3.1|2.3|36|IX(d) Other specified soft tissue sarcomas|15923833|2014
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15923833|2014
1-4|~|~|~|~|Not classified by ICCC|15923833|2014
1-4|7.5|10.5|8.9|142|V Retinoblastoma|15923833|2014
1-4|18.3|22.8|20.4|325|VI Renal tumors|15923833|2014
1-4|18.1|22.6|20.2|322|VI(a) Nephroblastoma and other nonepithelial renal tumors|15923833|2014
1-4|~|~|~|~|VI(b) Renal carcinomas|15923833|2014
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15923833|2014
1-4|4.7|7.2|5.8|93|VII Hepatic tumors|15923833|2014
1-4|4.7|7.1|5.8|92|VII(a) Hepatoblastoma|15923833|2014
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15923833|2014
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15923833|2014
1-4|1.3|2.7|1.9|30|VIII Malignant bone tumors|15923833|2014
1-4|~|~|~|~|VIII(a) Osteosarcomas|15923833|2014
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15923833|2014
1-4|0.7|1.9|1.2|19|VIII(c) Ewing tumor and related sarcomas of bone|15923833|2014
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15923833|2014
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15923833|2014
1-4|2.3|4.1|3.1|49|X Germ cell, trophoblastic tumors & neoplasms of gonads|15923833|2014
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15923833|2014
1-4|1.1|2.4|1.6|26|X(b) Malignant extracranial & extragonadal germ cell tumors|15923833|2014
1-4|0.7|1.8|1.1|18|X(c) Malignant gonadal germ cell tumors|15923833|2014
1-4|~|~|~|~|X(d) Gonadal carcinomas|15923833|2014
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15923833|2014
1-4|1.9|3.6|2.6|42|XI Other malignant epithelial neoplasms and malignant melanomas|15923833|2014
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15923833|2014
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15923833|2014
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15923833|2014
1-4|1.2|2.5|1.8|28|XI(d) Malignant melanomas|15923833|2014
1-4|~|~|~|~|XI(e) Skin carcinomas|15923833|2014
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15923833|2014
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15923833|2014
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15923833|2014
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15923833|2014
10-14|148.9|159.7|154.3|3189|All ICCC Groups Combined|20673760|2014
10-14|30.5|35.5|32.9|680|I Leukemias, myeloproliferative & myelodysplastic diseases|20673760|2014
10-14|19.4|23.4|21.3|441|I(a) Lymphoid leukemias|20673760|2014
10-14|5.6|7.9|6.7|138|I(b) Acute myeloid leukemias|20673760|2014
10-14|1.4|2.7|2.0|41|I(c) Chronic myeloproliferative diseases|20673760|2014
10-14|0.8|1.8|1.2|25|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20673760|2014
10-14|1.2|2.4|1.7|35|I(e) Unspecified and other specified leukemias|20673760|2014
10-14|28.4|33.3|30.8|636|II Lymphomas and reticuloendothelial neoplasms|20673760|2014
10-14|10.8|13.8|12.2|253|II(a) Hodgkin lymphomas|20673760|2014
10-14|10.1|13.1|11.5|238|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20673760|2014
10-14|2.5|4.1|3.2|66|II(c) Burkitt lymphoma|20673760|2014
10-14|2.7|4.3|3.4|71|II(d) Miscellaneous lymphoreticular neoplasms|20673760|2014
10-14|~|~|~|~|II(e) Unspecified lymphomas|20673760|2014
10-14|28.3|33.1|30.7|634|III CNS and misc intracranial and intraspinal neoplasms|20673760|2014
10-14|1.3|2.5|1.8|38|III(a) Ependymomas and choroid plexus tumor|20673760|2014
10-14|15.9|19.6|17.7|366|III(b) Astrocytomas|20673760|2014
10-14|3.7|5.6|4.6|95|III(c) Intracranial and intraspinal embryonal tumors|20673760|2014
10-14|4.5|6.5|5.4|112|III(d) Other gliomas|20673760|2014
10-14|0.4|1.3|0.8|16|III(e) Other specified intracranial & intraspinal neoplasms|20673760|2014
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20673760|2014
10-14|1.3|2.5|1.8|38|IV Neuroblastoma and other peripheral nervous cell tumors|20673760|2014
10-14|0.9|2.0|1.4|28|IV(a) Neuroblastoma and ganglioneuroblastoma|20673760|2014
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20673760|2014
10-14|10.8|13.9|12.3|254|IX Soft tissue and other extraosseous sarcomas|20673760|2014
10-14|2.4|4.0|3.1|64|IX(a) Rhabdomyosarcomas|20673760|2014
10-14|0.7|1.7|1.2|24|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20673760|2014
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20673760|2014
10-14|5.0|7.2|6.0|124|IX(d) Other specified soft tissue sarcomas|20673760|2014
10-14|1.5|2.7|2.0|42|IX(e) Unspecified soft tissue sarcomas|20673760|2014
10-14|~|~|~|~|Not classified by ICCC|20673760|2014
10-14|~|~|~|~|V Retinoblastoma|20673760|2014
10-14|1.0|2.1|1.5|31|VI Renal tumors|20673760|2014
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20673760|2014
10-14|0.6|1.4|0.9|19|VI(b) Renal carcinomas|20673760|2014
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20673760|2014
10-14|0.5|1.4|0.9|18|VII Hepatic tumors|20673760|2014
10-14|~|~|~|~|VII(a) Hepatoblastoma|20673760|2014
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20673760|2014
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20673760|2014
10-14|13.6|17.0|15.2|315|VIII Malignant bone tumors|20673760|2014
10-14|8.1|10.7|9.3|193|VIII(a) Osteosarcomas|20673760|2014
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20673760|2014
10-14|3.4|5.2|4.3|88|VIII(c) Ewing tumor and related sarcomas of bone|20673760|2014
10-14|0.5|1.4|0.9|18|VIII(d) Other specified malignant bone tumors|20673760|2014
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20673760|2014
10-14|6.6|9.0|7.7|160|X Germ cell, trophoblastic tumors & neoplasms of gonads|20673760|2014
10-14|2.0|3.5|2.7|55|X(a) Intracranial & intraspinal germ cell tumors|20673760|2014
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20673760|2014
10-14|3.2|5.0|4.1|84|X(c) Malignant gonadal germ cell tumors|20673760|2014
10-14|~|~|~|~|X(d) Gonadal carcinomas|20673760|2014
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20673760|2014
10-14|17.5|21.4|19.4|401|XI Other malignant epithelial neoplasms and malignant melanomas|20673760|2014
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20673760|2014
10-14|8.2|10.9|9.4|195|XI(b) Thyroid carcinomas|20673760|2014
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20673760|2014
10-14|2.1|3.6|2.8|58|XI(d) Malignant melanomas|20673760|2014
10-14|~|~|~|~|XI(e) Skin carcinomas|20673760|2014
10-14|5.6|7.9|6.7|138|XI(f) Other and unspecified carcinomas|20673760|2014
10-14|0.4|1.3|0.8|16|XII Other and unspecified malignant neoplasms|20673760|2014
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20673760|2014
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20673760|2014
15-19|229.0|242.2|235.5|4960|All ICCC Groups Combined|21060362|2014
15-19|33.9|39.1|36.5|768|I Leukemias, myeloproliferative & myelodysplastic diseases|21060362|2014
15-19|15.8|19.4|17.5|369|I(a) Lymphoid leukemias|21060362|2014
15-19|9.2|12.0|10.5|221|I(b) Acute myeloid leukemias|21060362|2014
15-19|4.3|6.3|5.3|111|I(c) Chronic myeloproliferative diseases|21060362|2014
15-19|0.9|1.9|1.3|28|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21060362|2014
15-19|1.3|2.5|1.9|39|I(e) Unspecified and other specified leukemias|21060362|2014
15-19|51.4|57.7|54.5|1147|II Lymphomas and reticuloendothelial neoplasms|21060362|2014
15-19|28.6|33.4|30.9|651|II(a) Hodgkin lymphomas|21060362|2014
15-19|16.3|20.0|18.0|380|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21060362|2014
15-19|1.7|3.0|2.3|48|II(c) Burkitt lymphoma|21060362|2014
15-19|1.8|3.2|2.5|52|II(d) Miscellaneous lymphoreticular neoplasms|21060362|2014
15-19|0.4|1.2|0.8|16|II(e) Unspecified lymphomas|21060362|2014
15-19|21.9|26.1|23.9|504|III CNS and misc intracranial and intraspinal neoplasms|21060362|2014
15-19|1.0|2.0|1.4|30|III(a) Ependymomas and choroid plexus tumor|21060362|2014
15-19|13.0|16.4|14.6|308|III(b) Astrocytomas|21060362|2014
15-19|1.5|2.8|2.1|44|III(c) Intracranial and intraspinal embryonal tumors|21060362|2014
15-19|3.6|5.4|4.4|93|III(d) Other gliomas|21060362|2014
15-19|0.5|1.4|0.9|18|III(e) Other specified intracranial & intraspinal neoplasms|21060362|2014
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21060362|2014
15-19|0.8|1.9|1.3|27|IV Neuroblastoma and other peripheral nervous cell tumors|21060362|2014
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21060362|2014
15-19|0.5|1.3|0.8|17|IV(b) Other peripheral nervous cell tumors|21060362|2014
15-19|14.2|17.7|15.9|335|IX Soft tissue and other extraosseous sarcomas|21060362|2014
15-19|2.0|3.5|2.7|56|IX(a) Rhabdomyosarcomas|21060362|2014
15-19|1.8|3.2|2.5|52|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21060362|2014
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21060362|2014
15-19|7.3|9.9|8.5|180|IX(d) Other specified soft tissue sarcomas|21060362|2014
15-19|1.5|2.8|2.0|43|IX(e) Unspecified soft tissue sarcomas|21060362|2014
15-19|~|~|~|~|Not classified by ICCC|21060362|2014
15-19|~|~|~|~|V Retinoblastoma|21060362|2014
15-19|1.3|2.5|1.8|38|VI Renal tumors|21060362|2014
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21060362|2014
15-19|0.8|1.9|1.3|27|VI(b) Renal carcinomas|21060362|2014
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21060362|2014
15-19|0.6|1.5|1.0|21|VII Hepatic tumors|21060362|2014
15-19|~|~|~|~|VII(a) Hepatoblastoma|21060362|2014
15-19|0.6|1.5|0.9|20|VII(b) Hepatic carcinomas|21060362|2014
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21060362|2014
15-19|12.2|15.4|13.8|290|VIII Malignant bone tumors|21060362|2014
15-19|6.5|8.9|7.6|161|VIII(a) Osteosarcomas|21060362|2014
15-19|0.5|1.3|0.8|17|VIII(b) Chondrosarcomas|21060362|2014
15-19|3.2|4.9|4.0|84|VIII(c) Ewing tumor and related sarcomas of bone|21060362|2014
15-19|0.4|1.2|0.8|16|VIII(d) Other specified malignant bone tumors|21060362|2014
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21060362|2014
15-19|25.6|30.1|27.8|585|X Germ cell, trophoblastic tumors & neoplasms of gonads|21060362|2014
15-19|1.6|3.0|2.2|47|X(a) Intracranial & intraspinal germ cell tumors|21060362|2014
15-19|1.2|2.4|1.8|37|X(b) Malignant extracranial & extragonadal germ cell tumors|21060362|2014
15-19|19.3|23.3|21.3|448|X(c) Malignant gonadal germ cell tumors|21060362|2014
15-19|1.1|2.3|1.6|34|X(d) Gonadal carcinomas|21060362|2014
15-19|0.5|1.4|0.9|19|X(e) Other and unspecified malignant gonadal tumors|21060362|2014
15-19|54.8|61.4|58.0|1222|XI Other malignant epithelial neoplasms and malignant melanomas|21060362|2014
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21060362|2014
15-19|28.7|33.5|31.1|654|XI(b) Thyroid carcinomas|21060362|2014
15-19|0.7|1.6|1.0|22|XI(c) Nasopharyngeal carcinomas|21060362|2014
15-19|8.6|11.4|9.9|209|XI(d) Malignant melanomas|21060362|2014
15-19|~|~|~|~|XI(e) Skin carcinomas|21060362|2014
15-19|13.9|17.4|15.6|328|XI(f) Other and unspecified carcinomas|21060362|2014
15-19|0.5|1.3|0.8|17|XII Other and unspecified malignant neoplasms|21060362|2014
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21060362|2014
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21060362|2014
5-9|132.7|142.9|137.8|2828|All ICCC Groups Combined|20526270|2014
5-9|40.9|46.7|43.7|897|I Leukemias, myeloproliferative & myelodysplastic diseases|20526270|2014
5-9|32.5|37.7|35.0|719|I(a) Lymphoid leukemias|20526270|2014
5-9|4.0|5.9|4.9|100|I(b) Acute myeloid leukemias|20526270|2014
5-9|0.7|1.7|1.2|24|I(c) Chronic myeloproliferative diseases|20526270|2014
5-9|0.6|1.4|0.9|19|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20526270|2014
5-9|1.2|2.4|1.7|35|I(e) Unspecified and other specified leukemias|20526270|2014
5-9|19.3|23.4|21.3|437|II Lymphomas and reticuloendothelial neoplasms|20526270|2014
5-9|3.1|4.9|3.9|80|II(a) Hodgkin lymphomas|20526270|2014
5-9|7.0|9.6|8.2|169|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20526270|2014
5-9|2.4|4.0|3.2|65|II(c) Burkitt lymphoma|20526270|2014
5-9|4.6|6.7|5.6|115|II(d) Miscellaneous lymphoreticular neoplasms|20526270|2014
5-9|~|~|~|~|II(e) Unspecified lymphomas|20526270|2014
5-9|34.0|39.2|36.5|750|III CNS and misc intracranial and intraspinal neoplasms|20526270|2014
5-9|2.0|3.5|2.7|55|III(a) Ependymomas and choroid plexus tumor|20526270|2014
5-9|16.2|20.0|18.0|370|III(b) Astrocytomas|20526270|2014
5-9|6.6|9.0|7.7|159|III(c) Intracranial and intraspinal embryonal tumors|20526270|2014
5-9|5.9|8.2|7.0|143|III(d) Other gliomas|20526270|2014
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20526270|2014
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20526270|2014
5-9|3.7|5.7|4.6|95|IV Neuroblastoma and other peripheral nervous cell tumors|20526270|2014
5-9|3.7|5.6|4.5|93|IV(a) Neuroblastoma and ganglioneuroblastoma|20526270|2014
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20526270|2014
5-9|7.7|10.3|8.9|183|IX Soft tissue and other extraosseous sarcomas|20526270|2014
5-9|3.4|5.3|4.3|88|IX(a) Rhabdomyosarcomas|20526270|2014
5-9|0.5|1.3|0.8|17|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20526270|2014
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20526270|2014
5-9|2.3|3.8|3.0|61|IX(d) Other specified soft tissue sarcomas|20526270|2014
5-9|0.5|1.3|0.8|17|IX(e) Unspecified soft tissue sarcomas|20526270|2014
5-9|~|~|~|~|Not classified by ICCC|20526270|2014
5-9|~|~|~|~|V Retinoblastoma|20526270|2014
5-9|5.6|7.9|6.7|137|VI Renal tumors|20526270|2014
5-9|5.3|7.6|6.4|131|VI(a) Nephroblastoma and other nonepithelial renal tumors|20526270|2014
5-9|~|~|~|~|VI(b) Renal carcinomas|20526270|2014
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20526270|2014
5-9|0.6|1.4|0.9|19|VII Hepatic tumors|20526270|2014
5-9|~|~|~|~|VII(a) Hepatoblastoma|20526270|2014
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20526270|2014
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20526270|2014
5-9|5.5|7.7|6.5|134|VIII Malignant bone tumors|20526270|2014
5-9|2.6|4.2|3.3|68|VIII(a) Osteosarcomas|20526270|2014
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20526270|2014
5-9|2.1|3.6|2.8|57|VIII(c) Ewing tumor and related sarcomas of bone|20526270|2014
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20526270|2014
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20526270|2014
5-9|2.0|3.4|2.6|54|X Germ cell, trophoblastic tumors & neoplasms of gonads|20526270|2014
5-9|0.7|1.7|1.2|24|X(a) Intracranial & intraspinal germ cell tumors|20526270|2014
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20526270|2014
5-9|0.6|1.6|1.0|21|X(c) Malignant gonadal germ cell tumors|20526270|2014
5-9|~|~|~|~|X(d) Gonadal carcinomas|20526270|2014
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20526270|2014
5-9|4.3|6.3|5.2|107|XI Other malignant epithelial neoplasms and malignant melanomas|20526270|2014
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20526270|2014
5-9|1.4|2.7|1.9|40|XI(b) Thyroid carcinomas|20526270|2014
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20526270|2014
5-9|1.4|2.7|1.9|40|XI(d) Malignant melanomas|20526270|2014
5-9|~|~|~|~|XI(e) Skin carcinomas|20526270|2014
5-9|0.6|1.6|1.0|21|XI(f) Other and unspecified carcinomas|20526270|2014
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20526270|2014
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20526270|2014
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20526270|2014
<1|268.1|301.6|284.5|1125|All ICCC Groups Combined|3954973|2014
<1|41.2|55.1|47.8|189|I Leukemias, myeloproliferative & myelodysplastic diseases|3954973|2014
<1|10.9|18.7|14.4|57|I(a) Lymphoid leukemias|3954973|2014
<1|15.6|24.6|19.7|78|I(b) Acute myeloid leukemias|3954973|2014
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3954973|2014
<1|4.9|10.5|7.3|29|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3954973|2014
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3954973|2014
<1|19.4|29.4|24.0|95|II Lymphomas and reticuloendothelial neoplasms|3954973|2014
<1|~|~|~|~|II(a) Hodgkin lymphomas|3954973|2014
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3954973|2014
<1|~|~|~|~|II(c) Burkitt lymphoma|3954973|2014
<1|16.0|25.2|20.2|80|II(d) Miscellaneous lymphoreticular neoplasms|3954973|2014
<1|~|~|~|~|II(e) Unspecified lymphomas|3954973|2014
<1|30.2|42.3|35.9|142|III CNS and misc intracranial and intraspinal neoplasms|3954973|2014
<1|3.3|8.1|5.3|21|III(a) Ependymomas and choroid plexus tumor|3954973|2014
<1|9.2|16.4|12.4|49|III(b) Astrocytomas|3954973|2014
<1|9.8|17.2|13.1|52|III(c) Intracranial and intraspinal embryonal tumors|3954973|2014
<1|~|~|~|~|III(d) Other gliomas|3954973|2014
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3954973|2014
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3954973|2014
<1|60.1|76.6|68.0|269|IV Neuroblastoma and other peripheral nervous cell tumors|3954973|2014
<1|60.1|76.6|68.0|269|IV(a) Neuroblastoma and ganglioneuroblastoma|3954973|2014
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3954973|2014
<1|12.2|20.4|15.9|63|IX Soft tissue and other extraosseous sarcomas|3954973|2014
<1|3.1|7.8|5.1|20|IX(a) Rhabdomyosarcomas|3954973|2014
<1|3.5|8.4|5.6|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3954973|2014
<1|~|~|~|~|IX(c) Kaposi sarcoma|3954973|2014
<1|2.7|7.2|4.6|18|IX(d) Other specified soft tissue sarcomas|3954973|2014
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3954973|2014
<1|~|~|~|~|Not classified by ICCC|3954973|2014
<1|24.7|35.7|29.8|118|V Retinoblastoma|3954973|2014
<1|13.8|22.4|17.7|70|VI Renal tumors|3954973|2014
<1|13.8|22.4|17.7|70|VI(a) Nephroblastoma and other nonepithelial renal tumors|3954973|2014
<1|~|~|~|~|VI(b) Renal carcinomas|3954973|2014
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3954973|2014
<1|10.9|18.7|14.4|57|VII Hepatic tumors|3954973|2014
<1|10.5|18.1|13.9|55|VII(a) Hepatoblastoma|3954973|2014
<1|~|~|~|~|VII(b) Hepatic carcinomas|3954973|2014
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3954973|2014
<1|~|~|~|~|VIII Malignant bone tumors|3954973|2014
<1|~|~|~|~|VIII(a) Osteosarcomas|3954973|2014
<1|~|~|~|~|VIII(b) Chondrosarcomas|3954973|2014
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3954973|2014
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3954973|2014
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3954973|2014
<1|17.6|27.1|22.0|87|X Germ cell, trophoblastic tumors & neoplasms of gonads|3954973|2014
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3954973|2014
<1|12.2|20.4|15.9|63|X(b) Malignant extracranial & extragonadal germ cell tumors|3954973|2014
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3954973|2014
<1|~|~|~|~|X(d) Gonadal carcinomas|3954973|2014
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3954973|2014
<1|3.5|8.4|5.6|22|XI Other malignant epithelial neoplasms and malignant melanomas|3954973|2014
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3954973|2014
<1|~|~|~|~|XI(b) Thyroid carcinomas|3954973|2014
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3954973|2014
<1|~|~|~|~|XI(d) Malignant melanomas|3954973|2014
<1|~|~|~|~|XI(e) Skin carcinomas|3954973|2014
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3954973|2014
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3954973|2014
<1|~|~|~|~|XII(a) Other specified malignant tumors|3954973|2014
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3954973|2014
1-4|229.1|244.2|236.6|3771|All ICCC Groups Combined|15940562|2015
1-4|91.7|101.4|96.5|1538|I Leukemias, myeloproliferative & myelodysplastic diseases|15940562|2015
1-4|75.9|84.8|80.2|1279|I(a) Lymphoid leukemias|15940562|2015
1-4|8.9|12.2|10.5|167|I(b) Acute myeloid leukemias|15940562|2015
1-4|0.9|2.2|1.4|23|I(c) Chronic myeloproliferative diseases|15940562|2015
1-4|0.9|2.2|1.4|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15940562|2015
1-4|2.1|3.8|2.9|46|I(e) Unspecified and other specified leukemias|15940562|2015
1-4|15.0|19.1|17.0|271|II Lymphomas and reticuloendothelial neoplasms|15940562|2015
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15940562|2015
1-4|3.8|6.0|4.8|77|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15940562|2015
1-4|1.5|3.1|2.2|35|II(c) Burkitt lymphoma|15940562|2015
1-4|7.6|10.6|9.0|143|II(d) Miscellaneous lymphoreticular neoplasms|15940562|2015
1-4|~|~|~|~|II(e) Unspecified lymphomas|15940562|2015
1-4|41.0|47.6|44.2|704|III CNS and misc intracranial and intraspinal neoplasms|15940562|2015
1-4|3.6|5.8|4.6|73|III(a) Ependymomas and choroid plexus tumor|15940562|2015
1-4|20.5|25.3|22.8|364|III(b) Astrocytomas|15940562|2015
1-4|9.2|12.5|10.8|172|III(c) Intracranial and intraspinal embryonal tumors|15940562|2015
1-4|3.8|6.0|4.8|76|III(d) Other gliomas|15940562|2015
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15940562|2015
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15940562|2015
1-4|21.6|26.4|23.9|381|IV Neuroblastoma and other peripheral nervous cell tumors|15940562|2015
1-4|21.5|26.4|23.8|380|IV(a) Neuroblastoma and ganglioneuroblastoma|15940562|2015
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15940562|2015
1-4|9.1|12.4|10.7|170|IX Soft tissue and other extraosseous sarcomas|15940562|2015
1-4|6.6|9.4|7.9|126|IX(a) Rhabdomyosarcomas|15940562|2015
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15940562|2015
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15940562|2015
1-4|1.2|2.6|1.8|29|IX(d) Other specified soft tissue sarcomas|15940562|2015
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15940562|2015
1-4|~|~|~|~|Not classified by ICCC|15940562|2015
1-4|7.7|10.7|9.1|145|V Retinoblastoma|15940562|2015
1-4|19.2|23.9|21.5|342|VI Renal tumors|15940562|2015
1-4|19.1|23.7|21.3|339|VI(a) Nephroblastoma and other nonepithelial renal tumors|15940562|2015
1-4|~|~|~|~|VI(b) Renal carcinomas|15940562|2015
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15940562|2015
1-4|5.2|7.7|6.3|101|VII Hepatic tumors|15940562|2015
1-4|5.1|7.6|6.3|100|VII(a) Hepatoblastoma|15940562|2015
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15940562|2015
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15940562|2015
1-4|1.0|2.3|1.6|25|VIII Malignant bone tumors|15940562|2015
1-4|~|~|~|~|VIII(a) Osteosarcomas|15940562|2015
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15940562|2015
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15940562|2015
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15940562|2015
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15940562|2015
1-4|1.6|3.1|2.3|36|X Germ cell, trophoblastic tumors & neoplasms of gonads|15940562|2015
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15940562|2015
1-4|0.6|1.6|1.0|16|X(b) Malignant extracranial & extragonadal germ cell tumors|15940562|2015
1-4|0.7|1.8|1.1|18|X(c) Malignant gonadal germ cell tumors|15940562|2015
1-4|~|~|~|~|X(d) Gonadal carcinomas|15940562|2015
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15940562|2015
1-4|1.4|2.9|2.1|33|XI Other malignant epithelial neoplasms and malignant melanomas|15940562|2015
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15940562|2015
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15940562|2015
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15940562|2015
1-4|0.8|2.0|1.3|21|XI(d) Malignant melanomas|15940562|2015
1-4|~|~|~|~|XI(e) Skin carcinomas|15940562|2015
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15940562|2015
1-4|0.9|2.2|1.4|23|XII Other and unspecified malignant neoplasms|15940562|2015
1-4|0.8|1.9|1.3|20|XII(a) Other specified malignant tumors|15940562|2015
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15940562|2015
10-14|149.1|159.9|154.4|3183|All ICCC Groups Combined|20614613|2015
10-14|31.3|36.4|33.8|697|I Leukemias, myeloproliferative & myelodysplastic diseases|20614613|2015
10-14|20.1|24.2|22.1|455|I(a) Lymphoid leukemias|20614613|2015
10-14|6.0|8.3|7.1|146|I(b) Acute myeloid leukemias|20614613|2015
10-14|1.3|2.6|1.9|39|I(c) Chronic myeloproliferative diseases|20614613|2015
10-14|0.9|1.9|1.3|27|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20614613|2015
10-14|1.0|2.1|1.5|30|I(e) Unspecified and other specified leukemias|20614613|2015
10-14|28.3|33.1|30.7|632|II Lymphomas and reticuloendothelial neoplasms|20614613|2015
10-14|11.3|14.4|12.8|263|II(a) Hodgkin lymphomas|20614613|2015
10-14|8.8|11.6|10.1|209|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20614613|2015
10-14|2.1|3.5|2.7|56|II(c) Burkitt lymphoma|20614613|2015
10-14|3.6|5.5|4.5|93|II(d) Miscellaneous lymphoreticular neoplasms|20614613|2015
10-14|~|~|~|~|II(e) Unspecified lymphomas|20614613|2015
10-14|25.5|30.1|27.7|572|III CNS and misc intracranial and intraspinal neoplasms|20614613|2015
10-14|1.6|2.9|2.1|44|III(a) Ependymomas and choroid plexus tumor|20614613|2015
10-14|13.8|17.2|15.4|318|III(b) Astrocytomas|20614613|2015
10-14|2.6|4.2|3.3|68|III(c) Intracranial and intraspinal embryonal tumors|20614613|2015
10-14|4.7|6.8|5.7|117|III(d) Other gliomas|20614613|2015
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20614613|2015
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20614613|2015
10-14|0.9|1.9|1.3|27|IV Neuroblastoma and other peripheral nervous cell tumors|20614613|2015
10-14|0.6|1.4|0.9|19|IV(a) Neuroblastoma and ganglioneuroblastoma|20614613|2015
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20614613|2015
10-14|12.3|15.5|13.8|285|IX Soft tissue and other extraosseous sarcomas|20614613|2015
10-14|3.4|5.2|4.2|87|IX(a) Rhabdomyosarcomas|20614613|2015
10-14|0.9|2.0|1.4|28|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20614613|2015
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20614613|2015
10-14|5.1|7.3|6.2|127|IX(d) Other specified soft tissue sarcomas|20614613|2015
10-14|1.5|2.8|2.0|42|IX(e) Unspecified soft tissue sarcomas|20614613|2015
10-14|~|~|~|~|Not classified by ICCC|20614613|2015
10-14|~|~|~|~|V Retinoblastoma|20614613|2015
10-14|1.3|2.5|1.8|37|VI Renal tumors|20614613|2015
10-14|0.7|1.7|1.2|24|VI(a) Nephroblastoma and other nonepithelial renal tumors|20614613|2015
10-14|~|~|~|~|VI(b) Renal carcinomas|20614613|2015
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20614613|2015
10-14|0.6|1.6|1.0|21|VII Hepatic tumors|20614613|2015
10-14|~|~|~|~|VII(a) Hepatoblastoma|20614613|2015
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20614613|2015
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20614613|2015
10-14|12.6|15.9|14.2|293|VIII Malignant bone tumors|20614613|2015
10-14|7.1|9.7|8.3|172|VIII(a) Osteosarcomas|20614613|2015
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20614613|2015
10-14|3.6|5.4|4.4|91|VIII(c) Ewing tumor and related sarcomas of bone|20614613|2015
10-14|0.4|1.3|0.8|16|VIII(d) Other specified malignant bone tumors|20614613|2015
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20614613|2015
10-14|7.0|9.5|8.2|169|X Germ cell, trophoblastic tumors & neoplasms of gonads|20614613|2015
10-14|2.2|3.7|2.9|60|X(a) Intracranial & intraspinal germ cell tumors|20614613|2015
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20614613|2015
10-14|3.6|5.5|4.5|92|X(c) Malignant gonadal germ cell tumors|20614613|2015
10-14|~|~|~|~|X(d) Gonadal carcinomas|20614613|2015
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20614613|2015
10-14|19.2|23.2|21.1|435|XI Other malignant epithelial neoplasms and malignant melanomas|20614613|2015
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20614613|2015
10-14|7.6|10.2|8.8|182|XI(b) Thyroid carcinomas|20614613|2015
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20614613|2015
10-14|2.4|4.0|3.2|65|XI(d) Malignant melanomas|20614613|2015
10-14|~|~|~|~|XI(e) Skin carcinomas|20614613|2015
10-14|7.2|9.8|8.4|174|XI(f) Other and unspecified carcinomas|20614613|2015
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20614613|2015
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20614613|2015
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20614613|2015
15-19|242.1|255.7|248.8|5248|All ICCC Groups Combined|21090272|2015
15-19|35.2|40.5|37.7|796|I Leukemias, myeloproliferative & myelodysplastic diseases|21090272|2015
15-19|17.6|21.4|19.4|410|I(a) Lymphoid leukemias|21090272|2015
15-19|8.5|11.2|9.8|207|I(b) Acute myeloid leukemias|21090272|2015
15-19|4.3|6.3|5.2|110|I(c) Chronic myeloproliferative diseases|21090272|2015
15-19|1.0|2.1|1.5|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21090272|2015
15-19|1.3|2.5|1.8|38|I(e) Unspecified and other specified leukemias|21090272|2015
15-19|50.8|57.1|53.9|1137|II Lymphomas and reticuloendothelial neoplasms|21090272|2015
15-19|29.4|34.3|31.8|670|II(a) Hodgkin lymphomas|21090272|2015
15-19|15.5|19.1|17.3|364|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21090272|2015
15-19|1.6|3.0|2.2|47|II(c) Burkitt lymphoma|21090272|2015
15-19|1.3|2.5|1.8|39|II(d) Miscellaneous lymphoreticular neoplasms|21090272|2015
15-19|0.5|1.3|0.8|17|II(e) Unspecified lymphomas|21090272|2015
15-19|22.0|26.3|24.1|508|III CNS and misc intracranial and intraspinal neoplasms|21090272|2015
15-19|1.2|2.4|1.8|37|III(a) Ependymomas and choroid plexus tumor|21090272|2015
15-19|10.7|13.7|12.1|256|III(b) Astrocytomas|21090272|2015
15-19|1.9|3.3|2.5|53|III(c) Intracranial and intraspinal embryonal tumors|21090272|2015
15-19|5.0|7.2|6.0|127|III(d) Other gliomas|21090272|2015
15-19|0.7|1.7|1.1|24|III(e) Other specified intracranial & intraspinal neoplasms|21090272|2015
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21090272|2015
15-19|0.9|2.0|1.4|29|IV Neuroblastoma and other peripheral nervous cell tumors|21090272|2015
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21090272|2015
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21090272|2015
15-19|14.7|18.2|16.4|346|IX Soft tissue and other extraosseous sarcomas|21090272|2015
15-19|2.9|4.6|3.7|77|IX(a) Rhabdomyosarcomas|21090272|2015
15-19|1.8|3.1|2.4|50|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21090272|2015
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21090272|2015
15-19|6.6|9.1|7.8|164|IX(d) Other specified soft tissue sarcomas|21090272|2015
15-19|1.8|3.2|2.4|51|IX(e) Unspecified soft tissue sarcomas|21090272|2015
15-19|~|~|~|~|Not classified by ICCC|21090272|2015
15-19|~|~|~|~|V Retinoblastoma|21090272|2015
15-19|1.7|3.0|2.3|48|VI Renal tumors|21090272|2015
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21090272|2015
15-19|1.5|2.7|2.0|43|VI(b) Renal carcinomas|21090272|2015
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21090272|2015
15-19|1.0|2.1|1.5|32|VII Hepatic tumors|21090272|2015
15-19|~|~|~|~|VII(a) Hepatoblastoma|21090272|2015
15-19|1.0|2.0|1.4|30|VII(b) Hepatic carcinomas|21090272|2015
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21090272|2015
15-19|12.7|15.9|14.2|300|VIII Malignant bone tumors|21090272|2015
15-19|6.7|9.2|7.9|166|VIII(a) Osteosarcomas|21090272|2015
15-19|0.5|1.3|0.9|18|VIII(b) Chondrosarcomas|21090272|2015
15-19|3.6|5.4|4.4|93|VIII(c) Ewing tumor and related sarcomas of bone|21090272|2015
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|21090272|2015
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21090272|2015
15-19|27.9|32.6|30.2|636|X Germ cell, trophoblastic tumors & neoplasms of gonads|21090272|2015
15-19|1.9|3.3|2.5|53|X(a) Intracranial & intraspinal germ cell tumors|21090272|2015
15-19|1.0|2.1|1.5|31|X(b) Malignant extracranial & extragonadal germ cell tumors|21090272|2015
15-19|21.6|25.8|23.6|498|X(c) Malignant gonadal germ cell tumors|21090272|2015
15-19|1.1|2.2|1.6|33|X(d) Gonadal carcinomas|21090272|2015
15-19|0.6|1.5|1.0|21|X(e) Other and unspecified malignant gonadal tumors|21090272|2015
15-19|62.1|69.1|65.5|1382|XI Other malignant epithelial neoplasms and malignant melanomas|21090272|2015
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21090272|2015
15-19|30.5|35.4|32.9|694|XI(b) Thyroid carcinomas|21090272|2015
15-19|1.3|2.5|1.8|38|XI(c) Nasopharyngeal carcinomas|21090272|2015
15-19|8.0|10.7|9.3|196|XI(d) Malignant melanomas|21090272|2015
15-19|~|~|~|~|XI(e) Skin carcinomas|21090272|2015
15-19|19.2|23.2|21.1|445|XI(f) Other and unspecified carcinomas|21090272|2015
15-19|0.9|1.9|1.3|28|XII Other and unspecified malignant neoplasms|21090272|2015
15-19|0.4|1.2|0.8|16|XII(a) Other specified malignant tumors|21090272|2015
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21090272|2015
5-9|133.4|143.6|138.4|2836|All ICCC Groups Combined|20490819|2015
5-9|41.4|47.2|44.2|906|I Leukemias, myeloproliferative & myelodysplastic diseases|20490819|2015
5-9|33.6|38.9|36.2|741|I(a) Lymphoid leukemias|20490819|2015
5-9|3.8|5.7|4.7|96|I(b) Acute myeloid leukemias|20490819|2015
5-9|0.7|1.6|1.1|22|I(c) Chronic myeloproliferative diseases|20490819|2015
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20490819|2015
5-9|1.1|2.2|1.6|32|I(e) Unspecified and other specified leukemias|20490819|2015
5-9|18.9|22.9|20.8|426|II Lymphomas and reticuloendothelial neoplasms|20490819|2015
5-9|3.2|5.0|4.1|83|II(a) Hodgkin lymphomas|20490819|2015
5-9|6.9|9.4|8.1|166|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20490819|2015
5-9|2.4|4.0|3.1|64|II(c) Burkitt lymphoma|20490819|2015
5-9|4.4|6.4|5.3|109|II(d) Miscellaneous lymphoreticular neoplasms|20490819|2015
5-9|~|~|~|~|II(e) Unspecified lymphomas|20490819|2015
5-9|35.3|40.7|37.9|777|III CNS and misc intracranial and intraspinal neoplasms|20490819|2015
5-9|1.8|3.2|2.4|50|III(a) Ependymomas and choroid plexus tumor|20490819|2015
5-9|17.1|20.9|18.9|387|III(b) Astrocytomas|20490819|2015
5-9|6.8|9.3|8.0|163|III(c) Intracranial and intraspinal embryonal tumors|20490819|2015
5-9|6.5|9.0|7.7|157|III(d) Other gliomas|20490819|2015
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20490819|2015
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20490819|2015
5-9|3.9|5.8|4.8|98|IV Neuroblastoma and other peripheral nervous cell tumors|20490819|2015
5-9|3.7|5.6|4.6|94|IV(a) Neuroblastoma and ganglioneuroblastoma|20490819|2015
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20490819|2015
5-9|6.9|9.4|8.1|166|IX Soft tissue and other extraosseous sarcomas|20490819|2015
5-9|3.2|5.0|4.1|83|IX(a) Rhabdomyosarcomas|20490819|2015
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20490819|2015
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20490819|2015
5-9|2.0|3.4|2.6|54|IX(d) Other specified soft tissue sarcomas|20490819|2015
5-9|0.4|1.3|0.8|16|IX(e) Unspecified soft tissue sarcomas|20490819|2015
5-9|~|~|~|~|Not classified by ICCC|20490819|2015
5-9|~|~|~|~|V Retinoblastoma|20490819|2015
5-9|5.9|8.2|7.0|143|VI Renal tumors|20490819|2015
5-9|5.5|7.7|6.5|134|VI(a) Nephroblastoma and other nonepithelial renal tumors|20490819|2015
5-9|~|~|~|~|VI(b) Renal carcinomas|20490819|2015
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20490819|2015
5-9|0.5|1.3|0.8|17|VII Hepatic tumors|20490819|2015
5-9|~|~|~|~|VII(a) Hepatoblastoma|20490819|2015
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20490819|2015
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20490819|2015
5-9|5.5|7.7|6.5|134|VIII Malignant bone tumors|20490819|2015
5-9|2.3|3.8|3.0|61|VIII(a) Osteosarcomas|20490819|2015
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20490819|2015
5-9|2.2|3.7|2.9|59|VIII(c) Ewing tumor and related sarcomas of bone|20490819|2015
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20490819|2015
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20490819|2015
5-9|1.8|3.2|2.4|49|X Germ cell, trophoblastic tumors & neoplasms of gonads|20490819|2015
5-9|0.9|2.0|1.4|29|X(a) Intracranial & intraspinal germ cell tumors|20490819|2015
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20490819|2015
5-9|~|~|~|~|X(c) Malignant gonadal germ cell tumors|20490819|2015
5-9|~|~|~|~|X(d) Gonadal carcinomas|20490819|2015
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20490819|2015
5-9|4.3|6.3|5.2|107|XI Other malignant epithelial neoplasms and malignant melanomas|20490819|2015
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20490819|2015
5-9|0.8|1.8|1.2|25|XI(b) Thyroid carcinomas|20490819|2015
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20490819|2015
5-9|1.2|2.4|1.8|36|XI(d) Malignant melanomas|20490819|2015
5-9|~|~|~|~|XI(e) Skin carcinomas|20490819|2015
5-9|1.6|2.9|2.1|44|XI(f) Other and unspecified carcinomas|20490819|2015
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20490819|2015
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20490819|2015
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20490819|2015
<1|278.3|312.3|294.9|1175|All ICCC Groups Combined|3984144|2015
<1|49.1|64.1|56.2|224|I Leukemias, myeloproliferative & myelodysplastic diseases|3984144|2015
<1|13.7|22.2|17.6|70|I(a) Lymphoid leukemias|3984144|2015
<1|15.0|23.9|19.1|76|I(b) Acute myeloid leukemias|3984144|2015
<1|5.9|11.9|8.5|34|I(c) Chronic myeloproliferative diseases|3984144|2015
<1|4.9|10.5|7.3|29|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3984144|2015
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3984144|2015
<1|18.8|28.6|23.3|93|II Lymphomas and reticuloendothelial neoplasms|3984144|2015
<1|~|~|~|~|II(a) Hodgkin lymphomas|3984144|2015
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3984144|2015
<1|~|~|~|~|II(c) Burkitt lymphoma|3984144|2015
<1|17.7|27.2|22.1|88|II(d) Miscellaneous lymphoreticular neoplasms|3984144|2015
<1|~|~|~|~|II(e) Unspecified lymphomas|3984144|2015
<1|29.1|40.9|34.6|138|III CNS and misc intracranial and intraspinal neoplasms|3984144|2015
<1|4.1|9.3|6.3|25|III(a) Ependymomas and choroid plexus tumor|3984144|2015
<1|8.9|16.0|12.0|48|III(b) Astrocytomas|3984144|2015
<1|8.5|15.4|11.5|46|III(c) Intracranial and intraspinal embryonal tumors|3984144|2015
<1|~|~|~|~|III(d) Other gliomas|3984144|2015
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3984144|2015
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3984144|2015
<1|55.7|71.6|63.3|252|IV Neuroblastoma and other peripheral nervous cell tumors|3984144|2015
<1|55.7|71.6|63.3|252|IV(a) Neuroblastoma and ganglioneuroblastoma|3984144|2015
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3984144|2015
<1|13.3|21.6|17.1|68|IX Soft tissue and other extraosseous sarcomas|3984144|2015
<1|3.7|8.7|5.8|23|IX(a) Rhabdomyosarcomas|3984144|2015
<1|2.7|7.1|4.5|18|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3984144|2015
<1|~|~|~|~|IX(c) Kaposi sarcoma|3984144|2015
<1|2.7|7.1|4.5|18|IX(d) Other specified soft tissue sarcomas|3984144|2015
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3984144|2015
<1|~|~|~|~|Not classified by ICCC|3984144|2015
<1|32.1|44.5|37.9|151|V Retinoblastoma|3984144|2015
<1|15.9|25.0|20.1|80|VI Renal tumors|3984144|2015
<1|15.7|24.7|19.8|79|VI(a) Nephroblastoma and other nonepithelial renal tumors|3984144|2015
<1|~|~|~|~|VI(b) Renal carcinomas|3984144|2015
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3984144|2015
<1|11.5|19.4|15.1|60|VII Hepatic tumors|3984144|2015
<1|11.1|18.8|14.6|58|VII(a) Hepatoblastoma|3984144|2015
<1|~|~|~|~|VII(b) Hepatic carcinomas|3984144|2015
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3984144|2015
<1|~|~|~|~|VIII Malignant bone tumors|3984144|2015
<1|~|~|~|~|VIII(a) Osteosarcomas|3984144|2015
<1|~|~|~|~|VIII(b) Chondrosarcomas|3984144|2015
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3984144|2015
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3984144|2015
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3984144|2015
<1|16.6|25.8|20.8|83|X Germ cell, trophoblastic tumors & neoplasms of gonads|3984144|2015
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3984144|2015
<1|11.5|19.4|15.1|60|X(b) Malignant extracranial & extragonadal germ cell tumors|3984144|2015
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3984144|2015
<1|~|~|~|~|X(d) Gonadal carcinomas|3984144|2015
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3984144|2015
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3984144|2015
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3984144|2015
<1|~|~|~|~|XI(b) Thyroid carcinomas|3984144|2015
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3984144|2015
<1|~|~|~|~|XI(d) Malignant melanomas|3984144|2015
<1|~|~|~|~|XI(e) Skin carcinomas|3984144|2015
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3984144|2015
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3984144|2015
<1|~|~|~|~|XII(a) Other specified malignant tumors|3984144|2015
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3984144|2015
1-4|220.8|235.7|228.1|3644|All ICCC Groups Combined|15973469|2016
1-4|87.4|96.9|92.1|1471|I Leukemias, myeloproliferative & myelodysplastic diseases|15973469|2016
1-4|71.2|79.8|75.4|1205|I(a) Lymphoid leukemias|15973469|2016
1-4|9.7|13.1|11.3|181|I(b) Acute myeloid leukemias|15973469|2016
1-4|1.0|2.2|1.5|24|I(c) Chronic myeloproliferative diseases|15973469|2016
1-4|1.0|2.2|1.5|24|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15973469|2016
1-4|1.6|3.2|2.3|37|I(e) Unspecified and other specified leukemias|15973469|2016
1-4|13.1|16.9|14.9|238|II Lymphomas and reticuloendothelial neoplasms|15973469|2016
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15973469|2016
1-4|3.8|6.0|4.8|77|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15973469|2016
1-4|1.7|3.3|2.4|38|II(c) Burkitt lymphoma|15973469|2016
1-4|5.6|8.2|6.8|109|II(d) Miscellaneous lymphoreticular neoplasms|15973469|2016
1-4|~|~|~|~|II(e) Unspecified lymphomas|15973469|2016
1-4|43.1|49.9|46.4|741|III CNS and misc intracranial and intraspinal neoplasms|15973469|2016
1-4|4.2|6.5|5.3|84|III(a) Ependymomas and choroid plexus tumor|15973469|2016
1-4|20.9|25.7|23.2|371|III(b) Astrocytomas|15973469|2016
1-4|7.9|11.0|9.4|150|III(c) Intracranial and intraspinal embryonal tumors|15973469|2016
1-4|5.7|8.3|6.9|110|III(d) Other gliomas|15973469|2016
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15973469|2016
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15973469|2016
1-4|18.7|23.2|20.8|333|IV Neuroblastoma and other peripheral nervous cell tumors|15973469|2016
1-4|18.6|23.1|20.8|332|IV(a) Neuroblastoma and ganglioneuroblastoma|15973469|2016
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15973469|2016
1-4|10.7|14.2|12.4|198|IX Soft tissue and other extraosseous sarcomas|15973469|2016
1-4|6.9|9.7|8.2|131|IX(a) Rhabdomyosarcomas|15973469|2016
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15973469|2016
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15973469|2016
1-4|2.3|4.1|3.1|49|IX(d) Other specified soft tissue sarcomas|15973469|2016
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15973469|2016
1-4|~|~|~|~|Not classified by ICCC|15973469|2016
1-4|6.6|9.5|8.0|127|V Retinoblastoma|15973469|2016
1-4|16.1|20.3|18.1|289|VI Renal tumors|15973469|2016
1-4|15.9|20.2|18.0|287|VI(a) Nephroblastoma and other nonepithelial renal tumors|15973469|2016
1-4|~|~|~|~|VI(b) Renal carcinomas|15973469|2016
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15973469|2016
1-4|4.5|6.9|5.6|90|VII Hepatic tumors|15973469|2016
1-4|4.4|6.8|5.5|88|VII(a) Hepatoblastoma|15973469|2016
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15973469|2016
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15973469|2016
1-4|1.2|2.5|1.8|28|VIII Malignant bone tumors|15973469|2016
1-4|~|~|~|~|VIII(a) Osteosarcomas|15973469|2016
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15973469|2016
1-4|0.8|1.9|1.3|20|VIII(c) Ewing tumor and related sarcomas of bone|15973469|2016
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15973469|2016
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15973469|2016
1-4|3.5|5.6|4.4|71|X Germ cell, trophoblastic tumors & neoplasms of gonads|15973469|2016
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15973469|2016
1-4|0.9|2.2|1.4|23|X(b) Malignant extracranial & extragonadal germ cell tumors|15973469|2016
1-4|1.4|2.9|2.1|33|X(c) Malignant gonadal germ cell tumors|15973469|2016
1-4|~|~|~|~|X(d) Gonadal carcinomas|15973469|2016
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15973469|2016
1-4|1.2|2.6|1.8|29|XI Other malignant epithelial neoplasms and malignant melanomas|15973469|2016
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15973469|2016
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15973469|2016
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15973469|2016
1-4|0.6|1.6|1.0|16|XI(d) Malignant melanomas|15973469|2016
1-4|~|~|~|~|XI(e) Skin carcinomas|15973469|2016
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15973469|2016
1-4|1.0|2.2|1.5|24|XII Other and unspecified malignant neoplasms|15973469|2016
1-4|0.7|1.9|1.2|19|XII(a) Other specified malignant tumors|15973469|2016
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15973469|2016
10-14|155.1|166.1|160.5|3312|All ICCC Groups Combined|20634000|2016
10-14|35.9|41.4|38.6|796|I Leukemias, myeloproliferative & myelodysplastic diseases|20634000|2016
10-14|23.2|27.6|25.3|522|I(a) Lymphoid leukemias|20634000|2016
10-14|6.9|9.4|8.1|167|I(b) Acute myeloid leukemias|20634000|2016
10-14|1.6|2.9|2.2|45|I(c) Chronic myeloproliferative diseases|20634000|2016
10-14|0.7|1.7|1.1|23|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20634000|2016
10-14|1.3|2.6|1.9|39|I(e) Unspecified and other specified leukemias|20634000|2016
10-14|28.8|33.7|31.2|644|II Lymphomas and reticuloendothelial neoplasms|20634000|2016
10-14|11.7|14.8|13.2|272|II(a) Hodgkin lymphomas|20634000|2016
10-14|10.6|13.6|12.0|248|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20634000|2016
10-14|1.8|3.2|2.4|50|II(c) Burkitt lymphoma|20634000|2016
10-14|2.5|4.1|3.2|67|II(d) Miscellaneous lymphoreticular neoplasms|20634000|2016
10-14|~|~|~|~|II(e) Unspecified lymphomas|20634000|2016
10-14|26.1|30.7|28.4|585|III CNS and misc intracranial and intraspinal neoplasms|20634000|2016
10-14|1.3|2.5|1.8|38|III(a) Ependymomas and choroid plexus tumor|20634000|2016
10-14|13.3|16.6|14.9|307|III(b) Astrocytomas|20634000|2016
10-14|3.6|5.4|4.4|91|III(c) Intracranial and intraspinal embryonal tumors|20634000|2016
10-14|5.1|7.3|6.1|126|III(d) Other gliomas|20634000|2016
10-14|0.5|1.3|0.8|17|III(e) Other specified intracranial & intraspinal neoplasms|20634000|2016
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20634000|2016
10-14|1.1|2.2|1.6|33|IV Neuroblastoma and other peripheral nervous cell tumors|20634000|2016
10-14|0.9|2.0|1.4|28|IV(a) Neuroblastoma and ganglioneuroblastoma|20634000|2016
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20634000|2016
10-14|10.6|13.7|12.1|249|IX Soft tissue and other extraosseous sarcomas|20634000|2016
10-14|3.7|5.6|4.6|95|IX(a) Rhabdomyosarcomas|20634000|2016
10-14|0.7|1.6|1.1|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20634000|2016
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20634000|2016
10-14|3.9|5.9|4.8|100|IX(d) Other specified soft tissue sarcomas|20634000|2016
10-14|1.1|2.2|1.6|32|IX(e) Unspecified soft tissue sarcomas|20634000|2016
10-14|~|~|~|~|Not classified by ICCC|20634000|2016
10-14|~|~|~|~|V Retinoblastoma|20634000|2016
10-14|1.4|2.6|1.9|40|VI Renal tumors|20634000|2016
10-14|0.6|1.4|0.9|19|VI(a) Nephroblastoma and other nonepithelial renal tumors|20634000|2016
10-14|0.6|1.6|1.0|21|VI(b) Renal carcinomas|20634000|2016
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20634000|2016
10-14|0.5|1.3|0.8|17|VII Hepatic tumors|20634000|2016
10-14|~|~|~|~|VII(a) Hepatoblastoma|20634000|2016
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20634000|2016
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20634000|2016
10-14|13.9|17.3|15.5|320|VIII Malignant bone tumors|20634000|2016
10-14|7.8|10.4|9.0|186|VIII(a) Osteosarcomas|20634000|2016
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20634000|2016
10-14|4.0|5.9|4.9|101|VIII(c) Ewing tumor and related sarcomas of bone|20634000|2016
10-14|0.6|1.4|0.9|19|VIII(d) Other specified malignant bone tumors|20634000|2016
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20634000|2016
10-14|6.7|9.2|7.9|163|X Germ cell, trophoblastic tumors & neoplasms of gonads|20634000|2016
10-14|2.5|4.1|3.2|67|X(a) Intracranial & intraspinal germ cell tumors|20634000|2016
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20634000|2016
10-14|2.9|4.6|3.7|76|X(c) Malignant gonadal germ cell tumors|20634000|2016
10-14|~|~|~|~|X(d) Gonadal carcinomas|20634000|2016
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20634000|2016
10-14|19.7|23.8|21.7|447|XI Other malignant epithelial neoplasms and malignant melanomas|20634000|2016
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20634000|2016
10-14|7.2|9.7|8.4|173|XI(b) Thyroid carcinomas|20634000|2016
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20634000|2016
10-14|2.1|3.6|2.8|58|XI(d) Malignant melanomas|20634000|2016
10-14|~|~|~|~|XI(e) Skin carcinomas|20634000|2016
10-14|8.5|11.2|9.8|202|XI(f) Other and unspecified carcinomas|20634000|2016
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20634000|2016
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20634000|2016
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20634000|2016
15-19|239.7|253.1|246.4|5208|All ICCC Groups Combined|21140143|2016
15-19|33.6|38.7|36.1|763|I Leukemias, myeloproliferative & myelodysplastic diseases|21140143|2016
15-19|16.8|20.5|18.5|392|I(a) Lymphoid leukemias|21140143|2016
15-19|8.3|11.0|9.6|203|I(b) Acute myeloid leukemias|21140143|2016
15-19|4.1|6.1|5.1|107|I(c) Chronic myeloproliferative diseases|21140143|2016
15-19|1.0|2.1|1.5|31|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21140143|2016
15-19|1.0|2.0|1.4|30|I(e) Unspecified and other specified leukemias|21140143|2016
15-19|51.3|57.7|54.4|1151|II Lymphomas and reticuloendothelial neoplasms|21140143|2016
15-19|30.2|35.1|32.5|688|II(a) Hodgkin lymphomas|21140143|2016
15-19|14.7|18.2|16.4|346|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21140143|2016
15-19|2.0|3.5|2.7|57|II(c) Burkitt lymphoma|21140143|2016
15-19|1.3|2.5|1.8|39|II(d) Miscellaneous lymphoreticular neoplasms|21140143|2016
15-19|0.6|1.5|1.0|21|II(e) Unspecified lymphomas|21140143|2016
15-19|18.6|22.6|20.5|434|III CNS and misc intracranial and intraspinal neoplasms|21140143|2016
15-19|1.0|2.1|1.5|31|III(a) Ependymomas and choroid plexus tumor|21140143|2016
15-19|9.8|12.7|11.2|237|III(b) Astrocytomas|21140143|2016
15-19|1.5|2.7|2.0|43|III(c) Intracranial and intraspinal embryonal tumors|21140143|2016
15-19|3.6|5.4|4.4|93|III(d) Other gliomas|21140143|2016
15-19|0.7|1.6|1.0|22|III(e) Other specified intracranial & intraspinal neoplasms|21140143|2016
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21140143|2016
15-19|~|~|~|~|IV Neuroblastoma and other peripheral nervous cell tumors|21140143|2016
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21140143|2016
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21140143|2016
15-19|14.9|18.4|16.6|350|IX Soft tissue and other extraosseous sarcomas|21140143|2016
15-19|2.8|4.5|3.6|76|IX(a) Rhabdomyosarcomas|21140143|2016
15-19|1.0|2.1|1.5|31|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21140143|2016
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21140143|2016
15-19|7.4|10.0|8.7|183|IX(d) Other specified soft tissue sarcomas|21140143|2016
15-19|2.1|3.6|2.8|59|IX(e) Unspecified soft tissue sarcomas|21140143|2016
15-19|~|~|~|~|Not classified by ICCC|21140143|2016
15-19|~|~|~|~|V Retinoblastoma|21140143|2016
15-19|1.4|2.7|2.0|42|VI Renal tumors|21140143|2016
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21140143|2016
15-19|1.3|2.5|1.8|38|VI(b) Renal carcinomas|21140143|2016
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21140143|2016
15-19|0.7|1.6|1.1|23|VII Hepatic tumors|21140143|2016
15-19|~|~|~|~|VII(a) Hepatoblastoma|21140143|2016
15-19|0.7|1.6|1.0|22|VII(b) Hepatic carcinomas|21140143|2016
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21140143|2016
15-19|13.7|17.0|15.3|323|VIII Malignant bone tumors|21140143|2016
15-19|6.9|9.3|8.0|170|VIII(a) Osteosarcomas|21140143|2016
15-19|~|~|~|~|VIII(b) Chondrosarcomas|21140143|2016
15-19|4.3|6.3|5.2|110|VIII(c) Ewing tumor and related sarcomas of bone|21140143|2016
15-19|0.7|1.7|1.1|24|VIII(d) Other specified malignant bone tumors|21140143|2016
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21140143|2016
15-19|25.5|30.0|27.7|585|X Germ cell, trophoblastic tumors & neoplasms of gonads|21140143|2016
15-19|1.9|3.3|2.6|54|X(a) Intracranial & intraspinal germ cell tumors|21140143|2016
15-19|0.9|2.0|1.4|29|X(b) Malignant extracranial & extragonadal germ cell tumors|21140143|2016
15-19|19.3|23.2|21.2|448|X(c) Malignant gonadal germ cell tumors|21140143|2016
15-19|1.1|2.2|1.6|33|X(d) Gonadal carcinomas|21140143|2016
15-19|0.6|1.5|1.0|21|X(e) Other and unspecified malignant gonadal tumors|21140143|2016
15-19|66.4|73.6|69.9|1478|XI Other malignant epithelial neoplasms and malignant melanomas|21140143|2016
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21140143|2016
15-19|32.0|37.0|34.4|728|XI(b) Thyroid carcinomas|21140143|2016
15-19|0.4|1.2|0.8|16|XI(c) Nasopharyngeal carcinomas|21140143|2016
15-19|8.5|11.3|9.8|208|XI(d) Malignant melanomas|21140143|2016
15-19|~|~|~|~|XI(e) Skin carcinomas|21140143|2016
15-19|22.2|26.5|24.3|513|XI(f) Other and unspecified carcinomas|21140143|2016
15-19|1.2|2.4|1.8|37|XII Other and unspecified malignant neoplasms|21140143|2016
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21140143|2016
15-19|0.7|1.6|1.1|23|XII(b) Other unspecified malignant tumors|21140143|2016
5-9|131.9|142.1|136.9|2800|All ICCC Groups Combined|20450557|2016
5-9|42.3|48.2|45.2|924|I Leukemias, myeloproliferative & myelodysplastic diseases|20450557|2016
5-9|34.1|39.4|36.7|750|I(a) Lymphoid leukemias|20450557|2016
5-9|3.4|5.2|4.2|86|I(b) Acute myeloid leukemias|20450557|2016
5-9|1.2|2.3|1.7|34|I(c) Chronic myeloproliferative diseases|20450557|2016
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20450557|2016
5-9|1.4|2.6|1.9|39|I(e) Unspecified and other specified leukemias|20450557|2016
5-9|17.5|21.4|19.4|396|II Lymphomas and reticuloendothelial neoplasms|20450557|2016
5-9|2.6|4.2|3.3|68|II(a) Hodgkin lymphomas|20450557|2016
5-9|7.3|9.9|8.5|174|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20450557|2016
5-9|2.2|3.7|2.9|59|II(c) Burkitt lymphoma|20450557|2016
5-9|3.7|5.6|4.5|93|II(d) Miscellaneous lymphoreticular neoplasms|20450557|2016
5-9|~|~|~|~|II(e) Unspecified lymphomas|20450557|2016
5-9|32.4|37.6|34.9|714|III CNS and misc intracranial and intraspinal neoplasms|20450557|2016
5-9|1.1|2.2|1.6|32|III(a) Ependymomas and choroid plexus tumor|20450557|2016
5-9|15.0|18.5|16.7|341|III(b) Astrocytomas|20450557|2016
5-9|5.5|7.8|6.6|134|III(c) Intracranial and intraspinal embryonal tumors|20450557|2016
5-9|7.6|10.2|8.9|181|III(d) Other gliomas|20450557|2016
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20450557|2016
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20450557|2016
5-9|4.3|6.4|5.3|108|IV Neuroblastoma and other peripheral nervous cell tumors|20450557|2016
5-9|4.2|6.3|5.2|106|IV(a) Neuroblastoma and ganglioneuroblastoma|20450557|2016
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20450557|2016
5-9|6.9|9.5|8.1|166|IX Soft tissue and other extraosseous sarcomas|20450557|2016
5-9|3.8|5.7|4.6|95|IX(a) Rhabdomyosarcomas|20450557|2016
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20450557|2016
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20450557|2016
5-9|1.5|2.8|2.1|42|IX(d) Other specified soft tissue sarcomas|20450557|2016
5-9|0.6|1.6|1.0|21|IX(e) Unspecified soft tissue sarcomas|20450557|2016
5-9|~|~|~|~|Not classified by ICCC|20450557|2016
5-9|~|~|~|~|V Retinoblastoma|20450557|2016
5-9|5.8|8.1|6.9|141|VI Renal tumors|20450557|2016
5-9|5.4|7.7|6.5|133|VI(a) Nephroblastoma and other nonepithelial renal tumors|20450557|2016
5-9|~|~|~|~|VI(b) Renal carcinomas|20450557|2016
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20450557|2016
5-9|0.7|1.6|1.1|22|VII Hepatic tumors|20450557|2016
5-9|0.6|1.5|0.9|19|VII(a) Hepatoblastoma|20450557|2016
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20450557|2016
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20450557|2016
5-9|5.8|8.1|6.8|140|VIII Malignant bone tumors|20450557|2016
5-9|2.9|4.6|3.7|75|VIII(a) Osteosarcomas|20450557|2016
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20450557|2016
5-9|2.0|3.4|2.6|54|VIII(c) Ewing tumor and related sarcomas of bone|20450557|2016
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20450557|2016
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20450557|2016
5-9|2.1|3.6|2.8|57|X Germ cell, trophoblastic tumors & neoplasms of gonads|20450557|2016
5-9|0.6|1.6|1.0|21|X(a) Intracranial & intraspinal germ cell tumors|20450557|2016
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20450557|2016
5-9|0.9|2.0|1.4|29|X(c) Malignant gonadal germ cell tumors|20450557|2016
5-9|~|~|~|~|X(d) Gonadal carcinomas|20450557|2016
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20450557|2016
5-9|4.3|6.3|5.2|107|XI Other malignant epithelial neoplasms and malignant melanomas|20450557|2016
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20450557|2016
5-9|1.0|2.2|1.5|31|XI(b) Thyroid carcinomas|20450557|2016
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20450557|2016
5-9|1.0|2.1|1.5|30|XI(d) Malignant melanomas|20450557|2016
5-9|~|~|~|~|XI(e) Skin carcinomas|20450557|2016
5-9|1.5|2.8|2.1|42|XI(f) Other and unspecified carcinomas|20450557|2016
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20450557|2016
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20450557|2016
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20450557|2016
<1|262.1|295.2|278.3|1103|All ICCC Groups Combined|3963268|2016
<1|45.6|60.1|52.5|208|I Leukemias, myeloproliferative & myelodysplastic diseases|3963268|2016
<1|15.3|24.3|19.4|77|I(a) Lymphoid leukemias|3963268|2016
<1|12.4|20.6|16.1|64|I(b) Acute myeloid leukemias|3963268|2016
<1|4.7|10.2|7.1|28|I(c) Chronic myeloproliferative diseases|3963268|2016
<1|4.5|9.9|6.8|27|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3963268|2016
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3963268|2016
<1|16.9|26.2|21.2|84|II Lymphomas and reticuloendothelial neoplasms|3963268|2016
<1|~|~|~|~|II(a) Hodgkin lymphomas|3963268|2016
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3963268|2016
<1|~|~|~|~|II(c) Burkitt lymphoma|3963268|2016
<1|13.8|22.3|17.7|70|II(d) Miscellaneous lymphoreticular neoplasms|3963268|2016
<1|~|~|~|~|II(e) Unspecified lymphomas|3963268|2016
<1|30.9|43.0|36.6|145|III CNS and misc intracranial and intraspinal neoplasms|3963268|2016
<1|3.3|8.1|5.3|21|III(a) Ependymomas and choroid plexus tumor|3963268|2016
<1|10.9|18.6|14.4|57|III(b) Astrocytomas|3963268|2016
<1|7.6|14.3|10.6|42|III(c) Intracranial and intraspinal embryonal tumors|3963268|2016
<1|~|~|~|~|III(d) Other gliomas|3963268|2016
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3963268|2016
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3963268|2016
<1|52.4|67.9|59.8|237|IV Neuroblastoma and other peripheral nervous cell tumors|3963268|2016
<1|52.4|67.9|59.8|237|IV(a) Neuroblastoma and ganglioneuroblastoma|3963268|2016
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3963268|2016
<1|16.0|25.1|20.2|80|IX Soft tissue and other extraosseous sarcomas|3963268|2016
<1|4.5|9.9|6.8|27|IX(a) Rhabdomyosarcomas|3963268|2016
<1|3.1|7.8|5.0|20|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3963268|2016
<1|~|~|~|~|IX(c) Kaposi sarcoma|3963268|2016
<1|4.9|10.5|7.3|29|IX(d) Other specified soft tissue sarcomas|3963268|2016
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3963268|2016
<1|~|~|~|~|Not classified by ICCC|3963268|2016
<1|26.0|37.3|31.3|124|V Retinoblastoma|3963268|2016
<1|11.8|19.8|15.4|61|VI Renal tumors|3963268|2016
<1|11.6|19.5|15.1|60|VI(a) Nephroblastoma and other nonepithelial renal tumors|3963268|2016
<1|~|~|~|~|VI(b) Renal carcinomas|3963268|2016
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3963268|2016
<1|12.4|20.6|16.1|64|VII Hepatic tumors|3963268|2016
<1|12.4|20.6|16.1|64|VII(a) Hepatoblastoma|3963268|2016
<1|~|~|~|~|VII(b) Hepatic carcinomas|3963268|2016
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3963268|2016
<1|~|~|~|~|VIII Malignant bone tumors|3963268|2016
<1|~|~|~|~|VIII(a) Osteosarcomas|3963268|2016
<1|~|~|~|~|VIII(b) Chondrosarcomas|3963268|2016
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3963268|2016
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3963268|2016
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3963268|2016
<1|13.5|22.0|17.4|69|X Germ cell, trophoblastic tumors & neoplasms of gonads|3963268|2016
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3963268|2016
<1|8.1|14.9|11.1|44|X(b) Malignant extracranial & extragonadal germ cell tumors|3963268|2016
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3963268|2016
<1|~|~|~|~|X(d) Gonadal carcinomas|3963268|2016
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3963268|2016
<1|2.7|7.2|4.5|18|XI Other malignant epithelial neoplasms and malignant melanomas|3963268|2016
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3963268|2016
<1|~|~|~|~|XI(b) Thyroid carcinomas|3963268|2016
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3963268|2016
<1|~|~|~|~|XI(d) Malignant melanomas|3963268|2016
<1|~|~|~|~|XI(e) Skin carcinomas|3963268|2016
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3963268|2016
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3963268|2016
<1|~|~|~|~|XII(a) Other specified malignant tumors|3963268|2016
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3963268|2016
1-4|216.8|223.5|220.1|16922|All ICCC Groups Combined|76880096|2016-2020
1-4|87.4|91.7|89.5|6883|I Leukemias, myeloproliferative & myelodysplastic diseases|76880096|2016-2020
1-4|72.5|76.4|74.4|5722|I(a) Lymphoid leukemias|76880096|2016-2020
1-4|9.2|10.6|9.8|757|I(b) Acute myeloid leukemias|76880096|2016-2020
1-4|0.7|1.2|0.9|70|I(c) Chronic myeloproliferative diseases|76880096|2016-2020
1-4|1.2|1.8|1.5|114|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|76880096|2016-2020
1-4|2.5|3.3|2.9|220|I(e) Unspecified and other specified leukemias|76880096|2016-2020
1-4|14.4|16.2|15.3|1174|II Lymphomas and reticuloendothelial neoplasms|76880096|2016-2020
1-4|0.6|1.1|0.8|64|II(a) Hodgkin lymphomas|76880096|2016-2020
1-4|4.3|5.3|4.8|371|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|76880096|2016-2020
1-4|1.8|2.4|2.1|159|II(c) Burkitt lymphoma|76880096|2016-2020
1-4|6.8|8.1|7.4|572|II(d) Miscellaneous lymphoreticular neoplasms|76880096|2016-2020
1-4|~|~|~|~|II(e) Unspecified lymphomas|76880096|2016-2020
1-4|37.4|40.2|38.8|2983|III CNS and misc intracranial and intraspinal neoplasms|76880096|2016-2020
1-4|4.8|5.9|5.3|411|III(a) Ependymomas and choroid plexus tumor|76880096|2016-2020
1-4|18.2|20.2|19.2|1476|III(b) Astrocytomas|76880096|2016-2020
1-4|7.3|8.6|7.9|608|III(c) Intracranial and intraspinal embryonal tumors|76880096|2016-2020
1-4|4.5|5.5|5.0|384|III(d) Other gliomas|76880096|2016-2020
1-4|0.6|1.0|0.8|60|III(e) Other specified intracranial & intraspinal neoplasms|76880096|2016-2020
1-4|0.4|0.8|0.6|44|III(f) Unspecified intracranial and intraspinal neoplasms|76880096|2016-2020
1-4|20.7|22.8|21.7|1669|IV Neuroblastoma and other peripheral nervous cell tumors|76880096|2016-2020
1-4|20.6|22.7|21.6|1663|IV(a) Neuroblastoma and ganglioneuroblastoma|76880096|2016-2020
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|76880096|2016-2020
1-4|10.4|11.9|11.1|855|IX Soft tissue and other extraosseous sarcomas|76880096|2016-2020
1-4|7.0|8.3|7.6|588|IX(a) Rhabdomyosarcomas|76880096|2016-2020
1-4|0.3|0.6|0.5|35|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|76880096|2016-2020
1-4|~|~|~|~|IX(c) Kaposi sarcoma|76880096|2016-2020
1-4|2.0|2.6|2.3|175|IX(d) Other specified soft tissue sarcomas|76880096|2016-2020
1-4|0.6|0.9|0.7|56|IX(e) Unspecified soft tissue sarcomas|76880096|2016-2020
1-4|2.5|3.3|2.9|223|Not classified by ICCC|76880096|2016-2020
1-4|7.2|8.5|7.8|602|V Retinoblastoma|76880096|2016-2020
1-4|17.8|19.8|18.8|1445|VI Renal tumors|76880096|2016-2020
1-4|17.7|19.6|18.6|1433|VI(a) Nephroblastoma and other nonepithelial renal tumors|76880096|2016-2020
1-4|~|~|~|~|VI(b) Renal carcinomas|76880096|2016-2020
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|76880096|2016-2020
1-4|5.5|6.6|6.1|466|VII Hepatic tumors|76880096|2016-2020
1-4|5.3|6.3|5.8|444|VII(a) Hepatoblastoma|76880096|2016-2020
1-4|0.1|0.4|0.2|18|VII(b) Hepatic carcinomas|76880096|2016-2020
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|76880096|2016-2020
1-4|1.3|1.9|1.6|123|VIII Malignant bone tumors|76880096|2016-2020
1-4|0.2|0.4|0.3|23|VIII(a) Osteosarcomas|76880096|2016-2020
1-4|~|~|~|~|VIII(b) Chondrosarcomas|76880096|2016-2020
1-4|0.8|1.2|1.0|76|VIII(c) Ewing tumor and related sarcomas of bone|76880096|2016-2020
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|76880096|2016-2020
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|76880096|2016-2020
1-4|3.1|4.0|3.5|272|X Germ cell, trophoblastic tumors & neoplasms of gonads|76880096|2016-2020
1-4|0.2|0.5|0.4|28|X(a) Intracranial & intraspinal germ cell tumors|76880096|2016-2020
1-4|1.2|1.8|1.5|115|X(b) Malignant extracranial & extragonadal germ cell tumors|76880096|2016-2020
1-4|1.3|1.9|1.6|120|X(c) Malignant gonadal germ cell tumors|76880096|2016-2020
1-4|~|~|~|~|X(d) Gonadal carcinomas|76880096|2016-2020
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|76880096|2016-2020
1-4|1.5|2.1|1.8|135|XI Other malignant epithelial neoplasms and malignant melanomas|76880096|2016-2020
1-4|0.2|0.5|0.4|27|XI(a) Adrenocortical carcinomas|76880096|2016-2020
1-4|0.2|0.4|0.3|20|XI(b) Thyroid carcinomas|76880096|2016-2020
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|76880096|2016-2020
1-4|0.8|1.2|1.0|74|XI(d) Malignant melanomas|76880096|2016-2020
1-4|~|~|~|~|XI(e) Skin carcinomas|76880096|2016-2020
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|76880096|2016-2020
1-4|1.0|1.5|1.2|92|XII Other and unspecified malignant neoplasms|76880096|2016-2020
1-4|0.7|1.1|0.9|68|XII(a) Other specified malignant tumors|76880096|2016-2020
1-4|0.2|0.5|0.3|24|XII(b) Other unspecified malignant tumors|76880096|2016-2020
10-14|152.4|157.3|154.8|15585|All ICCC Groups Combined|100666137|2016-2020
10-14|34.5|36.9|35.7|3592|I Leukemias, myeloproliferative & myelodysplastic diseases|100666137|2016-2020
10-14|22.8|24.7|23.8|2391|I(a) Lymphoid leukemias|100666137|2016-2020
10-14|6.9|8.0|7.4|749|I(b) Acute myeloid leukemias|100666137|2016-2020
10-14|1.7|2.3|2.0|202|I(c) Chronic myeloproliferative diseases|100666137|2016-2020
10-14|0.6|1.0|0.8|81|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|100666137|2016-2020
10-14|1.4|2.0|1.7|169|I(e) Unspecified and other specified leukemias|100666137|2016-2020
10-14|28.7|30.8|29.7|2992|II Lymphomas and reticuloendothelial neoplasms|100666137|2016-2020
10-14|11.9|13.2|12.5|1262|II(a) Hodgkin lymphomas|100666137|2016-2020
10-14|10.3|11.6|10.9|1097|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|100666137|2016-2020
10-14|2.3|3.0|2.7|267|II(c) Burkitt lymphoma|100666137|2016-2020
10-14|3.0|3.7|3.3|337|II(d) Miscellaneous lymphoreticular neoplasms|100666137|2016-2020
10-14|0.2|0.4|0.3|29|II(e) Unspecified lymphomas|100666137|2016-2020
10-14|25.1|27.1|26.1|2630|III CNS and misc intracranial and intraspinal neoplasms|100666137|2016-2020
10-14|1.4|1.9|1.6|163|III(a) Ependymomas and choroid plexus tumor|100666137|2016-2020
10-14|13.8|15.3|14.5|1464|III(b) Astrocytomas|100666137|2016-2020
10-14|2.9|3.6|3.2|326|III(c) Intracranial and intraspinal embryonal tumors|100666137|2016-2020
10-14|5.2|6.2|5.7|574|III(d) Other gliomas|100666137|2016-2020
10-14|0.4|0.7|0.6|56|III(e) Other specified intracranial & intraspinal neoplasms|100666137|2016-2020
10-14|0.3|0.6|0.5|47|III(f) Unspecified intracranial and intraspinal neoplasms|100666137|2016-2020
10-14|1.2|1.6|1.4|138|IV Neuroblastoma and other peripheral nervous cell tumors|100666137|2016-2020
10-14|0.9|1.4|1.1|115|IV(a) Neuroblastoma and ganglioneuroblastoma|100666137|2016-2020
10-14|0.1|0.3|0.2|23|IV(b) Other peripheral nervous cell tumors|100666137|2016-2020
10-14|11.4|12.8|12.1|1216|IX Soft tissue and other extraosseous sarcomas|100666137|2016-2020
10-14|3.5|4.2|3.8|387|IX(a) Rhabdomyosarcomas|100666137|2016-2020
10-14|0.8|1.2|1.0|103|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|100666137|2016-2020
10-14|~|~|~|~|IX(c) Kaposi sarcoma|100666137|2016-2020
10-14|5.0|5.9|5.4|544|IX(d) Other specified soft tissue sarcomas|100666137|2016-2020
10-14|1.5|2.1|1.8|180|IX(e) Unspecified soft tissue sarcomas|100666137|2016-2020
10-14|1.6|2.2|1.9|189|Not classified by ICCC|100666137|2016-2020
10-14|~|~|~|~|V Retinoblastoma|100666137|2016-2020
10-14|1.5|2.0|1.8|178|VI Renal tumors|100666137|2016-2020
10-14|0.7|1.1|0.9|92|VI(a) Nephroblastoma and other nonepithelial renal tumors|100666137|2016-2020
10-14|0.6|1.0|0.8|82|VI(b) Renal carcinomas|100666137|2016-2020
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|100666137|2016-2020
10-14|0.6|0.9|0.8|76|VII Hepatic tumors|100666137|2016-2020
10-14|~|~|~|~|VII(a) Hepatoblastoma|100666137|2016-2020
10-14|0.4|0.8|0.6|59|VII(b) Hepatic carcinomas|100666137|2016-2020
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|100666137|2016-2020
10-14|14.0|15.5|14.7|1481|VIII Malignant bone tumors|100666137|2016-2020
10-14|8.5|9.7|9.1|914|VIII(a) Osteosarcomas|100666137|2016-2020
10-14|0.3|0.5|0.4|39|VIII(b) Chondrosarcomas|100666137|2016-2020
10-14|3.9|4.8|4.3|437|VIII(c) Ewing tumor and related sarcomas of bone|100666137|2016-2020
10-14|0.5|0.8|0.6|62|VIII(d) Other specified malignant bone tumors|100666137|2016-2020
10-14|0.2|0.4|0.3|29|VIII(e) Unspecified malignant bone tumors|100666137|2016-2020
10-14|7.5|8.7|8.1|814|X Germ cell, trophoblastic tumors & neoplasms of gonads|100666137|2016-2020
10-14|2.5|3.2|2.8|285|X(a) Intracranial & intraspinal germ cell tumors|100666137|2016-2020
10-14|0.2|0.5|0.3|34|X(b) Malignant extracranial & extragonadal germ cell tumors|100666137|2016-2020
10-14|3.8|4.7|4.2|427|X(c) Malignant gonadal germ cell tumors|100666137|2016-2020
10-14|0.2|0.4|0.3|27|X(d) Gonadal carcinomas|100666137|2016-2020
10-14|0.3|0.6|0.4|41|X(e) Other and unspecified malignant gonadal tumors|100666137|2016-2020
10-14|21.2|23.0|22.1|2225|XI Other malignant epithelial neoplasms and malignant melanomas|100666137|2016-2020
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|100666137|2016-2020
10-14|8.2|9.4|8.8|887|XI(b) Thyroid carcinomas|100666137|2016-2020
10-14|0.4|0.6|0.5|48|XI(c) Nasopharyngeal carcinomas|100666137|2016-2020
10-14|2.2|2.8|2.5|247|XI(d) Malignant melanomas|100666137|2016-2020
10-14|~|~|~|~|XI(e) Skin carcinomas|100666137|2016-2020
10-14|9.5|10.7|10.1|1016|XI(f) Other and unspecified carcinomas|100666137|2016-2020
10-14|0.3|0.6|0.4|44|XII Other and unspecified malignant neoplasms|100666137|2016-2020
10-14|0.1|0.3|0.2|16|XII(a) Other specified malignant tumors|100666137|2016-2020
10-14|0.2|0.4|0.3|28|XII(b) Other unspecified malignant tumors|100666137|2016-2020
15-19|237.2|243.2|240.2|24536|All ICCC Groups Combined|102161808|2016-2020
15-19|34.1|36.4|35.2|3601|I Leukemias, myeloproliferative & myelodysplastic diseases|102161808|2016-2020
15-19|17.6|19.3|18.4|1882|I(a) Lymphoid leukemias|102161808|2016-2020
15-19|8.3|9.4|8.8|901|I(b) Acute myeloid leukemias|102161808|2016-2020
15-19|4.8|5.7|5.3|538|I(c) Chronic myeloproliferative diseases|102161808|2016-2020
15-19|0.9|1.3|1.1|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|102161808|2016-2020
15-19|1.4|1.9|1.6|167|I(e) Unspecified and other specified leukemias|102161808|2016-2020
15-19|51.0|53.8|52.4|5356|II Lymphomas and reticuloendothelial neoplasms|102161808|2016-2020
15-19|30.6|32.8|31.7|3241|II(a) Hodgkin lymphomas|102161808|2016-2020
15-19|15.4|16.9|16.1|1649|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|102161808|2016-2020
15-19|1.9|2.4|2.1|218|II(c) Burkitt lymphoma|102161808|2016-2020
15-19|1.5|2.0|1.7|174|II(d) Miscellaneous lymphoreticular neoplasms|102161808|2016-2020
15-19|0.6|0.9|0.7|74|II(e) Unspecified lymphomas|102161808|2016-2020
15-19|20.0|21.8|20.9|2135|III CNS and misc intracranial and intraspinal neoplasms|102161808|2016-2020
15-19|1.2|1.6|1.4|140|III(a) Ependymomas and choroid plexus tumor|102161808|2016-2020
15-19|11.6|13.0|12.3|1253|III(b) Astrocytomas|102161808|2016-2020
15-19|1.4|1.9|1.7|170|III(c) Intracranial and intraspinal embryonal tumors|102161808|2016-2020
15-19|4.0|4.8|4.4|448|III(d) Other gliomas|102161808|2016-2020
15-19|0.5|0.9|0.7|71|III(e) Other specified intracranial & intraspinal neoplasms|102161808|2016-2020
15-19|0.4|0.7|0.5|53|III(f) Unspecified intracranial and intraspinal neoplasms|102161808|2016-2020
15-19|0.9|1.3|1.1|112|IV Neuroblastoma and other peripheral nervous cell tumors|102161808|2016-2020
15-19|0.5|0.9|0.7|70|IV(a) Neuroblastoma and ganglioneuroblastoma|102161808|2016-2020
15-19|0.3|0.6|0.4|42|IV(b) Other peripheral nervous cell tumors|102161808|2016-2020
15-19|15.6|17.1|16.3|1668|IX Soft tissue and other extraosseous sarcomas|102161808|2016-2020
15-19|3.4|4.2|3.8|390|IX(a) Rhabdomyosarcomas|102161808|2016-2020
15-19|1.3|1.8|1.6|160|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|102161808|2016-2020
15-19|~|~|~|~|IX(c) Kaposi sarcoma|102161808|2016-2020
15-19|7.8|8.9|8.4|854|IX(d) Other specified soft tissue sarcomas|102161808|2016-2020
15-19|2.2|2.8|2.5|251|IX(e) Unspecified soft tissue sarcomas|102161808|2016-2020
15-19|1.4|1.9|1.6|168|Not classified by ICCC|102161808|2016-2020
15-19|~|~|~|~|V Retinoblastoma|102161808|2016-2020
15-19|1.8|2.3|2.0|209|VI Renal tumors|102161808|2016-2020
15-19|0.2|0.4|0.3|31|VI(a) Nephroblastoma and other nonepithelial renal tumors|102161808|2016-2020
15-19|1.5|2.0|1.7|175|VI(b) Renal carcinomas|102161808|2016-2020
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|102161808|2016-2020
15-19|1.2|1.6|1.4|142|VII Hepatic tumors|102161808|2016-2020
15-19|~|~|~|~|VII(a) Hepatoblastoma|102161808|2016-2020
15-19|1.1|1.6|1.3|135|VII(b) Hepatic carcinomas|102161808|2016-2020
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|102161808|2016-2020
15-19|14.1|15.6|14.9|1518|VIII Malignant bone tumors|102161808|2016-2020
15-19|7.6|8.7|8.2|833|VIII(a) Osteosarcomas|102161808|2016-2020
15-19|0.7|1.0|0.8|85|VIII(b) Chondrosarcomas|102161808|2016-2020
15-19|4.1|5.0|4.5|463|VIII(c) Ewing tumor and related sarcomas of bone|102161808|2016-2020
15-19|0.7|1.1|0.9|93|VIII(d) Other specified malignant bone tumors|102161808|2016-2020
15-19|0.3|0.6|0.4|44|VIII(e) Unspecified malignant bone tumors|102161808|2016-2020
15-19|25.6|27.6|26.6|2720|X Germ cell, trophoblastic tumors & neoplasms of gonads|102161808|2016-2020
15-19|2.4|3.0|2.7|273|X(a) Intracranial & intraspinal germ cell tumors|102161808|2016-2020
15-19|1.1|1.6|1.3|134|X(b) Malignant extracranial & extragonadal germ cell tumors|102161808|2016-2020
15-19|19.5|21.3|20.4|2082|X(c) Malignant gonadal germ cell tumors|102161808|2016-2020
15-19|1.1|1.5|1.3|132|X(d) Gonadal carcinomas|102161808|2016-2020
15-19|0.8|1.2|1.0|99|X(e) Other and unspecified malignant gonadal tumors|102161808|2016-2020
15-19|64.7|67.9|66.3|6772|XI Other malignant epithelial neoplasms and malignant melanomas|102161808|2016-2020
15-19|0.2|0.4|0.3|30|XI(a) Adrenocortical carcinomas|102161808|2016-2020
15-19|32.1|34.3|33.2|3388|XI(b) Thyroid carcinomas|102161808|2016-2020
15-19|0.9|1.3|1.1|110|XI(c) Nasopharyngeal carcinomas|102161808|2016-2020
15-19|7.6|8.7|8.2|834|XI(d) Malignant melanomas|102161808|2016-2020
15-19|0.2|0.4|0.3|26|XI(e) Skin carcinomas|102161808|2016-2020
15-19|22.4|24.3|23.3|2384|XI(f) Other and unspecified carcinomas|102161808|2016-2020
15-19|1.1|1.5|1.3|133|XII Other and unspecified malignant neoplasms|102161808|2016-2020
15-19|0.4|0.7|0.6|57|XII(a) Other specified malignant tumors|102161808|2016-2020
15-19|0.6|0.9|0.7|76|XII(b) Other unspecified malignant tumors|102161808|2016-2020
5-9|127.4|131.9|129.7|12748|All ICCC Groups Combined|98323876|2016-2020
5-9|42.1|44.8|43.4|4271|I Leukemias, myeloproliferative & myelodysplastic diseases|98323876|2016-2020
5-9|34.4|36.8|35.6|3500|I(a) Lymphoid leukemias|98323876|2016-2020
5-9|3.9|4.8|4.3|427|I(b) Acute myeloid leukemias|98323876|2016-2020
5-9|0.8|1.2|1.0|99|I(c) Chronic myeloproliferative diseases|98323876|2016-2020
5-9|0.5|0.9|0.7|67|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|98323876|2016-2020
5-9|1.6|2.1|1.8|178|I(e) Unspecified and other specified leukemias|98323876|2016-2020
5-9|17.6|19.3|18.4|1809|II Lymphomas and reticuloendothelial neoplasms|98323876|2016-2020
5-9|3.3|4.1|3.7|362|II(a) Hodgkin lymphomas|98323876|2016-2020
5-9|7.0|8.1|7.5|741|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|98323876|2016-2020
5-9|2.6|3.3|2.9|285|II(c) Burkitt lymphoma|98323876|2016-2020
5-9|3.8|4.6|4.2|412|II(d) Miscellaneous lymphoreticular neoplasms|98323876|2016-2020
5-9|~|~|~|~|II(e) Unspecified lymphomas|98323876|2016-2020
5-9|29.5|31.7|30.6|3006|III CNS and misc intracranial and intraspinal neoplasms|98323876|2016-2020
5-9|1.6|2.2|1.9|186|III(a) Ependymomas and choroid plexus tumor|98323876|2016-2020
5-9|14.8|16.3|15.5|1527|III(b) Astrocytomas|98323876|2016-2020
5-9|5.2|6.1|5.6|555|III(c) Intracranial and intraspinal embryonal tumors|98323876|2016-2020
5-9|5.9|7.0|6.4|633|III(d) Other gliomas|98323876|2016-2020
5-9|0.5|0.8|0.6|60|III(e) Other specified intracranial & intraspinal neoplasms|98323876|2016-2020
5-9|0.3|0.6|0.5|45|III(f) Unspecified intracranial and intraspinal neoplasms|98323876|2016-2020
5-9|4.0|4.8|4.4|431|IV Neuroblastoma and other peripheral nervous cell tumors|98323876|2016-2020
5-9|3.9|4.7|4.3|420|IV(a) Neuroblastoma and ganglioneuroblastoma|98323876|2016-2020
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|98323876|2016-2020
5-9|7.9|9.1|8.5|837|IX Soft tissue and other extraosseous sarcomas|98323876|2016-2020
5-9|4.1|5.0|4.5|445|IX(a) Rhabdomyosarcomas|98323876|2016-2020
5-9|0.4|0.7|0.5|51|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|98323876|2016-2020
5-9|~|~|~|~|IX(c) Kaposi sarcoma|98323876|2016-2020
5-9|2.1|2.7|2.4|232|IX(d) Other specified soft tissue sarcomas|98323876|2016-2020
5-9|0.9|1.3|1.1|108|IX(e) Unspecified soft tissue sarcomas|98323876|2016-2020
5-9|2.9|3.6|3.2|316|Not classified by ICCC|98323876|2016-2020
5-9|0.2|0.5|0.3|33|V Retinoblastoma|98323876|2016-2020
5-9|5.8|6.8|6.3|615|VI Renal tumors|98323876|2016-2020
5-9|5.4|6.4|5.9|576|VI(a) Nephroblastoma and other nonepithelial renal tumors|98323876|2016-2020
5-9|0.2|0.5|0.4|35|VI(b) Renal carcinomas|98323876|2016-2020
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|98323876|2016-2020
5-9|0.7|1.1|0.9|90|VII Hepatic tumors|98323876|2016-2020
5-9|0.4|0.8|0.6|57|VII(a) Hepatoblastoma|98323876|2016-2020
5-9|0.2|0.4|0.3|30|VII(b) Hepatic carcinomas|98323876|2016-2020
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|98323876|2016-2020
5-9|5.7|6.7|6.1|604|VIII Malignant bone tumors|98323876|2016-2020
5-9|2.9|3.7|3.3|324|VIII(a) Osteosarcomas|98323876|2016-2020
5-9|~|~|~|~|VIII(b) Chondrosarcomas|98323876|2016-2020
5-9|2.0|2.6|2.3|226|VIII(c) Ewing tumor and related sarcomas of bone|98323876|2016-2020
5-9|0.2|0.4|0.3|30|VIII(d) Other specified malignant bone tumors|98323876|2016-2020
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|98323876|2016-2020
5-9|2.2|2.9|2.5|249|X Germ cell, trophoblastic tumors & neoplasms of gonads|98323876|2016-2020
5-9|1.0|1.4|1.2|117|X(a) Intracranial & intraspinal germ cell tumors|98323876|2016-2020
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|98323876|2016-2020
5-9|0.9|1.3|1.1|106|X(c) Malignant gonadal germ cell tumors|98323876|2016-2020
5-9|~|~|~|~|X(d) Gonadal carcinomas|98323876|2016-2020
5-9|0.1|0.3|0.2|17|X(e) Other and unspecified malignant gonadal tumors|98323876|2016-2020
5-9|4.1|4.9|4.5|442|XI Other malignant epithelial neoplasms and malignant melanomas|98323876|2016-2020
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|98323876|2016-2020
5-9|1.2|1.6|1.4|136|XI(b) Thyroid carcinomas|98323876|2016-2020
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|98323876|2016-2020
5-9|0.8|1.2|1.0|97|XI(d) Malignant melanomas|98323876|2016-2020
5-9|~|~|~|~|XI(e) Skin carcinomas|98323876|2016-2020
5-9|1.7|2.2|1.9|190|XI(f) Other and unspecified carcinomas|98323876|2016-2020
5-9|0.3|0.6|0.5|45|XII Other and unspecified malignant neoplasms|98323876|2016-2020
5-9|~|~|~|~|XII(a) Other specified malignant tumors|98323876|2016-2020
5-9|0.2|0.4|0.3|31|XII(b) Other unspecified malignant tumors|98323876|2016-2020
<1|256.7|271.6|264.1|4907|All ICCC Groups Combined|18583091|2016-2020
<1|44.5|50.9|47.6|885|I Leukemias, myeloproliferative & myelodysplastic diseases|18583091|2016-2020
<1|15.7|19.6|17.6|327|I(a) Lymphoid leukemias|18583091|2016-2020
<1|15.1|18.9|17.0|315|I(b) Acute myeloid leukemias|18583091|2016-2020
<1|2.8|4.6|3.6|67|I(c) Chronic myeloproliferative diseases|18583091|2016-2020
<1|5.0|7.3|6.1|113|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|18583091|2016-2020
<1|2.6|4.3|3.4|63|I(e) Unspecified and other specified leukemias|18583091|2016-2020
<1|18.0|22.2|20.0|372|II Lymphomas and reticuloendothelial neoplasms|18583091|2016-2020
<1|~|~|~|~|II(a) Hodgkin lymphomas|18583091|2016-2020
<1|2.1|3.7|2.8|52|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|18583091|2016-2020
<1|~|~|~|~|II(c) Burkitt lymphoma|18583091|2016-2020
<1|15.2|19.0|17.0|316|II(d) Miscellaneous lymphoreticular neoplasms|18583091|2016-2020
<1|~|~|~|~|II(e) Unspecified lymphomas|18583091|2016-2020
<1|28.3|33.4|30.7|571|III CNS and misc intracranial and intraspinal neoplasms|18583091|2016-2020
<1|3.4|5.3|4.3|79|III(a) Ependymomas and choroid plexus tumor|18583091|2016-2020
<1|9.6|12.7|11.1|206|III(b) Astrocytomas|18583091|2016-2020
<1|8.3|11.2|9.7|180|III(c) Intracranial and intraspinal embryonal tumors|18583091|2016-2020
<1|2.2|3.9|3.0|55|III(d) Other gliomas|18583091|2016-2020
<1|0.5|1.5|0.9|17|III(e) Other specified intracranial & intraspinal neoplasms|18583091|2016-2020
<1|1.3|2.6|1.8|34|III(f) Unspecified intracranial and intraspinal neoplasms|18583091|2016-2020
<1|56.6|63.7|60.1|1117|IV Neuroblastoma and other peripheral nervous cell tumors|18583091|2016-2020
<1|56.5|63.6|59.9|1114|IV(a) Neuroblastoma and ganglioneuroblastoma|18583091|2016-2020
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|18583091|2016-2020
<1|17.0|21.0|18.9|351|IX Soft tissue and other extraosseous sarcomas|18583091|2016-2020
<1|4.8|7.1|5.9|109|IX(a) Rhabdomyosarcomas|18583091|2016-2020
<1|3.9|6.0|4.9|91|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|18583091|2016-2020
<1|~|~|~|~|IX(c) Kaposi sarcoma|18583091|2016-2020
<1|4.5|6.7|5.5|103|IX(d) Other specified soft tissue sarcomas|18583091|2016-2020
<1|1.9|3.4|2.5|47|IX(e) Unspecified soft tissue sarcomas|18583091|2016-2020
<1|1.1|2.3|1.6|30|Not classified by ICCC|18583091|2016-2020
<1|26.5|31.4|28.9|537|V Retinoblastoma|18583091|2016-2020
<1|12.7|16.3|14.4|268|VI Renal tumors|18583091|2016-2020
<1|12.4|15.9|14.1|262|VI(a) Nephroblastoma and other nonepithelial renal tumors|18583091|2016-2020
<1|~|~|~|~|VI(b) Renal carcinomas|18583091|2016-2020
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|18583091|2016-2020
<1|12.7|16.2|14.4|267|VII Hepatic tumors|18583091|2016-2020
<1|12.5|16.0|14.2|264|VII(a) Hepatoblastoma|18583091|2016-2020
<1|~|~|~|~|VII(b) Hepatic carcinomas|18583091|2016-2020
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|18583091|2016-2020
<1|0.5|1.4|0.9|16|VIII Malignant bone tumors|18583091|2016-2020
<1|~|~|~|~|VIII(a) Osteosarcomas|18583091|2016-2020
<1|~|~|~|~|VIII(b) Chondrosarcomas|18583091|2016-2020
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|18583091|2016-2020
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|18583091|2016-2020
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|18583091|2016-2020
<1|15.6|19.5|17.5|325|X Germ cell, trophoblastic tumors & neoplasms of gonads|18583091|2016-2020
<1|1.4|2.7|1.9|36|X(a) Intracranial & intraspinal germ cell tumors|18583091|2016-2020
<1|10.5|13.7|12.1|224|X(b) Malignant extracranial & extragonadal germ cell tumors|18583091|2016-2020
<1|2.4|4.0|3.1|58|X(c) Malignant gonadal germ cell tumors|18583091|2016-2020
<1|~|~|~|~|X(d) Gonadal carcinomas|18583091|2016-2020
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|18583091|2016-2020
<1|4.8|7.0|5.8|108|XI Other malignant epithelial neoplasms and malignant melanomas|18583091|2016-2020
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|18583091|2016-2020
<1|~|~|~|~|XI(b) Thyroid carcinomas|18583091|2016-2020
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|18583091|2016-2020
<1|1.8|3.3|2.5|46|XI(d) Malignant melanomas|18583091|2016-2020
<1|~|~|~|~|XI(e) Skin carcinomas|18583091|2016-2020
<1|1.7|3.1|2.3|43|XI(f) Other and unspecified carcinomas|18583091|2016-2020
<1|2.5|4.2|3.2|60|XII Other and unspecified malignant neoplasms|18583091|2016-2020
<1|1.2|2.5|1.8|33|XII(a) Other specified malignant tumors|18583091|2016-2020
<1|1.0|2.1|1.5|27|XII(b) Other unspecified malignant tumors|18583091|2016-2020
1-4|221.0|235.9|228.4|3657|All ICCC Groups Combined|16012579|2017
1-4|85.6|95.0|90.2|1445|I Leukemias, myeloproliferative & myelodysplastic diseases|16012579|2017
1-4|70.0|78.5|74.1|1187|I(a) Lymphoid leukemias|16012579|2017
1-4|9.1|12.4|10.7|171|I(b) Acute myeloid leukemias|16012579|2017
1-4|0.6|1.6|1.0|16|I(c) Chronic myeloproliferative diseases|16012579|2017
1-4|0.8|2.0|1.3|21|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|16012579|2017
1-4|2.3|4.1|3.1|50|I(e) Unspecified and other specified leukemias|16012579|2017
1-4|14.9|19.0|16.9|270|II Lymphomas and reticuloendothelial neoplasms|16012579|2017
1-4|~|~|~|~|II(a) Hodgkin lymphomas|16012579|2017
1-4|3.9|6.1|4.9|78|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|16012579|2017
1-4|1.3|2.7|1.9|30|II(c) Burkitt lymphoma|16012579|2017
1-4|7.9|10.9|9.3|149|II(d) Miscellaneous lymphoreticular neoplasms|16012579|2017
1-4|~|~|~|~|II(e) Unspecified lymphomas|16012579|2017
1-4|43.6|50.4|46.9|751|III CNS and misc intracranial and intraspinal neoplasms|16012579|2017
1-4|5.8|8.5|7.1|113|III(a) Ependymomas and choroid plexus tumor|16012579|2017
1-4|20.8|25.6|23.1|370|III(b) Astrocytomas|16012579|2017
1-4|8.0|11.1|9.4|151|III(c) Intracranial and intraspinal embryonal tumors|16012579|2017
1-4|5.1|7.6|6.2|100|III(d) Other gliomas|16012579|2017
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|16012579|2017
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|16012579|2017
1-4|18.7|23.2|20.9|334|IV Neuroblastoma and other peripheral nervous cell tumors|16012579|2017
1-4|18.6|23.2|20.8|333|IV(a) Neuroblastoma and ganglioneuroblastoma|16012579|2017
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|16012579|2017
1-4|9.9|13.3|11.5|184|IX Soft tissue and other extraosseous sarcomas|16012579|2017
1-4|7.0|9.9|8.4|134|IX(a) Rhabdomyosarcomas|16012579|2017
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|16012579|2017
1-4|~|~|~|~|IX(c) Kaposi sarcoma|16012579|2017
1-4|1.1|2.4|1.6|26|IX(d) Other specified soft tissue sarcomas|16012579|2017
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|16012579|2017
1-4|~|~|~|~|Not classified by ICCC|16012579|2017
1-4|6.8|9.7|8.2|131|V Retinoblastoma|16012579|2017
1-4|16.6|20.9|18.7|299|VI Renal tumors|16012579|2017
1-4|16.6|20.9|18.7|299|VI(a) Nephroblastoma and other nonepithelial renal tumors|16012579|2017
1-4|~|~|~|~|VI(b) Renal carcinomas|16012579|2017
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|16012579|2017
1-4|4.9|7.3|6.0|96|VII Hepatic tumors|16012579|2017
1-4|4.4|6.8|5.5|88|VII(a) Hepatoblastoma|16012579|2017
1-4|~|~|~|~|VII(b) Hepatic carcinomas|16012579|2017
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|16012579|2017
1-4|1.3|2.7|1.9|30|VIII Malignant bone tumors|16012579|2017
1-4|~|~|~|~|VIII(a) Osteosarcomas|16012579|2017
1-4|~|~|~|~|VIII(b) Chondrosarcomas|16012579|2017
1-4|0.7|1.9|1.2|19|VIII(c) Ewing tumor and related sarcomas of bone|16012579|2017
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|16012579|2017
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|16012579|2017
1-4|3.2|5.3|4.2|67|X Germ cell, trophoblastic tumors & neoplasms of gonads|16012579|2017
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|16012579|2017
1-4|1.6|3.2|2.3|37|X(b) Malignant extracranial & extragonadal germ cell tumors|16012579|2017
1-4|0.9|2.1|1.4|22|X(c) Malignant gonadal germ cell tumors|16012579|2017
1-4|~|~|~|~|X(d) Gonadal carcinomas|16012579|2017
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|16012579|2017
1-4|1.1|2.4|1.6|26|XI Other malignant epithelial neoplasms and malignant melanomas|16012579|2017
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|16012579|2017
1-4|~|~|~|~|XI(b) Thyroid carcinomas|16012579|2017
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|16012579|2017
1-4|~|~|~|~|XI(d) Malignant melanomas|16012579|2017
1-4|~|~|~|~|XI(e) Skin carcinomas|16012579|2017
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|16012579|2017
1-4|0.9|2.2|1.4|23|XII Other and unspecified malignant neoplasms|16012579|2017
1-4|0.7|1.9|1.2|19|XII(a) Other specified malignant tumors|16012579|2017
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|16012579|2017
10-14|150.6|161.4|155.9|3241|All ICCC Groups Combined|20783456|2017
10-14|32.5|37.7|35.0|728|I Leukemias, myeloproliferative & myelodysplastic diseases|20783456|2017
10-14|22.1|26.4|24.2|502|I(a) Lymphoid leukemias|20783456|2017
10-14|5.4|7.6|6.4|133|I(b) Acute myeloid leukemias|20783456|2017
10-14|1.6|2.9|2.2|45|I(c) Chronic myeloproliferative diseases|20783456|2017
10-14|0.5|1.3|0.8|17|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20783456|2017
10-14|1.0|2.1|1.5|31|I(e) Unspecified and other specified leukemias|20783456|2017
10-14|27.1|31.8|29.4|610|II Lymphomas and reticuloendothelial neoplasms|20783456|2017
10-14|11.0|14.1|12.5|259|II(a) Hodgkin lymphomas|20783456|2017
10-14|8.5|11.2|9.8|203|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20783456|2017
10-14|2.3|3.9|3.0|63|II(c) Burkitt lymphoma|20783456|2017
10-14|3.1|4.8|3.8|80|II(d) Miscellaneous lymphoreticular neoplasms|20783456|2017
10-14|~|~|~|~|II(e) Unspecified lymphomas|20783456|2017
10-14|28.7|33.6|31.1|646|III CNS and misc intracranial and intraspinal neoplasms|20783456|2017
10-14|1.3|2.6|1.9|39|III(a) Ependymomas and choroid plexus tumor|20783456|2017
10-14|16.0|19.7|17.8|369|III(b) Astrocytomas|20783456|2017
10-14|3.2|5.0|4.0|83|III(c) Intracranial and intraspinal embryonal tumors|20783456|2017
10-14|5.6|7.9|6.7|139|III(d) Other gliomas|20783456|2017
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20783456|2017
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20783456|2017
10-14|0.8|1.8|1.3|26|IV Neuroblastoma and other peripheral nervous cell tumors|20783456|2017
10-14|0.7|1.7|1.2|24|IV(a) Neuroblastoma and ganglioneuroblastoma|20783456|2017
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20783456|2017
10-14|9.9|12.8|11.3|234|IX Soft tissue and other extraosseous sarcomas|20783456|2017
10-14|2.8|4.5|3.6|74|IX(a) Rhabdomyosarcomas|20783456|2017
10-14|0.6|1.5|1.0|21|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20783456|2017
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20783456|2017
10-14|3.7|5.5|4.5|94|IX(d) Other specified soft tissue sarcomas|20783456|2017
10-14|1.6|2.9|2.2|45|IX(e) Unspecified soft tissue sarcomas|20783456|2017
10-14|~|~|~|~|Not classified by ICCC|20783456|2017
10-14|~|~|~|~|V Retinoblastoma|20783456|2017
10-14|1.4|2.6|1.9|40|VI Renal tumors|20783456|2017
10-14|0.6|1.4|0.9|19|VI(a) Nephroblastoma and other nonepithelial renal tumors|20783456|2017
10-14|0.6|1.5|1.0|20|VI(b) Renal carcinomas|20783456|2017
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20783456|2017
10-14|~|~|~|~|VII Hepatic tumors|20783456|2017
10-14|~|~|~|~|VII(a) Hepatoblastoma|20783456|2017
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20783456|2017
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20783456|2017
10-14|13.5|16.9|15.2|315|VIII Malignant bone tumors|20783456|2017
10-14|8.4|11.2|9.7|202|VIII(a) Osteosarcomas|20783456|2017
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20783456|2017
10-14|3.4|5.2|4.2|87|VIII(c) Ewing tumor and related sarcomas of bone|20783456|2017
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20783456|2017
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20783456|2017
10-14|7.6|10.2|8.8|183|X Germ cell, trophoblastic tumors & neoplasms of gonads|20783456|2017
10-14|2.7|4.3|3.4|71|X(a) Intracranial & intraspinal germ cell tumors|20783456|2017
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20783456|2017
10-14|3.5|5.4|4.4|91|X(c) Malignant gonadal germ cell tumors|20783456|2017
10-14|~|~|~|~|X(d) Gonadal carcinomas|20783456|2017
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20783456|2017
10-14|18.8|22.8|20.7|431|XI Other malignant epithelial neoplasms and malignant melanomas|20783456|2017
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20783456|2017
10-14|6.6|9.1|7.8|162|XI(b) Thyroid carcinomas|20783456|2017
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20783456|2017
10-14|1.5|2.8|2.1|43|XI(d) Malignant melanomas|20783456|2017
10-14|~|~|~|~|XI(e) Skin carcinomas|20783456|2017
10-14|8.7|11.5|10.0|208|XI(f) Other and unspecified carcinomas|20783456|2017
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20783456|2017
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20783456|2017
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20783456|2017
15-19|230.9|244.1|237.4|5011|All ICCC Groups Combined|21105586|2017
15-19|31.1|36.1|33.5|708|I Leukemias, myeloproliferative & myelodysplastic diseases|21105586|2017
15-19|15.2|18.7|16.9|356|I(a) Lymphoid leukemias|21105586|2017
15-19|7.6|10.2|8.8|186|I(b) Acute myeloid leukemias|21105586|2017
15-19|4.4|6.4|5.4|113|I(c) Chronic myeloproliferative diseases|21105586|2017
15-19|0.5|1.3|0.8|17|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21105586|2017
15-19|1.2|2.4|1.7|36|I(e) Unspecified and other specified leukemias|21105586|2017
15-19|49.5|55.8|52.6|1110|II Lymphomas and reticuloendothelial neoplasms|21105586|2017
15-19|28.9|33.8|31.3|660|II(a) Hodgkin lymphomas|21105586|2017
15-19|14.8|18.3|16.4|347|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21105586|2017
15-19|1.5|2.7|2.0|43|II(c) Burkitt lymphoma|21105586|2017
15-19|1.4|2.7|2.0|42|II(d) Miscellaneous lymphoreticular neoplasms|21105586|2017
15-19|0.5|1.3|0.9|18|II(e) Unspecified lymphomas|21105586|2017
15-19|22.1|26.4|24.2|510|III CNS and misc intracranial and intraspinal neoplasms|21105586|2017
15-19|0.9|2.0|1.4|29|III(a) Ependymomas and choroid plexus tumor|21105586|2017
15-19|12.2|15.4|13.7|290|III(b) Astrocytomas|21105586|2017
15-19|1.8|3.2|2.4|51|III(c) Intracranial and intraspinal embryonal tumors|21105586|2017
15-19|4.5|6.5|5.4|115|III(d) Other gliomas|21105586|2017
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21105586|2017
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21105586|2017
15-19|1.0|2.1|1.5|31|IV Neuroblastoma and other peripheral nervous cell tumors|21105586|2017
15-19|0.7|1.6|1.1|23|IV(a) Neuroblastoma and ganglioneuroblastoma|21105586|2017
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21105586|2017
15-19|15.5|19.1|17.2|363|IX Soft tissue and other extraosseous sarcomas|21105586|2017
15-19|3.6|5.4|4.4|93|IX(a) Rhabdomyosarcomas|21105586|2017
15-19|1.2|2.4|1.7|36|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21105586|2017
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21105586|2017
15-19|7.3|9.9|8.5|180|IX(d) Other specified soft tissue sarcomas|21105586|2017
15-19|1.8|3.2|2.5|52|IX(e) Unspecified soft tissue sarcomas|21105586|2017
15-19|~|~|~|~|Not classified by ICCC|21105586|2017
15-19|~|~|~|~|V Retinoblastoma|21105586|2017
15-19|1.2|2.4|1.8|37|VI Renal tumors|21105586|2017
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21105586|2017
15-19|0.9|2.0|1.4|29|VI(b) Renal carcinomas|21105586|2017
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21105586|2017
15-19|1.0|2.1|1.5|31|VII Hepatic tumors|21105586|2017
15-19|~|~|~|~|VII(a) Hepatoblastoma|21105586|2017
15-19|0.9|2.0|1.4|29|VII(b) Hepatic carcinomas|21105586|2017
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21105586|2017
15-19|13.7|17.1|15.4|324|VIII Malignant bone tumors|21105586|2017
15-19|7.3|9.8|8.5|179|VIII(a) Osteosarcomas|21105586|2017
15-19|0.5|1.3|0.8|17|VIII(b) Chondrosarcomas|21105586|2017
15-19|3.7|5.6|4.5|96|VIII(c) Ewing tumor and related sarcomas of bone|21105586|2017
15-19|0.6|1.5|0.9|20|VIII(d) Other specified malignant bone tumors|21105586|2017
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21105586|2017
15-19|24.1|28.5|26.2|554|X Germ cell, trophoblastic tumors & neoplasms of gonads|21105586|2017
15-19|2.2|3.7|2.8|60|X(a) Intracranial & intraspinal germ cell tumors|21105586|2017
15-19|0.5|1.4|0.9|19|X(b) Malignant extracranial & extragonadal germ cell tumors|21105586|2017
15-19|18.2|22.0|20.0|423|X(c) Malignant gonadal germ cell tumors|21105586|2017
15-19|0.8|1.9|1.3|27|X(d) Gonadal carcinomas|21105586|2017
15-19|0.8|1.7|1.2|25|X(e) Other and unspecified malignant gonadal tumors|21105586|2017
15-19|58.9|65.7|62.3|1314|XI Other malignant epithelial neoplasms and malignant melanomas|21105586|2017
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21105586|2017
15-19|28.6|33.4|30.9|653|XI(b) Thyroid carcinomas|21105586|2017
15-19|0.8|1.9|1.3|27|XI(c) Nasopharyngeal carcinomas|21105586|2017
15-19|6.7|9.2|7.9|166|XI(d) Malignant melanomas|21105586|2017
15-19|~|~|~|~|XI(e) Skin carcinomas|21105586|2017
15-19|19.7|23.7|21.6|456|XI(f) Other and unspecified carcinomas|21105586|2017
15-19|0.7|1.6|1.0|22|XII Other and unspecified malignant neoplasms|21105586|2017
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21105586|2017
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21105586|2017
5-9|126.4|136.4|131.3|2670|All ICCC Groups Combined|20330306|2017
5-9|37.6|43.1|40.3|819|I Leukemias, myeloproliferative & myelodysplastic diseases|20330306|2017
5-9|30.2|35.2|32.7|664|I(a) Lymphoid leukemias|20330306|2017
5-9|3.4|5.3|4.3|87|I(b) Acute myeloid leukemias|20330306|2017
5-9|0.7|1.7|1.1|23|I(c) Chronic myeloproliferative diseases|20330306|2017
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20330306|2017
5-9|1.1|2.2|1.6|32|I(e) Unspecified and other specified leukemias|20330306|2017
5-9|17.8|21.8|19.7|401|II Lymphomas and reticuloendothelial neoplasms|20330306|2017
5-9|3.1|4.8|3.9|79|II(a) Hodgkin lymphomas|20330306|2017
5-9|6.4|8.8|7.5|153|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20330306|2017
5-9|2.6|4.2|3.3|67|II(c) Burkitt lymphoma|20330306|2017
5-9|4.0|5.9|4.9|99|II(d) Miscellaneous lymphoreticular neoplasms|20330306|2017
5-9|~|~|~|~|II(e) Unspecified lymphomas|20330306|2017
5-9|34.6|40.0|37.2|757|III CNS and misc intracranial and intraspinal neoplasms|20330306|2017
5-9|1.5|2.8|2.1|43|III(a) Ependymomas and choroid plexus tumor|20330306|2017
5-9|16.5|20.3|18.3|373|III(b) Astrocytomas|20330306|2017
5-9|6.0|8.4|7.1|145|III(c) Intracranial and intraspinal embryonal tumors|20330306|2017
5-9|7.0|9.6|8.2|167|III(d) Other gliomas|20330306|2017
5-9|0.5|1.4|0.9|18|III(e) Other specified intracranial & intraspinal neoplasms|20330306|2017
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20330306|2017
5-9|3.5|5.3|4.3|88|IV Neuroblastoma and other peripheral nervous cell tumors|20330306|2017
5-9|3.3|5.2|4.2|85|IV(a) Neuroblastoma and ganglioneuroblastoma|20330306|2017
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20330306|2017
5-9|7.8|10.5|9.1|185|IX Soft tissue and other extraosseous sarcomas|20330306|2017
5-9|3.6|5.5|4.5|91|IX(a) Rhabdomyosarcomas|20330306|2017
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20330306|2017
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20330306|2017
5-9|2.2|3.7|2.9|58|IX(d) Other specified soft tissue sarcomas|20330306|2017
5-9|0.8|1.9|1.3|26|IX(e) Unspecified soft tissue sarcomas|20330306|2017
5-9|~|~|~|~|Not classified by ICCC|20330306|2017
5-9|~|~|~|~|V Retinoblastoma|20330306|2017
5-9|5.2|7.4|6.2|126|VI Renal tumors|20330306|2017
5-9|4.8|7.0|5.8|118|VI(a) Nephroblastoma and other nonepithelial renal tumors|20330306|2017
5-9|~|~|~|~|VI(b) Renal carcinomas|20330306|2017
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20330306|2017
5-9|0.4|1.3|0.8|16|VII Hepatic tumors|20330306|2017
5-9|~|~|~|~|VII(a) Hepatoblastoma|20330306|2017
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20330306|2017
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20330306|2017
5-9|4.5|6.6|5.5|111|VIII Malignant bone tumors|20330306|2017
5-9|2.4|4.0|3.1|63|VIII(a) Osteosarcomas|20330306|2017
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20330306|2017
5-9|1.3|2.5|1.8|37|VIII(c) Ewing tumor and related sarcomas of bone|20330306|2017
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20330306|2017
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20330306|2017
5-9|2.2|3.7|2.9|58|X Germ cell, trophoblastic tumors & neoplasms of gonads|20330306|2017
5-9|1.0|2.1|1.5|30|X(a) Intracranial & intraspinal germ cell tumors|20330306|2017
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20330306|2017
5-9|0.6|1.6|1.0|21|X(c) Malignant gonadal germ cell tumors|20330306|2017
5-9|~|~|~|~|X(d) Gonadal carcinomas|20330306|2017
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20330306|2017
5-9|3.5|5.4|4.4|89|XI Other malignant epithelial neoplasms and malignant melanomas|20330306|2017
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20330306|2017
5-9|1.0|2.0|1.4|29|XI(b) Thyroid carcinomas|20330306|2017
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20330306|2017
5-9|0.7|1.6|1.1|22|XI(d) Malignant melanomas|20330306|2017
5-9|~|~|~|~|XI(e) Skin carcinomas|20330306|2017
5-9|1.3|2.6|1.9|38|XI(f) Other and unspecified carcinomas|20330306|2017
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20330306|2017
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20330306|2017
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20330306|2017
<1|249.1|281.7|265.0|1029|All ICCC Groups Combined|3882437|2017
<1|43.2|57.5|50.0|194|I Leukemias, myeloproliferative & myelodysplastic diseases|3882437|2017
<1|12.9|21.3|16.7|65|I(a) Lymphoid leukemias|3882437|2017
<1|14.3|23.1|18.3|71|I(b) Acute myeloid leukemias|3882437|2017
<1|2.9|7.6|4.9|19|I(c) Chronic myeloproliferative diseases|3882437|2017
<1|5.0|10.7|7.5|29|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3882437|2017
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3882437|2017
<1|19.1|29.1|23.7|92|II Lymphomas and reticuloendothelial neoplasms|3882437|2017
<1|~|~|~|~|II(a) Hodgkin lymphomas|3882437|2017
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3882437|2017
<1|~|~|~|~|II(c) Burkitt lymphoma|3882437|2017
<1|16.3|25.6|20.6|80|II(d) Miscellaneous lymphoreticular neoplasms|3882437|2017
<1|~|~|~|~|II(e) Unspecified lymphomas|3882437|2017
<1|28.4|40.3|34.0|132|III CNS and misc intracranial and intraspinal neoplasms|3882437|2017
<1|2.4|6.7|4.1|16|III(a) Ependymomas and choroid plexus tumor|3882437|2017
<1|10.4|18.1|13.9|54|III(b) Astrocytomas|3882437|2017
<1|7.4|14.0|10.3|40|III(c) Intracranial and intraspinal embryonal tumors|3882437|2017
<1|~|~|~|~|III(d) Other gliomas|3882437|2017
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3882437|2017
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3882437|2017
<1|48.2|63.3|55.4|215|IV Neuroblastoma and other peripheral nervous cell tumors|3882437|2017
<1|47.7|62.7|54.9|213|IV(a) Neuroblastoma and ganglioneuroblastoma|3882437|2017
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3882437|2017
<1|13.4|21.9|17.3|67|IX Soft tissue and other extraosseous sarcomas|3882437|2017
<1|3.3|8.3|5.4|21|IX(a) Rhabdomyosarcomas|3882437|2017
<1|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3882437|2017
<1|~|~|~|~|IX(c) Kaposi sarcoma|3882437|2017
<1|3.1|8.0|5.2|20|IX(d) Other specified soft tissue sarcomas|3882437|2017
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3882437|2017
<1|~|~|~|~|Not classified by ICCC|3882437|2017
<1|24.2|35.3|29.4|114|V Retinoblastoma|3882437|2017
<1|10.9|18.7|14.4|56|VI Renal tumors|3882437|2017
<1|10.7|18.4|14.2|55|VI(a) Nephroblastoma and other nonepithelial renal tumors|3882437|2017
<1|~|~|~|~|VI(b) Renal carcinomas|3882437|2017
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3882437|2017
<1|8.7|15.8|11.8|46|VII Hepatic tumors|3882437|2017
<1|8.5|15.5|11.6|45|VII(a) Hepatoblastoma|3882437|2017
<1|~|~|~|~|VII(b) Hepatic carcinomas|3882437|2017
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3882437|2017
<1|~|~|~|~|VIII Malignant bone tumors|3882437|2017
<1|~|~|~|~|VIII(a) Osteosarcomas|3882437|2017
<1|~|~|~|~|VIII(b) Chondrosarcomas|3882437|2017
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3882437|2017
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3882437|2017
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3882437|2017
<1|14.5|23.4|18.5|72|X Germ cell, trophoblastic tumors & neoplasms of gonads|3882437|2017
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3882437|2017
<1|9.1|16.4|12.4|48|X(b) Malignant extracranial & extragonadal germ cell tumors|3882437|2017
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3882437|2017
<1|~|~|~|~|X(d) Gonadal carcinomas|3882437|2017
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3882437|2017
<1|~|~|~|~|XI Other malignant epithelial neoplasms and malignant melanomas|3882437|2017
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3882437|2017
<1|~|~|~|~|XI(b) Thyroid carcinomas|3882437|2017
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3882437|2017
<1|~|~|~|~|XI(d) Malignant melanomas|3882437|2017
<1|~|~|~|~|XI(e) Skin carcinomas|3882437|2017
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3882437|2017
<1|3.1|8.0|5.2|20|XII Other and unspecified malignant neoplasms|3882437|2017
<1|~|~|~|~|XII(a) Other specified malignant tumors|3882437|2017
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3882437|2017
1-4|212.8|227.4|220.0|3510|All ICCC Groups Combined|15951619|2018
1-4|89.2|98.7|93.8|1497|I Leukemias, myeloproliferative & myelodysplastic diseases|15951619|2018
1-4|75.4|84.2|79.7|1272|I(a) Lymphoid leukemias|15951619|2018
1-4|7.9|11.0|9.3|149|I(b) Acute myeloid leukemias|15951619|2018
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15951619|2018
1-4|0.8|1.9|1.3|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15951619|2018
1-4|2.1|3.8|2.9|46|I(e) Unspecified and other specified leukemias|15951619|2018
1-4|12.6|16.3|14.4|229|II Lymphomas and reticuloendothelial neoplasms|15951619|2018
1-4|0.8|2.0|1.3|21|II(a) Hodgkin lymphomas|15951619|2018
1-4|3.1|5.2|4.1|65|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15951619|2018
1-4|1.1|2.5|1.7|27|II(c) Burkitt lymphoma|15951619|2018
1-4|5.7|8.4|7.0|111|II(d) Miscellaneous lymphoreticular neoplasms|15951619|2018
1-4|~|~|~|~|II(e) Unspecified lymphomas|15951619|2018
1-4|33.3|39.3|36.2|578|III CNS and misc intracranial and intraspinal neoplasms|15951619|2018
1-4|3.3|5.4|4.3|68|III(a) Ependymomas and choroid plexus tumor|15951619|2018
1-4|17.3|21.7|19.4|309|III(b) Astrocytomas|15951619|2018
1-4|6.5|9.3|7.8|124|III(c) Intracranial and intraspinal embryonal tumors|15951619|2018
1-4|2.8|4.7|3.6|58|III(d) Other gliomas|15951619|2018
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15951619|2018
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15951619|2018
1-4|18.9|23.4|21.1|336|IV Neuroblastoma and other peripheral nervous cell tumors|15951619|2018
1-4|18.8|23.4|21.0|335|IV(a) Neuroblastoma and ganglioneuroblastoma|15951619|2018
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15951619|2018
1-4|9.1|12.3|10.6|169|IX Soft tissue and other extraosseous sarcomas|15951619|2018
1-4|5.7|8.4|7.0|111|IX(a) Rhabdomyosarcomas|15951619|2018
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15951619|2018
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15951619|2018
1-4|1.9|3.6|2.6|42|IX(d) Other specified soft tissue sarcomas|15951619|2018
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15951619|2018
1-4|3.8|6.0|4.8|77|Not classified by ICCC|15951619|2018
1-4|6.1|8.8|7.3|117|V Retinoblastoma|15951619|2018
1-4|16.1|20.3|18.1|289|VI Renal tumors|15951619|2018
1-4|15.9|20.1|17.9|285|VI(a) Nephroblastoma and other nonepithelial renal tumors|15951619|2018
1-4|~|~|~|~|VI(b) Renal carcinomas|15951619|2018
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15951619|2018
1-4|4.6|7.1|5.8|92|VII Hepatic tumors|15951619|2018
1-4|4.4|6.7|5.5|87|VII(a) Hepatoblastoma|15951619|2018
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15951619|2018
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15951619|2018
1-4|1.1|2.5|1.7|27|VIII Malignant bone tumors|15951619|2018
1-4|~|~|~|~|VIII(a) Osteosarcomas|15951619|2018
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15951619|2018
1-4|0.6|1.6|1.0|16|VIII(c) Ewing tumor and related sarcomas of bone|15951619|2018
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15951619|2018
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15951619|2018
1-4|2.5|4.3|3.3|53|X Germ cell, trophoblastic tumors & neoplasms of gonads|15951619|2018
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15951619|2018
1-4|0.9|2.2|1.4|23|X(b) Malignant extracranial & extragonadal germ cell tumors|15951619|2018
1-4|1.0|2.3|1.6|25|X(c) Malignant gonadal germ cell tumors|15951619|2018
1-4|~|~|~|~|X(d) Gonadal carcinomas|15951619|2018
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15951619|2018
1-4|1.4|2.9|2.1|33|XI Other malignant epithelial neoplasms and malignant melanomas|15951619|2018
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15951619|2018
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15951619|2018
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15951619|2018
1-4|0.7|1.8|1.1|18|XI(d) Malignant melanomas|15951619|2018
1-4|~|~|~|~|XI(e) Skin carcinomas|15951619|2018
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15951619|2018
1-4|~|~|~|~|XII Other and unspecified malignant neoplasms|15951619|2018
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15951619|2018
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15951619|2018
10-14|155.7|166.6|161.1|3364|All ICCC Groups Combined|20887842|2018
10-14|32.1|37.2|34.6|723|I Leukemias, myeloproliferative & myelodysplastic diseases|20887842|2018
10-14|20.0|24.1|22.0|459|I(a) Lymphoid leukemias|20887842|2018
10-14|6.3|8.7|7.5|156|I(b) Acute myeloid leukemias|20887842|2018
10-14|1.8|3.2|2.4|50|I(c) Chronic myeloproliferative diseases|20887842|2018
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20887842|2018
10-14|1.6|2.9|2.2|46|I(e) Unspecified and other specified leukemias|20887842|2018
10-14|29.6|34.5|32.0|669|II Lymphomas and reticuloendothelial neoplasms|20887842|2018
10-14|11.3|14.4|12.7|266|II(a) Hodgkin lymphomas|20887842|2018
10-14|10.7|13.7|12.1|253|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20887842|2018
10-14|2.1|3.6|2.8|58|II(c) Burkitt lymphoma|20887842|2018
10-14|3.4|5.2|4.3|89|II(d) Miscellaneous lymphoreticular neoplasms|20887842|2018
10-14|~|~|~|~|II(e) Unspecified lymphomas|20887842|2018
10-14|24.5|28.9|26.6|556|III CNS and misc intracranial and intraspinal neoplasms|20887842|2018
10-14|1.4|2.6|1.9|40|III(a) Ependymomas and choroid plexus tumor|20887842|2018
10-14|12.7|16.0|14.3|298|III(b) Astrocytomas|20887842|2018
10-14|2.4|3.9|3.1|64|III(c) Intracranial and intraspinal embryonal tumors|20887842|2018
10-14|5.3|7.5|6.3|132|III(d) Other gliomas|20887842|2018
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20887842|2018
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20887842|2018
10-14|0.9|2.0|1.4|29|IV Neuroblastoma and other peripheral nervous cell tumors|20887842|2018
10-14|0.7|1.6|1.1|22|IV(a) Neuroblastoma and ganglioneuroblastoma|20887842|2018
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20887842|2018
10-14|11.2|14.3|12.7|265|IX Soft tissue and other extraosseous sarcomas|20887842|2018
10-14|3.1|4.8|3.9|81|IX(a) Rhabdomyosarcomas|20887842|2018
10-14|0.8|1.8|1.2|25|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20887842|2018
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20887842|2018
10-14|5.0|7.1|6.0|125|IX(d) Other specified soft tissue sarcomas|20887842|2018
10-14|1.0|2.2|1.5|32|IX(e) Unspecified soft tissue sarcomas|20887842|2018
10-14|1.8|3.2|2.4|50|Not classified by ICCC|20887842|2018
10-14|~|~|~|~|V Retinoblastoma|20887842|2018
10-14|1.6|2.9|2.2|46|VI Renal tumors|20887842|2018
10-14|0.8|1.8|1.2|25|VI(a) Nephroblastoma and other nonepithelial renal tumors|20887842|2018
10-14|0.6|1.5|1.0|20|VI(b) Renal carcinomas|20887842|2018
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20887842|2018
10-14|~|~|~|~|VII Hepatic tumors|20887842|2018
10-14|~|~|~|~|VII(a) Hepatoblastoma|20887842|2018
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20887842|2018
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20887842|2018
10-14|13.9|17.3|15.6|325|VIII Malignant bone tumors|20887842|2018
10-14|8.0|10.7|9.3|194|VIII(a) Osteosarcomas|20887842|2018
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20887842|2018
10-14|3.9|5.8|4.7|99|VIII(c) Ewing tumor and related sarcomas of bone|20887842|2018
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20887842|2018
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20887842|2018
10-14|7.4|10.0|8.7|181|X Germ cell, trophoblastic tumors & neoplasms of gonads|20887842|2018
10-14|1.8|3.2|2.4|50|X(a) Intracranial & intraspinal germ cell tumors|20887842|2018
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20887842|2018
10-14|4.1|6.0|5.0|104|X(c) Malignant gonadal germ cell tumors|20887842|2018
10-14|~|~|~|~|X(d) Gonadal carcinomas|20887842|2018
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20887842|2018
10-14|21.7|26.0|23.8|497|XI Other malignant epithelial neoplasms and malignant melanomas|20887842|2018
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20887842|2018
10-14|9.1|11.9|10.4|217|XI(b) Thyroid carcinomas|20887842|2018
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20887842|2018
10-14|2.2|3.8|2.9|61|XI(d) Malignant melanomas|20887842|2018
10-14|~|~|~|~|XI(e) Skin carcinomas|20887842|2018
10-14|8.5|11.2|9.8|204|XI(f) Other and unspecified carcinomas|20887842|2018
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20887842|2018
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20887842|2018
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20887842|2018
15-19|236.2|249.5|242.8|5117|All ICCC Groups Combined|21077066|2018
15-19|35.0|40.3|37.6|792|I Leukemias, myeloproliferative & myelodysplastic diseases|21077066|2018
15-19|18.8|22.7|20.7|436|I(a) Lymphoid leukemias|21077066|2018
15-19|7.3|9.9|8.5|180|I(b) Acute myeloid leukemias|21077066|2018
15-19|4.5|6.5|5.4|114|I(c) Chronic myeloproliferative diseases|21077066|2018
15-19|0.6|1.5|1.0|21|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21077066|2018
15-19|1.4|2.6|1.9|41|I(e) Unspecified and other specified leukemias|21077066|2018
15-19|47.7|53.9|50.7|1069|II Lymphomas and reticuloendothelial neoplasms|21077066|2018
15-19|29.1|33.9|31.5|663|II(a) Hodgkin lymphomas|21077066|2018
15-19|13.6|16.9|15.2|320|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21077066|2018
15-19|1.5|2.8|2.1|44|II(c) Burkitt lymphoma|21077066|2018
15-19|0.9|1.9|1.3|28|II(d) Miscellaneous lymphoreticular neoplasms|21077066|2018
15-19|~|~|~|~|II(e) Unspecified lymphomas|21077066|2018
15-19|19.3|23.3|21.2|447|III CNS and misc intracranial and intraspinal neoplasms|21077066|2018
15-19|0.9|1.9|1.3|28|III(a) Ependymomas and choroid plexus tumor|21077066|2018
15-19|11.9|15.0|13.4|282|III(b) Astrocytomas|21077066|2018
15-19|0.6|1.5|1.0|21|III(c) Intracranial and intraspinal embryonal tumors|21077066|2018
15-19|3.4|5.2|4.3|90|III(d) Other gliomas|21077066|2018
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21077066|2018
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21077066|2018
15-19|0.5|1.3|0.9|18|IV Neuroblastoma and other peripheral nervous cell tumors|21077066|2018
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21077066|2018
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21077066|2018
15-19|12.9|16.2|14.5|306|IX Soft tissue and other extraosseous sarcomas|21077066|2018
15-19|2.6|4.2|3.4|71|IX(a) Rhabdomyosarcomas|21077066|2018
15-19|1.0|2.1|1.5|31|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21077066|2018
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21077066|2018
15-19|6.5|8.9|7.6|161|IX(d) Other specified soft tissue sarcomas|21077066|2018
15-19|1.4|2.7|2.0|42|IX(e) Unspecified soft tissue sarcomas|21077066|2018
15-19|1.6|2.9|2.1|45|Not classified by ICCC|21077066|2018
15-19|~|~|~|~|V Retinoblastoma|21077066|2018
15-19|1.5|2.8|2.1|44|VI Renal tumors|21077066|2018
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21077066|2018
15-19|1.1|2.2|1.6|33|VI(b) Renal carcinomas|21077066|2018
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21077066|2018
15-19|1.1|2.2|1.6|33|VII Hepatic tumors|21077066|2018
15-19|~|~|~|~|VII(a) Hepatoblastoma|21077066|2018
15-19|1.0|2.1|1.5|31|VII(b) Hepatic carcinomas|21077066|2018
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21077066|2018
15-19|13.3|16.6|14.9|314|VIII Malignant bone tumors|21077066|2018
15-19|7.3|9.9|8.5|180|VIII(a) Osteosarcomas|21077066|2018
15-19|0.5|1.3|0.8|17|VIII(b) Chondrosarcomas|21077066|2018
15-19|3.5|5.4|4.4|92|VIII(c) Ewing tumor and related sarcomas of bone|21077066|2018
15-19|0.5|1.3|0.9|18|VIII(d) Other specified malignant bone tumors|21077066|2018
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21077066|2018
15-19|23.0|27.3|25.1|529|X Germ cell, trophoblastic tumors & neoplasms of gonads|21077066|2018
15-19|1.5|2.7|2.0|43|X(a) Intracranial & intraspinal germ cell tumors|21077066|2018
15-19|1.0|2.0|1.4|30|X(b) Malignant extracranial & extragonadal germ cell tumors|21077066|2018
15-19|17.5|21.3|19.3|407|X(c) Malignant gonadal germ cell tumors|21077066|2018
15-19|0.9|2.0|1.4|29|X(d) Gonadal carcinomas|21077066|2018
15-19|0.6|1.5|0.9|20|X(e) Other and unspecified malignant gonadal tumors|21077066|2018
15-19|66.9|74.1|70.5|1485|XI Other malignant epithelial neoplasms and malignant melanomas|21077066|2018
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21077066|2018
15-19|33.8|39.0|36.3|766|XI(b) Thyroid carcinomas|21077066|2018
15-19|0.8|1.8|1.2|25|XI(c) Nasopharyngeal carcinomas|21077066|2018
15-19|7.1|9.6|8.3|175|XI(d) Malignant melanomas|21077066|2018
15-19|~|~|~|~|XI(e) Skin carcinomas|21077066|2018
15-19|22.0|26.2|24.1|507|XI(f) Other and unspecified carcinomas|21077066|2018
15-19|1.2|2.3|1.7|35|XII Other and unspecified malignant neoplasms|21077066|2018
15-19|0.5|1.3|0.9|18|XII(a) Other specified malignant tumors|21077066|2018
15-19|0.5|1.3|0.8|17|XII(b) Other unspecified malignant tumors|21077066|2018
5-9|126.5|136.5|131.4|2656|All ICCC Groups Combined|20212958|2018
5-9|41.1|47.0|44.0|889|I Leukemias, myeloproliferative & myelodysplastic diseases|20212958|2018
5-9|33.5|38.8|36.1|729|I(a) Lymphoid leukemias|20212958|2018
5-9|3.5|5.4|4.4|89|I(b) Acute myeloid leukemias|20212958|2018
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|20212958|2018
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20212958|2018
5-9|1.6|3.0|2.2|45|I(e) Unspecified and other specified leukemias|20212958|2018
5-9|16.9|20.7|18.7|378|II Lymphomas and reticuloendothelial neoplasms|20212958|2018
5-9|3.1|4.9|4.0|80|II(a) Hodgkin lymphomas|20212958|2018
5-9|6.9|9.4|8.1|163|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20212958|2018
5-9|1.9|3.3|2.5|51|II(c) Burkitt lymphoma|20212958|2018
5-9|3.2|5.0|4.1|82|II(d) Miscellaneous lymphoreticular neoplasms|20212958|2018
5-9|~|~|~|~|II(e) Unspecified lymphomas|20212958|2018
5-9|27.0|31.8|29.3|593|III CNS and misc intracranial and intraspinal neoplasms|20212958|2018
5-9|1.8|3.2|2.4|49|III(a) Ependymomas and choroid plexus tumor|20212958|2018
5-9|13.4|16.9|15.1|305|III(b) Astrocytomas|20212958|2018
5-9|4.5|6.6|5.4|110|III(c) Intracranial and intraspinal embryonal tumors|20212958|2018
5-9|4.3|6.3|5.2|106|III(d) Other gliomas|20212958|2018
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20212958|2018
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20212958|2018
5-9|3.5|5.4|4.4|89|IV Neuroblastoma and other peripheral nervous cell tumors|20212958|2018
5-9|3.4|5.3|4.3|87|IV(a) Neuroblastoma and ganglioneuroblastoma|20212958|2018
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20212958|2018
5-9|7.3|9.9|8.6|173|IX Soft tissue and other extraosseous sarcomas|20212958|2018
5-9|3.3|5.1|4.2|84|IX(a) Rhabdomyosarcomas|20212958|2018
5-9|0.5|1.3|0.8|16|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20212958|2018
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20212958|2018
5-9|2.1|3.7|2.8|57|IX(d) Other specified soft tissue sarcomas|20212958|2018
5-9|0.5|1.3|0.8|16|IX(e) Unspecified soft tissue sarcomas|20212958|2018
5-9|3.6|5.5|4.5|90|Not classified by ICCC|20212958|2018
5-9|~|~|~|~|V Retinoblastoma|20212958|2018
5-9|5.8|8.1|6.9|139|VI Renal tumors|20212958|2018
5-9|5.6|7.9|6.7|135|VI(a) Nephroblastoma and other nonepithelial renal tumors|20212958|2018
5-9|~|~|~|~|VI(b) Renal carcinomas|20212958|2018
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20212958|2018
5-9|0.5|1.4|0.9|18|VII Hepatic tumors|20212958|2018
5-9|~|~|~|~|VII(a) Hepatoblastoma|20212958|2018
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20212958|2018
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20212958|2018
5-9|5.5|7.8|6.6|133|VIII Malignant bone tumors|20212958|2018
5-9|2.3|3.9|3.0|61|VIII(a) Osteosarcomas|20212958|2018
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20212958|2018
5-9|2.1|3.6|2.8|56|VIII(c) Ewing tumor and related sarcomas of bone|20212958|2018
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20212958|2018
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20212958|2018
5-9|1.6|2.9|2.2|44|X Germ cell, trophoblastic tumors & neoplasms of gonads|20212958|2018
5-9|0.8|1.8|1.2|24|X(a) Intracranial & intraspinal germ cell tumors|20212958|2018
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20212958|2018
5-9|0.5|1.3|0.8|17|X(c) Malignant gonadal germ cell tumors|20212958|2018
5-9|~|~|~|~|X(d) Gonadal carcinomas|20212958|2018
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20212958|2018
5-9|3.9|5.9|4.8|97|XI Other malignant epithelial neoplasms and malignant melanomas|20212958|2018
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20212958|2018
5-9|1.0|2.2|1.5|31|XI(b) Thyroid carcinomas|20212958|2018
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20212958|2018
5-9|~|~|~|~|XI(d) Malignant melanomas|20212958|2018
5-9|~|~|~|~|XI(e) Skin carcinomas|20212958|2018
5-9|1.6|2.9|2.2|44|XI(f) Other and unspecified carcinomas|20212958|2018
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20212958|2018
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20212958|2018
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20212958|2018
<1|249.7|282.6|265.7|1017|All ICCC Groups Combined|3826908|2018
<1|42.1|56.4|48.9|187|I Leukemias, myeloproliferative & myelodysplastic diseases|3826908|2018
<1|13.3|21.9|17.2|66|I(a) Lymphoid leukemias|3826908|2018
<1|14.7|23.7|18.8|72|I(b) Acute myeloid leukemias|3826908|2018
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3826908|2018
<1|3.4|8.4|5.5|21|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3826908|2018
<1|3.2|8.1|5.2|20|I(e) Unspecified and other specified leukemias|3826908|2018
<1|15.4|24.6|19.6|75|II Lymphomas and reticuloendothelial neoplasms|3826908|2018
<1|~|~|~|~|II(a) Hodgkin lymphomas|3826908|2018
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3826908|2018
<1|~|~|~|~|II(c) Burkitt lymphoma|3826908|2018
<1|13.1|21.6|17.0|65|II(d) Miscellaneous lymphoreticular neoplasms|3826908|2018
<1|~|~|~|~|II(e) Unspecified lymphomas|3826908|2018
<1|20.6|30.9|25.3|97|III CNS and misc intracranial and intraspinal neoplasms|3826908|2018
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3826908|2018
<1|5.3|11.2|7.8|30|III(b) Astrocytomas|3826908|2018
<1|7.0|13.6|9.9|38|III(c) Intracranial and intraspinal embryonal tumors|3826908|2018
<1|~|~|~|~|III(d) Other gliomas|3826908|2018
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3826908|2018
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3826908|2018
<1|57.2|73.7|65.1|249|IV Neuroblastoma and other peripheral nervous cell tumors|3826908|2018
<1|57.0|73.4|64.8|248|IV(a) Neuroblastoma and ganglioneuroblastoma|3826908|2018
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3826908|2018
<1|12.4|20.8|16.2|62|IX Soft tissue and other extraosseous sarcomas|3826908|2018
<1|3.2|8.1|5.2|20|IX(a) Rhabdomyosarcomas|3826908|2018
<1|3.2|8.1|5.2|20|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3826908|2018
<1|~|~|~|~|IX(c) Kaposi sarcoma|3826908|2018
<1|~|~|~|~|IX(d) Other specified soft tissue sarcomas|3826908|2018
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3826908|2018
<1|~|~|~|~|Not classified by ICCC|3826908|2018
<1|26.5|38.1|31.9|122|V Retinoblastoma|3826908|2018
<1|10.1|17.8|13.6|52|VI Renal tumors|3826908|2018
<1|9.9|17.5|13.3|51|VI(a) Nephroblastoma and other nonepithelial renal tumors|3826908|2018
<1|~|~|~|~|VI(b) Renal carcinomas|3826908|2018
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3826908|2018
<1|12.4|20.8|16.2|62|VII Hepatic tumors|3826908|2018
<1|12.4|20.8|16.2|62|VII(a) Hepatoblastoma|3826908|2018
<1|~|~|~|~|VII(b) Hepatic carcinomas|3826908|2018
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3826908|2018
<1|~|~|~|~|VIII Malignant bone tumors|3826908|2018
<1|~|~|~|~|VIII(a) Osteosarcomas|3826908|2018
<1|~|~|~|~|VIII(b) Chondrosarcomas|3826908|2018
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3826908|2018
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3826908|2018
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3826908|2018
<1|13.6|22.2|17.5|67|X Germ cell, trophoblastic tumors & neoplasms of gonads|3826908|2018
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3826908|2018
<1|9.7|17.2|13.1|50|X(b) Malignant extracranial & extragonadal germ cell tumors|3826908|2018
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3826908|2018
<1|~|~|~|~|X(d) Gonadal carcinomas|3826908|2018
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3826908|2018
<1|3.0|7.8|5.0|19|XI Other malignant epithelial neoplasms and malignant melanomas|3826908|2018
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3826908|2018
<1|~|~|~|~|XI(b) Thyroid carcinomas|3826908|2018
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3826908|2018
<1|~|~|~|~|XI(d) Malignant melanomas|3826908|2018
<1|~|~|~|~|XI(e) Skin carcinomas|3826908|2018
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3826908|2018
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3826908|2018
<1|~|~|~|~|XII(a) Other specified malignant tumors|3826908|2018
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3826908|2018
1-4|206.0|220.4|213.1|3369|All ICCC Groups Combined|15809112|2019
1-4|80.0|89.2|84.5|1336|I Leukemias, myeloproliferative & myelodysplastic diseases|15809112|2019
1-4|65.4|73.7|69.5|1098|I(a) Lymphoid leukemias|15809112|2019
1-4|8.1|11.2|9.6|151|I(b) Acute myeloid leukemias|15809112|2019
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15809112|2019
1-4|1.4|2.9|2.0|32|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15809112|2019
1-4|1.9|3.6|2.7|42|I(e) Unspecified and other specified leukemias|15809112|2019
1-4|13.1|17.0|14.9|236|II Lymphomas and reticuloendothelial neoplasms|15809112|2019
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15809112|2019
1-4|4.4|6.8|5.5|87|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15809112|2019
1-4|1.1|2.4|1.6|26|II(c) Burkitt lymphoma|15809112|2019
1-4|5.8|8.5|7.1|112|II(d) Miscellaneous lymphoreticular neoplasms|15809112|2019
1-4|~|~|~|~|II(e) Unspecified lymphomas|15809112|2019
1-4|30.7|36.5|33.5|530|III CNS and misc intracranial and intraspinal neoplasms|15809112|2019
1-4|4.3|6.6|5.4|85|III(a) Ependymomas and choroid plexus tumor|15809112|2019
1-4|14.0|18.0|15.9|251|III(b) Astrocytomas|15809112|2019
1-4|5.4|8.0|6.6|104|III(c) Intracranial and intraspinal embryonal tumors|15809112|2019
1-4|3.5|5.6|4.4|70|III(d) Other gliomas|15809112|2019
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15809112|2019
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15809112|2019
1-4|21.0|25.8|23.3|368|IV Neuroblastoma and other peripheral nervous cell tumors|15809112|2019
1-4|20.8|25.6|23.2|366|IV(a) Neuroblastoma and ganglioneuroblastoma|15809112|2019
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15809112|2019
1-4|10.0|13.4|11.6|183|IX Soft tissue and other extraosseous sarcomas|15809112|2019
1-4|6.5|9.3|7.8|123|IX(a) Rhabdomyosarcomas|15809112|2019
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15809112|2019
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15809112|2019
1-4|2.0|3.7|2.7|43|IX(d) Other specified soft tissue sarcomas|15809112|2019
1-4|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|15809112|2019
1-4|3.8|6.1|4.9|77|Not classified by ICCC|15809112|2019
1-4|6.4|9.1|7.7|121|V Retinoblastoma|15809112|2019
1-4|16.7|21.0|18.7|296|VI Renal tumors|15809112|2019
1-4|16.5|20.8|18.6|294|VI(a) Nephroblastoma and other nonepithelial renal tumors|15809112|2019
1-4|~|~|~|~|VI(b) Renal carcinomas|15809112|2019
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15809112|2019
1-4|5.1|7.7|6.3|100|VII Hepatic tumors|15809112|2019
1-4|4.9|7.4|6.1|96|VII(a) Hepatoblastoma|15809112|2019
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15809112|2019
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15809112|2019
1-4|1.0|2.3|1.5|24|VIII Malignant bone tumors|15809112|2019
1-4|~|~|~|~|VIII(a) Osteosarcomas|15809112|2019
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15809112|2019
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15809112|2019
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15809112|2019
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15809112|2019
1-4|2.5|4.3|3.3|52|X Germ cell, trophoblastic tumors & neoplasms of gonads|15809112|2019
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15809112|2019
1-4|0.8|2.0|1.3|21|X(b) Malignant extracranial & extragonadal germ cell tumors|15809112|2019
1-4|1.0|2.3|1.5|24|X(c) Malignant gonadal germ cell tumors|15809112|2019
1-4|~|~|~|~|X(d) Gonadal carcinomas|15809112|2019
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15809112|2019
1-4|1.2|2.6|1.8|28|XI Other malignant epithelial neoplasms and malignant melanomas|15809112|2019
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15809112|2019
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15809112|2019
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15809112|2019
1-4|0.7|1.9|1.2|19|XI(d) Malignant melanomas|15809112|2019
1-4|~|~|~|~|XI(e) Skin carcinomas|15809112|2019
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15809112|2019
1-4|0.7|1.8|1.1|18|XII Other and unspecified malignant neoplasms|15809112|2019
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15809112|2019
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15809112|2019
10-14|148.5|159.2|153.8|3202|All ICCC Groups Combined|20820053|2019
10-14|32.9|38.1|35.4|738|I Leukemias, myeloproliferative & myelodysplastic diseases|20820053|2019
10-14|21.5|25.7|23.5|489|I(a) Lymphoid leukemias|20820053|2019
10-14|6.6|9.1|7.8|162|I(b) Acute myeloid leukemias|20820053|2019
10-14|1.2|2.4|1.7|36|I(c) Chronic myeloproliferative diseases|20820053|2019
10-14|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20820053|2019
10-14|1.3|2.6|1.9|39|I(e) Unspecified and other specified leukemias|20820053|2019
10-14|26.5|31.2|28.8|599|II Lymphomas and reticuloendothelial neoplasms|20820053|2019
10-14|11.0|14.1|12.4|259|II(a) Hodgkin lymphomas|20820053|2019
10-14|8.5|11.3|9.8|205|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20820053|2019
10-14|2.3|3.8|3.0|62|II(c) Burkitt lymphoma|20820053|2019
10-14|2.4|4.0|3.1|65|II(d) Miscellaneous lymphoreticular neoplasms|20820053|2019
10-14|~|~|~|~|II(e) Unspecified lymphomas|20820053|2019
10-14|21.3|25.5|23.3|485|III CNS and misc intracranial and intraspinal neoplasms|20820053|2019
10-14|0.9|1.9|1.3|27|III(a) Ependymomas and choroid plexus tumor|20820053|2019
10-14|12.6|15.9|14.2|295|III(b) Astrocytomas|20820053|2019
10-14|1.7|3.1|2.4|49|III(c) Intracranial and intraspinal embryonal tumors|20820053|2019
10-14|3.7|5.6|4.6|96|III(d) Other gliomas|20820053|2019
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20820053|2019
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20820053|2019
10-14|1.2|2.3|1.7|35|IV Neuroblastoma and other peripheral nervous cell tumors|20820053|2019
10-14|1.0|2.1|1.4|30|IV(a) Neuroblastoma and ganglioneuroblastoma|20820053|2019
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20820053|2019
10-14|10.9|14.0|12.4|258|IX Soft tissue and other extraosseous sarcomas|20820053|2019
10-14|2.6|4.2|3.3|69|IX(a) Rhabdomyosarcomas|20820053|2019
10-14|0.9|1.9|1.3|27|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20820053|2019
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20820053|2019
10-14|4.7|6.8|5.7|118|IX(d) Other specified soft tissue sarcomas|20820053|2019
10-14|1.5|2.8|2.1|44|IX(e) Unspecified soft tissue sarcomas|20820053|2019
10-14|2.5|4.1|3.2|67|Not classified by ICCC|20820053|2019
10-14|~|~|~|~|V Retinoblastoma|20820053|2019
10-14|0.9|1.9|1.3|27|VI Renal tumors|20820053|2019
10-14|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20820053|2019
10-14|~|~|~|~|VI(b) Renal carcinomas|20820053|2019
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20820053|2019
10-14|0.5|1.4|0.9|18|VII Hepatic tumors|20820053|2019
10-14|~|~|~|~|VII(a) Hepatoblastoma|20820053|2019
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20820053|2019
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20820053|2019
10-14|13.6|17.0|15.2|317|VIII Malignant bone tumors|20820053|2019
10-14|8.3|11.0|9.6|200|VIII(a) Osteosarcomas|20820053|2019
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20820053|2019
10-14|3.4|5.3|4.3|89|VIII(c) Ewing tumor and related sarcomas of bone|20820053|2019
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20820053|2019
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20820053|2019
10-14|6.0|8.4|7.1|148|X Germ cell, trophoblastic tumors & neoplasms of gonads|20820053|2019
10-14|2.1|3.5|2.7|57|X(a) Intracranial & intraspinal germ cell tumors|20820053|2019
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20820053|2019
10-14|2.8|4.5|3.6|74|X(c) Malignant gonadal germ cell tumors|20820053|2019
10-14|~|~|~|~|X(d) Gonadal carcinomas|20820053|2019
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20820053|2019
10-14|21.9|26.2|24.0|499|XI Other malignant epithelial neoplasms and malignant melanomas|20820053|2019
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20820053|2019
10-14|8.4|11.1|9.7|202|XI(b) Thyroid carcinomas|20820053|2019
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20820053|2019
10-14|1.9|3.3|2.5|53|XI(d) Malignant melanomas|20820053|2019
10-14|~|~|~|~|XI(e) Skin carcinomas|20820053|2019
10-14|9.6|12.5|11.0|229|XI(f) Other and unspecified carcinomas|20820053|2019
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20820053|2019
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20820053|2019
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20820053|2019
15-19|238.4|251.9|245.1|5163|All ICCC Groups Combined|21066423|2019
15-19|32.9|38.0|35.4|746|I Leukemias, myeloproliferative & myelodysplastic diseases|21066423|2019
15-19|16.7|20.4|18.5|389|I(a) Lymphoid leukemias|21066423|2019
15-19|7.4|9.9|8.6|181|I(b) Acute myeloid leukemias|21066423|2019
15-19|4.4|6.4|5.3|112|I(c) Chronic myeloproliferative diseases|21066423|2019
15-19|0.8|1.8|1.2|26|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|21066423|2019
15-19|1.3|2.5|1.8|38|I(e) Unspecified and other specified leukemias|21066423|2019
15-19|51.0|57.3|54.1|1140|II Lymphomas and reticuloendothelial neoplasms|21066423|2019
15-19|30.4|35.3|32.8|691|II(a) Hodgkin lymphomas|21066423|2019
15-19|15.1|18.6|16.8|354|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|21066423|2019
15-19|1.2|2.4|1.8|37|II(c) Burkitt lymphoma|21066423|2019
15-19|1.7|3.0|2.3|48|II(d) Miscellaneous lymphoreticular neoplasms|21066423|2019
15-19|~|~|~|~|II(e) Unspecified lymphomas|21066423|2019
15-19|17.4|21.1|19.2|404|III CNS and misc intracranial and intraspinal neoplasms|21066423|2019
15-19|0.9|1.9|1.3|28|III(a) Ependymomas and choroid plexus tumor|21066423|2019
15-19|10.6|13.6|12.1|254|III(b) Astrocytomas|21066423|2019
15-19|0.8|1.8|1.2|25|III(c) Intracranial and intraspinal embryonal tumors|21066423|2019
15-19|3.1|4.8|3.8|81|III(d) Other gliomas|21066423|2019
15-19|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|21066423|2019
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|21066423|2019
15-19|0.8|1.9|1.3|27|IV Neuroblastoma and other peripheral nervous cell tumors|21066423|2019
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|21066423|2019
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|21066423|2019
15-19|15.8|19.4|17.6|370|IX Soft tissue and other extraosseous sarcomas|21066423|2019
15-19|2.6|4.2|3.3|70|IX(a) Rhabdomyosarcomas|21066423|2019
15-19|1.4|2.6|1.9|41|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|21066423|2019
15-19|~|~|~|~|IX(c) Kaposi sarcoma|21066423|2019
15-19|8.0|10.7|9.3|195|IX(d) Other specified soft tissue sarcomas|21066423|2019
15-19|2.1|3.6|2.8|59|IX(e) Unspecified soft tissue sarcomas|21066423|2019
15-19|2.0|3.5|2.7|56|Not classified by ICCC|21066423|2019
15-19|~|~|~|~|V Retinoblastoma|21066423|2019
15-19|1.8|3.2|2.4|51|VI Renal tumors|21066423|2019
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|21066423|2019
15-19|1.6|2.9|2.2|46|VI(b) Renal carcinomas|21066423|2019
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|21066423|2019
15-19|0.9|1.9|1.3|28|VII Hepatic tumors|21066423|2019
15-19|~|~|~|~|VII(a) Hepatoblastoma|21066423|2019
15-19|0.8|1.9|1.3|27|VII(b) Hepatic carcinomas|21066423|2019
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|21066423|2019
15-19|12.2|15.4|13.7|289|VIII Malignant bone tumors|21066423|2019
15-19|6.3|8.7|7.4|156|VIII(a) Osteosarcomas|21066423|2019
15-19|0.6|1.5|0.9|20|VIII(b) Chondrosarcomas|21066423|2019
15-19|3.5|5.3|4.3|91|VIII(c) Ewing tumor and related sarcomas of bone|21066423|2019
15-19|0.5|1.3|0.8|17|VIII(d) Other specified malignant bone tumors|21066423|2019
15-19|~|~|~|~|VIII(e) Unspecified malignant bone tumors|21066423|2019
15-19|24.9|29.4|27.1|571|X Germ cell, trophoblastic tumors & neoplasms of gonads|21066423|2019
15-19|2.4|3.9|3.1|65|X(a) Intracranial & intraspinal germ cell tumors|21066423|2019
15-19|1.4|2.7|2.0|42|X(b) Malignant extracranial & extragonadal germ cell tumors|21066423|2019
15-19|18.2|22.1|20.1|423|X(c) Malignant gonadal germ cell tumors|21066423|2019
15-19|0.8|1.9|1.3|27|X(d) Gonadal carcinomas|21066423|2019
15-19|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|21066423|2019
15-19|65.7|72.9|69.3|1459|XI Other malignant epithelial neoplasms and malignant melanomas|21066423|2019
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|21066423|2019
15-19|32.8|37.9|35.3|744|XI(b) Thyroid carcinomas|21066423|2019
15-19|0.9|2.0|1.4|29|XI(c) Nasopharyngeal carcinomas|21066423|2019
15-19|6.7|9.2|7.9|166|XI(d) Malignant melanomas|21066423|2019
15-19|~|~|~|~|XI(e) Skin carcinomas|21066423|2019
15-19|22.1|26.4|24.2|509|XI(f) Other and unspecified carcinomas|21066423|2019
15-19|0.6|1.5|1.0|21|XII Other and unspecified malignant neoplasms|21066423|2019
15-19|~|~|~|~|XII(a) Other specified malignant tumors|21066423|2019
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|21066423|2019
5-9|120.2|130.0|125.0|2528|All ICCC Groups Combined|20221753|2019
5-9|40.1|45.8|42.9|867|I Leukemias, myeloproliferative & myelodysplastic diseases|20221753|2019
5-9|32.5|37.7|35.1|709|I(a) Lymphoid leukemias|20221753|2019
5-9|3.7|5.6|4.5|92|I(b) Acute myeloid leukemias|20221753|2019
5-9|~|~|~|~|I(c) Chronic myeloproliferative diseases|20221753|2019
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20221753|2019
5-9|1.4|2.7|2.0|40|I(e) Unspecified and other specified leukemias|20221753|2019
5-9|15.4|19.0|17.1|346|II Lymphomas and reticuloendothelial neoplasms|20221753|2019
5-9|2.8|4.5|3.6|72|II(a) Hodgkin lymphomas|20221753|2019
5-9|5.8|8.2|6.9|140|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20221753|2019
5-9|2.0|3.4|2.6|53|II(c) Burkitt lymphoma|20221753|2019
5-9|3.2|5.0|4.0|81|II(d) Miscellaneous lymphoreticular neoplasms|20221753|2019
5-9|~|~|~|~|II(e) Unspecified lymphomas|20221753|2019
5-9|24.4|29.0|26.6|538|III CNS and misc intracranial and intraspinal neoplasms|20221753|2019
5-9|1.3|2.6|1.9|38|III(a) Ependymomas and choroid plexus tumor|20221753|2019
5-9|12.9|16.2|14.5|293|III(b) Astrocytomas|20221753|2019
5-9|3.6|5.5|4.5|90|III(c) Intracranial and intraspinal embryonal tumors|20221753|2019
5-9|4.1|6.1|5.0|101|III(d) Other gliomas|20221753|2019
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20221753|2019
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20221753|2019
5-9|3.2|5.0|4.1|82|IV Neuroblastoma and other peripheral nervous cell tumors|20221753|2019
5-9|3.2|5.0|4.0|81|IV(a) Neuroblastoma and ganglioneuroblastoma|20221753|2019
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20221753|2019
5-9|7.1|9.7|8.3|168|IX Soft tissue and other extraosseous sarcomas|20221753|2019
5-9|3.5|5.4|4.4|88|IX(a) Rhabdomyosarcomas|20221753|2019
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20221753|2019
5-9|~|~|~|~|IX(c) Kaposi sarcoma|20221753|2019
5-9|1.6|2.9|2.2|44|IX(d) Other specified soft tissue sarcomas|20221753|2019
5-9|0.9|1.9|1.3|27|IX(e) Unspecified soft tissue sarcomas|20221753|2019
5-9|4.7|6.8|5.6|114|Not classified by ICCC|20221753|2019
5-9|~|~|~|~|V Retinoblastoma|20221753|2019
5-9|4.0|6.0|4.9|100|VI Renal tumors|20221753|2019
5-9|3.7|5.6|4.6|93|VI(a) Nephroblastoma and other nonepithelial renal tumors|20221753|2019
5-9|~|~|~|~|VI(b) Renal carcinomas|20221753|2019
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|20221753|2019
5-9|0.6|1.5|0.9|19|VII Hepatic tumors|20221753|2019
5-9|~|~|~|~|VII(a) Hepatoblastoma|20221753|2019
5-9|~|~|~|~|VII(b) Hepatic carcinomas|20221753|2019
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20221753|2019
5-9|5.2|7.4|6.2|126|VIII Malignant bone tumors|20221753|2019
5-9|2.8|4.5|3.6|72|VIII(a) Osteosarcomas|20221753|2019
5-9|~|~|~|~|VIII(b) Chondrosarcomas|20221753|2019
5-9|1.4|2.7|2.0|40|VIII(c) Ewing tumor and related sarcomas of bone|20221753|2019
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|20221753|2019
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20221753|2019
5-9|2.3|3.9|3.0|61|X Germ cell, trophoblastic tumors & neoplasms of gonads|20221753|2019
5-9|0.8|1.8|1.2|25|X(a) Intracranial & intraspinal germ cell tumors|20221753|2019
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20221753|2019
5-9|1.0|2.1|1.4|29|X(c) Malignant gonadal germ cell tumors|20221753|2019
5-9|~|~|~|~|X(d) Gonadal carcinomas|20221753|2019
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20221753|2019
5-9|3.6|5.5|4.5|91|XI Other malignant epithelial neoplasms and malignant melanomas|20221753|2019
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|20221753|2019
5-9|1.2|2.5|1.8|36|XI(b) Thyroid carcinomas|20221753|2019
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20221753|2019
5-9|0.6|1.6|1.0|21|XI(d) Malignant melanomas|20221753|2019
5-9|~|~|~|~|XI(e) Skin carcinomas|20221753|2019
5-9|1.1|2.2|1.6|32|XI(f) Other and unspecified carcinomas|20221753|2019
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|20221753|2019
5-9|~|~|~|~|XII(a) Other specified malignant tumors|20221753|2019
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|20221753|2019
<1|243.4|276.2|259.4|976|All ICCC Groups Combined|3762227|2019
<1|39.1|53.1|45.7|172|I Leukemias, myeloproliferative & myelodysplastic diseases|3762227|2019
<1|14.5|23.5|18.6|70|I(a) Lymphoid leukemias|3762227|2019
<1|12.6|21.1|16.5|62|I(b) Acute myeloid leukemias|3762227|2019
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3762227|2019
<1|3.2|8.2|5.3|20|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3762227|2019
<1|~|~|~|~|I(e) Unspecified and other specified leukemias|3762227|2019
<1|15.0|24.1|19.1|72|II Lymphomas and reticuloendothelial neoplasms|3762227|2019
<1|~|~|~|~|II(a) Hodgkin lymphomas|3762227|2019
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3762227|2019
<1|~|~|~|~|II(c) Burkitt lymphoma|3762227|2019
<1|13.1|21.7|17.0|64|II(d) Miscellaneous lymphoreticular neoplasms|3762227|2019
<1|~|~|~|~|II(e) Unspecified lymphomas|3762227|2019
<1|22.1|32.9|27.1|102|III CNS and misc intracranial and intraspinal neoplasms|3762227|2019
<1|2.8|7.6|4.8|18|III(a) Ependymomas and choroid plexus tumor|3762227|2019
<1|7.1|13.9|10.1|38|III(b) Astrocytomas|3762227|2019
<1|4.5|10.1|6.9|26|III(c) Intracranial and intraspinal embryonal tumors|3762227|2019
<1|~|~|~|~|III(d) Other gliomas|3762227|2019
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3762227|2019
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3762227|2019
<1|49.8|65.3|57.1|215|IV Neuroblastoma and other peripheral nervous cell tumors|3762227|2019
<1|49.8|65.3|57.1|215|IV(a) Neuroblastoma and ganglioneuroblastoma|3762227|2019
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3762227|2019
<1|15.2|24.4|19.4|73|IX Soft tissue and other extraosseous sarcomas|3762227|2019
<1|3.5|8.5|5.6|21|IX(a) Rhabdomyosarcomas|3762227|2019
<1|3.0|7.9|5.1|19|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3762227|2019
<1|~|~|~|~|IX(c) Kaposi sarcoma|3762227|2019
<1|3.9|9.2|6.1|23|IX(d) Other specified soft tissue sarcomas|3762227|2019
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3762227|2019
<1|~|~|~|~|Not classified by ICCC|3762227|2019
<1|22.3|33.2|27.4|103|V Retinoblastoma|3762227|2019
<1|11.0|19.0|14.6|55|VI Renal tumors|3762227|2019
<1|10.6|18.4|14.1|53|VI(a) Nephroblastoma and other nonepithelial renal tumors|3762227|2019
<1|~|~|~|~|VI(b) Renal carcinomas|3762227|2019
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3762227|2019
<1|11.5|19.6|15.2|57|VII Hepatic tumors|3762227|2019
<1|11.0|19.0|14.6|55|VII(a) Hepatoblastoma|3762227|2019
<1|~|~|~|~|VII(b) Hepatic carcinomas|3762227|2019
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3762227|2019
<1|~|~|~|~|VIII Malignant bone tumors|3762227|2019
<1|~|~|~|~|VIII(a) Osteosarcomas|3762227|2019
<1|~|~|~|~|VIII(b) Chondrosarcomas|3762227|2019
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3762227|2019
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3762227|2019
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3762227|2019
<1|14.3|23.2|18.3|69|X Germ cell, trophoblastic tumors & neoplasms of gonads|3762227|2019
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3762227|2019
<1|10.1|17.8|13.6|51|X(b) Malignant extracranial & extragonadal germ cell tumors|3762227|2019
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3762227|2019
<1|~|~|~|~|X(d) Gonadal carcinomas|3762227|2019
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3762227|2019
<1|6.7|13.2|9.6|36|XI Other malignant epithelial neoplasms and malignant melanomas|3762227|2019
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3762227|2019
<1|~|~|~|~|XI(b) Thyroid carcinomas|3762227|2019
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3762227|2019
<1|2.4|6.9|4.3|16|XI(d) Malignant melanomas|3762227|2019
<1|~|~|~|~|XI(e) Skin carcinomas|3762227|2019
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3762227|2019
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3762227|2019
<1|~|~|~|~|XII(a) Other specified malignant tumors|3762227|2019
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3762227|2019
1-4|202.1|216.7|209.3|3157|All ICCC Groups Combined|15082362|2020
1-4|81.9|91.3|86.5|1305|I Leukemias, myeloproliferative & myelodysplastic diseases|15082362|2020
1-4|68.4|77.0|72.6|1095|I(a) Lymphoid leukemias|15082362|2020
1-4|7.1|10.1|8.5|128|I(b) Acute myeloid leukemias|15082362|2020
1-4|~|~|~|~|I(c) Chronic myeloproliferative diseases|15082362|2020
1-4|0.8|2.0|1.3|19|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|15082362|2020
1-4|2.8|4.8|3.7|56|I(e) Unspecified and other specified leukemias|15082362|2020
1-4|13.0|16.9|14.9|224|II Lymphomas and reticuloendothelial neoplasms|15082362|2020
1-4|~|~|~|~|II(a) Hodgkin lymphomas|15082362|2020
1-4|3.8|6.1|4.8|73|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|15082362|2020
1-4|1.9|3.6|2.7|40|II(c) Burkitt lymphoma|15082362|2020
1-4|5.5|8.1|6.7|101|II(d) Miscellaneous lymphoreticular neoplasms|15082362|2020
1-4|~|~|~|~|II(e) Unspecified lymphomas|15082362|2020
1-4|27.4|33.0|30.1|454|III CNS and misc intracranial and intraspinal neoplasms|15082362|2020
1-4|3.8|6.1|4.8|73|III(a) Ependymomas and choroid plexus tumor|15082362|2020
1-4|11.7|15.5|13.5|204|III(b) Astrocytomas|15082362|2020
1-4|5.3|7.9|6.5|98|III(c) Intracranial and intraspinal embryonal tumors|15082362|2020
1-4|2.9|4.9|3.8|57|III(d) Other gliomas|15082362|2020
1-4|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|15082362|2020
1-4|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|15082362|2020
1-4|19.6|24.4|21.9|330|IV Neuroblastoma and other peripheral nervous cell tumors|15082362|2020
1-4|19.5|24.3|21.8|329|IV(a) Neuroblastoma and ganglioneuroblastoma|15082362|2020
1-4|~|~|~|~|IV(b) Other peripheral nervous cell tumors|15082362|2020
1-4|8.6|11.9|10.1|153|IX Soft tissue and other extraosseous sarcomas|15082362|2020
1-4|5.8|8.6|7.1|107|IX(a) Rhabdomyosarcomas|15082362|2020
1-4|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|15082362|2020
1-4|~|~|~|~|IX(c) Kaposi sarcoma|15082362|2020
1-4|1.0|2.3|1.5|23|IX(d) Other specified soft tissue sarcomas|15082362|2020
1-4|0.7|1.9|1.2|18|IX(e) Unspecified soft tissue sarcomas|15082362|2020
1-4|3.3|5.5|4.3|65|Not classified by ICCC|15082362|2020
1-4|6.4|9.3|7.8|117|V Retinoblastoma|15082362|2020
1-4|18.3|22.9|20.5|309|VI Renal tumors|15082362|2020
1-4|18.0|22.6|20.2|305|VI(a) Nephroblastoma and other nonepithelial renal tumors|15082362|2020
1-4|~|~|~|~|VI(b) Renal carcinomas|15082362|2020
1-4|~|~|~|~|VI(c) Unspecified malignant renal tumors|15082362|2020
1-4|5.6|8.3|6.8|103|VII Hepatic tumors|15082362|2020
1-4|5.3|8.0|6.6|99|VII(a) Hepatoblastoma|15082362|2020
1-4|~|~|~|~|VII(b) Hepatic carcinomas|15082362|2020
1-4|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|15082362|2020
1-4|0.8|2.0|1.3|19|VIII Malignant bone tumors|15082362|2020
1-4|~|~|~|~|VIII(a) Osteosarcomas|15082362|2020
1-4|~|~|~|~|VIII(b) Chondrosarcomas|15082362|2020
1-4|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|15082362|2020
1-4|~|~|~|~|VIII(d) Other specified malignant bone tumors|15082362|2020
1-4|~|~|~|~|VIII(e) Unspecified malignant bone tumors|15082362|2020
1-4|1.9|3.6|2.7|40|X Germ cell, trophoblastic tumors & neoplasms of gonads|15082362|2020
1-4|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|15082362|2020
1-4|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|15082362|2020
1-4|0.9|2.2|1.5|22|X(c) Malignant gonadal germ cell tumors|15082362|2020
1-4|~|~|~|~|X(d) Gonadal carcinomas|15082362|2020
1-4|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|15082362|2020
1-4|0.8|2.0|1.3|20|XI Other malignant epithelial neoplasms and malignant melanomas|15082362|2020
1-4|~|~|~|~|XI(a) Adrenocortical carcinomas|15082362|2020
1-4|~|~|~|~|XI(b) Thyroid carcinomas|15082362|2020
1-4|~|~|~|~|XI(c) Nasopharyngeal carcinomas|15082362|2020
1-4|~|~|~|~|XI(d) Malignant melanomas|15082362|2020
1-4|~|~|~|~|XI(e) Skin carcinomas|15082362|2020
1-4|~|~|~|~|XI(f) Other and unspecified carcinomas|15082362|2020
1-4|0.7|1.9|1.2|18|XII Other and unspecified malignant neoplasms|15082362|2020
1-4|~|~|~|~|XII(a) Other specified malignant tumors|15082362|2020
1-4|~|~|~|~|XII(b) Other unspecified malignant tumors|15082362|2020
10-14|136.9|147.4|142.1|2857|All ICCC Groups Combined|20107666|2020
10-14|31.9|37.1|34.5|693|I Leukemias, myeloproliferative & myelodysplastic diseases|20107666|2020
10-14|21.7|26.1|23.8|479|I(a) Lymphoid leukemias|20107666|2020
10-14|6.1|8.5|7.2|145|I(b) Acute myeloid leukemias|20107666|2020
10-14|1.0|2.2|1.5|31|I(c) Chronic myeloproliferative diseases|20107666|2020
10-14|0.5|1.4|0.8|17|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20107666|2020
10-14|0.6|1.6|1.0|21|I(e) Unspecified and other specified leukemias|20107666|2020
10-14|24.6|29.2|26.8|539|II Lymphomas and reticuloendothelial neoplasms|20107666|2020
10-14|10.3|13.3|11.7|236|II(a) Hodgkin lymphomas|20107666|2020
10-14|9.0|11.9|10.4|209|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20107666|2020
10-14|1.5|2.8|2.1|42|II(c) Burkitt lymphoma|20107666|2020
10-14|1.7|3.1|2.3|46|II(d) Miscellaneous lymphoreticular neoplasms|20107666|2020
10-14|~|~|~|~|II(e) Unspecified lymphomas|20107666|2020
10-14|19.5|23.6|21.4|431|III CNS and misc intracranial and intraspinal neoplasms|20107666|2020
10-14|0.6|1.6|1.0|21|III(a) Ependymomas and choroid plexus tumor|20107666|2020
10-14|10.4|13.5|11.9|239|III(b) Astrocytomas|20107666|2020
10-14|1.7|3.1|2.3|46|III(c) Intracranial and intraspinal embryonal tumors|20107666|2020
10-14|4.0|6.0|5.0|100|III(d) Other gliomas|20107666|2020
10-14|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|20107666|2020
10-14|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20107666|2020
10-14|0.6|1.5|0.9|19|IV Neuroblastoma and other peripheral nervous cell tumors|20107666|2020
10-14|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20107666|2020
10-14|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20107666|2020
10-14|10.7|13.8|12.1|244|IX Soft tissue and other extraosseous sarcomas|20107666|2020
10-14|3.2|5.0|4.0|81|IX(a) Rhabdomyosarcomas|20107666|2020
10-14|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20107666|2020
10-14|~|~|~|~|IX(c) Kaposi sarcoma|20107666|2020
10-14|5.0|7.2|6.0|121|IX(d) Other specified soft tissue sarcomas|20107666|2020
10-14|1.0|2.1|1.5|30|IX(e) Unspecified soft tissue sarcomas|20107666|2020
10-14|2.6|4.2|3.3|67|Not classified by ICCC|20107666|2020
10-14|~|~|~|~|V Retinoblastoma|20107666|2020
10-14|1.0|2.2|1.5|31|VI Renal tumors|20107666|2020
10-14|0.5|1.4|0.8|17|VI(a) Nephroblastoma and other nonepithelial renal tumors|20107666|2020
10-14|~|~|~|~|VI(b) Renal carcinomas|20107666|2020
10-14|~|~|~|~|VI(c) Unspecified malignant renal tumors|20107666|2020
10-14|0.5|1.4|0.8|17|VII Hepatic tumors|20107666|2020
10-14|~|~|~|~|VII(a) Hepatoblastoma|20107666|2020
10-14|~|~|~|~|VII(b) Hepatic carcinomas|20107666|2020
10-14|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20107666|2020
10-14|10.9|14.1|12.4|250|VIII Malignant bone tumors|20107666|2020
10-14|6.8|9.3|8.0|161|VIII(a) Osteosarcomas|20107666|2020
10-14|~|~|~|~|VIII(b) Chondrosarcomas|20107666|2020
10-14|2.8|4.5|3.6|72|VIII(c) Ewing tumor and related sarcomas of bone|20107666|2020
10-14|~|~|~|~|VIII(d) Other specified malignant bone tumors|20107666|2020
10-14|~|~|~|~|VIII(e) Unspecified malignant bone tumors|20107666|2020
10-14|6.9|9.5|8.1|163|X Germ cell, trophoblastic tumors & neoplasms of gonads|20107666|2020
10-14|1.8|3.3|2.5|50|X(a) Intracranial & intraspinal germ cell tumors|20107666|2020
10-14|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|20107666|2020
10-14|3.7|5.6|4.6|92|X(c) Malignant gonadal germ cell tumors|20107666|2020
10-14|~|~|~|~|X(d) Gonadal carcinomas|20107666|2020
10-14|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|20107666|2020
10-14|17.7|21.6|19.6|394|XI Other malignant epithelial neoplasms and malignant melanomas|20107666|2020
10-14|~|~|~|~|XI(a) Adrenocortical carcinomas|20107666|2020
10-14|6.3|8.8|7.5|150|XI(b) Thyroid carcinomas|20107666|2020
10-14|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20107666|2020
10-14|1.5|2.8|2.1|42|XI(d) Malignant melanomas|20107666|2020
10-14|~|~|~|~|XI(e) Skin carcinomas|20107666|2020
10-14|8.1|10.8|9.3|188|XI(f) Other and unspecified carcinomas|20107666|2020
10-14|~|~|~|~|XII Other and unspecified malignant neoplasms|20107666|2020
10-14|~|~|~|~|XII(a) Other specified malignant tumors|20107666|2020
10-14|~|~|~|~|XII(b) Other unspecified malignant tumors|20107666|2020
15-19|221.4|234.6|227.9|4632|All ICCC Groups Combined|20322846|2020
15-19|30.9|36.0|33.4|678|I Leukemias, myeloproliferative & myelodysplastic diseases|20322846|2020
15-19|16.0|19.7|17.8|361|I(a) Lymphoid leukemias|20322846|2020
15-19|7.1|9.7|8.3|169|I(b) Acute myeloid leukemias|20322846|2020
15-19|4.0|5.9|4.9|99|I(c) Chronic myeloproliferative diseases|20322846|2020
15-19|0.5|1.4|0.9|18|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|20322846|2020
15-19|1.0|2.2|1.5|31|I(e) Unspecified and other specified leukemias|20322846|2020
15-19|47.6|53.8|50.6|1029|II Lymphomas and reticuloendothelial neoplasms|20322846|2020
15-19|28.1|33.0|30.5|619|II(a) Hodgkin lymphomas|20322846|2020
15-19|14.3|17.8|15.9|324|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|20322846|2020
15-19|1.7|3.1|2.3|47|II(c) Burkitt lymphoma|20322846|2020
15-19|0.8|1.9|1.3|26|II(d) Miscellaneous lymphoreticular neoplasms|20322846|2020
15-19|~|~|~|~|II(e) Unspecified lymphomas|20322846|2020
15-19|18.2|22.1|20.1|408|III CNS and misc intracranial and intraspinal neoplasms|20322846|2020
15-19|0.9|2.0|1.4|28|III(a) Ependymomas and choroid plexus tumor|20322846|2020
15-19|9.9|12.8|11.3|229|III(b) Astrocytomas|20322846|2020
15-19|1.2|2.3|1.7|34|III(c) Intracranial and intraspinal embryonal tumors|20322846|2020
15-19|3.4|5.2|4.2|86|III(d) Other gliomas|20322846|2020
15-19|0.5|1.3|0.8|17|III(e) Other specified intracranial & intraspinal neoplasms|20322846|2020
15-19|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|20322846|2020
15-19|0.7|1.6|1.1|22|IV Neuroblastoma and other peripheral nervous cell tumors|20322846|2020
15-19|~|~|~|~|IV(a) Neuroblastoma and ganglioneuroblastoma|20322846|2020
15-19|~|~|~|~|IV(b) Other peripheral nervous cell tumors|20322846|2020
15-19|13.9|17.4|15.6|317|IX Soft tissue and other extraosseous sarcomas|20322846|2020
15-19|3.5|5.3|4.3|88|IX(a) Rhabdomyosarcomas|20322846|2020
15-19|0.7|1.7|1.1|23|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|20322846|2020
15-19|~|~|~|~|IX(c) Kaposi sarcoma|20322846|2020
15-19|6.6|9.1|7.8|158|IX(d) Other specified soft tissue sarcomas|20322846|2020
15-19|1.6|2.9|2.2|44|IX(e) Unspecified soft tissue sarcomas|20322846|2020
15-19|2.1|3.6|2.8|56|Not classified by ICCC|20322846|2020
15-19|~|~|~|~|V Retinoblastoma|20322846|2020
15-19|1.5|2.9|2.1|43|VI Renal tumors|20322846|2020
15-19|~|~|~|~|VI(a) Nephroblastoma and other nonepithelial renal tumors|20322846|2020
15-19|1.3|2.5|1.8|37|VI(b) Renal carcinomas|20322846|2020
15-19|~|~|~|~|VI(c) Unspecified malignant renal tumors|20322846|2020
15-19|0.9|2.0|1.4|28|VII Hepatic tumors|20322846|2020
15-19|~|~|~|~|VII(a) Hepatoblastoma|20322846|2020
15-19|0.9|1.9|1.3|27|VII(b) Hepatic carcinomas|20322846|2020
15-19|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|20322846|2020
15-19|13.3|16.7|14.9|303|VIII Malignant bone tumors|20322846|2020
15-19|7.0|9.5|8.2|166|VIII(a) Osteosarcomas|20322846|2020
15-19|0.6|1.5|0.9|19|VIII(b) Chondrosarcomas|20322846|2020
15-19|3.5|5.3|4.3|88|VIII(c) Ewing tumor and related sarcomas of bone|20322846|2020
15-19|~|~|~|~|VIII(d) Other specified malignant bone tumors|20322846|2020
15-19|0.5|1.3|0.8|16|VIII(e) Unspecified malignant bone tumors|20322846|2020
15-19|24.9|29.5|27.1|551|X Germ cell, trophoblastic tumors & neoplasms of gonads|20322846|2020
15-19|2.3|3.8|3.0|60|X(a) Intracranial & intraspinal germ cell tumors|20322846|2020
15-19|0.6|1.5|1.0|20|X(b) Malignant extracranial & extragonadal germ cell tumors|20322846|2020
15-19|19.2|23.3|21.2|430|X(c) Malignant gonadal germ cell tumors|20322846|2020
15-19|0.5|1.4|0.9|18|X(d) Gonadal carcinomas|20322846|2020
15-19|0.7|1.7|1.1|23|X(e) Other and unspecified malignant gonadal tumors|20322846|2020
15-19|54.5|61.2|57.8|1174|XI Other malignant epithelial neoplasms and malignant melanomas|20322846|2020
15-19|~|~|~|~|XI(a) Adrenocortical carcinomas|20322846|2020
15-19|25.7|30.3|27.9|568|XI(b) Thyroid carcinomas|20322846|2020
15-19|~|~|~|~|XI(c) Nasopharyngeal carcinomas|20322846|2020
15-19|5.7|8.0|6.8|138|XI(d) Malignant melanomas|20322846|2020
15-19|~|~|~|~|XI(e) Skin carcinomas|20322846|2020
15-19|20.0|24.1|21.9|446|XI(f) Other and unspecified carcinomas|20322846|2020
15-19|0.7|1.7|1.1|23|XII Other and unspecified malignant neoplasms|20322846|2020
15-19|~|~|~|~|XII(a) Other specified malignant tumors|20322846|2020
15-19|~|~|~|~|XII(b) Other unspecified malignant tumors|20322846|2020
5-9|116.5|126.3|121.3|2379|All ICCC Groups Combined|19608494|2020
5-9|41.2|47.2|44.1|865|I Leukemias, myeloproliferative & myelodysplastic diseases|19608494|2020
5-9|34.2|39.6|36.8|722|I(a) Lymphoid leukemias|19608494|2020
5-9|3.3|5.1|4.1|81|I(b) Acute myeloid leukemias|19608494|2020
5-9|0.5|1.5|0.9|18|I(c) Chronic myeloproliferative diseases|19608494|2020
5-9|~|~|~|~|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|19608494|2020
5-9|1.1|2.3|1.6|32|I(e) Unspecified and other specified leukemias|19608494|2020
5-9|15.0|18.6|16.7|328|II Lymphomas and reticuloendothelial neoplasms|19608494|2020
5-9|2.6|4.2|3.3|65|II(a) Hodgkin lymphomas|19608494|2020
5-9|5.7|8.0|6.8|133|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|19608494|2020
5-9|2.3|3.9|3.1|60|II(c) Burkitt lymphoma|19608494|2020
5-9|2.6|4.3|3.4|67|II(d) Miscellaneous lymphoreticular neoplasms|19608494|2020
5-9|~|~|~|~|II(e) Unspecified lymphomas|19608494|2020
5-9|22.2|26.6|24.3|477|III CNS and misc intracranial and intraspinal neoplasms|19608494|2020
5-9|1.2|2.4|1.7|33|III(a) Ependymomas and choroid plexus tumor|19608494|2020
5-9|11.1|14.3|12.6|248|III(b) Astrocytomas|19608494|2020
5-9|3.6|5.6|4.5|89|III(c) Intracranial and intraspinal embryonal tumors|19608494|2020
5-9|3.7|5.7|4.6|91|III(d) Other gliomas|19608494|2020
5-9|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|19608494|2020
5-9|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|19608494|2020
5-9|3.0|4.8|3.8|75|IV Neuroblastoma and other peripheral nervous cell tumors|19608494|2020
5-9|2.9|4.6|3.7|72|IV(a) Neuroblastoma and ganglioneuroblastoma|19608494|2020
5-9|~|~|~|~|IV(b) Other peripheral nervous cell tumors|19608494|2020
5-9|6.9|9.5|8.2|160|IX Soft tissue and other extraosseous sarcomas|19608494|2020
5-9|3.9|5.9|4.8|94|IX(a) Rhabdomyosarcomas|19608494|2020
5-9|~|~|~|~|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|19608494|2020
5-9|~|~|~|~|IX(c) Kaposi sarcoma|19608494|2020
5-9|1.3|2.6|1.9|37|IX(d) Other specified soft tissue sarcomas|19608494|2020
5-9|0.6|1.6|1.0|20|IX(e) Unspecified soft tissue sarcomas|19608494|2020
5-9|4.7|6.9|5.8|113|Not classified by ICCC|19608494|2020
5-9|~|~|~|~|V Retinoblastoma|19608494|2020
5-9|5.4|7.7|6.5|127|VI Renal tumors|19608494|2020
5-9|4.8|7.0|5.9|115|VI(a) Nephroblastoma and other nonepithelial renal tumors|19608494|2020
5-9|~|~|~|~|VI(b) Renal carcinomas|19608494|2020
5-9|~|~|~|~|VI(c) Unspecified malignant renal tumors|19608494|2020
5-9|0.5|1.4|0.9|17|VII Hepatic tumors|19608494|2020
5-9|~|~|~|~|VII(a) Hepatoblastoma|19608494|2020
5-9|~|~|~|~|VII(b) Hepatic carcinomas|19608494|2020
5-9|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|19608494|2020
5-9|4.4|6.5|5.4|106|VIII Malignant bone tumors|19608494|2020
5-9|2.2|3.8|3.0|58|VIII(a) Osteosarcomas|19608494|2020
5-9|~|~|~|~|VIII(b) Chondrosarcomas|19608494|2020
5-9|1.6|3.0|2.2|44|VIII(c) Ewing tumor and related sarcomas of bone|19608494|2020
5-9|~|~|~|~|VIII(d) Other specified malignant bone tumors|19608494|2020
5-9|~|~|~|~|VIII(e) Unspecified malignant bone tumors|19608494|2020
5-9|1.3|2.5|1.8|36|X Germ cell, trophoblastic tumors & neoplasms of gonads|19608494|2020
5-9|0.5|1.5|0.9|18|X(a) Intracranial & intraspinal germ cell tumors|19608494|2020
5-9|~|~|~|~|X(b) Malignant extracranial & extragonadal germ cell tumors|19608494|2020
5-9|0.5|1.3|0.8|16|X(c) Malignant gonadal germ cell tumors|19608494|2020
5-9|~|~|~|~|X(d) Gonadal carcinomas|19608494|2020
5-9|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|19608494|2020
5-9|2.6|4.2|3.3|65|XI Other malignant epithelial neoplasms and malignant melanomas|19608494|2020
5-9|~|~|~|~|XI(a) Adrenocortical carcinomas|19608494|2020
5-9|~|~|~|~|XI(b) Thyroid carcinomas|19608494|2020
5-9|~|~|~|~|XI(c) Nasopharyngeal carcinomas|19608494|2020
5-9|~|~|~|~|XI(d) Malignant melanomas|19608494|2020
5-9|~|~|~|~|XI(e) Skin carcinomas|19608494|2020
5-9|1.3|2.5|1.8|36|XI(f) Other and unspecified carcinomas|19608494|2020
5-9|~|~|~|~|XII Other and unspecified malignant neoplasms|19608494|2020
5-9|~|~|~|~|XII(a) Other specified malignant tumors|19608494|2020
5-9|~|~|~|~|XII(b) Other unspecified malignant tumors|19608494|2020
<1|234.9|267.8|250.9|908|All ICCC Groups Combined|3618856|2020
<1|34.8|48.3|41.2|149|I Leukemias, myeloproliferative & myelodysplastic diseases|3618856|2020
<1|12.4|21.0|16.3|59|I(a) Lymphoid leukemias|3618856|2020
<1|10.5|18.5|14.1|51|I(b) Acute myeloid leukemias|3618856|2020
<1|~|~|~|~|I(c) Chronic myeloproliferative diseases|3618856|2020
<1|3.2|8.2|5.3|19|I(d) Myelodysplastic syndrome and other myeloproliferative diseases|3618856|2020
<1|2.5|7.2|4.4|16|I(e) Unspecified and other specified leukemias|3618856|2020
<1|11.7|20.1|15.5|56|II Lymphomas and reticuloendothelial neoplasms|3618856|2020
<1|~|~|~|~|II(a) Hodgkin lymphomas|3618856|2020
<1|~|~|~|~|II(b) Non-Hodgkin lymphomas (except Burkitt lymphoma)|3618856|2020
<1|~|~|~|~|II(c) Burkitt lymphoma|3618856|2020
<1|8.6|16.0|11.9|43|II(d) Miscellaneous lymphoreticular neoplasms|3618856|2020
<1|~|~|~|~|II(e) Unspecified lymphomas|3618856|2020
<1|27.0|39.0|32.6|118|III CNS and misc intracranial and intraspinal neoplasms|3618856|2020
<1|~|~|~|~|III(a) Ependymomas and choroid plexus tumor|3618856|2020
<1|6.3|12.8|9.1|33|III(b) Astrocytomas|3618856|2020
<1|7.9|15.1|11.1|40|III(c) Intracranial and intraspinal embryonal tumors|3618856|2020
<1|3.2|8.2|5.3|19|III(d) Other gliomas|3618856|2020
<1|~|~|~|~|III(e) Other specified intracranial & intraspinal neoplasms|3618856|2020
<1|~|~|~|~|III(f) Unspecified intracranial and intraspinal neoplasms|3618856|2020
<1|53.3|69.7|61.1|221|IV Neuroblastoma and other peripheral nervous cell tumors|3618856|2020
<1|53.3|69.7|61.1|221|IV(a) Neuroblastoma and ganglioneuroblastoma|3618856|2020
<1|~|~|~|~|IV(b) Other peripheral nervous cell tumors|3618856|2020
<1|16.3|26.0|20.7|75|IX Soft tissue and other extraosseous sarcomas|3618856|2020
<1|3.6|8.9|5.8|21|IX(a) Rhabdomyosarcomas|3618856|2020
<1|3.8|9.2|6.1|22|IX(b) Fibrosarcomas, peripheral nerve sheath tumors & other fibrous neoplams|3618856|2020
<1|~|~|~|~|IX(c) Kaposi sarcoma|3618856|2020
<1|3.6|8.9|5.8|21|IX(d) Other specified soft tissue sarcomas|3618856|2020
<1|~|~|~|~|IX(e) Unspecified soft tissue sarcomas|3618856|2020
<1|~|~|~|~|Not classified by ICCC|3618856|2020
<1|19.5|30.0|24.3|88|V Retinoblastoma|3618856|2020
<1|10.3|18.2|13.8|50|VI Renal tumors|3618856|2020
<1|10.0|17.9|13.5|49|VI(a) Nephroblastoma and other nonepithelial renal tumors|3618856|2020
<1|~|~|~|~|VI(b) Renal carcinomas|3618856|2020
<1|~|~|~|~|VI(c) Unspecified malignant renal tumors|3618856|2020
<1|9.1|16.6|12.4|45|VII Hepatic tumors|3618856|2020
<1|9.1|16.6|12.4|45|VII(a) Hepatoblastoma|3618856|2020
<1|~|~|~|~|VII(b) Hepatic carcinomas|3618856|2020
<1|~|~|~|~|VII(c) Unspecified malignant hepatic tumors|3618856|2020
<1|~|~|~|~|VIII Malignant bone tumors|3618856|2020
<1|~|~|~|~|VIII(a) Osteosarcomas|3618856|2020
<1|~|~|~|~|VIII(b) Chondrosarcomas|3618856|2020
<1|~|~|~|~|VIII(c) Ewing tumor and related sarcomas of bone|3618856|2020
<1|~|~|~|~|VIII(d) Other specified malignant bone tumors|3618856|2020
<1|~|~|~|~|VIII(e) Unspecified malignant bone tumors|3618856|2020
<1|12.4|21.0|16.3|59|X Germ cell, trophoblastic tumors & neoplasms of gonads|3618856|2020
<1|~|~|~|~|X(a) Intracranial & intraspinal germ cell tumors|3618856|2020
<1|7.7|14.7|10.8|39|X(b) Malignant extracranial & extragonadal germ cell tumors|3618856|2020
<1|~|~|~|~|X(c) Malignant gonadal germ cell tumors|3618856|2020
<1|~|~|~|~|X(d) Gonadal carcinomas|3618856|2020
<1|~|~|~|~|X(e) Other and unspecified malignant gonadal tumors|3618856|2020
<1|3.8|9.2|6.1|22|XI Other malignant epithelial neoplasms and malignant melanomas|3618856|2020
<1|~|~|~|~|XI(a) Adrenocortical carcinomas|3618856|2020
<1|~|~|~|~|XI(b) Thyroid carcinomas|3618856|2020
<1|~|~|~|~|XI(c) Nasopharyngeal carcinomas|3618856|2020
<1|~|~|~|~|XI(d) Malignant melanomas|3618856|2020
<1|~|~|~|~|XI(e) Skin carcinomas|3618856|2020
<1|~|~|~|~|XI(f) Other and unspecified carcinomas|3618856|2020
<1|~|~|~|~|XII Other and unspecified malignant neoplasms|3618856|2020
<1|~|~|~|~|XII(a) Other specified malignant tumors|3618856|2020
<1|~|~|~|~|XII(b) Other unspecified malignant tumors|3618856|2020
